data_6tl0_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6tl0 _Structure_validation_residue.Date_analyzed 2020-10-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.022 0.439 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 152' ' ' LEU . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.652 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' CD2' HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HE2' HD13 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.412 ' CG1' HD11 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.577 ' CG2' HG21 ' A' ' 112' ' ' ILE . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.415 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.758 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.852 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.852 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.577 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.575 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.575 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.532 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.814 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.632 HD13 ' HE2' ' A' ' 30' ' ' LYS . 3.5 mp . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.471 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.654 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.774 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 HD21 HD12 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.423 ' CE1' ' OD2' ' A' ' 55' ' ' ASP . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.461 ' CG2' HG21 ' A' ' 112' ' ' ILE . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.778 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.405 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.778 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.65 HD11 ' HG ' ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.446 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 155' ' ' ILE . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.471 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.469 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 HG23 ' HE1' ' A' ' 153' ' ' MET . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.735 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.684 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.456 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.855 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.774 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 9.5 mt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 HD22 ' A' ' 152' ' ' LEU . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.64 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD22 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.41 ' N ' HD22 ' A' ' 40' ' ' LEU . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.462 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.463 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.628 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.561 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' A' ' 165' ' ' TYR . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.401 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.401 HG23 ' HE1' ' A' ' 153' ' ' MET . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.628 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 163' ' ' TYR . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.795 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.795 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 3.3 mp . . . . . 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 152' ' ' LEU . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.657 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD21 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.538 ' CG2' HG21 ' A' ' 112' ' ' ILE . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.763 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.763 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.856 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.538 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.589 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.589 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.853 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.737 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 10.7 mt . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.549 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 120.48 0.181 . . . . 0.0 111.188 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 152' ' ' LEU . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.644 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.417 HD21 HD21 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.494 ' CG2' HG21 ' A' ' 112' ' ' ILE . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.857 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.494 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.656 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.596 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.541 HD11 ' OH ' ' A' ' 165' ' ' TYR . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HG3' ' A' ' 0' ' ' ARG . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.409 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.634 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 164' ' ' VAL . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 172' ' ' VAL . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 165' ' ' TYR . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.852 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 2.5 mp . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.655 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 4' ' ' LEU . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.427 ' CG2' HD22 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.797 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.797 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.861 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.861 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.423 ' CD1' ' HB ' ' A' ' 130' ' ' ILE . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.595 HD12 ' HG2' ' B' ' 713' ' ' PRO . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.41 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.41 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.699 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.451 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.835 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.835 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 4.3 mp . . . . . 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.468 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.864 0.364 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 152' ' ' LEU . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.665 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.795 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD13 ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HE2' ' CD2' ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' HD22 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.415 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 130' ' ' ILE . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.691 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.443 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 155' ' ' ILE . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.443 HG23 ' HE1' ' A' ' 153' ' ' MET . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.581 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.691 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.793 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.795 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.5 mt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.077 0.465 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 152' ' ' LEU . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.65 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' HD12 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.512 ' CG2' HG21 ' A' ' 112' ' ' ILE . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.766 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.766 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.512 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.612 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.652 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.612 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG23 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.416 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.816 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.594 HD11 ' HE2' ' A' ' 30' ' ' LYS . 4.1 mp . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 HD22 ' A' ' 152' ' ' LEU . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.664 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.634 ' HE2' HD11 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 112' ' ' ILE . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.864 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.864 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.577 HD13 ' OH ' ' A' ' 165' ' ' TYR . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.437 ' HE1' HG23 ' A' ' 162' ' ' THR . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.437 HG23 ' HE1' ' A' ' 153' ' ' MET . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.668 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.586 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.815 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.634 HD11 ' HE2' ' A' ' 30' ' ' LYS . 3.5 mp . . . . . 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.483 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.995 0.426 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 152' ' ' LEU . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.632 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.459 ' CE ' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' HD22 ' B' ' 714' ' ' LEU . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.541 ' CG2' HG21 ' A' ' 112' ' ' ILE . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.781 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.781 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.626 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.569 HD22 HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.409 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' HE1' ' A' ' 153' ' ' MET . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 163' ' ' TYR . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.456 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.89 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.89 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 6.5 mt . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 152' ' ' LEU . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.63 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.793 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD21 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.402 ' HD2' ' CG2' ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.506 ' CG2' HG21 ' A' ' 112' ' ' ILE . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.791 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.506 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.583 HD13 ' HG ' ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.424 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.424 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.713 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.601 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.645 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.469 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.824 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.824 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.793 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 9.0 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 152' ' ' LEU . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.641 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 170' ' ' ASP . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.776 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD21 HD11 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE2' HD21 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.791 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.791 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.463 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.634 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.42 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 153' ' ' MET . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.572 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.634 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.402 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.476 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.817 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.776 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.655 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.57 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE2' HD13 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.464 ' CG2' HG21 ' A' ' 112' ' ' ILE . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.464 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.487 HD13 ' OH ' ' A' ' 165' ' ' TYR . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.448 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.411 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.448 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.61 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.871 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 10.4 mp . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.475 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 152' ' ' LEU . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.652 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' CD2' HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HE2' ' CD1' ' B' ' 714' ' ' LEU . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.51 ' CG2' HG21 ' A' ' 112' ' ' ILE . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.77 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.77 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.462 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.51 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.587 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 165' ' ' TYR . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.412 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 155' ' ' ILE . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.475 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.412 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.564 ' OH ' HD11 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.587 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.8 mttm . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.779 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.779 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 1.6 mp . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 152' ' ' LEU . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD21 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' CG2' HD22 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.786 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.424 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.786 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.425 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.571 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.595 HD11 ' HG ' ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.426 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 153' ' ' MET . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.48 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.48 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.84 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.84 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.838 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.642 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.57 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.57 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' HD11 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.478 ' CG2' HG21 ' A' ' 112' ' ' ILE . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.594 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.522 HD11 ' OH ' ' A' ' 165' ' ' TYR . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 164' ' ' VAL . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.594 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.44 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.815 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 2.2 mp . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.09 0.471 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.54 HD23 ' HB3' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 152' ' ' LEU . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.637 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' CD2' HD21 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.501 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.789 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.789 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.501 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.65 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.53 HD11 ' OH ' ' A' ' 165' ' ' TYR . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 164' ' ' VAL . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.65 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 163' ' ' TYR . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.853 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 3.9 mp . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' B' ' 713' ' ' PRO . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 152' ' ' LEU . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.4 m80 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD21 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 112' ' ' ILE . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.42 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.574 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CD2' HD12 ' A' ' 4' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.427 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.427 HG23 ' HE1' ' A' ' 153' ' ' MET . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.674 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.86 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.86 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.0 mt . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.391 0.615 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 152' ' ' LEU . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.663 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HE2' ' CD2' ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' CG2' HD22 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.423 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.453 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.706 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.419 ' HE1' HG23 ' A' ' 162' ' ' THR . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.419 HG23 ' HE1' ' A' ' 153' ' ' MET . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.806 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.579 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.706 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.408 HG13 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.838 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.491 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 152' ' ' LEU . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.666 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 112' ' ' ILE . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.412 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.457 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.571 HD11 ' HG ' ' B' ' 714' ' ' LEU . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.491 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 153' ' ' MET . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.609 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.762 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.445 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.406 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.4 mttm . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.833 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.78 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.989 0.423 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 HD22 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.645 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.664 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.478 ' CG2' HG21 ' A' ' 112' ' ' ILE . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.404 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.587 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.716 HD12 ' HG ' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.409 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' HE1' ' A' ' 153' ' ' MET . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.587 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.655 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.824 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.824 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 152' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.443 HD12 HD22 ' A' ' 152' ' ' LEU . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.626 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.667 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD21 HD11 ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.509 ' CG2' HG21 ' A' ' 112' ' ' ILE . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.853 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.569 ' CD2' ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' HD2' ' A' ' 0' ' ' ARG . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' C ' ' HG3' ' A' ' 0' ' ' ARG . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.424 ' HA ' ' HG3' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.752 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.7 mttm . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.6 mt . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.707 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 152' ' ' LEU . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.662 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HE2' HD22 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.446 ' CG2' HD22 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.862 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.446 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.707 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.648 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.578 ' CD2' ' HE1' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 153' ' ' MET . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.742 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.707 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.814 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.0 mt . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.401 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 31.3 ptt180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.191 0.52 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 152' ' ' LEU . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.626 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD21 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HE2' HD13 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.489 ' CG2' HG21 ' A' ' 112' ' ' ILE . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.795 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' N ' HD22 ' A' ' 40' ' ' LEU . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.795 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.489 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.63 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.532 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' B' ' 713' ' ' PRO . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.416 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 179' ' ' TYR . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.416 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.532 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.63 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 46.9 mttm . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.793 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.793 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 5.5 mp . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 0' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 152' ' ' LEU . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.66 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 HD12 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' CG2' HD22 ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.863 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 165' ' ' TYR . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.453 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 179' ' ' TYR . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.453 HG23 ' HE1' ' A' ' 153' ' ' MET . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 712' ' ' HIS . . . . . 0.882 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 713' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 714' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.5 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.0 p -117.71 157.84 46.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -1.099 . . . . 0.0 110.244 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.96 136.57 32.8 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.768 1.404 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.99 -38.53 91.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.878 . . . . 0.0 110.358 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . 0.443 ' CD2' ' N ' ' A' ' -4' ' ' GLY . 30.2 t80 -137.2 161.59 35.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.047 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' -5' ' ' PHE . . . -66.82 -69.96 1.24 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' -5' ' ' PHE . 63.9 p -122.72 163.16 20.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -115.77 133.38 56.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 0.0 110.417 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -117.32 18.06 14.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 -54.84 140.25 37.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.891 . . . . 0.0 110.916 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 152' ' ' LEU . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.652 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' CD2' HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HE2' HD13 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.412 ' CG1' HD11 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.577 ' CG2' HG21 ' A' ' 112' ' ' ILE . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.758 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.415 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.758 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.852 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.852 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.577 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.575 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.575 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.532 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm -50.61 -34.34 25.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.48 148.19 66.36 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.789 1.415 . . . . 0.0 110.532 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.72 -35.84 77.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 0.0 110.28 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -96.57 119.58 6.37 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 88.3 p -62.24 -25.87 68.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -1.108 . . . . 0.0 110.334 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 76.4 p -65.33 133.13 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.3 -32.92 72.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -0.806 . . . . 0.0 110.75 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -98.48 136.81 38.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.711 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -169.85 28.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.1 mt -100.52 125.58 46.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.165 -0.959 . . . . 0.0 110.347 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.74 -38.48 73.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -132.51 123.8 27.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.33 -0.856 . . . . 0.0 110.24 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.15 83.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.418 -0.802 . . . . 0.0 110.726 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -127.92 149.31 50.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 110.87 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -100.58 170.26 8.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.0 110.22 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 43.0 p -117.6 161.59 19.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.9 152.64 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 84.7 p -148.24 157.21 43.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -76.06 -58.46 3.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -153.89 152.4 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.39 74.61 80.82 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.17 144.42 51.78 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.784 1.412 . . . . 0.0 110.544 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.6 149.19 30.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -109.61 132.6 53.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 111.646 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.0 m -90.17 -46.29 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.294 1.045 . . . . 0.0 108.44 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.814 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -159.77 -178.74 0.94 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.632 HD13 ' HE2' ' A' ' 30' ' ' LYS . 3.5 mp 68.72 37.57 2.41 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.598 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.73 77.9 1.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.539 -1.35 . . . . 0.0 108.54 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.409 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 17.6 mp0 -81.6 16.85 1.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.968 0.89 . . . . 0.0 109.796 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.621 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.9 p -45.69 171.56 0.05 OUTLIER Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.394 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.05 -54.99 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.34 1.705 . . . . 0.0 108.767 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 18.9 mttp -160.9 -14.08 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.727 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.7 m 56.98 26.8 12.3 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -70.63 151.2 95.45 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.4 -8.06 22.72 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.886 1.466 . . . . 0.0 111.243 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.71 114.85 2.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.087 -1.008 . . . . 0.0 110.3 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -146.51 -174.06 4.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 0.0 109.843 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.85 -37.67 69.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.198 -0.939 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -58.94 -35.25 72.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.839 . . . . 0.0 110.208 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.32 131.16 35.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -99.66 137.94 37.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -99.33 146.6 26.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 63.3 t -63.51 129.62 93.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.979 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.36 148.47 61.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.674 1.355 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -159.84 41.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.87 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.4 t -117.39 140.16 49.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.321 -0.862 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -79.3 -61.54 2.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.1 tp -99.84 133.17 44.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.422 -1.046 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -162.35 -168.45 24.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.82 -29.01 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -1.084 . . . . 0.0 110.411 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -54.9 -30.83 59.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.378 -0.826 . . . . 0.0 110.355 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.75 135.33 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 110.317 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.6 p -120.95 161.48 21.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 109.941 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.7 p -118.92 148.95 42.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.521 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -125.91 147.53 49.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.999 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.56 114.03 19.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.69 97.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 91.2 p -63.7 -36.18 83.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -63.75 -34.91 78.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.317 -0.864 . . . . 0.0 110.17 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.5 t90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.277 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.98 74.49 66.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.356 -1.085 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.13 60.16 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.714 1.376 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -112.09 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.387 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.23 133.46 51.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -136.95 170.96 23.26 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 50.8 m -89.81 132.56 35.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -1.154 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -121.54 20.57 11.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.737 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -53.49 -36.16 61.39 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.198 -0.939 . . . . 0.0 110.125 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.471 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 -119.49 149.64 41.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 109.037 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.654 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.774 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 HD21 HD12 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.423 ' CE1' ' OD2' ' A' ' 55' ' ' ASP . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.461 ' CG2' HG21 ' A' ' 112' ' ' ILE . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.778 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.405 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.778 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.65 HD11 ' HG ' ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.446 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 155' ' ' ILE . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.471 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.469 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 HG23 ' HE1' ' A' ' 153' ' ' MET . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.735 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.684 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.456 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.15 -34.47 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.549 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.22 -27.61 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.735 1.387 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.57 143.14 31.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.818 . . . . 0.0 109.926 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.69 -176.4 51.42 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 44.3 m -63.16 152.41 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -1.084 . . . . 0.0 110.284 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 44.6 m -59.09 -38.4 79.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 110.28 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.85 152.65 30.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.87 129.34 55.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -65.22 -35.84 82.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.375 -0.828 . . . . 0.0 110.5 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.36 -34.76 72.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.385 -0.822 . . . . 0.0 110.959 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -109.11 151.5 26.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.971 . . . . 0.0 110.587 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -141.72 173.06 11.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 110.041 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -98.91 134.89 41.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -105.11 139.25 40.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 109.652 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -104.61 165.42 11.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 68.8 p -109.12 -146.69 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.71 145.32 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.982 -1.074 . . . . 0.0 110.383 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 28.5 m -59.48 -28.36 66.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.18 47.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 0.0 110.691 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.65 146.04 37.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.34 162.5 31.86 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.351 -0.843 . . . . 0.0 110.406 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.95 152.59 68.39 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.907 1.477 . . . . 0.0 110.51 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -104.2 153.85 20.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 0.0 110.469 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -97.31 134.63 40.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.78 . . . . 0.0 111.425 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 46.8 m -76.45 -38.08 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.994 0.902 . . . . 0.0 108.921 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.855 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 -171.05 -177.08 0.41 Allowed Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.774 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 9.5 mt 70.2 39.47 1.31 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.565 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -131.45 77.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.371 -1.456 . . . . 0.0 108.392 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -80.74 18.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.004 0.907 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.599 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -49.21 170.81 0.13 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.275 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -73.15 -54.04 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.367 1.72 . . . . 0.0 108.919 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 32.4 mttt -161.17 -14.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.873 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.7 m 57.35 27.4 13.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -118.59 151.33 49.66 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.95 131.46 18.26 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.663 1.349 . . . . 0.0 110.485 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -156.67 146.88 21.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 110.186 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -131.68 156.42 45.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.394 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -59.55 -35.18 73.74 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.372 -0.83 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -77.26 157.57 30.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.513 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 7.8 tt -84.71 131.02 34.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 109.805 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -143.65 158.88 43.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -91.12 146.75 23.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 109.98 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.31 155.7 46.62 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 150.44 58.6 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.836 1.44 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.97 147.86 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.822 . . . . 0.0 109.974 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.9 p -64.82 161.68 17.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . 0.444 ' HA2' ' ND2' ' B' ' 738' ' ' ASN . . . 124.63 38.71 0.5 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.7 tp -100.22 133.47 44.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -1.063 . . . . 0.0 109.96 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.84 -105.08 2.16 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -128.24 139.12 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -1.152 . . . . 0.0 110.402 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . 0.444 ' ND2' ' HA2' ' B' ' 734' ' ' GLY . 11.8 p-10 -171.51 -152.47 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.66 138.27 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 109.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 14.9 t -128.42 161.95 28.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 29.5 t -75.58 133.88 40.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.67 -36.28 83.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.399 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -153.14 160.08 42.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -135.2 16.67 4.13 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.8 t -139.06 139.51 37.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.164 -1.198 . . . . 0.0 110.427 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 43.9 m -129.23 149.2 51.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.357 -0.84 . . . . 0.0 110.337 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.209 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 12.3 p -112.52 149.23 40.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.32 -1.106 . . . . 0.0 110.34 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -70.8 -17.97 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.868 1.457 . . . . 0.0 110.502 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -101.41 151.83 21.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.49 155.41 40.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -70.35 176.47 34.58 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 43.7 m -116.91 126.73 53.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -1.198 . . . . 0.0 110.546 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . 0.434 ' HB3' ' OE1' ' A' ' 156' ' ' GLN . 97.8 mtt180 -144.78 151.84 39.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 156' ' ' GLN . 58.1 t0 -86.6 115.98 24.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.188 -0.945 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -135.42 155.56 50.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.861 . . . . 0.0 109.845 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 HD22 ' A' ' 152' ' ' LEU . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.64 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD22 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HE2' HD11 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' N ' HD22 ' A' ' 40' ' ' LEU . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.462 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.463 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.628 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.561 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' A' ' 165' ' ' TYR . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.401 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' -2' ' ' ARG . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.401 HG23 ' HE1' ' A' ' 153' ' ' MET . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.602 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.561 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.628 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 163' ' ' TYR . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.21 144.56 7.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.336 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.12 -17.18 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.81 1.426 . . . . 0.0 110.691 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.1 145.29 27.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -83.24 179.38 52.74 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.9 m -76.82 158.36 30.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.539 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 5.1 m -98.79 157.19 16.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.777 . . . . 0.0 109.735 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.16 147.15 7.92 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.905 . . . . 0.0 110.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.96 -37.22 73.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -109.09 105.61 15.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.999 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.32 -38.46 91.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.28 -0.888 . . . . 0.0 110.519 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.08 148.63 28.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.806 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -52.89 -36.34 59.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.0 110.451 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -89.77 137.53 32.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.08 -32.35 73.7 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.35 -174.66 3.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.952 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 52.1 p -119.74 151.81 38.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.9 143.7 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.131 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 4.9 m -131.37 49.77 2.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.53 45.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.12 73.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.12 72.16 70.6 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 169.22 22.51 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.743 1.391 . . . . 0.0 110.177 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.74 146.88 15.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -107.67 134.39 50.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 111.83 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.4 m -79.4 -47.67 15.32 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.231 1.015 . . . . 0.0 108.666 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.795 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER -155.54 -178.93 0.97 Allowed Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.795 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 3.3 mp 71.88 41.69 0.66 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.562 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -134.23 79.38 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.352 -1.467 . . . . 0.0 108.479 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.66 16.83 1.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.597 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.2 p -47.54 170.51 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.324 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.597 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.19 -54.26 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.403 1.739 . . . . 0.0 108.904 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 18.5 mttp -161.7 -13.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.859 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.3 m 56.92 27.64 13.4 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -123.95 161.4 47.04 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.033 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -77.06 -65.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -165.4 141.6 5.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -115.43 137.01 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.37 142.27 27.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -65.21 156.92 30.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.97 129.89 36.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -174.69 135.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.428 -0.795 . . . . 0.0 109.943 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -93.69 -68.14 0.82 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 110.148 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 9.2 p -147.51 122.39 5.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.53 144.71 56.17 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.523 1.275 . . . . 0.0 110.65 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -171.05 94.03 0.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 29.7 t -124.25 143.53 50.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 0.0 110.389 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -154.6 123.51 1.38 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.9 -39.65 82.13 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -1.075 . . . . 0.0 110.28 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.49 -29.62 69.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.3 129.53 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.303 -1.116 . . . . 0.0 110.541 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -125.17 19.7 8.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.71 142.61 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.295 -0.878 . . . . 0.0 110.103 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 57.1 p -68.45 157.76 35.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.372 -0.83 . . . . 0.0 110.02 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 741' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 83.9 p -141.01 167.41 22.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.445 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' B' ' 741' ' ' SER . 92.2 mt-30 57.82 43.78 21.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.442 -0.786 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -123.23 119.65 30.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.174 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 91.77 4.7 67.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 49.1 m -121.97 148.05 45.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -1.228 . . . . 0.0 110.184 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 93.9 p -134.0 158.35 43.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.279 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.118 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 6.4 m 53.5 64.48 6.78 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.333 -1.098 . . . . 0.0 110.4 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 144.14 49.87 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.782 1.412 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.28 -27.98 67.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.211 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.3 148.94 25.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.412 -0.805 . . . . 0.0 110.361 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 118.57 114.79 2.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 61.9 m -120.39 135.93 54.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 110.718 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.78 123.96 48.42 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' -1' ' ' ASP . 53.5 p30 -116.64 148.0 41.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 -113.2 121.71 45.3 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.417 HD12 HD23 ' A' ' 152' ' ' LEU . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.657 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.737 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD21 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.538 ' CG2' HG21 ' A' ' 112' ' ' ILE . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.763 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.763 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.856 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.538 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.578 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.589 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.601 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.589 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.583 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -50.48 -34.58 25.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.338 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.33 -23.5 38.37 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.728 1.383 . . . . 0.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.1 -37.42 74.5 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -56.75 -25.46 51.74 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 23.7 m -55.13 -34.23 63.56 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -1.058 . . . . 0.0 110.709 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 64.4 p -82.98 156.84 23.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -121.04 153.63 37.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.388 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.12 143.17 57.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.362 -0.836 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.36 167.69 21.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.0 110.158 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 82.0 mt -71.17 147.8 47.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.843 . . . . 0.0 110.098 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.16 140.26 53.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.274 -0.891 . . . . 0.0 110.409 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -92.48 5.08 52.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.433 -0.792 . . . . 0.0 110.805 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.02 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.108 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.94 42.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.843 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -78.39 94.03 4.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.297 -0.877 . . . . 0.0 110.348 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.6 m -122.24 149.16 44.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.117 -0.989 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.6 m -54.96 152.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.456 -0.778 . . . . 0.0 110.212 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 21.7 m -54.95 -39.53 69.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 110.747 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . 178.61 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.149 -0.97 . . . . 0.0 111.122 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.67 150.32 13.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.069 . . . . 0.0 110.457 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . 0.429 ' N ' ' CD ' ' B' ' 708' ' ' PRO . 4.0 p30 -130.38 53.84 12.89 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 707' ' ' ASP . 48.7 Cg_endo -74.24 141.84 29.61 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.629 1.331 . . . . 0.0 110.364 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 144.17 56.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 109.83 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -122.5 136.11 54.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 111.368 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 34.9 m -92.79 -44.03 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.853 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -161.9 -177.88 0.77 Allowed Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.737 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 10.7 mt 70.07 43.54 0.88 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -129.95 79.01 1.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.256 -1.528 . . . . 0.0 109.643 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -84.14 19.35 1.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.106 0.955 . . . . 0.0 108.94 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.578 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.6 p -42.73 169.34 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.921 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.89 -55.62 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.564 1.823 . . . . 0.0 108.955 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 46.3 mttt -159.38 -14.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.624 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 18.9 m 56.57 26.99 11.7 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -79.09 158.92 74.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.277 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.18 138.95 40.96 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.769 1.405 . . . . 0.0 110.795 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -85.41 1.4 48.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -57.84 -34.09 69.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -85.56 140.71 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -123.61 145.85 48.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 86.7 mt -61.35 -36.1 79.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.81 148.0 29.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.411 -0.806 . . . . 0.0 110.193 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -85.88 144.7 27.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.38 131.42 94.95 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.996 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.31 140.87 41.59 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.708 1.372 . . . . 0.0 110.584 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -150.97 153.75 35.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.401 -0.812 . . . . 0.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 20.1 m -59.22 -39.24 82.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 52.27 -137.84 32.88 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.14 -32.17 73.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.452 -1.028 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.45 55.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.42 20.43 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -1.168 . . . . 0.0 110.465 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -73.88 157.17 36.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.887 . . . . 0.0 110.388 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.5 161.01 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 62.7 m -78.65 135.21 37.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.0 110.542 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -85.56 167.5 15.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.75 . . . . 0.0 110.017 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -85.03 107.8 17.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -94.75 122.42 37.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.297 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 141.74 64.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 22.7 t -58.42 -34.29 70.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -1.084 . . . . 0.0 110.268 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.5 t -117.94 138.76 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.114 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.1 m -125.61 74.82 69.85 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.307 -1.113 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 152.62 73.34 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.779 1.41 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.47 144.83 25.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.49 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.98 168.66 19.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 88.25 39.47 6.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 80.9 p -109.71 -167.52 1.21 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -1.043 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -50.24 141.91 10.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -168.25 178.36 4.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.082 . . . . 0.0 111.649 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.549 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 -45.93 139.48 4.28 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.188 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD12 HD22 ' A' ' 152' ' ' LEU . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.644 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD21 HD21 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.494 ' CG2' HG21 ' A' ' 112' ' ' ILE . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.857 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.494 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.656 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.596 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.541 HD11 ' OH ' ' A' ' 165' ' ' TYR . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HG3' ' A' ' 0' ' ' ARG . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.409 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.634 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 164' ' ' VAL . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.656 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 172' ' ' VAL . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 165' ' ' TYR . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -50.55 -34.33 25.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.138 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.43 -17.69 43.9 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.843 1.444 . . . . 0.0 110.725 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.6 tp -55.96 -37.9 69.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 110.438 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 130.29 172.82 13.22 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.9 m -122.32 150.29 42.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.386 -1.067 . . . . 0.0 110.321 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 56.6 p -116.38 167.12 11.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.364 -0.835 . . . . 0.0 109.902 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.43 -36.13 75.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.9 135.08 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 110.22 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -105.01 145.1 30.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 110.293 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -102.44 139.12 38.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.232 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.72 -33.94 76.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -85.35 121.92 28.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -132.28 156.62 46.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -93.3 146.45 23.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.812 . . . . 0.0 110.037 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' B' ' 701' ' ' ASP . 31.4 p-10 -61.19 132.96 55.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 110.387 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.8 m -61.07 -34.61 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 48.5 t -102.81 133.42 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 110.423 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 24.1 t -59.88 -29.97 68.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -56.46 144.52 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.426 -0.797 . . . . 0.0 110.445 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.05 -130.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.468 -0.77 . . . . 0.0 109.745 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 140.46 85.76 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.2 119.91 6.62 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.624 1.328 . . . . 0.0 110.872 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -132.87 148.01 52.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.866 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.44 141.14 51.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 111.489 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.68 -40.09 12.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.115 0.96 . . . . 0.0 108.627 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.852 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 -166.45 -175.44 0.43 Allowed Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.852 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 2.5 mp 67.1 44.15 1.98 Allowed 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.579 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.26 78.74 1.75 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.196 -1.565 . . . . 0.0 109.187 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.34 17.76 2.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.181 0.991 . . . . 0.0 109.401 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.628 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 26.5 p -44.33 172.41 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.914 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.8 Cg_endo -73.06 -55.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.406 1.74 . . . . 0.0 108.844 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 41.4 mtmt -159.74 -13.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.3 m 58.19 27.72 15.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.72 142.9 25.28 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.19 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.11 149.53 64.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.635 1.334 . . . . 0.0 110.335 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.25 58.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.095 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -134.24 161.83 33.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -79.05 147.65 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 109.916 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 63.9 mtp85 -60.76 142.56 55.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.276 -0.89 . . . . 0.0 110.735 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 50.3 tp -112.68 130.66 55.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.164 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.2 136.39 35.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -96.28 141.13 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.74 69.71 71.78 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.441 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.52 145.8 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.702 1.369 . . . . 0.0 110.471 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -143.33 148.6 36.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.9 m 49.67 21.08 0.59 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.28 24.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.2 tp -58.19 -38.46 76.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.5 -1.0 . . . . 0.0 110.582 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 142.91 -167.67 26.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.44 129.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -1.137 . . . . 0.0 110.167 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -172.33 164.85 5.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 50.5 t -120.64 130.5 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.4 m -65.14 -36.87 85.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.367 -0.833 . . . . 0.0 110.47 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 33.0 t -85.39 151.13 24.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.435 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -94.7 115.26 27.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.27 136.58 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -86.53 -178.23 49.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.2 t -59.28 -35.83 74.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.336 -1.096 . . . . 0.0 110.138 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.9 m -121.79 148.07 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.063 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 64.3 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.208 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 60.6 p -123.01 161.2 45.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.407 -1.055 . . . . 0.0 110.227 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 145.16 59.19 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.77 1.405 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.07 144.5 55.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.8 . . . . 0.0 110.309 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.28 130.24 52.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.37 -0.831 . . . . 0.0 110.174 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -91.66 -178.05 42.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 39.2 m -60.93 -30.54 70.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.549 -0.971 . . . . 0.0 110.228 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -49.51 -23.75 1.74 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.41 -36.7 6.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.327 -0.858 . . . . 0.0 111.158 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 -65.02 142.93 58.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 0.0 109.577 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.655 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 4' ' ' LEU . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' CG2' HD22 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.797 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.797 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.861 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.861 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.423 ' CD1' ' HB ' ' A' ' 130' ' ' ILE . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.699 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.59 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.595 HD12 ' HG2' ' B' ' 713' ' ' PRO . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.41 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.41 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.699 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.472 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.451 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm -49.99 144.46 6.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.27 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.99 146.93 66.61 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.729 1.384 . . . . 0.0 110.528 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.6 tp -98.95 129.19 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.355 -0.841 . . . . 0.0 110.264 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.36 47.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 26.3 m -61.59 -29.48 70.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.456 -1.026 . . . . 0.0 110.505 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 50.1 p -71.31 162.35 29.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 0.0 110.378 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.23 154.15 17.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.24 147.53 35.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.479 -0.763 . . . . 0.0 110.449 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.59 159.85 4.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.433 -0.792 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 22.6 tp -80.27 128.79 33.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.286 -0.884 . . . . 0.0 110.291 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -117.75 161.91 18.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.487 -0.758 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -88.13 10.78 18.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -0.817 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . 63.88 13.26 7.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.289 -0.882 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.03 145.9 50.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 110.11 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' B' ' 701' ' ' ASP . 28.9 p-10 -109.69 123.02 48.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 50.9 m -124.34 135.65 53.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.236 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 12.0 p -134.19 136.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 71.4 m -91.82 4.49 52.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -101.62 138.97 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 0.0 110.555 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -102.59 8.87 39.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.82 . . . . 0.0 110.421 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -126.94 80.37 71.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 149.16 72.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.754 1.397 . . . . 0.0 110.709 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -88.8 149.1 23.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.434 -0.791 . . . . 0.0 109.874 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -113.17 137.4 51.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 0.0 111.986 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 72.2 m -102.55 -55.43 2.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.835 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -144.53 -177.97 0.73 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.835 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 4.3 mp 72.1 39.72 0.77 Allowed 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.568 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -133.24 78.62 1.79 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.424 -1.423 . . . . 0.0 108.876 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -83.84 17.79 2.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.123 0.963 . . . . 0.0 109.548 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.653 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.22 172.24 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.643 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.16 -55.25 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.495 1.787 . . . . 0.0 109.067 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.3 mttm -160.54 -13.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.885 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.5 m 56.92 26.84 12.22 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.6 49.57 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.628 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.38 163.34 39.42 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.742 1.391 . . . . 0.0 110.553 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -68.81 114.56 7.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -65.25 -33.88 77.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.423 -0.798 . . . . 0.0 111.014 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -91.56 150.5 21.16 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.907 . . . . 0.0 111.243 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -119.28 168.98 10.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 31.1 tp -81.15 120.5 24.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.13 58.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.408 -0.808 . . . . 0.0 111.129 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -72.87 140.8 47.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.121 -0.987 . . . . 0.0 110.572 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.9 m -122.42 162.57 37.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.994 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 42.4 Cg_endo -68.44 143.2 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.72 1.379 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -111.01 160.06 17.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.4 t -100.24 141.22 33.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.05 127.13 0.95 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.4 mt -97.39 144.79 26.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.301 -1.117 . . . . 0.0 110.23 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -153.82 -170.16 19.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.63 165.42 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.088 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -56.68 120.93 8.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 110.202 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 84.6 t -67.3 -44.99 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.459 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 12.5 t -141.17 152.78 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.622 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 178.22 4.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.826 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.72 153.8 35.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -52.56 -41.08 63.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 50.55 -136.33 27.62 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 79.4 p -151.06 167.47 27.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -1.018 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 29.4 t -78.69 144.5 35.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -0.864 . . . . 0.0 109.974 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.292 -179.873 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 15.4 p -124.31 158.45 61.16 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.357 -1.084 . . . . 0.0 110.237 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.44 -13.77 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.924 1.487 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.43 141.98 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.0 110.333 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.66 129.38 45.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 159.68 -113.44 0.57 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 44.4 m -57.16 -35.88 70.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -1.061 . . . . 0.0 109.937 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -114.52 139.67 49.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.463 -0.773 . . . . 0.0 109.756 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -157.73 178.92 9.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.0 110.639 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.468 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 -59.3 145.53 42.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.793 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 152' ' ' LEU . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.665 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.795 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD13 ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HE2' ' CD2' ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' CG2' HD22 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.415 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 130' ' ' ILE . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.691 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.443 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 155' ' ' ILE . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.443 HG23 ' HE1' ' A' ' 153' ' ' MET . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.843 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.581 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.691 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.02 -34.37 21.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.161 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.47 -25.46 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.867 1.457 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.8 tp -104.29 129.3 52.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -148.64 25.37 1.34 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.5 t -125.37 145.25 50.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.366 -1.079 . . . . 0.0 110.22 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.1 m -78.61 136.11 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.936 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -112.72 151.95 29.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.593 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.25 -25.12 68.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.477 -0.764 . . . . 0.0 110.141 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -50.94 -32.92 22.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.63 134.01 40.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -143.06 -39.72 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.31 145.52 55.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -99.37 162.04 13.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 110.112 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.27 -30.11 66.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -71.15 169.75 14.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 110.293 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 5.7 m -127.92 50.27 2.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.56 -39.52 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 31.8 t -118.54 141.71 48.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -71.71 153.61 41.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 110.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.94 146.13 39.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -66.93 148.66 98.8 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.439 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.66 144.08 53.39 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.771 1.406 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.93 156.62 30.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.754 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.12 150.92 47.03 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.545 0.688 . . . . 0.0 111.559 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 56.2 m -64.66 -38.35 90.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 -175.02 179.74 0.44 Allowed Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.793 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.795 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.5 mt 68.67 46.49 0.95 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.566 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -139.15 78.53 1.68 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.217 -1.552 . . . . 0.0 108.845 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -82.26 17.41 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.167 0.984 . . . . 0.0 109.808 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.677 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 28.5 p -47.62 173.58 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.269 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.73 -54.49 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.359 1.715 . . . . 0.0 108.884 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 81.5 mttt -161.88 -13.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.928 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.0 m 58.22 26.9 14.4 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -103.87 125.68 33.92 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.283 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.75 145.51 51.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.683 1.36 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -166.48 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.0 110.271 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -98.42 157.84 15.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -115.79 147.56 40.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.301 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 80.0 mt -90.57 53.38 2.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.72 -21.75 66.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -59.51 138.63 57.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.366 -0.833 . . . . 0.0 110.226 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.12 113.31 53.05 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.449 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.13 -19.47 29.7 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.556 1.292 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -99.98 149.77 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.417 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.3 m -117.64 150.13 39.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.169 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -63.9 148.76 50.8 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.46 128.67 52.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -1.083 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 52.92 89.25 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.98 -34.24 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -1.062 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -107.48 149.11 28.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 110.246 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.8 137.45 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.363 -0.836 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 42.1 m -115.65 134.81 54.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 20.7 m -61.03 -35.47 76.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.816 . . . . 0.0 110.506 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.67 3.63 32.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.866 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.79 46.76 25.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.163 -0.961 . . . . 0.0 110.256 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -54.17 -26.0 34.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 34.1 m -57.04 154.2 10.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -1.093 . . . . 0.0 110.386 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 44.6 m -118.35 148.85 42.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.224 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.17 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 94.0 p -120.35 160.56 43.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.357 -1.084 . . . . 0.0 109.911 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.76 -28.85 29.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.761 1.401 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -138.21 112.39 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.173 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -61.88 -40.5 95.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.9 0.56 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 69.4 p -68.58 -9.83 52.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -1.058 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -53.69 147.02 12.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -127.22 143.35 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.404 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 -69.67 147.28 50.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -0.805 . . . . 0.0 110.606 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 152' ' ' LEU . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.65 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' HD12 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.512 ' CG2' HG21 ' A' ' 112' ' ' ILE . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.766 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.766 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.512 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.612 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.652 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.612 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG23 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.416 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -50.28 141.04 12.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.499 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.55 139.87 42.03 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.744 1.392 . . . . 0.0 110.579 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.97 131.75 52.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 0.0 110.046 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.82 -86.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.0 m -123.0 147.77 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.407 -1.055 . . . . 0.0 110.341 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 62.6 p -71.23 -16.36 62.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.435 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.21 -31.74 70.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.448 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.23 -25.53 67.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.872 . . . . 0.0 110.209 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.62 -33.98 68.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.351 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.6 mt -77.77 148.11 34.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.851 . . . . 0.0 110.186 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.76 153.81 21.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.363 -0.835 . . . . 0.0 110.377 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -148.17 175.26 11.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -63.08 147.0 52.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.84 151.86 27.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -110.05 172.16 7.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 110.38 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 48.4 p -80.58 162.3 24.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.336 -0.853 . . . . 0.0 110.029 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.71 132.31 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.412 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 91.2 p -137.92 155.92 48.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.816 . . . . 0.0 109.91 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -95.59 -66.7 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.504 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.61 59.74 47.91 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.604 -0.685 . . . . 0.0 109.586 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.6 62.86 5.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.843 1.444 . . . . 0.0 110.361 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.08 148.19 33.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -104.65 136.66 43.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 111.629 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 43.7 m -67.4 -36.36 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.816 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -176.7 -178.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.594 HD11 ' HE2' ' A' ' 30' ' ' LYS . 4.1 mp 66.78 41.42 2.89 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.566 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.36 75.41 1.53 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.337 -1.477 . . . . 0.0 108.955 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.422 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 24.5 mp0 -82.59 18.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.221 1.01 . . . . 0.0 109.029 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.5 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.6 p -44.51 167.31 0.1 Allowed Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.011 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -74.09 -54.18 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.593 1.839 . . . . 0.0 108.702 176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 53.2 mttp -158.55 -12.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.475 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.3 m 61.6 28.58 17.75 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -89.38 171.73 8.43 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.65 130.7 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.595 1.313 . . . . 0.0 110.364 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.75 41.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -91.03 136.75 32.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.118 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.84 151.17 25.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -115.67 153.47 31.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.452 -0.78 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.8 tp -93.36 133.39 36.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 110.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.59 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.28 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -80.12 148.3 31.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 113.39 11.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.24 -23.1 28.99 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.647 1.341 . . . . 0.0 110.631 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -102.53 151.95 21.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.4 p -65.69 162.57 18.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 110.277 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.65 -171.63 29.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 9.3 tt -95.69 129.15 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -1.09 . . . . 0.0 110.247 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 145.13 164.29 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.3 t -121.8 136.86 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.01 112.63 25.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.155 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.78 131.96 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 8.5 m -107.26 -10.91 15.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 110.549 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -86.67 158.91 19.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.428 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -108.63 137.89 45.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.698 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -89.63 15.0 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.276 -0.89 . . . . 0.0 111.034 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -79.19 -177.12 49.55 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.4 t -112.82 147.5 36.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -1.055 . . . . 0.0 110.24 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -33.76 67.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.447 -0.783 . . . . 0.0 110.371 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.11 179.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.0 p -127.94 70.57 78.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.57 -24.74 30.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.721 1.38 . . . . 0.0 110.275 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 148.53 41.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 0.0 110.379 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.11 135.09 35.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 142.73 58.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.7 t -131.47 162.48 30.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.476 -1.014 . . . . 0.0 110.038 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -93.84 126.36 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.04 -35.94 80.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.451 -0.78 . . . . 0.0 110.691 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 -102.48 123.98 47.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 110.565 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD12 HD22 ' A' ' 152' ' ' LEU . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.664 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.634 ' HE2' HD11 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 112' ' ' ILE . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.864 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.864 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.455 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.586 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.577 HD13 ' OH ' ' A' ' 165' ' ' TYR . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.437 ' HE1' HG23 ' A' ' 162' ' ' THR . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.437 HG23 ' HE1' ' A' ' 153' ' ' MET . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.668 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.586 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -50.39 -34.51 24.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.238 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 140.75 44.9 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.71 1.374 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.16 -31.01 72.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -52.96 145.5 20.72 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 25.4 t -142.84 162.11 36.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.468 -1.019 . . . . 0.0 110.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 14.3 t -128.74 152.55 48.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.68 137.91 58.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.375 -0.828 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -76.28 -33.1 59.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.97 -42.42 89.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.313 -0.867 . . . . 0.0 110.746 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.14 142.93 45.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.892 . . . . 0.0 110.597 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -113.26 161.17 17.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.473 -0.767 . . . . 0.0 110.121 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -136.32 171.83 13.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.864 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -50.57 145.95 6.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.21 141.71 45.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 110.638 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -104.65 173.5 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 71.9 p -115.2 167.81 10.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.87 143.75 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 46.3 m -112.0 150.08 31.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.862 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -74.54 126.99 31.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.436 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.06 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.456 -0.777 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.85 153.69 5.69 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.438 -0.788 . . . . 0.0 110.534 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.66 154.38 71.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.837 1.441 . . . . 0.0 110.456 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.16 147.89 26.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.602 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -110.09 138.13 46.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 49.9 m -75.73 -37.62 59.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.815 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -176.01 -178.7 0.33 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.634 HD11 ' HE2' ' A' ' 30' ' ' LYS . 3.5 mp 67.38 36.48 3.87 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.632 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.95 74.94 1.49 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.642 -1.286 . . . . 0.0 108.199 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.413 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 27.1 mp0 -80.08 17.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.048 0.928 . . . . 0.0 109.797 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.555 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 28.3 p -48.01 169.79 0.12 Allowed Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.224 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.83 -54.46 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.439 1.757 . . . . 0.0 108.518 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 40.9 mtmt -160.22 -12.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.51 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.1 m 61.68 28.52 17.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.95 122.71 53.78 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.09 -39.9 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.673 1.354 . . . . 0.0 110.528 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -177.54 -32.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -95.89 154.57 17.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -58.09 -21.27 45.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.706 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -39.12 107.77 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.495 -0.753 . . . . 0.0 111.552 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.35 146.43 29.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.655 -0.653 . . . . 0.0 109.71 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -50.6 140.78 13.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.229 -0.92 . . . . 0.0 110.301 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -90.46 129.91 36.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.863 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.26 87.57 53.36 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.492 -0.755 . . . . 0.0 109.59 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 114.96 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.655 1.345 . . . . 0.0 110.679 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -160.27 155.18 24.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 109.914 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -120.5 146.2 46.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -107.12 141.17 15.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.7 -35.51 78.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -1.095 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 137.81 -167.27 24.9 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.97 133.49 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -1.067 . . . . 0.0 110.089 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.04 -154.18 0.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.446 -0.784 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.14 152.66 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.892 . . . . 0.0 110.181 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 81.6 p -95.58 1.41 53.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 53.8 p -68.54 152.26 45.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -110.0 -66.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.18 -40.58 77.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.381 -0.825 . . . . 0.0 110.594 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.58 67.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 53.7 p -66.97 159.36 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -1.073 . . . . 0.0 110.421 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -62.76 -27.43 69.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 110.229 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.272 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.8 p -66.39 146.64 99.06 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 110.165 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.96 147.78 62.32 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.65 1.342 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.26 143.22 31.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.68 -6.71 39.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -161.64 51.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 58.9 p -120.95 154.48 35.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -1.145 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -134.77 155.93 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -134.72 157.15 47.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 110.177 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.483 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 -113.06 144.7 42.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.962 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 152' ' ' LEU . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.632 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' CE ' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' HD22 ' B' ' 714' ' ' LEU . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.541 ' CG2' HG21 ' A' ' 112' ' ' ILE . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.781 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.781 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.626 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.569 HD22 HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.409 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' HE1' ' A' ' 153' ' ' MET . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.472 HG21 ' CE1' ' A' ' 163' ' ' TYR . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.456 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -50.32 144.41 7.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.454 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.89 148.53 70.85 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.789 1.415 . . . . 0.0 110.525 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.54 -32.59 71.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.758 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 90.08 -163.57 30.54 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 41.9 m -60.27 150.56 29.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.378 -1.072 . . . . 0.0 110.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 41.2 m -60.65 -39.21 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.516 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.47 148.05 38.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.314 -0.867 . . . . 0.0 110.43 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -101.43 -62.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.109 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -134.09 163.57 29.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.803 . . . . 0.0 109.759 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 26.0 tp -100.43 111.82 24.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.59 -29.46 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.736 . . . . 0.0 110.427 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.56 141.32 58.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.732 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -147.29 159.73 43.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.563 -0.711 . . . . 0.0 109.63 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -89.56 128.83 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -172.94 169.84 4.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -0.811 . . . . 0.0 110.102 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 87.5 m -103.27 142.45 34.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 0.0 109.494 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.9 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.767 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 26.1 t -119.11 153.27 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.605 -0.684 . . . . 0.0 109.819 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -56.21 -27.33 54.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.24 -0.912 . . . . 0.0 110.399 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.04 -26.5 67.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.55 153.74 48.85 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.91 139.65 43.8 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.756 1.398 . . . . 0.0 110.714 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -122.82 157.66 31.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.468 -0.77 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -74.26 137.88 43.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 111.398 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 35.8 m -83.42 -37.8 22.76 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.821 0.82 . . . . 0.0 109.048 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.89 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -173.63 -175.11 0.26 Allowed Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.89 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 6.5 mt 70.29 40.95 1.09 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.563 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -136.98 78.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.833 -1.547 . . . . 0.0 109.269 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -83.78 18.35 2.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.21 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.55 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.1 p -47.29 168.91 0.12 Allowed Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.829 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -74.42 -54.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.484 1.781 . . . . 0.0 108.542 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 31.1 mttt -159.21 -12.1 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.515 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.6 m 62.51 28.13 16.59 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.64 138.65 21.09 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.566 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.88 119.35 6.31 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.478 1.252 . . . . 0.0 110.688 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . 176.55 141.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.457 -0.777 . . . . 0.0 110.203 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 55.42 50.83 13.97 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.891 . . . . 0.0 110.614 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -61.58 142.38 57.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -54.36 -37.02 64.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 56.5 mt -86.51 141.14 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.472 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -167.72 68.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -58.52 -32.69 69.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.393 -0.817 . . . . 0.0 110.61 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.41 141.04 96.56 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.232 -0.917 . . . . 0.0 110.022 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.09 58.77 5.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.633 1.333 . . . . 0.0 110.491 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.07 91.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.3 t -139.57 148.7 42.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.822 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.16 -176.13 37.71 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.44 143.4 34.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -1.06 . . . . 0.0 110.461 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.49 157.65 31.43 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.3 m -133.9 159.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.455 -1.026 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -106.32 144.36 33.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.32 4.51 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.679 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 7.2 m 56.64 111.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.833 . . . . 0.0 111.39 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 741' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 51.0 m -123.51 152.59 41.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.68 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' B' ' 741' ' ' SER . 93.7 mt-30 58.18 54.41 5.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.268 -0.895 . . . . 0.0 110.163 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' B' ' 743' ' ' ASP . 24.5 p-10 -54.84 -33.88 62.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.338 -0.851 . . . . 0.0 110.639 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -80.19 -176.74 50.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.2 t -112.69 141.63 46.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -1.128 . . . . 0.0 110.086 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 28.3 t -124.13 144.4 49.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -8' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -170.71 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.346 -1.091 . . . . 0.0 110.431 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.3 Cg_endo -68.72 153.12 73.78 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.435 1.229 . . . . 0.0 110.628 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -87.48 144.46 26.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.255 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.97 155.37 39.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.865 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 97.69 -174.35 29.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.6 p -118.95 159.91 22.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.287 -1.125 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -107.2 2.32 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.25 -39.7 73.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.919 -1.113 . . . . 0.0 109.524 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 -130.56 132.68 45.68 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 152' ' ' LEU . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.63 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.793 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD21 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.402 ' HD2' ' CG2' ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.506 ' CG2' HG21 ' A' ' 112' ' ' ILE . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.791 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.459 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.506 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.601 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.583 HD13 ' HG ' ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.424 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.424 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.713 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.601 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.645 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.469 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -50.57 144.36 8.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.176 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.62 149.95 68.44 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.752 1.396 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 7.4 tt 51.26 80.22 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -0.837 . . . . 0.0 110.383 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -145.7 95.64 0.17 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.5 m -121.32 147.86 45.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -1.063 . . . . 0.0 109.786 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.9 t -133.82 152.08 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -92.44 4.52 53.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 0.0 110.457 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.5 mt-10 -60.31 149.12 34.52 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.173 -0.954 . . . . 0.0 110.555 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 81.8 m-20 57.48 50.93 10.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.1 -37.22 71.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -107.7 134.46 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -112.49 168.14 9.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -81.41 108.41 14.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -36.74 85.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.436 -0.79 . . . . 0.0 110.313 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -169.63 -177.9 2.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 110.52 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 1.5 m -86.54 179.49 6.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.455 -0.778 . . . . 0.0 109.729 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.47 136.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 9.3 p -170.05 -75.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 0.0 109.867 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.08 83.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.858 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -70.2 146.75 50.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.5 133.44 94.32 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.17 145.7 55.51 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.605 1.319 . . . . 0.0 110.595 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.88 145.21 51.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.89 . . . . 0.0 110.032 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -113.62 133.28 55.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 111.354 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -102.42 -56.37 2.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.173 0.987 . . . . 0.0 108.633 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.824 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -143.82 -178.33 0.77 Allowed Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.824 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.793 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 9.0 mt 72.24 42.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.534 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -136.04 80.44 1.83 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.425 -1.422 . . . . 0.0 109.214 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -84.41 18.33 2.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.139 0.971 . . . . 0.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.63 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 25.6 p -44.77 171.91 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.699 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -71.92 -55.73 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.339 1.704 . . . . 0.0 109.003 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 44.8 mttp -160.37 -14.52 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.38 27.01 9.39 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -89.28 159.23 45.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.33 143.67 53.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.803 1.423 . . . . 0.0 110.445 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 111.016 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -126.65 156.37 41.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.85 130.37 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.435 -0.79 . . . . 0.0 110.035 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -132.19 142.38 49.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 110.309 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 5.7 mp -138.1 72.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -152.0 157.59 41.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -118.53 123.86 46.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.157 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 61.5 t -139.89 89.51 11.36 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 110.156 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.99 -25.18 38.53 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.743 1.391 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' B' ' 735' ' ' LEU . . . -74.14 134.29 42.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.339 -0.851 . . . . 0.0 110.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.2 m -126.41 150.96 48.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.573 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 91.71 10.37 61.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' B' ' 732' ' ' ALA . 50.1 mt -96.92 133.73 41.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.274 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.99 -179.44 53.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.25 136.25 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -1.103 . . . . 0.0 110.2 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -130.38 -162.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.836 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.64 137.27 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 47.4 m -113.09 140.26 48.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 48.3 m -64.5 153.25 39.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.471 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -126.91 161.78 27.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.439 -0.788 . . . . 0.0 110.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -53.96 -38.46 65.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 110.567 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 61.08 -123.41 32.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.1 t -120.59 141.32 50.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 90.5 p -137.66 159.39 42.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.297 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -124.58 83.12 58.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.989 . . . . 0.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 144.59 62.57 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.862 1.454 . . . . 0.0 110.363 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.94 111.89 23.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.24 -32.74 63.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 122.92 131.89 3.91 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.3 m -98.52 -12.38 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.165 -1.197 . . . . 0.0 111.228 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.23 139.17 45.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.063 -1.023 . . . . 0.0 109.959 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -146.05 103.98 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.521 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 -122.96 152.71 40.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.397 -0.815 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 152' ' ' LEU . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.641 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 170' ' ' ASP . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.776 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD21 HD11 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE2' HD21 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.791 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.791 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.463 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.634 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.572 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.627 HD11 ' HG ' ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.42 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.486 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.42 HG23 ' HE1' ' A' ' 153' ' ' MET . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.673 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.572 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.634 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.402 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.476 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.23 -34.38 22.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 -18.24 42.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.707 1.372 . . . . 0.0 110.646 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.15 -38.14 78.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.212 -0.93 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 80.43 -171.43 54.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 90.4 p -63.82 -30.38 71.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.19 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.2 p -124.64 158.11 33.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.95 143.04 57.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.218 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -108.84 142.51 39.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.037 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -88.54 114.21 24.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 36.1 tp -172.68 -99.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.061 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' B' ' 697' ' ' GLU . 78.4 tt0 50.84 26.47 2.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.907 -1.121 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -84.38 -1.09 54.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.913 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.31 -36.86 81.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.94 143.17 50.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 110.264 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.5 p30 -100.22 169.62 9.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.7 m -117.29 138.88 51.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.9 t -118.05 141.34 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.467 -0.771 . . . . 0.0 109.785 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.3 m -101.59 140.16 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.342 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -165.86 164.44 18.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -59.61 143.53 50.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -70.41 113.92 21.98 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.37 145.69 48.73 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.634 1.334 . . . . 0.0 110.491 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -108.57 150.0 28.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 110.135 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -117.3 144.57 44.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.365 -0.834 . . . . 0.0 111.385 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.75 -58.33 2.29 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.266 1.031 . . . . 0.0 108.36 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.817 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 -140.73 -179.02 0.9 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.817 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.776 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 10.2 mt 69.84 46.76 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.471 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -130.63 82.31 2.05 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.281 -1.512 . . . . 0.0 109.349 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -85.32 18.64 2.58 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.086 0.946 . . . . 0.0 109.385 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.64 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.255 24.2 p -43.94 172.33 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.724 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.4 Cg_endo -69.87 -57.08 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.454 1.765 . . . . 0.0 108.84 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 4.3 mtmp? -159.67 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.686 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 53.47 27.55 6.61 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.24 122.71 88.32 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.814 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 154.14 35.57 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.867 1.456 . . . . 0.0 110.443 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -97.22 131.99 43.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.6 121.43 44.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -136.83 135.37 37.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -0.861 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -69.38 153.91 42.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 109.922 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.27 142.78 41.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -104.56 146.72 28.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -59.73 -34.46 72.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 110.539 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.69 106.86 58.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 110.731 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.17 160.26 50.2 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.642 1.338 . . . . 0.0 110.547 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.45 152.48 8.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.369 -0.832 . . . . 0.0 110.535 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 8.0 t -129.81 -163.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.478 -0.764 . . . . 0.0 110.29 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -52.24 164.44 1.5 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.09 -40.41 73.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.305 -1.115 . . . . 0.0 110.641 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 51.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.77 130.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -1.132 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -90.57 -57.63 2.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.541 -0.724 . . . . 0.0 109.98 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.24 143.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 110.125 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 45.4 m -92.74 137.53 32.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.487 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 741' ' ' SER . . . . . 0.465 ' O ' ' N ' ' B' ' 743' ' ' ASP . 5.4 t -148.94 -55.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.03 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' B' ' 741' ' ' SER . 62.9 tt0 61.61 -72.13 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.616 -0.678 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' B' ' 741' ' ' SER . 93.1 m-20 -55.25 -37.47 67.27 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -137.91 175.12 21.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.7 t -124.7 127.36 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -1.198 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.4 m -63.0 -34.61 77.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 83.1 t90 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.157 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 92.7 p -121.34 96.0 48.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -1.071 . . . . 0.0 110.162 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.01 136.23 40.4 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.709 1.373 . . . . 0.0 110.6 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.71 -27.32 69.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.462 -0.774 . . . . 0.0 110.593 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -98.18 135.11 40.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -139.72 -117.03 1.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 45.3 m -118.46 138.09 52.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -1.117 . . . . 0.0 110.094 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -71.47 140.86 50.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.359 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -165.48 163.32 19.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 109.949 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 -121.65 147.66 45.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.024 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.655 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.57 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD21 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE2' HD13 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.464 ' CG2' HG21 ' A' ' 112' ' ' ILE . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.464 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.668 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.487 HD13 ' OH ' ' A' ' 165' ' ' TYR . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.448 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.448 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.61 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -50.51 144.32 7.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.6 -30.2 28.82 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.712 1.375 . . . . 0.0 110.296 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.71 -31.64 70.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.456 -0.777 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 111.1 3.45 27.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 45.7 m -117.33 150.02 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 24.7 m -108.5 132.53 53.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.601 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.0 -18.33 64.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.556 -0.715 . . . . 0.0 110.49 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.56 -30.82 55.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.303 -0.873 . . . . 0.0 110.618 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.83 135.59 57.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.9 tp -105.64 130.69 53.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.816 . . . . 0.0 110.525 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.6 143.87 55.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 110.089 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -76.43 175.85 8.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.354 -0.841 . . . . 0.0 110.522 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.15 155.12 21.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.389 -0.819 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.16 -33.55 53.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.204 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.77 169.74 10.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 110.035 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 35.3 m 50.66 59.32 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.253 -0.904 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.7 147.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.5 m -109.36 146.53 34.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.14 77.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 110.965 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -146.22 159.67 43.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.0 169.82 7.49 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.12 132.9 10.67 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.683 1.36 . . . . 0.0 111.088 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -127.54 152.12 48.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.42 132.32 51.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.306 -0.872 . . . . 0.0 111.716 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' B' ' 720' ' ' CYS . 75.5 m -80.56 -43.09 21.21 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.345 1.069 . . . . 0.0 109.367 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.871 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER -172.22 -174.13 0.26 Allowed Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.871 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 10.4 mp 66.23 63.06 0.56 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 86.06 3.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.125 -0.985 . . . . 0.0 109.164 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.411 ' OE1' HD23 ' A' ' 25' ' ' LEU . 25.9 mp0 -96.02 7.83 45.34 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.08 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.91 144.14 54.81 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.91 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.26 -55.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 125.069 2.089 . . . . 0.0 113.784 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.402 ' HB3' ' HB1' ' B' ' 721' ' ' ALA . 68.8 mttm -87.47 -11.52 48.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.41 ' HB3' ' SG ' ' B' ' 711' ' ' CYS . 98.4 m 49.37 29.13 2.64 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' B' ' 719' ' ' LYS . . . -117.72 152.53 49.96 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.278 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.12 148.01 30.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.938 1.493 . . . . 0.0 110.186 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -114.12 20.67 15.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.662 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -123.55 156.29 35.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.964 . . . . 0.0 110.722 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -84.7 154.25 22.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 110.177 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -60.56 143.09 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.38 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 71.5 mt -107.83 139.78 41.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.395 -0.816 . . . . 0.0 110.265 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.91 -68.76 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -129.71 131.49 46.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.0 109.567 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.81 79.17 74.05 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 111.122 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.1 148.15 49.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.634 1.334 . . . . 0.0 110.129 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.94 71.55 10.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 22.9 m -59.89 -36.51 77.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.409 -0.807 . . . . 0.0 110.967 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -103.36 118.46 6.06 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.337 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -114.64 129.32 56.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -1.059 . . . . 0.0 109.877 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.11 8.32 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.22 -38.29 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.407 -1.055 . . . . 0.0 110.487 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -90.89 121.78 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.947 . . . . 0.0 110.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.69 135.36 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.259 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 41.8 p -122.57 165.64 16.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 0.0 109.715 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 69.1 m -106.02 124.74 50.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.22 -34.91 75.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -83.63 121.25 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.92 -146.86 15.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.3 m -114.18 145.61 41.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -1.13 . . . . 0.0 110.181 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 746' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 747' ' ' TRP . 23.0 m -59.43 -36.9 76.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . 0.425 ' CG ' ' O ' ' B' ' 746' ' ' SER . 99.3 m95 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 20.7 t -103.52 113.83 65.31 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.61 54.3 3.88 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.58 1.306 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -125.58 142.1 51.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -62.9 -31.63 72.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 124.41 40.12 0.45 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 37.9 m -57.39 -37.15 72.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -1.108 . . . . 0.0 110.237 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . 0.409 ' O ' ' OE1' ' A' ' 156' ' ' GLN . 55.7 ttt85 -55.39 -34.34 64.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -80.01 147.08 31.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.475 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 -117.84 152.04 36.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.368 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 152' ' ' LEU . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.652 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.595 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' CD2' HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HE2' ' CD1' ' B' ' 714' ' ' LEU . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.51 ' CG2' HG21 ' A' ' 112' ' ' ILE . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.77 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.77 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.462 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.51 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.587 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.564 HD11 ' OH ' ' A' ' 165' ' ' TYR . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.412 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 155' ' ' ILE . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.475 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.412 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.564 ' OH ' HD11 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.587 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.454 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -50.02 -34.59 21.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.92 150.62 73.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.756 1.398 . . . . 0.0 110.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 82.9 mt -59.55 -35.28 73.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 0.0 110.168 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -135.6 159.19 24.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 86.5 p -64.21 -31.03 72.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 110.304 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 m -126.42 138.27 53.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.838 . . . . 0.0 110.31 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.73 139.9 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.19 -88.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.569 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -105.81 18.44 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.552 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.99 -36.22 70.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.291 -0.88 . . . . 0.0 110.528 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.4 143.1 56.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.252 -0.905 . . . . 0.0 109.919 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -166.53 -151.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.222 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -54.4 167.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.286 -0.884 . . . . 0.0 110.475 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.03 138.57 43.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.425 -0.797 . . . . 0.0 110.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -63.99 -35.17 79.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.372 -0.83 . . . . 0.0 111.012 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 34.7 m -90.66 143.31 26.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.558 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.63 154.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.77 . . . . 0.0 110.208 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 25.7 m -59.64 -36.04 75.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.429 -0.795 . . . . 0.0 111.012 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.88 -57.09 11.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.396 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . 46.43 26.14 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 111.298 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.46 148.09 21.55 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 110.797 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.67 158.28 47.34 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.852 1.449 . . . . 0.0 110.623 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.07 152.78 24.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.667 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -100.74 142.0 32.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.414 -0.804 . . . . 0.0 111.849 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 37.4 m -74.57 -43.73 54.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.02 0.915 . . . . 0.0 108.911 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.779 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -167.14 -179.94 0.88 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.779 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 1.6 mp 68.34 44.92 1.26 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.578 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.66 79.34 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.243 -1.536 . . . . 0.0 109.153 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -83.93 18.99 1.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.027 0.918 . . . . 0.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.609 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 24.5 p -44.12 171.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.743 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.72 -56.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.468 1.772 . . . . 0.0 108.833 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.6 mttp -160.18 -15.28 0.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.693 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 54.38 26.76 7.33 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -88.05 137.18 31.46 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.557 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.22 148.22 55.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.662 1.349 . . . . 0.0 110.399 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -84.42 129.35 34.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -121.41 144.38 48.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 726' ' ' ARG . 98.4 mttt -132.14 111.47 11.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 110.105 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' B' ' 725' ' ' LYS . 66.9 mtm180 52.56 165.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.473 -0.767 . . . . 0.0 111.123 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.51 -36.13 82.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.145 -0.972 . . . . 0.0 110.911 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.72 157.15 43.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.994 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -115.84 134.74 54.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.0 109.815 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.36 112.1 5.85 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.298 -0.876 . . . . 0.0 110.351 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.66 144.42 28.12 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.646 1.34 . . . . 0.0 110.419 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.81 85.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.722 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.3 t -153.71 152.74 31.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 96.61 168.37 33.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.26 -35.8 81.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.38 -1.071 . . . . 0.0 110.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 100.43 78.02 1.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.12 163.08 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -1.031 . . . . 0.0 110.334 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -82.92 129.28 35.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.029 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 14.2 p -61.23 -39.91 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.39 -0.819 . . . . 0.0 110.686 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 46.7 m -131.04 137.42 49.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.898 . . . . 0.0 110.262 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 36.3 t -165.39 24.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.691 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -122.29 140.91 52.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 0.0 110.462 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -137.65 160.17 39.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.792 . . . . 0.0 109.971 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -159.87 53.97 0.35 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 83.7 p -62.6 -26.99 68.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -1.078 . . . . 0.0 110.409 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 91.3 p -121.45 156.82 31.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.907 . . . . 0.0 110.405 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 86.5 m95 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -8' ' ' SER . . . . . 0.497 ' N ' ' HD2' ' A' ' -7' ' ' PRO . 0.3 OUTLIER -51.59 -55.28 30.93 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.374 -1.074 . . . . 0.0 110.707 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' -8' ' ' SER . 42.8 Cg_endo -70.28 145.04 53.04 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.597 1.314 . . . . 0.0 110.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.72 168.35 9.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.163 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -55.28 -36.05 65.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 110.454 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 84.61 20.29 58.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 56.4 m -120.72 143.13 48.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 109.943 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.79 138.75 57.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 110.069 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -108.65 149.39 29.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 50.46 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 110.929 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 152' ' ' LEU . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD21 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' CG2' HD22 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.786 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.424 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.786 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.86 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.425 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.571 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.595 HD11 ' HG ' ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.426 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 153' ' ' MET . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.723 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.48 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.48 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm -49.98 -34.82 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.263 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 -20.58 37.73 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.795 1.418 . . . . 0.0 110.736 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.37 141.15 29.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 144.39 148.97 4.96 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 87.1 p -63.12 -28.24 69.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.0 t -135.87 156.8 48.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.408 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.2 143.09 44.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 110.196 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -132.04 169.54 16.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.039 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -58.64 150.25 23.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.743 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.7 mt -83.82 125.43 31.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.925 . . . . 0.0 110.523 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.74 -6.56 14.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.88 -38.14 72.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 111.012 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -141.63 32.54 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -99.75 127.44 45.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.99 . . . . 0.0 110.121 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -177.37 -46.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.813 . . . . 0.0 110.433 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 12.7 t -146.09 155.83 43.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 110.825 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.97 138.16 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.504 -0.748 . . . . 0.0 109.685 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 99.5 p -111.83 145.47 39.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -69.06 -29.74 67.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.795 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.06 44.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.25 160.51 52.24 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 110.46 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.65 156.28 57.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.887 1.467 . . . . 0.0 110.635 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' B' ' 710' ' ' PHE . 76.8 mm-40 -105.2 156.91 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.423 -0.798 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' B' ' 709' ' ' GLU . 34.1 m-85 53.59 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.903 0.858 . . . . 0.0 112.295 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 39.5 m -65.75 -40.25 91.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.091 0.948 . . . . 0.0 108.912 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.84 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -168.56 -177.45 0.51 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.84 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.838 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.8 mt 67.8 45.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.556 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.32 80.89 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.383 -1.448 . . . . 0.0 109.26 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -84.65 17.63 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.102 0.953 . . . . 0.0 109.414 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.659 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.256 27.9 p -45.95 172.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.659 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.4 Cg_endo -74.55 -55.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.546 1.814 . . . . 0.0 108.923 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -159.21 -14.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.657 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.8 m 57.31 25.83 11.66 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.99 131.87 80.75 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.962 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.02 148.59 70.21 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.601 1.316 . . . . 0.0 110.559 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -114.09 -85.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -121.86 122.23 38.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.71 149.26 22.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.371 -0.83 . . . . 0.0 110.512 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.0 tp -92.9 128.63 38.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.995 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -72.49 143.18 48.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.4 -0.812 . . . . 0.0 110.54 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.49 145.61 31.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 109.867 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.77 104.99 20.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.345 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.55 151.34 58.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.617 1.325 . . . . 0.0 110.297 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -93.05 132.47 37.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.1 t -137.86 142.4 40.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.308 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.97 134.78 12.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.8 mt -102.48 139.49 38.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -122.08 76.88 0.34 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.2 m -128.15 161.71 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -1.127 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -82.66 133.49 35.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 110.066 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.78 147.89 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.344 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 13.5 t -126.89 160.12 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.436 -0.79 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.0 m -114.28 152.61 31.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -91.22 123.11 34.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 109.953 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -98.99 161.81 13.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 98.15 17.74 28.76 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.3 t -75.25 137.08 40.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -1.198 . . . . 0.0 109.965 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 46.1 m -124.73 150.62 46.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.386 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.463 179.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -125.79 73.52 69.94 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.336 -1.097 . . . . 0.0 110.084 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -23.32 35.09 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.724 1.381 . . . . 0.0 110.706 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.08 -35.5 80.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.01 156.76 34.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -88.92 176.06 43.83 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 30.1 p -144.0 45.46 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -1.062 . . . . 0.0 110.263 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -115.73 149.75 37.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.177 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 156' ' ' GLN . 64.9 t0 -145.94 97.38 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.574 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -157.49 159.21 37.01 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.086 -1.009 . . . . 0.0 109.668 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.642 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.57 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.57 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' HD11 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.478 ' CG2' HG21 ' A' ' 112' ' ' ILE . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.664 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.594 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.522 HD11 ' OH ' ' A' ' 165' ' ' TYR . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 164' ' ' VAL . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.594 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.664 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.44 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -50.51 -34.51 25.45 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.229 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.71 -19.15 41.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.859 1.452 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.22 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.261 -0.899 . . . . 0.0 110.603 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -89.61 49.46 3.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 83.9 p -60.76 -28.22 68.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.303 -1.116 . . . . 0.0 110.227 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.1 m -86.25 134.57 33.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -138.0 -54.94 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 110.473 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.87 -36.63 81.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.815 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -92.85 111.4 23.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.9 mt -119.1 131.79 55.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.355 -0.84 . . . . 0.0 109.888 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.06 131.95 44.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.491 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -116.25 142.12 47.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.985 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.62 47.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.78 127.36 47.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.62 6.71 39.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.849 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.1 m -122.46 139.61 53.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.958 . . . . 0.0 110.325 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 52.4 t -120.44 138.04 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.101 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.9 m -114.64 149.73 36.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.7 52.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.432 -0.792 . . . . 0.0 110.539 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -66.37 156.55 34.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.04 96.89 10.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.076 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.03 156.24 63.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.776 1.409 . . . . 0.0 110.568 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.94 153.99 17.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.389 -0.819 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.25 146.72 28.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.485 -0.759 . . . . 0.0 111.321 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.09 -40.88 95.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.173 0.987 . . . . 0.0 108.622 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.815 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -165.54 -178.05 0.69 Allowed Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 2.2 mp 67.74 59.54 0.47 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.534 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.74 76.74 1.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.152 -1.593 . . . . 0.0 109.068 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -84.44 19.87 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.224 1.011 . . . . 0.0 109.055 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.618 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 21.9 p -43.05 171.36 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.073 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.37 -56.7 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.488 1.783 . . . . 0.0 108.874 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 21.2 mttp -158.91 -15.15 0.07 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.3 m 55.21 26.99 9.03 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.59 150.45 88.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.311 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.99 -17.46 41.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.78 1.41 . . . . 0.0 110.793 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -59.55 145.59 43.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -108.99 161.11 15.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.12 148.18 42.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.38 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -115.9 154.44 29.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.4 tp -93.16 122.2 35.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.98 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -163.43 156.95 19.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -126.63 119.19 26.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.992 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.63 134.85 9.11 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 109.997 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.04 146.78 53.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.32 . . . . 0.0 110.688 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -67.23 139.08 57.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.069 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 733' ' ' SER . . . . . 0.466 ' O ' ' O ' ' B' ' 736' ' ' GLY . 28.6 p -118.25 30.37 7.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.462 -0.774 . . . . 0.0 110.351 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.5 25.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.12 -36.55 80.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.169 -1.195 . . . . 0.0 111.011 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' B' ' 733' ' ' SER . . . -140.1 165.86 25.87 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.94 132.3 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.084 -1.245 . . . . 0.0 110.574 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -136.14 74.73 1.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 160.71 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.811 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 45.8 m 51.0 26.1 2.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.416 -0.802 . . . . 0.0 110.527 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 26.5 t -147.76 147.99 30.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -98.91 104.81 16.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.976 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -136.09 140.54 43.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.212 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -90.16 -175.23 45.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 60.5 p -66.75 166.27 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -1.093 . . . . 0.0 109.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.0 m -54.7 -33.83 61.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.172 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 1.3 m95 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.073 179.733 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.8 m -109.51 113.87 57.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.99 141.27 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.506 1.267 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.58 127.2 53.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 0.0 110.705 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -79.29 -44.31 21.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.495 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -177.56 179.5 48.18 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.7 p -131.07 165.26 23.62 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.369 -1.077 . . . . 0.0 110.546 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -114.17 129.83 56.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 109.978 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -64.61 -36.0 82.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.314 -0.866 . . . . 0.0 110.999 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 -70.59 146.66 49.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.229 -0.919 . . . . 0.0 110.878 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.54 HD23 ' HB3' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 HD12 HD21 ' A' ' 152' ' ' LEU . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.637 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' CD2' HD21 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.501 ' CG2' HG21 ' A' ' 112' ' ' ILE . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.789 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.789 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.501 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.65 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.53 HD11 ' OH ' ' A' ' 165' ' ' TYR . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 164' ' ' VAL . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 150' ' ' PHE . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.65 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 163' ' ' TYR . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -50.22 -34.44 22.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.451 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 148.41 71.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.789 1.415 . . . . 0.0 110.462 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.7 tp -57.66 -37.01 72.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -0.873 . . . . 0.0 110.347 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.08 126.43 33.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 80.6 p -149.39 167.82 25.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -1.06 . . . . 0.0 109.997 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 p -75.49 154.58 36.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.84 134.79 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 110.259 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.81 -73.37 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 110.114 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -153.26 -61.59 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.464 -0.773 . . . . 0.0 110.208 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 17.5 mt 52.78 19.94 1.43 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.364 -0.835 . . . . 0.0 111.047 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.17 -35.18 80.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -78.57 138.74 38.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.444 -0.785 . . . . 0.0 110.159 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -106.28 142.15 36.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -116.17 146.58 42.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.127 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -135.58 176.78 8.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.567 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 43.1 p -80.69 164.05 23.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.865 . . . . 0.0 110.193 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.7 -41.71 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.6 p -142.0 157.28 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -124.48 42.17 3.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . 53.88 -173.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.357 -0.84 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.27 112.0 5.17 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.98 143.6 45.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.639 1.336 . . . . 0.0 110.627 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.22 150.91 36.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.386 -0.821 . . . . 0.0 110.092 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -104.82 132.26 51.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -69.24 -43.41 74.07 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.023 0.916 . . . . 0.0 109.111 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.853 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -163.21 -177.25 0.66 Allowed Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 3.9 mp 71.04 48.06 0.39 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.563 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -133.57 77.79 1.74 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.271 -1.518 . . . . 0.0 108.848 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -82.81 18.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.104 0.954 . . . . 0.0 109.3 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.579 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.2 p -43.58 169.67 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.736 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.95 -55.81 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.396 1.735 . . . . 0.0 108.97 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.412 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 14.2 mtpp -159.76 -15.04 0.06 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.71 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.4 m 55.25 27.18 9.4 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -91.55 154.48 44.22 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.79 -16.42 33.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.813 1.428 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.82 140.12 52.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.119 -0.988 . . . . 0.0 110.35 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -87.1 -77.6 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 0.0 110.538 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.03 28.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.238 -0.914 . . . . 0.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -61.37 -33.79 74.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.071 -1.018 . . . . 0.0 110.544 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 9.1 tt -95.5 124.73 39.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -159.59 158.73 32.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.477 -0.764 . . . . 0.0 110.069 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -83.98 147.74 27.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.014 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.48 97.4 48.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 110.346 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.97 151.67 67.96 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.741 1.39 . . . . 0.0 110.177 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.64 89.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.188 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.7 m -59.33 -35.18 73.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -57.01 -33.58 64.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 32.2 tp -100.87 128.3 46.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.47 -1.018 . . . . 0.0 110.148 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 66.13 124.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.24 137.57 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -1.084 . . . . 0.0 110.063 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -100.24 141.79 32.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 110.266 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.19 143.79 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.7 m -120.78 137.29 54.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.365 -0.834 . . . . 0.0 110.455 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.4 p -134.12 156.58 48.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.44 -0.787 . . . . 0.0 109.901 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -115.37 138.65 50.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.3 -0.875 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -102.96 11.56 37.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 110.321 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 117.01 -73.97 0.28 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 26.6 t -124.39 139.5 53.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.107 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -35.38 73.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.187 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 25.8 p -66.57 155.61 88.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.42 -1.047 . . . . 0.0 110.397 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.96 139.67 47.9 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.841 1.443 . . . . 0.0 110.417 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -63.56 -36.11 82.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -111.3 133.91 53.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 172.87 149.58 6.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 12.4 t -140.29 156.77 46.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.406 -1.055 . . . . 0.0 110.557 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -101.3 6.0 42.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.308 -0.87 . . . . 0.0 110.51 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -73.51 156.04 38.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 -51.54 149.96 4.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.363 -0.836 . . . . 0.0 109.693 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' B' ' 713' ' ' PRO . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 152' ' ' LEU . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.4 m80 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.695 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD21 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.633 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 112' ' ' ILE . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.42 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.574 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.526 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CD2' HD12 ' A' ' 4' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.427 ' HE1' HG23 ' A' ' 162' ' ' THR . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.414 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.427 HG23 ' HE1' ' A' ' 153' ' ' MET . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.674 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm -50.55 144.37 7.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.469 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.37 -20.94 41.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.797 1.419 . . . . 0.0 110.606 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.16 -37.34 79.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 73.31 27.81 67.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 27.3 t -120.03 145.68 46.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -1.124 . . . . 0.0 110.456 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 60.6 m -74.93 133.48 41.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 0.0 110.197 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.73 144.42 57.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.762 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.9 mt-10 -62.73 -23.32 67.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.091 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 85.5 m-20 57.57 39.14 27.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.513 -0.742 . . . . 0.0 110.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.26 130.59 56.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 109.526 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.55 132.35 38.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.314 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -79.59 136.32 36.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.813 . . . . 0.0 110.319 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -90.77 129.84 36.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.147 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.33 138.36 58.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.403 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' B' ' 704' ' ' SER . 4.5 p30 -93.27 7.42 44.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.504 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 41.9 m -66.46 -37.33 84.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.64 -40.95 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.364 -0.835 . . . . 0.0 111.159 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 704' ' ' SER . . . . . 0.409 ' O ' ' O ' ' B' ' 701' ' ' ASP . 92.3 p -120.09 153.53 35.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.049 -1.032 . . . . 0.0 110.878 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -82.15 136.82 35.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.303 -0.873 . . . . 0.0 110.361 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.11 72.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.542 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -66.72 127.97 93.66 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.3 -0.875 . . . . 0.0 110.495 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' B' ' 709' ' ' GLU . 44.4 Cg_endo -71.71 -15.0 30.3 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.678 1.357 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 708' ' ' PRO . 94.7 mt-10 60.0 146.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.5 -0.75 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.82 132.0 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.408 -0.808 . . . . 0.0 111.731 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 78.3 m -73.55 -38.78 65.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.157 0.98 . . . . 0.0 109.059 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.86 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -173.4 -174.42 0.25 Allowed Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.86 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.0 mt 74.88 41.96 0.29 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.597 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.1 t -139.15 81.68 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.814 -1.804 . . . . 0.0 109.154 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -84.37 17.2 2.69 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.143 0.973 . . . . 0.0 109.505 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.629 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.6 p -46.12 172.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.749 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.629 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.95 -55.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.497 1.788 . . . . 0.0 108.936 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 41.1 mttt -160.52 -14.94 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.76 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 55.33 25.96 8.12 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -93.45 126.7 49.26 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.234 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.35 133.46 24.54 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.556 1.292 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -125.14 26.58 6.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -99.51 121.72 41.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.526 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -168.76 62.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.484 -0.76 . . . . 0.0 110.048 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -93.19 5.57 51.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.91 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.39 -31.79 69.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.093 -1.004 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -61.32 150.25 35.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 110.074 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . 0.427 ' HG2' ' HD3' ' B' ' 731' ' ' PRO . 42.0 tttp -74.77 129.98 38.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.12 76.71 71.98 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.402 -0.812 . . . . 0.0 109.885 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . 0.427 ' HD3' ' HG2' ' B' ' 729' ' ' LYS . 46.3 Cg_endo -72.5 146.74 44.91 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.862 1.453 . . . . 0.0 110.847 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.65 161.57 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.482 -0.761 . . . . 0.0 109.701 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.8 m -110.72 143.52 41.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.487 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.72 26.7 0.23 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.46 -33.24 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -1.13 . . . . 0.0 110.356 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.66 7.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.01 137.11 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -1.12 . . . . 0.0 110.109 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -54.44 -37.32 65.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.4 t 51.19 95.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.337 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.3 p -80.04 158.31 26.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.353 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.3 m -122.26 150.64 42.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.143 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -100.91 136.44 40.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.86 117.11 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -102.75 29.98 11.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 20.8 t -57.01 -35.35 69.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -1.122 . . . . 0.0 110.53 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -138.96 160.91 38.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.872 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.087 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -123.98 76.61 58.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.389 -1.065 . . . . 0.0 110.07 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.78 142.91 49.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.824 1.434 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -112.24 155.02 24.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.72 141.33 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.233 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -86.45 -174.16 49.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 33.1 m -112.92 137.76 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 109.989 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -65.59 148.73 51.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.514 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -57.89 -34.86 70.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.67 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 -106.97 148.93 28.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.109 -0.994 . . . . 0.0 110.609 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 152' ' ' LEU . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.663 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HE2' ' CD2' ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' CG2' HD22 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.859 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.423 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.453 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.706 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.581 HD11 ' HG ' ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.419 ' HE1' HG23 ' A' ' 162' ' ' THR . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.419 HG23 ' HE1' ' A' ' 153' ' ' MET . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.806 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.453 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.579 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.706 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.408 HG13 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.51 147.62 4.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.232 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.402 ' HG2' ' CD2' ' B' ' 689' ' ' LEU . 41.9 Cg_endo -69.08 -17.65 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.875 1.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' B' ' 689' ' ' LEU . 4.4 mm? -87.67 144.94 26.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -0.941 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 106.96 -103.57 2.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 51.7 m -115.7 145.91 42.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 41.3 m -92.15 135.01 34.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.57 -28.75 68.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.73 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -57.07 136.0 56.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.77 -41.52 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 84.3 mt -113.17 134.25 54.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.78 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -107.07 -71.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.972 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -128.6 -173.01 2.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -69.62 119.5 13.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.865 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.49 -35.53 81.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.44 -0.787 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -91.47 173.94 7.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.67 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 15.0 t -127.28 154.29 45.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.15 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.305 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.7 p -61.58 -29.19 69.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.434 -0.791 . . . . 0.0 110.325 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -121.92 151.57 40.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 110.265 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -133.07 -162.15 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -122.67 73.19 42.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 110.331 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.69 -21.22 34.11 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.763 1.401 . . . . 0.0 110.446 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -113.18 163.62 14.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 110.605 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -55.52 149.1 14.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.531 0.681 . . . . 0.0 111.633 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -63.73 -40.15 96.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.351 1.072 . . . . 0.0 108.155 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.838 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.16 -179.14 0.53 Allowed Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.6 mt 68.56 52.02 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -139.24 78.11 1.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.239 -1.538 . . . . 0.0 108.867 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -82.09 18.5 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.075 0.94 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.628 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 24.8 p -45.17 171.99 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.397 179.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -71.09 -55.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.282 1.675 . . . . 0.0 108.879 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' B' ' 721' ' ' ALA . 97.9 mttt -160.49 -15.11 0.05 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.05 27.22 7.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 719' ' ' LYS . . . -128.73 159.25 69.15 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.42 104.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.798 1.42 . . . . 0.0 110.058 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -64.85 -34.07 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -126.07 163.65 22.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -68.19 156.48 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.948 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -59.61 133.51 56.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.813 . . . . 0.0 110.486 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.3 -34.08 65.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 109.926 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' B' ' 729' ' ' LYS . . . -109.13 155.87 20.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 728' ' ' ALA . 17.1 mttp 58.75 44.51 16.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.537 -0.727 . . . . 0.0 110.558 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 12.8 p -110.39 116.35 53.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 126.67 13.58 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.32 1.168 . . . . 0.0 110.317 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.56 74.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.182 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 16.7 m -79.62 84.45 5.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -87.31 178.87 47.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.53 -35.01 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -1.14 . . . . 0.0 110.098 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 162.2 -114.33 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 128.67 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.093 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -153.08 171.66 18.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.3 119.71 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -0.945 . . . . 0.0 110.096 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 60.0 m -79.22 -36.68 39.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 110.382 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.4 m -65.81 159.71 24.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.775 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -93.82 126.33 38.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.54 -0.725 . . . . 0.0 109.91 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.83 119.43 25.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.367 -0.833 . . . . 0.0 110.464 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.44 109.87 3.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 33.8 t -145.49 157.01 44.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -1.061 . . . . 0.0 110.232 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.3 m -115.88 148.02 40.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.442 -0.786 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.288 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 150.58 95.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 110.167 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.86 150.51 73.6 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.75 1.395 . . . . 0.0 110.262 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.9 137.23 33.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.868 . . . . 0.0 110.363 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -141.97 161.42 38.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 89.57 -52.24 3.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 63.6 p -70.58 -19.87 62.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -1.04 . . . . 0.0 110.119 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -117.14 144.22 44.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -82.76 150.42 26.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 111.019 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.491 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 -111.0 150.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 152' ' ' LEU . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.666 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.806 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 112' ' ' ILE . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.458 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.457 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.611 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.571 HD11 ' HG ' ' B' ' 714' ' ' LEU . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.491 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 153' ' ' MET . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.609 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.762 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.406 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -50.23 144.39 7.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.36 -18.64 44.17 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.727 1.383 . . . . 0.0 110.8 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.3 142.69 27.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.155 -0.966 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 86.64 -171.09 42.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 14.9 p -147.07 68.2 1.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -1.082 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 11.3 t -136.01 160.73 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 110.387 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.8 150.09 20.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 110.048 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.6 138.51 57.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.365 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.7 118.88 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.412 -0.805 . . . . 0.0 110.04 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.7 tp -98.86 122.01 41.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -137.08 148.03 46.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 110.056 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -158.08 162.77 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -151.07 150.94 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 110.131 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 31.6 p-10 -141.1 111.95 7.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 54.4 p -122.63 156.59 33.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.72 136.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.251 -0.905 . . . . 0.0 110.596 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.1 m -119.23 147.23 44.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -145.26 154.67 42.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.584 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -143.17 93.27 2.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -125.43 87.86 55.05 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.408 -0.808 . . . . 0.0 110.291 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 137.16 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.736 1.388 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -72.26 147.12 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -99.57 142.52 30.95 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.838 0.828 . . . . 0.0 111.791 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 55.9 m -65.25 -39.09 92.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.833 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 -174.66 177.28 0.63 Allowed Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.78 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.806 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.1 mt 74.65 41.36 0.34 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.487 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.5 t -133.0 85.34 2.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.476 -1.39 . . . . 0.0 107.588 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -78.99 15.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.79 0.805 . . . . 0.0 110.299 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.584 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -48.78 170.26 0.13 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.905 -0.497 . . . . 0.0 111.294 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.584 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 35.8 Cg_endo -68.05 -53.21 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.054 1.555 . . . . 0.0 108.134 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.518 ' HB3' ' HB1' ' B' ' 721' ' ' ALA . 26.2 mtmt -164.7 -15.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.8 m 53.82 26.48 6.13 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' B' ' 719' ' ' LYS . . . -132.73 168.22 18.93 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.544 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 -59.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.825 1.434 . . . . 0.0 110.27 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . 177.88 44.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.191 -0.943 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -104.8 133.06 50.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 0.0 110.589 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -112.95 154.1 26.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.478 -0.764 . . . . 0.0 110.051 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -86.42 152.35 22.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.994 . . . . 0.0 110.537 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 21.3 tp -100.11 125.94 46.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.384 -0.822 . . . . 0.0 109.771 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.54 29.72 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 110.499 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -93.11 145.05 24.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.852 . . . . 0.0 110.153 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.18 160.33 27.38 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.842 . . . . 0.0 110.489 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.32 159.54 53.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.62 147.97 17.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.8 t -74.41 146.72 42.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.434 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -177.98 69.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.32 136.42 34.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -1.1 . . . . 0.0 110.299 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.23 -32.44 76.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -129.84 144.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -1.102 . . . . 0.0 110.287 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -99.99 131.32 46.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.357 -0.839 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.15 138.24 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 31.7 m -77.26 131.59 38.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.8 m -128.91 149.56 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.422 -0.799 . . . . 0.0 110.316 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 51.12 73.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.321 -0.862 . . . . 0.0 110.654 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.45 -38.2 74.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.99 47.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 13.7 t -170.01 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.38 -1.071 . . . . 0.0 110.261 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -122.01 144.24 49.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 0.0 110.168 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.179 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.91 85.64 60.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.076 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.97 -23.16 47.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.586 1.308 . . . . 0.0 110.138 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.68 -20.62 65.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.46 -0.775 . . . . 0.0 110.055 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -50.65 -41.67 55.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 111.064 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 177.81 -82.84 0.07 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.407 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 57.9 m -69.33 137.71 53.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.354 -1.086 . . . . 0.0 110.897 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -89.67 146.34 24.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -67.8 133.55 49.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.322 -0.861 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 52.24 108.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.672 . . . . 0.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD12 HD22 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.645 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.664 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.478 ' CG2' HG21 ' A' ' 112' ' ' ILE . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.404 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.788 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.478 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.587 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.716 HD12 ' HG ' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.409 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 179' ' ' TYR . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.409 HG23 ' HE1' ' A' ' 153' ' ' MET . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.587 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.655 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm -50.11 -34.38 21.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.617 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.78 -17.94 42.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.808 1.425 . . . . 0.0 110.532 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.83 145.64 26.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 0.0 110.104 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 138.82 -24.56 2.86 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 47.3 m -118.27 146.85 43.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -1.114 . . . . 0.0 110.024 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 73.3 p -83.69 127.29 33.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.398 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -69.58 -35.12 75.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.82 -178.47 4.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 110.259 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.34 143.81 48.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.72 -174.86 4.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' B' ' 697' ' ' GLU . 80.4 tt0 56.66 47.7 17.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.48 -0.763 . . . . 0.0 110.129 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.07 -38.44 76.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -171.09 67.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.22 -0.925 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.8 -29.22 68.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -58.93 -32.93 70.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.407 -0.808 . . . . 0.0 110.879 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 13.8 t -129.64 157.03 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.37 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.59 133.14 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.7 m -123.56 145.84 48.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.747 . . . . 0.0 109.874 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.75 38.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -73.42 142.85 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.828 . . . . 0.0 110.151 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.53 156.27 91.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.7 -20.97 45.89 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.73 1.384 . . . . 0.0 110.486 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.1 150.64 20.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.358 -0.839 . . . . 0.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.87 139.91 44.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 111.427 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 45.3 m -74.05 -39.78 63.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.122 0.963 . . . . 0.0 108.849 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.824 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER -171.21 -178.74 0.5 Allowed Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.824 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.716 ' HG ' HD12 ' A' ' 152' ' ' LEU . 9.4 mt 74.18 44.04 0.26 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.99 80.86 1.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.288 -1.507 . . . . 0.0 109.261 178.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.94 17.76 2.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.093 0.949 . . . . 0.0 109.353 178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.61 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 27.8 p -45.59 170.69 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.61 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.79 -55.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.518 1.799 . . . . 0.0 108.817 175.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 51.0 mtmt -159.43 -13.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.598 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.9 m 59.47 27.36 16.49 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -175.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -75.66 171.11 12.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.852 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.87 121.77 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.593 1.312 . . . . 0.0 110.576 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -75.86 -19.94 58.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 110.661 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -70.53 142.48 51.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.867 . . . . 0.0 110.734 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -103.31 159.85 15.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.902 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -114.87 144.17 43.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.16 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 72.4 mt -99.17 138.3 36.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 110.067 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -90.67 109.49 20.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.095 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -131.79 147.16 52.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.45 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.1 m -97.0 164.08 18.65 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.429 -0.794 . . . . 0.0 109.64 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 43.9 Cg_endo -71.25 57.03 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.523 1.275 . . . . 0.0 110.651 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.48 64.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.1 t -55.3 -35.82 65.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -58.7 -34.1 75.5 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.0 tp -103.94 130.25 51.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.438 -1.036 . . . . 0.0 110.2 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -126.97 42.71 1.43 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.8 145.22 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -1.11 . . . . 0.0 110.323 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.36 135.13 57.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.376 -0.828 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 137.92 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.827 . . . . 0.0 110.179 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 55.7 p -118.45 164.28 15.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 0.0 110.352 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 32.8 t -110.66 151.32 27.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.469 -0.77 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -127.96 159.38 35.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 110.285 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.97 116.65 22.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.455 -0.778 . . . . 0.0 110.44 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -129.71 -64.57 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.9 t -124.69 143.58 50.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -1.08 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 53.5 p -70.17 161.53 30.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.121 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 -179.987 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -8' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -103.25 -64.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.829 -179.83 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.6 Cg_endo -70.64 133.76 24.65 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 O-C-N 123.225 1.118 . . . . 0.0 110.711 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -68.53 -31.49 70.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.18 157.74 25.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.533 -0.73 . . . . 0.0 110.495 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 175.95 -127.0 1.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 48.3 m -58.24 -36.04 72.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.047 . . . . 0.0 110.966 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.07 146.22 48.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 156' ' ' GLN . 27.3 t70 -97.29 113.67 25.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 -132.59 134.77 45.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.446 -0.783 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.443 HD12 HD22 ' A' ' 152' ' ' LEU . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.626 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.667 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD21 HD11 ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.509 ' CG2' HG21 ' A' ' 112' ' ' ILE . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.853 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.61 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.569 ' CD2' ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' HD2' ' A' ' 0' ' ' ARG . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' C ' ' HG3' ' A' ' 0' ' ' ARG . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 179' ' ' TYR . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.752 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.7 mttm -50.55 -34.37 25.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.185 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.83 161.63 45.21 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.794 1.418 . . . . 0.0 110.395 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.5 mt -74.04 144.25 45.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -71.27 136.25 24.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.0 t -126.57 142.52 51.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.474 -1.015 . . . . 0.0 109.648 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 45.2 m -122.98 137.18 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.92 169.64 10.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 109.561 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.11 137.06 56.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 109.961 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.64 119.76 29.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.653 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.79 142.28 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.463 -0.773 . . . . 0.0 109.702 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.02 141.68 33.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 55.2 t0 49.5 37.81 13.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 110.721 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -124.4 -85.46 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.414 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -123.79 144.88 49.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.435 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -125.12 173.63 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.802 . . . . 0.0 110.205 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.0 m -76.06 134.4 40.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.62 131.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 23.2 t -61.17 -38.61 87.11 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.17 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -149.58 154.69 39.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.459 -0.775 . . . . 0.0 109.975 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.04 94.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.242 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.59 80.82 18.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 110.504 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.44 -171.09 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.714 1.376 . . . . 0.0 110.251 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -55.01 147.73 15.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -100.99 131.12 47.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 111.595 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.61 -41.11 76.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.26 1.029 . . . . 0.0 108.703 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -167.17 -176.63 0.49 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.6 mt 69.48 45.48 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.519 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.21 80.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.189 -1.57 . . . . 0.0 108.888 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -82.92 17.16 2.0 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.034 0.921 . . . . 0.0 109.673 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.623 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.64 172.18 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.6 179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -72.49 -55.47 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.398 1.736 . . . . 0.0 108.842 175.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 97.6 mttt -160.5 -14.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 55.49 27.28 10.02 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -107.1 164.85 13.93 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -178.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 143.69 57.79 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.705 1.371 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -90.95 145.44 24.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.263 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -94.12 128.17 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.927 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -79.92 132.99 36.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 110.628 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 46.89 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 111.184 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 28.5 tp 50.43 64.01 1.98 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.467 -0.771 . . . . 0.0 110.655 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -102.82 143.86 31.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -82.23 132.7 35.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.5 t -70.47 139.7 86.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.07 104.17 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.654 1.344 . . . . 0.0 110.287 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -175.8 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.392 -0.817 . . . . 0.0 110.154 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.5 m -58.48 -36.31 73.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.299 -0.875 . . . . 0.0 110.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.2 36.22 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.35 142.0 30.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -1.055 . . . . 0.0 109.989 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -156.99 -178.14 30.77 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.0 t -120.41 137.88 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.394 -1.062 . . . . 0.0 110.04 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -101.41 136.03 41.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.67 137.92 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.389 -0.819 . . . . 0.0 109.97 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 69.2 p -101.67 149.23 24.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.204 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 52.6 p -93.47 -3.57 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -115.24 146.53 41.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.653 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -172.39 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -120.74 89.68 0.45 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 46.6 t -82.93 -0.45 48.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -1.046 . . . . 0.0 110.666 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.2 t -57.24 -34.78 68.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 92.7 m95 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 179.97 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.87 64.17 6.91 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.251 -1.147 . . . . 0.0 110.485 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 159.75 52.55 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.813 1.428 . . . . 0.0 110.575 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.29 148.12 15.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.52 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -63.55 155.64 28.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -0.817 . . . . 0.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.69 22.63 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 38.3 m -89.49 147.04 24.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.429 -1.042 . . . . 0.0 110.688 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -56.65 -27.91 59.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.521 -0.737 . . . . 0.0 110.514 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -52.8 -35.72 57.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.707 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 -81.79 128.79 34.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.448 -0.782 . . . . 0.0 109.182 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 152' ' ' LEU . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.662 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HE2' HD22 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.446 ' CG2' HD22 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.79 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.79 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.862 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.446 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.707 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.648 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.578 ' CD2' ' HE1' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 162' ' ' THR . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 80' ' ' PHE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 153' ' ' MET . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.742 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 119' ' ' PHE . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.707 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.449 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm -50.17 -34.32 22.13 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.248 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.35 -26.45 35.18 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.769 1.405 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.42 -36.33 75.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 0.0 110.364 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 142.58 58.62 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 29.3 t -110.42 146.22 36.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -1.024 . . . . 0.0 110.058 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.9 m -107.85 136.03 48.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.0 150.04 39.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.122 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.28 139.43 58.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.026 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -142.69 141.37 31.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.384 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 21.2 tp -105.73 126.72 52.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -127.11 123.87 37.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.394 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.19 -29.52 67.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.208 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.14 68.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 110.969 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -104.6 149.83 25.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.127 -0.983 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -138.25 171.84 13.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 14.9 t -133.8 141.67 47.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 111.355 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.88 140.69 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.7 . . . . 0.0 109.352 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 82.5 p -147.72 162.46 39.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.081 -1.012 . . . . 0.0 111.063 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.01 44.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.679 . . . . 0.0 109.715 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -97.04 136.07 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.172 -0.955 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -162.7 129.38 2.45 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.69 -18.58 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.612 1.322 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -96.44 168.22 10.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.129 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 7.6 m-30 -46.89 156.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.049 0.928 . . . . 0.0 112.007 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 57.0 m -56.69 -36.14 69.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.814 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.13 -179.03 0.53 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 7.0 mt 71.39 44.71 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -135.57 81.22 1.88 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.241 -1.537 . . . . 0.0 108.733 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.472 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 11.9 mp0 -82.49 18.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.088 0.947 . . . . 0.0 109.757 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.575 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.2 p -46.25 169.62 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.254 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.5 Cg_endo -70.3 -55.04 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.313 1.691 . . . . 0.0 108.672 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 73.8 mttt -160.89 -15.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.569 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.54 26.81 7.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.99 39.41 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.812 -178.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.77 153.97 59.0 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.791 1.416 . . . . 0.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' B' ' 724' ' ' GLN . . . -152.19 -147.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.078 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' B' ' 723' ' ' ALA . 92.3 mt-30 58.58 48.59 11.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.311 -0.868 . . . . 0.0 110.543 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -73.26 125.03 26.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.259 -0.901 . . . . 0.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -137.74 141.75 40.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.844 . . . . 0.0 110.038 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 77.8 mt -88.07 8.33 27.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.794 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -63.23 -21.82 66.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.657 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -66.53 142.63 57.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.173 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.0 t -123.44 77.22 54.25 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.81 156.48 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.781 1.411 . . . . 0.0 110.299 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -56.55 148.73 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 87.3 p -103.48 154.14 19.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -149.9 -138.31 2.89 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.14 134.56 41.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -1.049 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -81.84 -174.16 49.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.16 130.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.291 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -168.39 132.89 1.64 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.474 -0.766 . . . . 0.0 110.086 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.18 153.42 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.2 m -124.82 137.53 54.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.196 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 27.2 t -132.38 148.08 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 125.3 34.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.949 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -165.66 174.45 9.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.082 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.52 9.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 29.2 t -108.75 87.38 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -1.202 . . . . 0.0 109.993 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 74.1 m -86.55 5.52 35.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.348 -0.845 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.247 -179.835 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.36 142.8 31.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.204 -1.174 . . . . 0.0 110.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.53 168.02 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.708 1.373 . . . . 0.0 110.462 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.15 146.63 18.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -90.14 135.5 33.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.563 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 86.63 178.49 49.33 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 64.1 p -99.99 -0.38 39.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -1.033 . . . . 0.0 110.6 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -127.02 152.65 46.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.84 172.03 15.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 110.144 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.401 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 31.3 ptt180 -110.34 150.69 28.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 152' ' ' LEU . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.626 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD21 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HE2' HD13 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.489 ' CG2' HG21 ' A' ' 112' ' ' ILE . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.795 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' N ' HD22 ' A' ' 40' ' ' LEU . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 HD22 ' CG2' ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.795 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.858 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.489 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.444 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.63 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.532 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.629 HD12 ' HG2' ' B' ' 713' ' ' PRO . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.416 ' HE1' HG23 ' A' ' 162' ' ' THR . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 179' ' ' TYR . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.416 HG23 ' HE1' ' A' ' 153' ' ' MET . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.532 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.63 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -50.04 144.38 6.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.216 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.63 149.64 73.94 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.751 1.395 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.52 138.59 32.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -0.81 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 94.68 -167.89 27.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 56.3 p -70.29 161.61 30.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -1.078 . . . . 0.0 110.55 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 55.6 m -119.16 141.04 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 0.0 109.894 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.04 141.75 55.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.293 -0.879 . . . . 0.0 110.569 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.31 149.5 27.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.772 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.25 136.6 58.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 79.3 mt -92.49 3.96 54.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.811 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.99 141.99 54.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.02 -1.05 . . . . 0.0 110.207 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -133.49 164.53 26.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 110.202 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -112.28 148.16 34.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . 0.41 ' HG3' ' CG2' ' B' ' 702' ' ' THR . 22.7 pt-20 -108.57 164.6 12.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.475 -0.766 . . . . 0.0 109.828 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 23.8 p-10 -81.72 100.38 9.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.21 -0.931 . . . . 0.0 111.451 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 702' ' ' THR . . . . . 0.41 ' CG2' ' HG3' ' B' ' 700' ' ' GLU . 34.0 p -126.87 142.39 51.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.88 123.64 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.625 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 53.0 p -97.45 -3.09 40.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.409 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.04 72.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 0.0 110.903 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.82 136.02 57.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.246 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -157.16 72.69 4.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 110.39 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.2 154.18 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.632 1.333 . . . . 0.0 110.329 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -55.96 146.46 22.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 8.6 m-30 -110.44 149.53 30.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.226 1.012 . . . . 0.0 112.478 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 83.6 m -60.34 -34.14 73.4 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.793 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -175.63 179.87 0.41 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.193 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.793 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' B' ' 713' ' ' PRO . 5.5 mp 74.46 36.09 0.66 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.527 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -137.3 77.4 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.418 -1.426 . . . . 0.0 107.411 177.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . 0.603 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 27.8 mp0 -76.67 18.39 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.879 0.847 . . . . 0.0 110.091 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.515 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.7 p -52.62 167.4 0.38 Allowed Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' B' ' 719' ' ' LYS . 36.7 Cg_endo -70.22 -51.47 0.34 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.143 1.601 . . . . 0.0 108.641 176.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 10.3 mtmt -164.38 -14.53 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.2 m 56.89 26.52 11.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -175.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' B' ' 719' ' ' LYS . . . -138.57 161.84 56.46 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.742 -178.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.7 126.09 11.73 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.545 1.287 . . . . 0.0 109.896 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -113.7 143.56 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.55 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -120.49 139.31 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.81 . . . . 0.0 110.01 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -130.63 148.76 52.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.95 126.86 51.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.857 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' B' ' 729' ' ' LYS . 27.4 tp -60.46 -38.8 85.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.514 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . 57.56 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.362 -0.836 . . . . 0.0 110.205 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' B' ' 727' ' ' LEU . 60.1 tttp -130.24 139.91 50.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.98 140.19 86.98 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.376 -0.828 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.91 -36.66 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.992 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.01 140.14 56.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 95.8 p -122.14 151.35 41.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.35 96.98 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.6 tp -111.51 128.39 56.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.232 -1.158 . . . . 0.0 110.403 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -90.34 178.91 43.34 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.26 153.34 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -1.143 . . . . 0.0 110.234 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -115.89 147.83 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.171 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.29 153.89 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 35.6 m -125.24 138.69 54.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 93.8 p -126.26 153.71 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.08 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -58.67 -37.44 76.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.362 -0.837 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.84 -36.4 74.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -64.48 145.63 49.69 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.4 m -121.32 150.45 41.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.994 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.9 t -111.95 142.76 43.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.822 . . . . 0.0 110.035 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.17 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -65.01 141.7 98.46 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.094 . . . . 0.0 110.223 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.65 137.43 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.686 1.361 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -113.41 131.52 55.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 110.208 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -115.0 137.83 51.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 171.05 37.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.319 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 30.5 m -58.4 -40.79 83.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.996 -1.296 . . . . 0.0 109.54 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -58.11 -35.58 71.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 109.661 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -75.67 134.05 40.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.664 -0.648 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 -53.39 145.98 13.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.29 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 152' ' ' LEU . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.66 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.726 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 HD12 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HB3' ' CD2' ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' CG2' HD22 ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' HD1' ' HB3' ' A' ' 86' ' ' HIS . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' CD1' ' N ' ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.863 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.485 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HB3' HD13 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 165' ' ' TYR . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.453 ' HE1' HG23 ' A' ' 162' ' ' THR . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 179' ' ' TYR . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.453 HG23 ' HE1' ' A' ' 153' ' ' MET . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.77 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CD2' ' CE1' ' A' ' 150' ' ' PHE . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -49.81 -34.67 20.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.19 -179.987 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 149.65 68.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.791 1.417 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.7 tp -94.7 127.71 40.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.075 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.35 -122.61 29.84 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.6 p -68.54 166.58 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -1.099 . . . . 0.0 109.545 179.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 65.1 p -63.64 146.91 52.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.832 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.18 -56.49 2.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -113.26 128.24 56.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 695' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' B' ' 695' ' ' ASP . 26.8 p-10 -67.42 -33.22 74.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 110.545 179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.81 147.02 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.46 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.85 140.61 45.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 110.167 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -110.01 149.07 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.475 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -71.22 158.32 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.928 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.64 142.68 32.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.3 -0.875 . . . . 0.0 110.185 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -143.42 170.06 16.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.433 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.9 p -123.29 161.38 24.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.83 141.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.025 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 54.7 p -78.62 155.15 29.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 110.351 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -111.78 143.29 42.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.092 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -167.82 30.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.338 -0.851 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 75.87 78.33 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.47 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.48 -21.29 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.756 1.398 . . . . 0.0 110.004 179.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.35 168.68 11.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.988 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -49.59 139.2 12.82 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.69 0.757 . . . . 0.0 111.587 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 47.5 m -71.46 -38.29 71.29 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.037 0.922 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 712' ' ' HIS . . . . . 0.882 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -174.0 -176.26 0.29 Allowed Pre-proline 0 C--N 1.301 -1.528 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 713' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 714' ' ' LEU . . . . . 0.726 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 8.5 mt 68.02 46.22 1.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 715' ' ' CYS . . . . . 0.527 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.84 77.02 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.186 -1.571 . . . . 0.0 108.964 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -82.86 18.63 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.217 1.008 . . . . 0.0 109.238 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 717' ' ' CYS . . . . . 0.584 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.0 p -46.14 170.12 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.692 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 718' ' ' PRO . . . . . 0.584 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -72.83 -54.31 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.529 1.805 . . . . 0.0 108.972 176.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 719' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 52.0 mtpt -160.75 -14.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.6 m 58.22 27.47 15.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -95.38 168.47 10.91 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.006 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.8 145.4 62.67 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.645 1.34 . . . . 0.0 110.549 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -141.95 151.67 42.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.138 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -85.25 -1.84 57.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.358 -0.839 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -79.39 141.86 36.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -138.73 161.05 38.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.442 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 75.8 mt -84.13 150.57 25.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.783 . . . . 0.0 109.927 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -58.17 140.68 52.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 110.339 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -96.48 147.05 24.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 110.104 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.2 m -54.84 149.9 21.08 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.271 -0.893 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 -21.14 43.79 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.739 1.389 . . . . 0.0 110.859 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.51 127.22 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 83.9 p -142.88 158.6 43.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.25 -169.9 43.04 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 9.1 tt -93.1 125.41 37.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -1.009 . . . . 0.0 110.041 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.29 -169.16 52.48 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.88 149.08 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 110.013 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 21.3 m120 53.26 38.56 27.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.369 -0.832 . . . . 0.0 109.98 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.28 172.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 59.8 p -62.48 148.61 45.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 43.5 t -142.51 125.45 16.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.623 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -140.91 154.03 45.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 110.051 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -84.91 138.89 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 85.14 -173.39 48.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 1.8 t -128.12 141.24 51.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.005 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 31.0 t -75.59 -84.19 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.068 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 98.0 m95 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.562 -179.529 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.022 0.439 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 33' ' ' HIS . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.933 HD23 HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.704 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.81 HD11 HD21 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.729 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 84' ' ' LEU . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.769 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 12' ' ' PRO . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 49' ' ' LEU . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' HB2' HD23 ' A' ' 35' ' ' LEU . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 84' ' ' LEU . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.734 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.769 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.409 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.954 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.589 ' CG1' HG23 ' A' ' 160' ' ' VAL . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.589 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 152' ' ' LEU . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.656 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.834 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.834 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 152' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.456 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 34' ' ' ILE . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.701 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.802 HD23 HD13 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.99 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.472 HD11 HD11 ' B' ' 714' ' ' LEU . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.946 HG22 HD21 ' A' ' 84' ' ' LEU . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 84' ' ' LEU . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.946 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.766 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.887 HD11 HD12 ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.497 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 128' ' ' PHE . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.763 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' A' ' 152' ' ' LEU . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.813 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.813 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.867 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.99 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.5 mt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 31' ' ' ILE . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.694 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.898 HD23 HD23 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.798 HD11 HD21 ' B' ' 714' ' ' LEU . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.409 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.824 HG22 HD21 ' A' ' 84' ' ' LEU . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG13 HD13 ' A' ' 84' ' ' LEU . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.43 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.808 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.654 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.875 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.941 HD11 HD22 ' B' ' 714' ' ' LEU . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.541 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.541 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.784 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.784 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.823 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.823 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.941 HD22 HD11 ' A' ' 152' ' ' LEU . 3.3 mp . . . . . 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.422 ' HB3' HG12 ' A' ' 34' ' ' ILE . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.661 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.822 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.864 HD23 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.887 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.709 HG22 ' CD2' ' A' ' 84' ' ' LEU . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.776 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 84' ' ' LEU . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.776 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.888 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.888 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.624 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.822 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.99 HD11 HD12 ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.772 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.624 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.78 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.78 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.87 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.99 HD12 HD11 ' A' ' 152' ' ' LEU . 10.7 mt . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.573 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 120.48 0.181 . . . . 0.0 111.188 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.702 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.952 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.548 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.927 HD11 HD21 ' B' ' 714' ' ' LEU . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD21 ' A' ' 84' ' ' LEU . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.428 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.918 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.622 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.901 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.044 HD11 HD22 ' B' ' 714' ' ' LEU . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 160' ' ' VAL . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 155' ' ' ILE . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.667 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 152' ' ' LEU . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.768 HD12 HG12 ' A' ' 172' ' ' VAL . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 167' ' ' LEU . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 152' ' ' LEU . 2.5 mp . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 HD23 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.719 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.839 HD23 HD23 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.692 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 714' ' ' LEU . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 3' ' ' VAL . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.832 HG22 HD21 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.812 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.541 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.812 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.886 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.977 HD11 HD22 ' B' ' 714' ' ' LEU . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.531 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.44 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 152' ' ' LEU . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.799 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.861 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.861 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 152' ' ' LEU . 4.3 mp . . . . . 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.451 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.864 0.364 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.703 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 26' ' ' LEU . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.034 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 714' ' ' LEU . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.717 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.527 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.436 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.518 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.74 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.714 HD11 ' CD1' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 155' ' ' ILE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.518 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 152' ' ' LEU . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.696 HG12 HD12 ' A' ' 167' ' ' LEU . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.034 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.5 mt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.077 0.465 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 31' ' ' ILE . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.654 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.936 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.901 HD23 HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 30' ' ' LYS . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.839 HD11 HD21 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.75 HG22 ' CD2' ' A' ' 84' ' ' LEU . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.777 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.55 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.75 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.777 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.658 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.936 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.948 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 160' ' ' VAL . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.669 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.669 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.848 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.948 HD22 ' CD1' ' A' ' 152' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 31' ' ' ILE . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 132' ' ' PRO . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.727 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.84 HD23 HD23 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 30' ' ' LYS . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.677 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 HD21 ' B' ' 714' ' ' LEU . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 57' ' ' HIS . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.4 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 HD21 ' A' ' 84' ' ' LEU . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.837 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.895 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.557 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.511 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 131' ' ' ASN . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.769 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.716 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.973 HD11 HD22 ' B' ' 714' ' ' LEU . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.571 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.511 HG21 ' HE1' ' A' ' 128' ' ' PHE . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.795 ' CE2' HD12 ' A' ' 152' ' ' LEU . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.769 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.807 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.595 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.807 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.973 HD22 HD11 ' A' ' 152' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.48 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.995 0.426 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.426 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.67 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.803 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.73 HD23 HD13 ' B' ' 714' ' ' LEU . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.9 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.739 ' HB2' HG22 ' A' ' 3' ' ' VAL . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 84' ' ' LEU . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.536 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.498 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.673 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.803 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.84 HD21 ' CD1' ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.48 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.408 HG21 ' HE1' ' A' ' 128' ' ' PHE . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.673 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.773 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.773 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.905 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.905 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.9 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.5 mt . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 34' ' ' ILE . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.687 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.919 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HD11 ' B' ' 714' ' ' LEU . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.762 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.787 HG22 ' CD2' ' A' ' 84' ' ' LEU . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.498 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 HD13 ' A' ' 84' ' ' LEU . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.432 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.787 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.643 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.688 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.745 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.813 HD11 HD12 ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 155' ' ' ILE . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.418 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.75 ' CE2' HD12 ' A' ' 152' ' ' LEU . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.663 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.663 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' B' ' 712' ' ' HIS . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.919 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.0 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.696 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.821 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.861 HD23 HD13 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 27' ' ' VAL . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.904 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HD11 ' B' ' 714' ' ' LEU . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.518 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.679 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.821 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.98 HD11 HD12 ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.572 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.572 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.402 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.744 ' CE2' HD12 ' A' ' 152' ' ' LEU . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.679 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.659 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 167' ' ' LEU . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.659 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.847 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 152' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 713' ' ' PRO . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD13 HD21 ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.693 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.788 HD23 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.703 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.405 HD13 HD22 ' A' ' 4' ' ' LEU . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.696 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 HD21 ' A' ' 84' ' ' LEU . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.592 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 45' ' ' SER . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' HD22 ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.512 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.83 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.05 HD11 HD22 ' B' ' 714' ' ' LEU . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.542 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.542 HG23 HG12 ' A' ' 155' ' ' ILE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 173' ' ' LYS . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 167' ' ' LEU . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.69 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.05 HD22 HD11 ' A' ' 152' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.749 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.764 HG22 ' CD2' ' A' ' 84' ' ' LEU . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.449 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.764 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.779 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.622 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.419 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.863 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.055 HD11 HD22 ' B' ' 714' ' ' LEU . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 155' ' ' ILE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.428 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.732 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.797 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.782 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.782 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.494 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.8 mttm . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.805 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.805 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 152' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.723 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.856 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.853 HD23 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 26' ' ' LEU . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.947 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.508 HD11 HD11 ' B' ' 714' ' ' LEU . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' HD22 ' A' ' 40' ' ' LEU . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.866 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.766 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.836 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.915 HD11 HD12 ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.456 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.754 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.737 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.634 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' B' ' 712' ' ' HIS . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.851 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.947 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.3 ptt85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.849 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.947 HD23 HD23 ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HD21 ' B' ' 714' ' ' LEU . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.75 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 HD21 ' A' ' 84' ' ' LEU . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.804 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.023 HD11 HD22 ' B' ' 714' ' ' LEU . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 160' ' ' VAL . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.56 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.703 ' CE1' HD12 ' A' ' 152' ' ' LEU . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.714 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.804 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 167' ' ' LEU . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.804 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.4 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.845 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.023 HD22 HD11 ' A' ' 152' ' ' LEU . 2.2 mp . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.09 0.471 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.945 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.955 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.792 HG22 HD21 ' A' ' 84' ' ' LEU . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.495 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.795 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.435 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.792 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.7 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.876 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.958 HD11 HD22 ' B' ' 714' ' ' LEU . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 160' ' ' VAL . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 155' ' ' ILE . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.683 ' CE1' HD12 ' A' ' 152' ' ' LEU . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.7 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.783 HD12 ' HD2' ' A' ' 173' ' ' LYS . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.872 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 152' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.442 ' HB2' HG21 ' A' ' 31' ' ' ILE . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.439 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.2 m-70 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.439 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.712 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.902 ' HE2' HD23 ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG21 ' HB2' ' A' ' 4' ' ' LEU . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.72 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HD21 ' A' ' 84' ' ' LEU . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 49' ' ' LEU . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.807 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.578 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 25' ' ' LEU . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' B' ' 714' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.441 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.534 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.416 HG21 ' HE1' ' A' ' 128' ' ' PHE . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.67 ' CE2' HD12 ' A' ' 152' ' ' LEU . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.45 HG21 ' HE1' ' A' ' 22' ' ' PHE . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 160' ' ' VAL . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.896 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.896 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.902 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.391 0.615 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.696 HD23 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.024 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 HD11 ' B' ' 714' ' ' LEU . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.842 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.516 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.842 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.537 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.805 HD11 HD12 ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 155' ' ' ILE . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.425 HG21 ' HE1' ' A' ' 128' ' ' PHE . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.719 ' CE2' HD12 ' A' ' 152' ' ' LEU . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 172' ' ' VAL . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.673 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.857 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.024 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.711 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.1 m-70 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.824 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.954 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 4' ' ' LEU . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.704 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HD21 ' A' ' 84' ' ' LEU . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.795 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.879 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.577 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.804 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 165' ' ' TYR . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.562 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.479 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.48 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.804 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.79 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 167' ' ' LEU . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.79 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.4 mttm . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.859 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.954 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.1 mt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.989 0.423 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.563 ' HA ' HD23 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.699 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.575 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.786 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.918 HD23 HD13 ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.7 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 4' ' ' LEU . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.746 ' HB2' HG22 ' A' ' 3' ' ' VAL . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.84 HG22 HD21 ' A' ' 84' ' ' LEU . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.493 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.419 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.786 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.882 HD11 ' CD1' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.774 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.765 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 172' ' ' VAL . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.765 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.918 HD13 HD23 ' A' ' 26' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.447 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.683 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' CD1' ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.013 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.496 HD11 HD11 ' B' ' 714' ' ' LEU . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.817 HG22 HD21 ' A' ' 84' ' ' LEU . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.605 HD23 ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 160' ' ' VAL . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 155' ' ' ILE . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.7 mttm . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.909 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.909 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.013 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.6 mt . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.694 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 31' ' ' ILE . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.824 HD23 HD13 ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.923 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 HD11 HD11 ' B' ' 714' ' ' LEU . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 HD21 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.424 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.509 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.808 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.723 HD21 HD11 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 160' ' ' VAL . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.694 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 155' ' ' ILE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.49 HG21 ' HE1' ' A' ' 128' ' ' PHE . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.774 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 167' ' ' LEU . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.777 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.826 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.826 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.923 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.191 0.52 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 31' ' ' ILE . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.68 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.779 HD23 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 4' ' ' LEU . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.806 HG22 HD21 ' A' ' 84' ' ' LEU . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.81 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.43 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.806 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.81 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.67 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 25' ' ' LEU . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.079 HD11 HD22 ' B' ' 714' ' ' LEU . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.411 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 152' ' ' LEU . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.67 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.803 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 46.9 mttm . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.818 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 152' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 0' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HB3' HG12 ' A' ' 34' ' ' ILE . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' PRO . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 HD13 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.995 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 HD11 ' B' ' 714' ' ' LEU . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.823 HG22 ' CD2' ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.823 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.811 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.893 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.893 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.573 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HG3' HG12 ' A' ' 5' ' ' VAL . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.756 HD11 HD12 ' B' ' 714' ' ' LEU . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.573 HG21 ' HE1' ' A' ' 128' ' ' PHE . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.799 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.715 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.734 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.801 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 172' ' ' VAL . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.801 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 714' ' ' LEU . . . . . 0.995 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.5 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.0 p -117.71 157.84 46.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -1.099 . . . . 0.0 110.244 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.96 136.57 32.8 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.768 1.404 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.99 -38.53 91.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.878 . . . . 0.0 110.358 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' PHE . . . . . 0.443 ' CD2' ' N ' ' A' ' -4' ' ' GLY . 30.2 t80 -137.2 161.59 35.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.047 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' -5' ' ' PHE . . . -66.82 -69.96 1.24 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -3' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' -5' ' ' PHE . 63.9 p -122.72 163.16 20.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -115.77 133.38 56.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 0.0 110.417 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -117.32 18.06 14.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 -54.84 140.25 37.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.891 . . . . 0.0 110.916 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 33' ' ' HIS . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.933 HD23 HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.704 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.81 HD11 HD21 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.729 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 84' ' ' LEU . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.769 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 12' ' ' PRO . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 49' ' ' LEU . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' HB2' HD23 ' A' ' 35' ' ' LEU . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 84' ' ' LEU . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.734 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.769 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.409 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.954 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.589 ' CG1' HG23 ' A' ' 160' ' ' VAL . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.589 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 152' ' ' LEU . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.656 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm -50.61 -34.34 25.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.48 148.19 66.36 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.789 1.415 . . . . 0.0 110.532 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.72 -35.84 77.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 0.0 110.28 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -96.57 119.58 6.37 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 88.3 p -62.24 -25.87 68.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -1.108 . . . . 0.0 110.334 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 76.4 p -65.33 133.13 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.3 -32.92 72.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -0.806 . . . . 0.0 110.75 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -98.48 136.81 38.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.711 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -169.85 28.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.1 mt -100.52 125.58 46.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.165 -0.959 . . . . 0.0 110.347 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.74 -38.48 73.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -132.51 123.8 27.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.33 -0.856 . . . . 0.0 110.24 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.15 83.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.418 -0.802 . . . . 0.0 110.726 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -127.92 149.31 50.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 110.87 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -100.58 170.26 8.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.0 110.22 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 43.0 p -117.6 161.59 19.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.9 152.64 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 84.7 p -148.24 157.21 43.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -76.06 -58.46 3.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -153.89 152.4 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.39 74.61 80.82 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.17 144.42 51.78 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.784 1.412 . . . . 0.0 110.544 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.6 149.19 30.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -109.61 132.6 53.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 111.646 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.0 m -90.17 -46.29 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.294 1.045 . . . . 0.0 108.44 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.834 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -159.77 -178.74 0.94 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.834 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 152' ' ' LEU . 3.5 mp 68.72 37.57 2.41 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.73 77.9 1.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.539 -1.35 . . . . 0.0 108.54 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.6 16.85 1.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.968 0.89 . . . . 0.0 109.796 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.626 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.9 p -45.69 171.56 0.05 OUTLIER Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.394 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.05 -54.99 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.34 1.705 . . . . 0.0 108.767 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 18.9 mttp -160.9 -14.08 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.727 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' H ' ' H ' ' B' ' 719' ' ' LYS . 19.7 m 56.98 26.8 12.3 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -70.63 151.2 95.45 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.4 -8.06 22.72 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.886 1.466 . . . . 0.0 111.243 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.71 114.85 2.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.087 -1.008 . . . . 0.0 110.3 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -146.51 -174.06 4.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 0.0 109.843 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.85 -37.67 69.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.198 -0.939 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -58.94 -35.25 72.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.839 . . . . 0.0 110.208 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.32 131.16 35.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -99.66 137.94 37.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -99.33 146.6 26.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 63.3 t -63.51 129.62 93.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.979 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.36 148.47 61.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.674 1.355 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -159.84 41.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.87 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.4 t -117.39 140.16 49.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.321 -0.862 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -79.3 -61.54 2.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.1 tp -99.84 133.17 44.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.422 -1.046 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -162.35 -168.45 24.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.82 -29.01 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -1.084 . . . . 0.0 110.411 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -54.9 -30.83 59.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.378 -0.826 . . . . 0.0 110.355 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.75 135.33 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 110.317 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.6 p -120.95 161.48 21.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 109.941 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.7 p -118.92 148.95 42.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.521 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -125.91 147.53 49.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.999 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.56 114.03 19.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.69 97.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 91.2 p -63.7 -36.18 83.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -63.75 -34.91 78.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.317 -0.864 . . . . 0.0 110.17 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.5 t90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.277 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.98 74.49 66.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.356 -1.085 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.13 60.16 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.714 1.376 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -112.09 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.387 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.23 133.46 51.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -136.95 170.96 23.26 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 50.8 m -89.81 132.56 35.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -1.154 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -121.54 20.57 11.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.737 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -53.49 -36.16 61.39 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.198 -0.939 . . . . 0.0 110.125 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.456 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 -119.49 149.64 41.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 109.037 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 34' ' ' ILE . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.701 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.802 HD23 HD13 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.99 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.472 HD11 HD11 ' B' ' 714' ' ' LEU . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.946 HG22 HD21 ' A' ' 84' ' ' LEU . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 84' ' ' LEU . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.946 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.766 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.887 HD11 HD12 ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.497 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 128' ' ' PHE . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.763 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' A' ' 152' ' ' LEU . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.813 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.813 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.15 -34.47 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.549 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.22 -27.61 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.735 1.387 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.57 143.14 31.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.818 . . . . 0.0 109.926 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.69 -176.4 51.42 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 44.3 m -63.16 152.41 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -1.084 . . . . 0.0 110.284 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 44.6 m -59.09 -38.4 79.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 110.28 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.85 152.65 30.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.87 129.34 55.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -65.22 -35.84 82.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.375 -0.828 . . . . 0.0 110.5 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.36 -34.76 72.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.385 -0.822 . . . . 0.0 110.959 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -109.11 151.5 26.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.971 . . . . 0.0 110.587 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -141.72 173.06 11.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 110.041 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -98.91 134.89 41.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -105.11 139.25 40.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 109.652 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -104.61 165.42 11.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 68.8 p -109.12 -146.69 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.71 145.32 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.982 -1.074 . . . . 0.0 110.383 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 28.5 m -59.48 -28.36 66.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.18 47.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 0.0 110.691 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.65 146.04 37.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.34 162.5 31.86 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.351 -0.843 . . . . 0.0 110.406 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.95 152.59 68.39 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.907 1.477 . . . . 0.0 110.51 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -104.2 153.85 20.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 0.0 110.469 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -97.31 134.63 40.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.78 . . . . 0.0 111.425 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 46.8 m -76.45 -38.08 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.994 0.902 . . . . 0.0 108.921 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.867 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 -171.05 -177.08 0.41 Allowed Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.99 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.5 mt 70.2 39.47 1.31 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.572 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -131.45 77.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.371 -1.456 . . . . 0.0 108.392 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -80.74 18.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.004 0.907 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.608 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -49.21 170.81 0.13 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.275 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -73.15 -54.04 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.367 1.72 . . . . 0.0 108.919 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 32.4 mttt -161.17 -14.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.873 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.7 m 57.35 27.4 13.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -118.59 151.33 49.66 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.95 131.46 18.26 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.663 1.349 . . . . 0.0 110.485 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -156.67 146.88 21.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 110.186 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -131.68 156.42 45.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.394 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -59.55 -35.18 73.74 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.372 -0.83 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -77.26 157.57 30.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.513 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.542 ' C ' HD23 ' B' ' 727' ' ' LEU . 7.8 tt -84.71 131.02 34.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 109.805 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 728' ' ' ALA . . . . . 0.481 ' N ' HD23 ' B' ' 727' ' ' LEU . . . -143.65 158.88 43.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -91.12 146.75 23.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 109.98 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.31 155.7 46.62 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 150.44 58.6 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.836 1.44 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.97 147.86 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.822 . . . . 0.0 109.974 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.9 p -64.82 161.68 17.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 734' ' ' GLY . . . . . 0.466 ' HA2' ' ND2' ' B' ' 738' ' ' ASN . . . 124.63 38.71 0.5 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.7 tp -100.22 133.47 44.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -1.063 . . . . 0.0 109.96 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.84 -105.08 2.16 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -128.24 139.12 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -1.152 . . . . 0.0 110.402 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 738' ' ' ASN . . . . . 0.466 ' ND2' ' HA2' ' B' ' 734' ' ' GLY . 11.8 p-10 -171.51 -152.47 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.66 138.27 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 109.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 14.9 t -128.42 161.95 28.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 29.5 t -75.58 133.88 40.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.67 -36.28 83.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.399 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -153.14 160.08 42.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -135.2 16.67 4.13 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.8 t -139.06 139.51 37.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.164 -1.198 . . . . 0.0 110.427 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 43.9 m -129.23 149.2 51.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.357 -0.84 . . . . 0.0 110.337 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.209 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 12.3 p -112.52 149.23 40.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.32 -1.106 . . . . 0.0 110.34 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -70.8 -17.97 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.868 1.457 . . . . 0.0 110.502 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -101.41 151.83 21.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.49 155.41 40.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -70.35 176.47 34.58 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 43.7 m -116.91 126.73 53.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -1.198 . . . . 0.0 110.546 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ARG . . . . . 0.462 ' HB3' ' OE1' ' A' ' 156' ' ' GLN . 97.8 mtt180 -144.78 151.84 39.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 156' ' ' GLN . 58.1 t0 -86.6 115.98 24.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.188 -0.945 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -135.42 155.56 50.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.861 . . . . 0.0 109.845 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 31' ' ' ILE . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.898 HD23 HD23 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.798 HD11 HD21 ' B' ' 714' ' ' LEU . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.409 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.824 HG22 HD21 ' A' ' 84' ' ' LEU . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG13 HD13 ' A' ' 84' ' ' LEU . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.43 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.808 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.654 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.875 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.941 HD11 HD22 ' B' ' 714' ' ' LEU . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.541 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' -2' ' ' ARG . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.541 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.784 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.784 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.21 144.56 7.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.336 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.12 -17.18 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.81 1.426 . . . . 0.0 110.691 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.1 145.29 27.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -83.24 179.38 52.74 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.9 m -76.82 158.36 30.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.539 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 5.1 m -98.79 157.19 16.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.777 . . . . 0.0 109.735 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.16 147.15 7.92 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.905 . . . . 0.0 110.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.96 -37.22 73.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -109.09 105.61 15.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.999 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.32 -38.46 91.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.28 -0.888 . . . . 0.0 110.519 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.08 148.63 28.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.806 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -52.89 -36.34 59.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.0 110.451 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -89.77 137.53 32.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.08 -32.35 73.7 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.35 -174.66 3.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.952 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 52.1 p -119.74 151.81 38.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.9 143.7 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.131 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 4.9 m -131.37 49.77 2.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.53 45.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.12 73.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.12 72.16 70.6 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 169.22 22.51 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.743 1.391 . . . . 0.0 110.177 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.74 146.88 15.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -107.67 134.39 50.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 111.83 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.4 m -79.4 -47.67 15.32 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.231 1.015 . . . . 0.0 108.666 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.823 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER -155.54 -178.93 0.97 Allowed Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.823 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.941 HD22 HD11 ' A' ' 152' ' ' LEU . 3.3 mp 71.88 41.69 0.66 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -134.23 79.38 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.352 -1.467 . . . . 0.0 108.479 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.66 16.83 1.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.607 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.2 p -47.54 170.51 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.324 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.19 -54.26 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.403 1.739 . . . . 0.0 108.904 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 18.5 mttp -161.7 -13.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.859 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.3 m 56.92 27.64 13.4 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -123.95 161.4 47.04 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.033 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -77.06 -65.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -165.4 141.6 5.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -115.43 137.01 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.37 142.27 27.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -65.21 156.92 30.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.97 129.89 36.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -174.69 135.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.428 -0.795 . . . . 0.0 109.943 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -93.69 -68.14 0.82 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 110.148 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.556 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -147.51 122.39 5.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.53 144.71 56.17 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.523 1.275 . . . . 0.0 110.65 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -171.05 94.03 0.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 29.7 t -124.25 143.53 50.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 0.0 110.389 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -154.6 123.51 1.38 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.9 -39.65 82.13 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -1.075 . . . . 0.0 110.28 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.49 -29.62 69.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.3 129.53 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.303 -1.116 . . . . 0.0 110.541 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -125.17 19.7 8.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.71 142.61 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.295 -0.878 . . . . 0.0 110.103 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 57.1 p -68.45 157.76 35.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.372 -0.83 . . . . 0.0 110.02 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 741' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 83.9 p -141.01 167.41 22.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.445 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 742' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' B' ' 741' ' ' SER . 92.2 mt-30 57.82 43.78 21.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.442 -0.786 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -123.23 119.65 30.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.174 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 91.77 4.7 67.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 49.1 m -121.97 148.05 45.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -1.228 . . . . 0.0 110.184 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 93.9 p -134.0 158.35 43.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.279 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.118 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 6.4 m 53.5 64.48 6.78 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.333 -1.098 . . . . 0.0 110.4 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 144.14 49.87 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.782 1.412 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.28 -27.98 67.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.211 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.3 148.94 25.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.412 -0.805 . . . . 0.0 110.361 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 118.57 114.79 2.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 61.9 m -120.39 135.93 54.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 110.718 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.78 123.96 48.42 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' -1' ' ' ASP . 53.5 p30 -116.64 148.0 41.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 -113.2 121.71 45.3 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' HB3' HG12 ' A' ' 34' ' ' ILE . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.661 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.822 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.864 HD23 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.887 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.709 HG22 ' CD2' ' A' ' 84' ' ' LEU . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.776 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 84' ' ' LEU . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.776 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.888 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.888 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.624 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.822 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.99 HD11 HD12 ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.772 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.624 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.78 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.78 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -50.48 -34.58 25.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.338 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.33 -23.5 38.37 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.728 1.383 . . . . 0.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.1 -37.42 74.5 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -56.75 -25.46 51.74 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 23.7 m -55.13 -34.23 63.56 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -1.058 . . . . 0.0 110.709 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 64.4 p -82.98 156.84 23.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -121.04 153.63 37.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.388 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.12 143.17 57.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.362 -0.836 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.36 167.69 21.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.0 110.158 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 82.0 mt -71.17 147.8 47.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.843 . . . . 0.0 110.098 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.16 140.26 53.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.274 -0.891 . . . . 0.0 110.409 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -92.48 5.08 52.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.433 -0.792 . . . . 0.0 110.805 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.02 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.108 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.94 42.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.843 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -78.39 94.03 4.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.297 -0.877 . . . . 0.0 110.348 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.6 m -122.24 149.16 44.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.117 -0.989 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.6 m -54.96 152.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.456 -0.778 . . . . 0.0 110.212 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 704' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' B' ' 705' ' ' ALA . 21.7 m -54.95 -39.53 69.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 110.747 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' B' ' 704' ' ' SER . . . 178.61 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.149 -0.97 . . . . 0.0 111.122 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.67 150.32 13.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.069 . . . . 0.0 110.457 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 707' ' ' ASP . . . . . 0.429 ' N ' ' CD ' ' B' ' 708' ' ' PRO . 4.0 p30 -130.38 53.84 12.89 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 707' ' ' ASP . 48.7 Cg_endo -74.24 141.84 29.61 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.629 1.331 . . . . 0.0 110.364 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 144.17 56.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 109.83 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 710' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' B' ' 708' ' ' PRO . 41.9 m-85 -122.5 136.11 54.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 111.368 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 34.9 m -92.79 -44.03 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.87 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -161.9 -177.88 0.77 Allowed Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.99 HD12 HD11 ' A' ' 152' ' ' LEU . 10.7 mt 70.07 43.54 0.88 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -129.95 79.01 1.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.256 -1.528 . . . . 0.0 109.643 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.14 19.35 1.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.106 0.955 . . . . 0.0 108.94 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.585 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.6 p -42.73 169.34 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.921 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.89 -55.62 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.564 1.823 . . . . 0.0 108.955 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.421 ' H ' ' H ' ' B' ' 720' ' ' CYS . 46.3 mttt -159.38 -14.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.624 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.421 ' H ' ' H ' ' B' ' 719' ' ' LYS . 18.9 m 56.57 26.99 11.7 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -79.09 158.92 74.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.277 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.18 138.95 40.96 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.769 1.405 . . . . 0.0 110.795 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -85.41 1.4 48.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -57.84 -34.09 69.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -85.56 140.71 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -123.61 145.85 48.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 86.7 mt -61.35 -36.1 79.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.81 148.0 29.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.411 -0.806 . . . . 0.0 110.193 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -85.88 144.7 27.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -65.38 131.42 94.95 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.996 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.31 140.87 41.59 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.708 1.372 . . . . 0.0 110.584 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -150.97 153.75 35.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.401 -0.812 . . . . 0.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 20.1 m -59.22 -39.24 82.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 52.27 -137.84 32.88 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 735' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 737' ' ' VAL . 86.5 mt -63.14 -32.17 73.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.452 -1.028 . . . . 0.0 110.258 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.45 55.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 737' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 735' ' ' LEU . 34.2 m -111.42 20.43 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -1.168 . . . . 0.0 110.465 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -73.88 157.17 36.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.887 . . . . 0.0 110.388 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.5 161.01 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 62.7 m -78.65 135.21 37.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.0 110.542 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -85.56 167.5 15.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.75 . . . . 0.0 110.017 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -85.03 107.8 17.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -94.75 122.42 37.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.297 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 141.74 64.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 22.7 t -58.42 -34.29 70.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -1.084 . . . . 0.0 110.268 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.5 t -117.94 138.76 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.114 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.1 m -125.61 74.82 69.85 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.307 -1.113 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 152.62 73.34 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.779 1.41 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.47 144.83 25.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.49 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.98 168.66 19.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 88.25 39.47 6.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 80.9 p -109.71 -167.52 1.21 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -1.043 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -50.24 141.91 10.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -168.25 178.36 4.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.082 . . . . 0.0 111.649 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.573 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 -45.93 139.48 4.28 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.188 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.702 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.952 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.548 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.927 HD11 HD21 ' B' ' 714' ' ' LEU . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD21 ' A' ' 84' ' ' LEU . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.428 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.918 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.622 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.901 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.044 HD11 HD22 ' B' ' 714' ' ' LEU . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 160' ' ' VAL . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 155' ' ' ILE . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.667 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 152' ' ' LEU . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.768 HD12 HG12 ' A' ' 172' ' ' VAL . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 167' ' ' LEU . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -50.55 -34.33 25.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.138 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.43 -17.69 43.9 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.843 1.444 . . . . 0.0 110.725 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.6 tp -55.96 -37.9 69.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 110.438 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 130.29 172.82 13.22 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.9 m -122.32 150.29 42.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.386 -1.067 . . . . 0.0 110.321 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 56.6 p -116.38 167.12 11.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.364 -0.835 . . . . 0.0 109.902 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.43 -36.13 75.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.9 135.08 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 110.22 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -105.01 145.1 30.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 110.293 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -102.44 139.12 38.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.232 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.72 -33.94 76.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -85.35 121.92 28.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -132.28 156.62 46.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -93.3 146.45 23.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.812 . . . . 0.0 110.037 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' B' ' 701' ' ' ASP . 31.4 p-10 -61.19 132.96 55.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 110.387 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.8 m -61.07 -34.61 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.538 HG12 ' H ' ' B' ' 705' ' ' ALA . 48.5 t -102.81 133.42 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 110.423 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 24.1 t -59.88 -29.97 68.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.538 ' H ' HG12 ' B' ' 703' ' ' VAL . . . -56.46 144.52 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.426 -0.797 . . . . 0.0 110.445 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.05 -130.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.468 -0.77 . . . . 0.0 109.745 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 140.46 85.76 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.2 119.91 6.62 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.624 1.328 . . . . 0.0 110.872 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -132.87 148.01 52.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.866 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.44 141.14 51.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 111.489 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.68 -40.09 12.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.115 0.96 . . . . 0.0 108.627 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 -166.45 -175.44 0.43 Allowed Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 152' ' ' LEU . 2.5 mp 67.1 44.15 1.98 Allowed 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.586 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.26 78.74 1.75 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.196 -1.565 . . . . 0.0 109.187 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.34 17.76 2.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.181 0.991 . . . . 0.0 109.401 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.63 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 26.5 p -44.33 172.41 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.914 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.8 Cg_endo -73.06 -55.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.406 1.74 . . . . 0.0 108.844 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 41.4 mtmt -159.74 -13.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.3 m 58.19 27.72 15.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.72 142.9 25.28 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.19 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.11 149.53 64.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.635 1.334 . . . . 0.0 110.335 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.25 58.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.095 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -134.24 161.83 33.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -79.05 147.65 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 109.916 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 63.9 mtp85 -60.76 142.56 55.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.276 -0.89 . . . . 0.0 110.735 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 50.3 tp -112.68 130.66 55.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.164 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.2 136.39 35.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -96.28 141.13 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.546 HG23 ' O ' ' B' ' 730' ' ' VAL . 34.4 m -126.74 69.71 71.78 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.441 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.52 145.8 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.702 1.369 . . . . 0.0 110.471 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -143.33 148.6 36.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.9 m 49.67 21.08 0.59 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.28 24.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.2 tp -58.19 -38.46 76.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.5 -1.0 . . . . 0.0 110.582 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 142.91 -167.67 26.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.44 129.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -1.137 . . . . 0.0 110.167 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -172.33 164.85 5.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 50.5 t -120.64 130.5 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.4 m -65.14 -36.87 85.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.367 -0.833 . . . . 0.0 110.47 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 33.0 t -85.39 151.13 24.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.435 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -94.7 115.26 27.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.27 136.58 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -86.53 -178.23 49.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.2 t -59.28 -35.83 74.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.336 -1.096 . . . . 0.0 110.138 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.9 m -121.79 148.07 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.063 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 64.3 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.208 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 60.6 p -123.01 161.2 45.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.407 -1.055 . . . . 0.0 110.227 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 145.16 59.19 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.77 1.405 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.07 144.5 55.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.8 . . . . 0.0 110.309 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.28 130.24 52.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.37 -0.831 . . . . 0.0 110.174 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -91.66 -178.05 42.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 39.2 m -60.93 -30.54 70.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.549 -0.971 . . . . 0.0 110.228 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -49.51 -23.75 1.74 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.41 -36.7 6.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.327 -0.858 . . . . 0.0 111.158 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 -65.02 142.93 58.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 0.0 109.577 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 HD23 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.719 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.839 HD23 HD23 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.692 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 714' ' ' LEU . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 3' ' ' VAL . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.832 HG22 HD21 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.812 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.541 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.812 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.886 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.977 HD11 HD22 ' B' ' 714' ' ' LEU . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.531 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.44 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 152' ' ' LEU . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.799 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm -49.99 144.46 6.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.27 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.99 146.93 66.61 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.729 1.384 . . . . 0.0 110.528 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.6 tp -98.95 129.19 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.355 -0.841 . . . . 0.0 110.264 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.36 47.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 26.3 m -61.59 -29.48 70.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.456 -1.026 . . . . 0.0 110.505 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 50.1 p -71.31 162.35 29.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 0.0 110.378 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.23 154.15 17.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.24 147.53 35.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.479 -0.763 . . . . 0.0 110.449 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.59 159.85 4.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.433 -0.792 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 22.6 tp -80.27 128.79 33.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.286 -0.884 . . . . 0.0 110.291 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -117.75 161.91 18.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.487 -0.758 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 698' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 699' ' ' ALA . 53.0 p30 -88.13 10.78 18.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -0.817 . . . . 0.0 110.704 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 699' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 698' ' ' ASP . . . 63.88 13.26 7.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.289 -0.882 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.03 145.9 50.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 110.11 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -109.69 123.02 48.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 0.0 110.335 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 50.9 m -124.34 135.65 53.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.236 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 705' ' ' ALA . 12.0 p -134.19 136.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 71.4 m -91.82 4.49 52.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.718 ' H ' HG22 ' B' ' 703' ' ' VAL . . . -101.62 138.97 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 0.0 110.555 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -102.59 8.87 39.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.82 . . . . 0.0 110.421 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -126.94 80.37 71.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 149.16 72.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.754 1.397 . . . . 0.0 110.709 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -88.8 149.1 23.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.434 -0.791 . . . . 0.0 109.874 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -113.17 137.4 51.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 0.0 111.986 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 72.2 m -102.55 -55.43 2.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.861 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -144.53 -177.97 0.73 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.861 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 152' ' ' LEU . 4.3 mp 72.1 39.72 0.77 Allowed 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.576 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -133.24 78.62 1.79 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.424 -1.423 . . . . 0.0 108.876 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.447 ' NE2' HG21 ' A' ' 27' ' ' VAL . 14.1 mp0 -83.84 17.79 2.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.123 0.963 . . . . 0.0 109.548 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.66 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.22 172.24 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.643 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.16 -55.25 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.495 1.787 . . . . 0.0 109.067 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.3 mttm -160.54 -13.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.885 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.5 m 56.92 26.84 12.22 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.6 49.57 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.628 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.38 163.34 39.42 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.742 1.391 . . . . 0.0 110.553 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -68.81 114.56 7.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -65.25 -33.88 77.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.423 -0.798 . . . . 0.0 111.014 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -91.56 150.5 21.16 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.907 . . . . 0.0 111.243 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -119.28 168.98 10.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 31.1 tp -81.15 120.5 24.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.13 58.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.408 -0.808 . . . . 0.0 111.129 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -72.87 140.8 47.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.121 -0.987 . . . . 0.0 110.572 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.9 m -122.42 162.57 37.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.994 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 42.4 Cg_endo -68.44 143.2 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.72 1.379 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -111.01 160.06 17.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.4 t -100.24 141.22 33.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.05 127.13 0.95 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.4 mt -97.39 144.79 26.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.301 -1.117 . . . . 0.0 110.23 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -153.82 -170.16 19.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.63 165.42 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.088 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -56.68 120.93 8.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 110.202 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 84.6 t -67.3 -44.99 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.459 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 12.5 t -141.17 152.78 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.622 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 178.22 4.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.826 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.72 153.8 35.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -52.56 -41.08 63.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 50.55 -136.33 27.62 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 79.4 p -151.06 167.47 27.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -1.018 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 29.4 t -78.69 144.5 35.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -0.864 . . . . 0.0 109.974 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.292 -179.873 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 15.4 p -124.31 158.45 61.16 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.357 -1.084 . . . . 0.0 110.237 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.44 -13.77 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.924 1.487 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.43 141.98 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.0 110.333 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.66 129.38 45.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 159.68 -113.44 0.57 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 44.4 m -57.16 -35.88 70.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -1.061 . . . . 0.0 109.937 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -114.52 139.67 49.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.463 -0.773 . . . . 0.0 109.756 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -157.73 178.92 9.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.0 110.639 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.451 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 -59.3 145.53 42.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.793 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.703 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 26' ' ' LEU . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.034 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 714' ' ' LEU . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.717 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.527 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.436 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.518 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.74 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.714 HD11 ' CD1' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 155' ' ' ILE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.518 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 152' ' ' LEU . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.696 HG12 HD12 ' A' ' 167' ' ' LEU . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.02 -34.37 21.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.161 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.47 -25.46 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.867 1.457 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.8 tp -104.29 129.3 52.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -148.64 25.37 1.34 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.5 t -125.37 145.25 50.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.366 -1.079 . . . . 0.0 110.22 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.1 m -78.61 136.11 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.936 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -112.72 151.95 29.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.593 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.25 -25.12 68.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.477 -0.764 . . . . 0.0 110.141 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -50.94 -32.92 22.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.63 134.01 40.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -143.06 -39.72 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.31 145.52 55.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 699' ' ' ALA . . . . . 0.52 ' HB3' ' OD2' ' B' ' 701' ' ' ASP . . . -99.37 162.04 13.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 110.112 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.27 -30.11 66.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.52 ' OD2' ' HB3' ' B' ' 699' ' ' ALA . 50.1 p30 -71.15 169.75 14.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 110.293 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 5.7 m -127.92 50.27 2.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.56 -39.52 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 31.8 t -118.54 141.71 48.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -71.71 153.61 41.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 110.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.94 146.13 39.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -66.93 148.66 98.8 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.439 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.66 144.08 53.39 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.771 1.406 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.93 156.62 30.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.754 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.12 150.92 47.03 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.545 0.688 . . . . 0.0 111.559 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 56.2 m -64.66 -38.35 90.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 -175.02 179.74 0.44 Allowed Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.034 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.5 mt 68.67 46.49 0.95 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.575 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -139.15 78.53 1.68 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.217 -1.552 . . . . 0.0 108.845 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -82.26 17.41 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.167 0.984 . . . . 0.0 109.808 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.681 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 28.5 p -47.62 173.58 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.269 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.73 -54.49 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.359 1.715 . . . . 0.0 108.884 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 81.5 mttt -161.88 -13.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.928 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.0 m 58.22 26.9 14.4 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -103.87 125.68 33.92 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.283 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.75 145.51 51.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.683 1.36 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -166.48 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.0 110.271 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -98.42 157.84 15.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -115.79 147.56 40.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.301 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 80.0 mt -90.57 53.38 2.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.72 -21.75 66.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -59.51 138.63 57.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.366 -0.833 . . . . 0.0 110.226 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -87.12 113.31 53.05 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.449 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.13 -19.47 29.7 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.556 1.292 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 732' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 730' ' ' VAL . . . -99.98 149.77 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.417 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.3 m -117.64 150.13 39.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.169 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -63.9 148.76 50.8 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.46 128.67 52.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -1.083 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 52.92 89.25 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.98 -34.24 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -1.062 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -107.48 149.11 28.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 110.246 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.8 137.45 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.363 -0.836 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 42.1 m -115.65 134.81 54.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 20.7 m -61.03 -35.47 76.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.816 . . . . 0.0 110.506 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -83.67 3.63 32.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.866 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.79 46.76 25.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.163 -0.961 . . . . 0.0 110.256 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -54.17 -26.0 34.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 34.1 m -57.04 154.2 10.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -1.093 . . . . 0.0 110.386 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 44.6 m -118.35 148.85 42.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.224 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.17 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 94.0 p -120.35 160.56 43.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.357 -1.084 . . . . 0.0 109.911 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.76 -28.85 29.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.761 1.401 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -138.21 112.39 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.173 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -61.88 -40.5 95.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.9 0.56 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 69.4 p -68.58 -9.83 52.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -1.058 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -53.69 147.02 12.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -127.22 143.35 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.404 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 -69.67 147.28 50.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -0.805 . . . . 0.0 110.606 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 31' ' ' ILE . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.654 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.936 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.901 HD23 HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 30' ' ' LYS . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.839 HD11 HD21 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.75 HG22 ' CD2' ' A' ' 84' ' ' LEU . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.777 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.55 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.75 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.777 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.658 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.936 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.948 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 160' ' ' VAL . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.669 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.669 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -50.28 141.04 12.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.499 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.55 139.87 42.03 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.744 1.392 . . . . 0.0 110.579 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 689' ' ' LEU . . . . . 0.401 HD11 ' OE1' ' B' ' 694' ' ' GLU . 22.5 tp -105.97 131.75 52.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 0.0 110.046 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.82 -86.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.0 m -123.0 147.77 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.407 -1.055 . . . . 0.0 110.341 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 62.6 p -71.23 -16.36 62.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.435 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.21 -31.74 70.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.448 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.401 ' OE1' HD11 ' B' ' 689' ' ' LEU . 1.0 OUTLIER -62.23 -25.53 67.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.872 . . . . 0.0 110.209 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.62 -33.98 68.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.351 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.6 mt -77.77 148.11 34.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.851 . . . . 0.0 110.186 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.76 153.81 21.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.363 -0.835 . . . . 0.0 110.377 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -148.17 175.26 11.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -63.08 147.0 52.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.84 151.86 27.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -110.05 172.16 7.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 110.38 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 48.4 p -80.58 162.3 24.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.336 -0.853 . . . . 0.0 110.029 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.71 132.31 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.412 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 91.2 p -137.92 155.92 48.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.816 . . . . 0.0 109.91 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.747 ' HB1' ' HG3' ' B' ' 708' ' ' PRO . . . -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -95.59 -66.7 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.504 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.61 59.74 47.91 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.604 -0.685 . . . . 0.0 109.586 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.747 ' HG3' ' HB1' ' B' ' 705' ' ' ALA . 47.4 Cg_endo -74.6 62.86 5.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.843 1.444 . . . . 0.0 110.361 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.08 148.19 33.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -104.65 136.66 43.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 111.629 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 43.7 m -67.4 -36.36 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.848 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -176.7 -178.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.948 HD22 ' CD1' ' A' ' 152' ' ' LEU . 4.1 mp 66.78 41.42 2.89 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.36 75.41 1.53 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.337 -1.477 . . . . 0.0 108.955 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.439 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 24.5 mp0 -82.59 18.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.221 1.01 . . . . 0.0 109.029 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.501 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.6 p -44.51 167.31 0.1 Allowed Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.011 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -74.09 -54.18 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.593 1.839 . . . . 0.0 108.702 176.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 53.2 mttp -158.55 -12.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.475 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.3 m 61.6 28.58 17.75 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 721' ' ' ALA . . . . . 0.637 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -89.38 171.73 8.43 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.449 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.637 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 42.0 Cg_endo -67.65 130.7 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.595 1.313 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.75 41.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -91.03 136.75 32.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.118 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.84 151.17 25.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -115.67 153.47 31.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.452 -0.78 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.8 tp -93.36 133.39 36.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 110.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.59 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.28 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -80.12 148.3 31.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.6 HG12 ' O ' ' B' ' 732' ' ' ALA . 60.3 t -65.9 113.39 11.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.24 -23.1 28.99 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.647 1.341 . . . . 0.0 110.631 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 732' ' ' ALA . . . . . 0.6 ' O ' HG12 ' B' ' 730' ' ' VAL . . . -102.53 151.95 21.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.4 p -65.69 162.57 18.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 110.277 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.65 -171.63 29.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 735' ' ' LEU . . . . . 0.493 HD23 ' C ' ' B' ' 735' ' ' LEU . 9.3 tt -95.69 129.15 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -1.09 . . . . 0.0 110.247 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 145.13 164.29 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.3 t -121.8 136.86 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.01 112.63 25.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.155 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.78 131.96 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 8.5 m -107.26 -10.91 15.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 110.549 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -86.67 158.91 19.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.428 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -108.63 137.89 45.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.698 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -89.63 15.0 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.276 -0.89 . . . . 0.0 111.034 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -79.19 -177.12 49.55 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.4 t -112.82 147.5 36.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -1.055 . . . . 0.0 110.24 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -33.76 67.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.447 -0.783 . . . . 0.0 110.371 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.11 179.878 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.0 p -127.94 70.57 78.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.57 -24.74 30.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.721 1.38 . . . . 0.0 110.275 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 148.53 41.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 0.0 110.379 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.11 135.09 35.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 142.73 58.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.7 t -131.47 162.48 30.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.476 -1.014 . . . . 0.0 110.038 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -93.84 126.36 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.04 -35.94 80.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.451 -0.78 . . . . 0.0 110.691 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 -102.48 123.98 47.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 110.565 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 31' ' ' ILE . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 132' ' ' PRO . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.727 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD23 HD23 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 30' ' ' LYS . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.677 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 HD21 ' B' ' 714' ' ' LEU . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 57' ' ' HIS . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.4 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 HD21 ' A' ' 84' ' ' LEU . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.487 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.837 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.895 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.557 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.511 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 131' ' ' ASN . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.769 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.716 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.973 HD11 HD22 ' B' ' 714' ' ' LEU . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.571 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.511 HG21 ' HE1' ' A' ' 128' ' ' PHE . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.795 ' CE2' HD12 ' A' ' 152' ' ' LEU . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.769 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.807 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.595 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.807 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -50.39 -34.51 24.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.238 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 140.75 44.9 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.71 1.374 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.16 -31.01 72.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -52.96 145.5 20.72 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 25.4 t -142.84 162.11 36.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.468 -1.019 . . . . 0.0 110.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 14.3 t -128.74 152.55 48.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.68 137.91 58.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.375 -0.828 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -76.28 -33.1 59.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.97 -42.42 89.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.313 -0.867 . . . . 0.0 110.746 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.14 142.93 45.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.892 . . . . 0.0 110.597 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -113.26 161.17 17.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.473 -0.767 . . . . 0.0 110.121 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -136.32 171.83 13.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.864 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -50.57 145.95 6.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.21 141.71 45.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 110.638 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -104.65 173.5 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 71.9 p -115.2 167.81 10.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.87 143.75 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 46.3 m -112.0 150.08 31.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.862 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -74.54 126.99 31.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.436 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.06 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.456 -0.777 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.85 153.69 5.69 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.438 -0.788 . . . . 0.0 110.534 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.66 154.38 71.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.837 1.441 . . . . 0.0 110.456 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.16 147.89 26.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.602 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -110.09 138.13 46.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 49.9 m -75.73 -37.62 59.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -176.01 -178.7 0.33 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.973 HD22 HD11 ' A' ' 152' ' ' LEU . 3.5 mp 67.38 36.48 3.87 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.646 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.95 74.94 1.49 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.642 -1.286 . . . . 0.0 108.199 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.42 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 27.1 mp0 -80.08 17.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.048 0.928 . . . . 0.0 109.797 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.557 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 28.3 p -48.01 169.79 0.12 Allowed Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.224 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.83 -54.46 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.439 1.757 . . . . 0.0 108.518 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 40.9 mtmt -160.22 -12.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.51 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.1 m 61.68 28.52 17.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.95 122.71 53.78 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.09 -39.9 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.673 1.354 . . . . 0.0 110.528 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -177.54 -32.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -95.89 154.57 17.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -58.09 -21.27 45.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.706 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -39.12 107.77 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.495 -0.753 . . . . 0.0 111.552 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.35 146.43 29.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.655 -0.653 . . . . 0.0 109.71 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -50.6 140.78 13.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.229 -0.92 . . . . 0.0 110.301 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -90.46 129.91 36.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.863 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.26 87.57 53.36 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.492 -0.755 . . . . 0.0 109.59 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 114.96 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.655 1.345 . . . . 0.0 110.679 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -160.27 155.18 24.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 109.914 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -120.5 146.2 46.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -107.12 141.17 15.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.7 -35.51 78.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -1.095 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 137.81 -167.27 24.9 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.97 133.49 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -1.067 . . . . 0.0 110.089 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.04 -154.18 0.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.446 -0.784 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.14 152.66 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.892 . . . . 0.0 110.181 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 81.6 p -95.58 1.41 53.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 53.8 p -68.54 152.26 45.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -110.0 -66.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.18 -40.58 77.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.381 -0.825 . . . . 0.0 110.594 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.58 67.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 53.7 p -66.97 159.36 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -1.073 . . . . 0.0 110.421 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -62.76 -27.43 69.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 110.229 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.272 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.8 p -66.39 146.64 99.06 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 110.165 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.96 147.78 62.32 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.65 1.342 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.26 143.22 31.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.68 -6.71 39.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -161.64 51.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 58.9 p -120.95 154.48 35.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -1.145 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -134.77 155.93 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -134.72 157.15 47.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 110.177 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.48 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 -113.06 144.7 42.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.962 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.67 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.803 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.73 HD23 HD13 ' B' ' 714' ' ' LEU . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.9 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.739 ' HB2' HG22 ' A' ' 3' ' ' VAL . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 84' ' ' LEU . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.481 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.536 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.498 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.673 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.803 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.84 HD21 ' CD1' ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.48 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.408 HG21 ' HE1' ' A' ' 128' ' ' PHE . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.673 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.773 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.773 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -50.32 144.41 7.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.454 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.89 148.53 70.85 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.789 1.415 . . . . 0.0 110.525 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.54 -32.59 71.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.758 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 90.08 -163.57 30.54 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 41.9 m -60.27 150.56 29.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.378 -1.072 . . . . 0.0 110.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 41.2 m -60.65 -39.21 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.516 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.47 148.05 38.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.314 -0.867 . . . . 0.0 110.43 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -101.43 -62.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.109 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -134.09 163.57 29.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.803 . . . . 0.0 109.759 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 26.0 tp -100.43 111.82 24.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.59 -29.46 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.736 . . . . 0.0 110.427 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.56 141.32 58.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.732 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -147.29 159.73 43.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.563 -0.711 . . . . 0.0 109.63 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -89.56 128.83 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -172.94 169.84 4.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -0.811 . . . . 0.0 110.102 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 87.5 m -103.27 142.45 34.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 0.0 109.494 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.9 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.767 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 26.1 t -119.11 153.27 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.605 -0.684 . . . . 0.0 109.819 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -56.21 -27.33 54.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.24 -0.912 . . . . 0.0 110.399 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.04 -26.5 67.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.55 153.74 48.85 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' B' ' 718' ' ' PRO . 43.6 Cg_endo -68.91 139.65 43.8 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.756 1.398 . . . . 0.0 110.714 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -122.82 157.66 31.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.468 -0.77 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -74.26 137.88 43.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 111.398 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 35.8 m -83.42 -37.8 22.76 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.821 0.82 . . . . 0.0 109.048 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.905 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -173.63 -175.11 0.26 Allowed Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.905 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.9 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.5 mt 70.29 40.95 1.09 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.57 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -136.98 78.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.833 -1.547 . . . . 0.0 109.269 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -83.78 18.35 2.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.21 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.1 p -47.29 168.91 0.12 Allowed Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.829 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -74.42 -54.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.484 1.781 . . . . 0.0 108.542 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 31.1 mttt -159.21 -12.1 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.515 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.6 m 62.51 28.13 16.59 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.64 138.65 21.09 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.566 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' B' ' 723' ' ' ALA . 43.6 Cg_endo -69.88 119.35 6.31 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.478 1.252 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 723' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' B' ' 722' ' ' PRO . . . 176.55 141.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.457 -0.777 . . . . 0.0 110.203 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 55.42 50.83 13.97 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.891 . . . . 0.0 110.614 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -61.58 142.38 57.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -54.36 -37.02 64.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 56.5 mt -86.51 141.14 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.472 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -167.72 68.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -58.52 -32.69 69.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.393 -0.817 . . . . 0.0 110.61 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.41 141.04 96.56 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.232 -0.917 . . . . 0.0 110.022 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.09 58.77 5.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.633 1.333 . . . . 0.0 110.491 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.07 91.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.3 t -139.57 148.7 42.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.822 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.16 -176.13 37.71 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.44 143.4 34.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -1.06 . . . . 0.0 110.461 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.49 157.65 31.43 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.3 m -133.9 159.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.455 -1.026 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -106.32 144.36 33.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 739' ' ' VAL . . . . . 0.494 ' O ' HG22 ' B' ' 739' ' ' VAL . 10.6 p -104.32 4.51 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.679 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 7.2 m 56.64 111.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.833 . . . . 0.0 111.39 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 741' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 51.0 m -123.51 152.59 41.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.68 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 742' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' B' ' 741' ' ' SER . 93.7 mt-30 58.18 54.41 5.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.268 -0.895 . . . . 0.0 110.163 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 743' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' B' ' 743' ' ' ASP . 24.5 p-10 -54.84 -33.88 62.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.338 -0.851 . . . . 0.0 110.639 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -80.19 -176.74 50.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.2 t -112.69 141.63 46.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -1.128 . . . . 0.0 110.086 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 28.3 t -124.13 144.4 49.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -8' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -170.71 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.346 -1.091 . . . . 0.0 110.431 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' -7' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.3 Cg_endo -68.72 153.12 73.78 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.435 1.229 . . . . 0.0 110.628 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -87.48 144.46 26.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.255 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.97 155.37 39.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.865 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 97.69 -174.35 29.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.6 p -118.95 159.91 22.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.287 -1.125 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -107.2 2.32 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.25 -39.7 73.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.919 -1.113 . . . . 0.0 109.524 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 -130.56 132.68 45.68 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 34' ' ' ILE . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.687 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.919 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HD11 ' B' ' 714' ' ' LEU . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.762 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.787 HG22 ' CD2' ' A' ' 84' ' ' LEU . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.498 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 HD13 ' A' ' 84' ' ' LEU . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.432 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.787 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.643 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.688 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.745 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.813 HD11 HD12 ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 155' ' ' ILE . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.418 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.75 ' CE2' HD12 ' A' ' 152' ' ' LEU . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.663 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.663 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -50.57 144.36 8.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.176 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.62 149.95 68.44 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.752 1.396 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 689' ' ' LEU . . . . . 0.632 HD23 ' O ' ' B' ' 689' ' ' LEU . 7.4 tt 51.26 80.22 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -0.837 . . . . 0.0 110.383 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -145.7 95.64 0.17 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.5 m -121.32 147.86 45.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -1.063 . . . . 0.0 109.786 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.9 t -133.82 152.08 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -92.44 4.52 53.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 0.0 110.457 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.5 mt-10 -60.31 149.12 34.52 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.173 -0.954 . . . . 0.0 110.555 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 695' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 81.8 m-20 57.48 50.93 10.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.1 -37.22 71.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -107.7 134.46 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -112.49 168.14 9.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -81.41 108.41 14.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -36.74 85.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.436 -0.79 . . . . 0.0 110.313 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -169.63 -177.9 2.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 110.52 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 702' ' ' THR . . . . . 0.485 HG22 ' H ' ' B' ' 703' ' ' VAL . 1.5 m -86.54 179.49 6.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.455 -0.778 . . . . 0.0 109.729 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.485 ' H ' HG22 ' B' ' 702' ' ' THR . 14.7 p -120.47 136.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 9.3 p -170.05 -75.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 0.0 109.867 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.08 83.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.858 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -70.2 146.75 50.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.5 133.44 94.32 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.424 ' HB2' ' O ' ' B' ' 717' ' ' CYS . 42.9 Cg_endo -70.17 145.7 55.51 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.605 1.319 . . . . 0.0 110.595 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.88 145.21 51.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.89 . . . . 0.0 110.032 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -113.62 133.28 55.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 111.354 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -102.42 -56.37 2.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.173 0.987 . . . . 0.0 108.633 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.3 p-80 -143.82 -178.33 0.77 Allowed Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.919 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.0 mt 72.24 42.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.675 ' HB2' ' CD2' ' B' ' 712' ' ' HIS . 5.4 t -136.04 80.44 1.83 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.425 -1.422 . . . . 0.0 109.214 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -84.41 18.33 2.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.139 0.971 . . . . 0.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.642 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 25.6 p -44.77 171.91 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.699 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -71.92 -55.73 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.339 1.704 . . . . 0.0 109.003 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 44.8 mttp -160.37 -14.52 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.38 27.01 9.39 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -89.28 159.23 45.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.33 143.67 53.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.803 1.423 . . . . 0.0 110.445 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 111.016 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -126.65 156.37 41.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.85 130.37 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.435 -0.79 . . . . 0.0 110.035 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 726' ' ' ARG . . . . . 0.762 ' C ' HD12 ' B' ' 727' ' ' LEU . 94.9 mtt-85 -132.19 142.38 49.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 110.309 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.762 HD12 ' C ' ' B' ' 726' ' ' ARG . 5.7 mp -138.1 72.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -152.0 157.59 41.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -118.53 123.86 46.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.157 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 61.5 t -139.89 89.51 11.36 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 110.156 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.99 -25.18 38.53 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.743 1.391 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 732' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' B' ' 735' ' ' LEU . . . -74.14 134.29 42.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.339 -0.851 . . . . 0.0 110.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.2 m -126.41 150.96 48.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.573 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 91.71 10.37 61.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 735' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' B' ' 732' ' ' ALA . 50.1 mt -96.92 133.73 41.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.274 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.99 -179.44 53.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.25 136.25 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -1.103 . . . . 0.0 110.2 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -130.38 -162.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.836 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.64 137.27 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 47.4 m -113.09 140.26 48.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 48.3 m -64.5 153.25 39.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.471 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -126.91 161.78 27.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.439 -0.788 . . . . 0.0 110.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -53.96 -38.46 65.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 110.567 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 61.08 -123.41 32.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.1 t -120.59 141.32 50.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 90.5 p -137.66 159.39 42.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.297 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -124.58 83.12 58.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.989 . . . . 0.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 144.59 62.57 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.862 1.454 . . . . 0.0 110.363 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.94 111.89 23.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.24 -32.74 63.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 122.92 131.89 3.91 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.3 m -98.52 -12.38 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.165 -1.197 . . . . 0.0 111.228 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.23 139.17 45.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.063 -1.023 . . . . 0.0 109.959 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -146.05 103.98 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.521 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 -122.96 152.71 40.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.397 -0.815 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.696 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.821 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.861 HD23 HD13 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 27' ' ' VAL . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.904 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HD11 ' B' ' 714' ' ' LEU . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.518 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.679 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.821 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.98 HD11 HD12 ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.572 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.572 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.402 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.744 ' CE2' HD12 ' A' ' 152' ' ' LEU . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.679 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.659 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 167' ' ' LEU . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.659 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.23 -34.38 22.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 -18.24 42.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.707 1.372 . . . . 0.0 110.646 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.15 -38.14 78.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.212 -0.93 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 80.43 -171.43 54.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 90.4 p -63.82 -30.38 71.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.19 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.2 p -124.64 158.11 33.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.95 143.04 57.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.218 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -108.84 142.51 39.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.037 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -88.54 114.21 24.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 36.1 tp -172.68 -99.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.061 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 697' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' B' ' 697' ' ' GLU . 78.4 tt0 50.84 26.47 2.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.907 -1.121 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -84.38 -1.09 54.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.913 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.31 -36.86 81.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.94 143.17 50.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 110.264 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.5 p30 -100.22 169.62 9.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.7 m -117.29 138.88 51.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.9 t -118.05 141.34 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.467 -0.771 . . . . 0.0 109.785 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.3 m -101.59 140.16 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.342 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -165.86 164.44 18.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -59.61 143.53 50.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -70.41 113.92 21.98 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.37 145.69 48.73 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.634 1.334 . . . . 0.0 110.491 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -108.57 150.0 28.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 110.135 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -117.3 144.57 44.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.365 -0.834 . . . . 0.0 111.385 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.75 -58.33 2.29 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.266 1.031 . . . . 0.0 108.36 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.847 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 -140.73 -179.02 0.9 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 152' ' ' LEU . 10.2 mt 69.84 46.76 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.475 ' HB2' ' ND1' ' B' ' 712' ' ' HIS . 5.4 t -130.63 82.31 2.05 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.281 -1.512 . . . . 0.0 109.349 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.32 18.64 2.58 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.086 0.946 . . . . 0.0 109.385 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.641 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.255 24.2 p -43.94 172.33 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.724 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.4 Cg_endo -69.87 -57.08 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.454 1.765 . . . . 0.0 108.84 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 4.3 mtmp? -159.67 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.686 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 53.47 27.55 6.61 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.24 122.71 88.32 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.814 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 154.14 35.57 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.867 1.456 . . . . 0.0 110.443 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -97.22 131.99 43.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.6 121.43 44.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -136.83 135.37 37.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -0.861 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -69.38 153.91 42.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 109.922 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.27 142.78 41.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -104.56 146.72 28.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -59.73 -34.46 72.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 110.539 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 730' ' ' VAL . 35.5 m -109.69 106.86 58.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 110.731 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 730' ' ' VAL . 44.0 Cg_endo -70.17 160.26 50.2 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.642 1.338 . . . . 0.0 110.547 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.45 152.48 8.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.369 -0.832 . . . . 0.0 110.535 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 8.0 t -129.81 -163.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.478 -0.764 . . . . 0.0 110.29 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -52.24 164.44 1.5 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.09 -40.41 73.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.305 -1.115 . . . . 0.0 110.641 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 51.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.77 130.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -1.132 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -90.57 -57.63 2.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.541 -0.724 . . . . 0.0 109.98 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.24 143.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 110.125 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 45.4 m -92.74 137.53 32.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.487 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 741' ' ' SER . . . . . 0.465 ' O ' ' N ' ' B' ' 743' ' ' ASP . 5.4 t -148.94 -55.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.03 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 742' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' B' ' 741' ' ' SER . 62.9 tt0 61.61 -72.13 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.616 -0.678 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 743' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' B' ' 741' ' ' SER . 93.1 m-20 -55.25 -37.47 67.27 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -137.91 175.12 21.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.7 t -124.7 127.36 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -1.198 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.4 m -63.0 -34.61 77.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 83.1 t90 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.157 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 92.7 p -121.34 96.0 48.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -1.071 . . . . 0.0 110.162 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.01 136.23 40.4 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.709 1.373 . . . . 0.0 110.6 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.71 -27.32 69.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.462 -0.774 . . . . 0.0 110.593 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -98.18 135.11 40.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -139.72 -117.03 1.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 45.3 m -118.46 138.09 52.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -1.117 . . . . 0.0 110.094 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -71.47 140.86 50.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.359 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -165.48 163.32 19.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 109.949 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 -121.65 147.66 45.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.024 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 713' ' ' PRO . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD13 HD21 ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.693 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.788 HD23 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.703 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 HD13 HD22 ' A' ' 4' ' ' LEU . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.696 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 HD21 ' A' ' 84' ' ' LEU . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.592 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 45' ' ' SER . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' HD22 ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 49' ' ' LEU . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.512 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.83 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.05 HD11 HD22 ' B' ' 714' ' ' LEU . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.542 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.542 HG23 HG12 ' A' ' 155' ' ' ILE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 173' ' ' LYS . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' B' ' 723' ' ' ALA . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 167' ' ' LEU . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.69 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -50.51 144.32 7.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.6 -30.2 28.82 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.712 1.375 . . . . 0.0 110.296 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.71 -31.64 70.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.456 -0.777 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 111.1 3.45 27.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 45.7 m -117.33 150.02 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 692' ' ' THR . . . . . 0.548 HG22 ' H ' ' B' ' 694' ' ' GLU . 24.7 m -108.5 132.53 53.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.601 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.0 -18.33 64.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.556 -0.715 . . . . 0.0 110.49 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.548 ' H ' HG22 ' B' ' 692' ' ' THR . 97.2 mt-10 -54.56 -30.82 55.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.303 -0.873 . . . . 0.0 110.618 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.83 135.59 57.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.9 tp -105.64 130.69 53.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.816 . . . . 0.0 110.525 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.6 143.87 55.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 110.089 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 698' ' ' ASP . . . . . 0.507 ' OD2' HG23 ' B' ' 703' ' ' VAL . 50.1 p30 -76.43 175.85 8.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.354 -0.841 . . . . 0.0 110.522 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.15 155.12 21.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.389 -0.819 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.16 -33.55 53.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.204 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.77 169.74 10.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 110.035 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 35.3 m 50.66 59.32 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.253 -0.904 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.507 HG23 ' OD2' ' B' ' 698' ' ' ASP . 12.3 p -125.7 147.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.297 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.5 m -109.36 146.53 34.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.14 77.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 110.965 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -146.22 159.67 43.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.0 169.82 7.49 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.12 132.9 10.67 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.683 1.36 . . . . 0.0 111.088 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -127.54 152.12 48.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.42 132.32 51.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.306 -0.872 . . . . 0.0 111.716 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 711' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' B' ' 720' ' ' CYS . 75.5 m -80.56 -43.09 21.21 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.345 1.069 . . . . 0.0 109.367 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER -172.22 -174.13 0.26 Allowed Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.05 HD22 HD11 ' A' ' 152' ' ' LEU . 10.4 mp 66.23 63.06 0.56 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 715' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 86.06 3.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.125 -0.985 . . . . 0.0 109.164 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.438 ' OE1' HD23 ' A' ' 25' ' ' LEU . 25.9 mp0 -96.02 7.83 45.34 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.08 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 717' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.91 144.14 54.81 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.91 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 718' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.26 -55.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 125.069 2.089 . . . . 0.0 113.784 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 719' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.47 -11.52 48.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' B' ' 711' ' ' CYS . 98.4 m 49.37 29.13 2.64 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -117.72 152.53 49.96 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.278 -177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.12 148.01 30.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.938 1.493 . . . . 0.0 110.186 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 723' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . . . -114.12 20.67 15.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.662 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -123.55 156.29 35.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.964 . . . . 0.0 110.722 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -84.7 154.25 22.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 110.177 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -60.56 143.09 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.38 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 71.5 mt -107.83 139.78 41.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.395 -0.816 . . . . 0.0 110.265 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.91 -68.76 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -129.71 131.49 46.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.0 109.567 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.606 ' O ' HG13 ' B' ' 730' ' ' VAL . 7.2 p -127.81 79.17 74.05 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 111.122 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.1 148.15 49.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.634 1.334 . . . . 0.0 110.129 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.94 71.55 10.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 22.9 m -59.89 -36.51 77.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.409 -0.807 . . . . 0.0 110.967 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -103.36 118.46 6.06 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.337 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -114.64 129.32 56.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -1.059 . . . . 0.0 109.877 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.11 8.32 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.22 -38.29 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.407 -1.055 . . . . 0.0 110.487 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -90.89 121.78 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.947 . . . . 0.0 110.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.69 135.36 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.259 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 41.8 p -122.57 165.64 16.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 0.0 109.715 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 69.1 m -106.02 124.74 50.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.22 -34.91 75.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -83.63 121.25 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.92 -146.86 15.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.3 m -114.18 145.61 41.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -1.13 . . . . 0.0 110.181 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 746' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 747' ' ' TRP . 23.0 m -59.43 -36.9 76.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 747' ' ' TRP . . . . . 0.425 ' CG ' ' O ' ' B' ' 746' ' ' SER . 99.3 m95 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 20.7 t -103.52 113.83 65.31 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.61 54.3 3.88 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.58 1.306 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -125.58 142.1 51.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -62.9 -31.63 72.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 124.41 40.12 0.45 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 37.9 m -57.39 -37.15 72.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -1.108 . . . . 0.0 110.237 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ARG . . . . . 0.409 ' O ' ' OE1' ' A' ' 156' ' ' GLN . 55.7 ttt85 -55.39 -34.34 64.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -80.01 147.08 31.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 -117.84 152.04 36.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.368 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.749 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.764 HG22 ' CD2' ' A' ' 84' ' ' LEU . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.449 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.764 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.779 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.622 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.419 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.863 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.055 HD11 HD22 ' B' ' 714' ' ' LEU . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 155' ' ' ILE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.428 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.732 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.797 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.782 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.782 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.494 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.8 mttm -50.02 -34.59 21.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.92 150.62 73.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.756 1.398 . . . . 0.0 110.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 82.9 mt -59.55 -35.28 73.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 0.0 110.168 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -135.6 159.19 24.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 86.5 p -64.21 -31.03 72.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 110.304 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 m -126.42 138.27 53.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.838 . . . . 0.0 110.31 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.73 139.9 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.19 -88.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.569 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -105.81 18.44 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.552 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.99 -36.22 70.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.291 -0.88 . . . . 0.0 110.528 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.4 143.1 56.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.252 -0.905 . . . . 0.0 109.919 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -166.53 -151.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.222 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -54.4 167.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.286 -0.884 . . . . 0.0 110.475 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.03 138.57 43.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.425 -0.797 . . . . 0.0 110.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -63.99 -35.17 79.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.372 -0.83 . . . . 0.0 111.012 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 34.7 m -90.66 143.31 26.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.558 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.699 HG23 ' H ' ' B' ' 706' ' ' ALA . 34.9 m -125.63 154.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.77 . . . . 0.0 110.208 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 25.7 m -59.64 -36.04 75.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.429 -0.795 . . . . 0.0 111.012 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.88 -57.09 11.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.396 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 706' ' ' ALA . . . . . 0.699 ' H ' HG23 ' B' ' 703' ' ' VAL . . . 46.43 26.14 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 111.298 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.46 148.09 21.55 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 110.797 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.67 158.28 47.34 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.852 1.449 . . . . 0.0 110.623 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.07 152.78 24.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.667 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -100.74 142.0 32.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.414 -0.804 . . . . 0.0 111.849 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 37.4 m -74.57 -43.73 54.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.02 0.915 . . . . 0.0 108.911 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.805 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -167.14 -179.94 0.88 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.805 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 152' ' ' LEU . 1.6 mp 68.34 44.92 1.26 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.587 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.66 79.34 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.243 -1.536 . . . . 0.0 109.153 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -83.93 18.99 1.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.027 0.918 . . . . 0.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.62 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 24.5 p -44.12 171.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.743 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.72 -56.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.468 1.772 . . . . 0.0 108.833 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.6 mttp -160.18 -15.28 0.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.693 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 54.38 26.76 7.33 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -88.05 137.18 31.46 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.557 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.22 148.22 55.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.662 1.349 . . . . 0.0 110.399 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -84.42 129.35 34.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -121.41 144.38 48.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 726' ' ' ARG . 98.4 mttt -132.14 111.47 11.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 110.105 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 726' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' B' ' 725' ' ' LYS . 66.9 mtm180 52.56 165.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.473 -0.767 . . . . 0.0 111.123 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.51 -36.13 82.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.145 -0.972 . . . . 0.0 110.911 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.72 157.15 43.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.994 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -115.84 134.74 54.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.0 109.815 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 730' ' ' VAL . 35.9 m -62.36 112.1 5.85 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.298 -0.876 . . . . 0.0 110.351 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.42 ' HG3' ' HA3' ' B' ' 736' ' ' GLY . 49.1 Cg_endo -75.66 144.42 28.12 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.646 1.34 . . . . 0.0 110.419 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.81 85.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.722 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.3 t -153.71 152.74 31.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 96.61 168.37 33.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.26 -35.8 81.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.38 -1.071 . . . . 0.0 110.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 736' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' B' ' 731' ' ' PRO . . . 100.43 78.02 1.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.12 163.08 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -1.031 . . . . 0.0 110.334 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -82.92 129.28 35.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.029 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 739' ' ' VAL . . . . . 0.489 HG13 ' N ' ' B' ' 740' ' ' THR . 14.2 p -61.23 -39.91 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.39 -0.819 . . . . 0.0 110.686 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 740' ' ' THR . . . . . 0.489 ' N ' HG13 ' B' ' 739' ' ' VAL . 46.7 m -131.04 137.42 49.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.898 . . . . 0.0 110.262 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 36.3 t -165.39 24.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.691 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -122.29 140.91 52.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 0.0 110.462 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -137.65 160.17 39.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.792 . . . . 0.0 109.971 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -159.87 53.97 0.35 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 83.7 p -62.6 -26.99 68.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -1.078 . . . . 0.0 110.409 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 91.3 p -121.45 156.82 31.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.907 . . . . 0.0 110.405 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 86.5 m95 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -8' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' -7' ' ' PRO . 0.3 OUTLIER -51.59 -55.28 30.93 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.374 -1.074 . . . . 0.0 110.707 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' -7' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' -8' ' ' SER . 42.8 Cg_endo -70.28 145.04 53.04 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.597 1.314 . . . . 0.0 110.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.72 168.35 9.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.163 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -55.28 -36.05 65.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 110.454 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 84.61 20.29 58.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 56.4 m -120.72 143.13 48.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 109.943 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.79 138.75 57.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 110.069 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -108.65 149.39 29.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 50.46 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 110.929 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.723 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.856 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.853 HD23 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 26' ' ' LEU . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.947 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.508 HD11 HD11 ' B' ' 714' ' ' LEU . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' HD22 ' A' ' 40' ' ' LEU . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.866 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.766 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.836 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.915 HD11 HD12 ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.456 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.754 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.737 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.634 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' B' ' 712' ' ' HIS . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm -49.98 -34.82 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.263 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 -20.58 37.73 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.795 1.418 . . . . 0.0 110.736 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.37 141.15 29.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 144.39 148.97 4.96 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 87.1 p -63.12 -28.24 69.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.0 t -135.87 156.8 48.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.408 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.2 143.09 44.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 110.196 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -132.04 169.54 16.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.039 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -58.64 150.25 23.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.743 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.7 mt -83.82 125.43 31.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.925 . . . . 0.0 110.523 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.74 -6.56 14.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.88 -38.14 72.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 111.012 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -141.63 32.54 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -99.75 127.44 45.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.99 . . . . 0.0 110.121 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.797 ' OD2' HG22 ' B' ' 702' ' ' THR . 2.7 p30 -177.37 -46.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.813 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 702' ' ' THR . . . . . 0.797 HG22 ' OD2' ' B' ' 701' ' ' ASP . 12.7 t -146.09 155.83 43.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.97 138.16 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.504 -0.748 . . . . 0.0 109.685 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 99.5 p -111.83 145.47 39.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -69.06 -29.74 67.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.795 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.06 44.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.25 160.51 52.24 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 110.46 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.65 156.28 57.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.887 1.467 . . . . 0.0 110.635 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 709' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' B' ' 710' ' ' PHE . 76.8 mm-40 -105.2 156.91 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.423 -0.798 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 710' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' B' ' 709' ' ' GLU . 34.1 m-85 53.59 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.903 0.858 . . . . 0.0 112.295 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 39.5 m -65.75 -40.25 91.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.091 0.948 . . . . 0.0 108.912 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.851 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -168.56 -177.45 0.51 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.947 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.8 mt 67.8 45.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.561 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.32 80.89 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.383 -1.448 . . . . 0.0 109.26 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -84.65 17.63 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.102 0.953 . . . . 0.0 109.414 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.664 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.256 27.9 p -45.95 172.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.664 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.4 Cg_endo -74.55 -55.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.546 1.814 . . . . 0.0 108.923 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 14.2 mtpp -159.21 -14.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.657 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.8 m 57.31 25.83 11.66 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.99 131.87 80.75 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.962 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.02 148.59 70.21 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.601 1.316 . . . . 0.0 110.559 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -114.09 -85.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -121.86 122.23 38.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.71 149.26 22.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.371 -0.83 . . . . 0.0 110.512 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.0 tp -92.9 128.63 38.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.995 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -72.49 143.18 48.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.4 -0.812 . . . . 0.0 110.54 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.49 145.61 31.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 109.867 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.77 104.99 20.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.345 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.55 151.34 58.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.617 1.325 . . . . 0.0 110.297 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -93.05 132.47 37.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.1 t -137.86 142.4 40.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.308 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.97 134.78 12.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.8 mt -102.48 139.49 38.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -122.08 76.88 0.34 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.2 m -128.15 161.71 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -1.127 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -82.66 133.49 35.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 110.066 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.78 147.89 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.344 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 13.5 t -126.89 160.12 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.436 -0.79 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.0 m -114.28 152.61 31.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -91.22 123.11 34.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 109.953 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -98.99 161.81 13.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 98.15 17.74 28.76 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.3 t -75.25 137.08 40.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -1.198 . . . . 0.0 109.965 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 46.1 m -124.73 150.62 46.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.386 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.463 179.748 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -125.79 73.52 69.94 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.336 -1.097 . . . . 0.0 110.084 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -23.32 35.09 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.724 1.381 . . . . 0.0 110.706 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.08 -35.5 80.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.01 156.76 34.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -88.92 176.06 43.83 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 30.1 p -144.0 45.46 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -1.062 . . . . 0.0 110.263 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -115.73 149.75 37.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.177 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 156' ' ' GLN . 64.9 t0 -145.94 97.38 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.574 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.3 ptt85 -157.49 159.21 37.01 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.086 -1.009 . . . . 0.0 109.668 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.849 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.947 HD23 HD23 ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HD21 ' B' ' 714' ' ' LEU . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.75 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 HD21 ' A' ' 84' ' ' LEU . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.804 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.023 HD11 HD22 ' B' ' 714' ' ' LEU . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 160' ' ' VAL . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.703 ' CE1' HD12 ' A' ' 152' ' ' LEU . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.714 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.804 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 167' ' ' LEU . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.804 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.4 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -50.51 -34.51 25.45 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.229 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.71 -19.15 41.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.859 1.452 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.22 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.261 -0.899 . . . . 0.0 110.603 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -89.61 49.46 3.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 83.9 p -60.76 -28.22 68.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.303 -1.116 . . . . 0.0 110.227 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.1 m -86.25 134.57 33.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -138.0 -54.94 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 110.473 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.87 -36.63 81.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.815 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -92.85 111.4 23.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.9 mt -119.1 131.79 55.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.355 -0.84 . . . . 0.0 109.888 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.06 131.95 44.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.491 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -116.25 142.12 47.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.985 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.62 47.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.78 127.36 47.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.62 6.71 39.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.849 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.1 m -122.46 139.61 53.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.958 . . . . 0.0 110.325 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 52.4 t -120.44 138.04 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.101 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.9 m -114.64 149.73 36.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.7 52.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.432 -0.792 . . . . 0.0 110.539 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -66.37 156.55 34.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 707' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' B' ' 708' ' ' PRO . 1.7 m-20 -104.04 96.89 10.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.076 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' B' ' 707' ' ' ASP . 44.2 Cg_endo -70.03 156.24 63.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.776 1.409 . . . . 0.0 110.568 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.94 153.99 17.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.389 -0.819 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.25 146.72 28.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.485 -0.759 . . . . 0.0 111.321 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.09 -40.88 95.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.173 0.987 . . . . 0.0 108.622 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.845 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -165.54 -178.05 0.69 Allowed Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.023 HD22 HD11 ' A' ' 152' ' ' LEU . 2.2 mp 67.74 59.54 0.47 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.537 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.74 76.74 1.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.152 -1.593 . . . . 0.0 109.068 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -84.44 19.87 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.224 1.011 . . . . 0.0 109.055 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.626 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 21.9 p -43.05 171.36 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.073 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.37 -56.7 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.488 1.783 . . . . 0.0 108.874 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 21.2 mttp -158.91 -15.15 0.07 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.3 m 55.21 26.99 9.03 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.59 150.45 88.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.311 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.99 -17.46 41.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.78 1.41 . . . . 0.0 110.793 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -59.55 145.59 43.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -108.99 161.11 15.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.12 148.18 42.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.38 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -115.9 154.44 29.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.4 tp -93.16 122.2 35.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.98 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -163.43 156.95 19.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.463 ' C ' HG13 ' B' ' 730' ' ' VAL . 9.5 tptp -126.63 119.19 26.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.992 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.463 HG13 ' C ' ' B' ' 729' ' ' LYS . 30.2 m -151.63 134.85 9.11 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.04 146.78 53.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.32 . . . . 0.0 110.688 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -67.23 139.08 57.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.069 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 733' ' ' SER . . . . . 0.466 ' O ' ' O ' ' B' ' 736' ' ' GLY . 28.6 p -118.25 30.37 7.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.462 -0.774 . . . . 0.0 110.351 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.5 25.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.12 -36.55 80.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.169 -1.195 . . . . 0.0 111.011 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 736' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' B' ' 733' ' ' SER . . . -140.1 165.86 25.87 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.94 132.3 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.084 -1.245 . . . . 0.0 110.574 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -136.14 74.73 1.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 160.71 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.811 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 740' ' ' THR . . . . . 0.589 HG22 ' O ' ' B' ' 740' ' ' THR . 45.8 m 51.0 26.1 2.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.416 -0.802 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 26.5 t -147.76 147.99 30.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -98.91 104.81 16.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.976 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -136.09 140.54 43.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.212 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -90.16 -175.23 45.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 60.5 p -66.75 166.27 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -1.093 . . . . 0.0 109.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.0 m -54.7 -33.83 61.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.172 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 1.3 m95 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.073 179.733 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.8 m -109.51 113.87 57.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.99 141.27 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.506 1.267 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.58 127.2 53.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 0.0 110.705 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -79.29 -44.31 21.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.495 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -177.56 179.5 48.18 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.7 p -131.07 165.26 23.62 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.369 -1.077 . . . . 0.0 110.546 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -114.17 129.83 56.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 109.978 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -64.61 -36.0 82.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.314 -0.866 . . . . 0.0 110.999 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 -70.59 146.66 49.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.229 -0.919 . . . . 0.0 110.878 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.945 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.955 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.792 HG22 HD21 ' A' ' 84' ' ' LEU . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.495 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.795 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.435 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.792 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.7 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.876 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.958 HD11 HD22 ' B' ' 714' ' ' LEU . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 160' ' ' VAL . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 155' ' ' ILE . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.683 ' CE1' HD12 ' A' ' 152' ' ' LEU . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.7 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.783 HD12 ' HD2' ' A' ' 173' ' ' LYS . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -50.22 -34.44 22.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.451 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 148.41 71.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.789 1.415 . . . . 0.0 110.462 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.7 tp -57.66 -37.01 72.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -0.873 . . . . 0.0 110.347 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.08 126.43 33.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 80.6 p -149.39 167.82 25.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -1.06 . . . . 0.0 109.997 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 p -75.49 154.58 36.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.84 134.79 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 110.259 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.81 -73.37 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 110.114 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -153.26 -61.59 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.464 -0.773 . . . . 0.0 110.208 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 17.5 mt 52.78 19.94 1.43 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.364 -0.835 . . . . 0.0 111.047 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.17 -35.18 80.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -78.57 138.74 38.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.444 -0.785 . . . . 0.0 110.159 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -106.28 142.15 36.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -116.17 146.58 42.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.127 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -135.58 176.78 8.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.567 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 702' ' ' THR . . . . . 0.721 HG22 ' HE3' ' B' ' 729' ' ' LYS . 43.1 p -80.69 164.05 23.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.865 . . . . 0.0 110.193 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.7 -41.71 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.6 p -142.0 157.28 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -124.48 42.17 3.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . 53.88 -173.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.357 -0.84 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.27 112.0 5.17 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.98 143.6 45.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.639 1.336 . . . . 0.0 110.627 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.22 150.91 36.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.386 -0.821 . . . . 0.0 110.092 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -104.82 132.26 51.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -69.24 -43.41 74.07 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.023 0.916 . . . . 0.0 109.111 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -163.21 -177.25 0.66 Allowed Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.872 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 152' ' ' LEU . 3.9 mp 71.04 48.06 0.39 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -133.57 77.79 1.74 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.271 -1.518 . . . . 0.0 108.848 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -82.81 18.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.104 0.954 . . . . 0.0 109.3 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.586 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.2 p -43.58 169.67 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.736 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.95 -55.81 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.396 1.735 . . . . 0.0 108.97 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' B' ' 718' ' ' PRO . 14.2 mtpp -159.76 -15.04 0.06 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.71 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.4 m 55.25 27.18 9.4 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -91.55 154.48 44.22 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.79 -16.42 33.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.813 1.428 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.82 140.12 52.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.119 -0.988 . . . . 0.0 110.35 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -87.1 -77.6 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 0.0 110.538 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.03 28.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.238 -0.914 . . . . 0.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -61.37 -33.79 74.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.071 -1.018 . . . . 0.0 110.544 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 727' ' ' LEU . 9.1 tt -95.5 124.73 39.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -159.59 158.73 32.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.477 -0.764 . . . . 0.0 110.069 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' B' ' 702' ' ' THR . 91.2 mttt -83.98 147.74 27.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.014 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' B' ' 731' ' ' PRO . 71.5 t -115.48 97.4 48.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 110.346 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' B' ' 730' ' ' VAL . 43.3 Cg_endo -69.97 151.67 67.96 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.741 1.39 . . . . 0.0 110.177 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.64 89.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.188 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.7 m -59.33 -35.18 73.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -57.01 -33.58 64.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 32.2 tp -100.87 128.3 46.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.47 -1.018 . . . . 0.0 110.148 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 66.13 124.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.24 137.57 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -1.084 . . . . 0.0 110.063 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -100.24 141.79 32.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 110.266 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.19 143.79 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.7 m -120.78 137.29 54.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.365 -0.834 . . . . 0.0 110.455 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.4 p -134.12 156.58 48.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.44 -0.787 . . . . 0.0 109.901 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -115.37 138.65 50.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.3 -0.875 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -102.96 11.56 37.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 110.321 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 117.01 -73.97 0.28 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 26.6 t -124.39 139.5 53.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.107 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -35.38 73.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.187 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 25.8 p -66.57 155.61 88.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.42 -1.047 . . . . 0.0 110.397 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.96 139.67 47.9 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.841 1.443 . . . . 0.0 110.417 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -63.56 -36.11 82.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -111.3 133.91 53.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 172.87 149.58 6.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 12.4 t -140.29 156.77 46.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.406 -1.055 . . . . 0.0 110.557 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -101.3 6.0 42.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.308 -0.87 . . . . 0.0 110.51 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -73.51 156.04 38.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 -51.54 149.96 4.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.363 -0.836 . . . . 0.0 109.693 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' HB2' HG21 ' A' ' 31' ' ' ILE . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.439 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.2 m-70 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.439 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.712 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.902 ' HE2' HD23 ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.442 HG21 ' HB2' ' A' ' 4' ' ' LEU . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.72 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HD21 ' A' ' 84' ' ' LEU . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 49' ' ' LEU . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.807 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.578 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 25' ' ' LEU . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' B' ' 714' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.441 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.534 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.416 HG21 ' HE1' ' A' ' 128' ' ' PHE . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.67 ' CE2' HD12 ' A' ' 152' ' ' LEU . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.45 HG21 ' HE1' ' A' ' 22' ' ' PHE . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 160' ' ' VAL . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm -50.55 144.37 7.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.469 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.37 -20.94 41.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.797 1.419 . . . . 0.0 110.606 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.16 -37.34 79.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 73.31 27.81 67.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 27.3 t -120.03 145.68 46.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -1.124 . . . . 0.0 110.456 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 60.6 m -74.93 133.48 41.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 0.0 110.197 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.73 144.42 57.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.762 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.9 mt-10 -62.73 -23.32 67.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.091 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 695' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 85.5 m-20 57.57 39.14 27.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.513 -0.742 . . . . 0.0 110.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.26 130.59 56.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 109.526 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.55 132.35 38.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.314 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -79.59 136.32 36.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.813 . . . . 0.0 110.319 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -90.77 129.84 36.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.147 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.33 138.36 58.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.403 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' B' ' 704' ' ' SER . 4.5 p30 -93.27 7.42 44.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.504 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 41.9 m -66.46 -37.33 84.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.64 -40.95 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.364 -0.835 . . . . 0.0 111.159 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 704' ' ' SER . . . . . 0.409 ' O ' ' O ' ' B' ' 701' ' ' ASP . 92.3 p -120.09 153.53 35.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.049 -1.032 . . . . 0.0 110.878 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.517 ' HB1' ' OD1' ' B' ' 707' ' ' ASP . . . -82.15 136.82 35.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.303 -0.873 . . . . 0.0 110.361 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.11 72.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.542 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 707' ' ' ASP . . . . . 0.517 ' OD1' ' HB1' ' B' ' 705' ' ' ALA . 4.1 p30 -66.72 127.97 93.66 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.3 -0.875 . . . . 0.0 110.495 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 708' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' B' ' 709' ' ' GLU . 44.4 Cg_endo -71.71 -15.0 30.3 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.678 1.357 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 709' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' B' ' 708' ' ' PRO . 94.7 mt-10 60.0 146.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.5 -0.75 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.82 132.0 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.408 -0.808 . . . . 0.0 111.731 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 78.3 m -73.55 -38.78 65.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.157 0.98 . . . . 0.0 109.059 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.896 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -173.4 -174.42 0.25 Allowed Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.896 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.902 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt 74.88 41.96 0.29 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.607 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.1 t -139.15 81.68 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.814 -1.804 . . . . 0.0 109.154 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -84.37 17.2 2.69 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.143 0.973 . . . . 0.0 109.505 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.636 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.6 p -46.12 172.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.749 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.95 -55.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.497 1.788 . . . . 0.0 108.936 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 41.1 mttt -160.52 -14.94 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.76 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 55.33 25.96 8.12 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -93.45 126.7 49.26 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.234 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.35 133.46 24.54 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.556 1.292 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -125.14 26.58 6.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -99.51 121.72 41.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.526 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -168.76 62.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.484 -0.76 . . . . 0.0 110.048 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -93.19 5.57 51.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.91 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.39 -31.79 69.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.093 -1.004 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -61.32 150.25 35.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 110.074 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.42 ' HG2' ' HD3' ' B' ' 731' ' ' PRO . 42.0 tttp -74.77 129.98 38.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.621 ' O ' HG13 ' B' ' 730' ' ' VAL . 7.1 p -126.12 76.71 71.98 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.402 -0.812 . . . . 0.0 109.885 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 729' ' ' LYS . 46.3 Cg_endo -72.5 146.74 44.91 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.862 1.453 . . . . 0.0 110.847 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.65 161.57 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.482 -0.761 . . . . 0.0 109.701 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.8 m -110.72 143.52 41.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.487 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.72 26.7 0.23 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.46 -33.24 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -1.13 . . . . 0.0 110.356 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.66 7.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 737' ' ' VAL . . . . . 0.529 ' O ' HG23 ' B' ' 739' ' ' VAL . 48.1 t -107.01 137.11 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -1.12 . . . . 0.0 110.109 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -54.44 -37.32 65.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 739' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 737' ' ' VAL . 57.4 t 51.19 95.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.3 p -80.04 158.31 26.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.353 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.3 m -122.26 150.64 42.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.143 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -100.91 136.44 40.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.86 117.11 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -102.75 29.98 11.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 20.8 t -57.01 -35.35 69.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -1.122 . . . . 0.0 110.53 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -138.96 160.91 38.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.872 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.087 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -123.98 76.61 58.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.389 -1.065 . . . . 0.0 110.07 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.78 142.91 49.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.824 1.434 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -112.24 155.02 24.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.72 141.33 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.233 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -86.45 -174.16 49.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 33.1 m -112.92 137.76 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 109.989 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -65.59 148.73 51.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.514 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -57.89 -34.86 70.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.67 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 -106.97 148.93 28.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.109 -0.994 . . . . 0.0 110.609 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.438 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.0 m-70 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.696 HD23 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.024 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 HD11 ' B' ' 714' ' ' LEU . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.842 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.516 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.842 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.537 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.805 HD11 HD12 ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 155' ' ' ILE . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.425 HG21 ' HE1' ' A' ' 128' ' ' PHE . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.719 ' CE2' HD12 ' A' ' 152' ' ' LEU . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 172' ' ' VAL . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.673 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.51 147.62 4.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.232 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.08 -17.65 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.875 1.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 689' ' ' LEU . . . . . 0.555 ' N ' HD22 ' B' ' 689' ' ' LEU . 4.4 mm? -87.67 144.94 26.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -0.941 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 106.96 -103.57 2.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 51.7 m -115.7 145.91 42.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 692' ' ' THR . . . . . 0.448 HG22 ' H ' ' B' ' 694' ' ' GLU . 41.3 m -92.15 135.01 34.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.57 -28.75 68.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.73 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.448 ' H ' HG22 ' B' ' 692' ' ' THR . 96.6 mt-10 -57.07 136.0 56.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.77 -41.52 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 84.3 mt -113.17 134.25 54.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.78 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -107.07 -71.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.972 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -128.6 -173.01 2.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -69.62 119.5 13.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.865 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.49 -35.53 81.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.44 -0.787 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -91.47 173.94 7.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.67 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 15.0 t -127.28 154.29 45.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.15 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.305 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.7 p -61.58 -29.19 69.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.434 -0.791 . . . . 0.0 110.325 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -121.92 151.57 40.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 110.265 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -133.07 -162.15 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -122.67 73.19 42.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 110.331 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.69 -21.22 34.11 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.763 1.401 . . . . 0.0 110.446 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -113.18 163.62 14.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 110.605 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -55.52 149.1 14.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.531 0.681 . . . . 0.0 111.633 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -63.73 -40.15 96.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.351 1.072 . . . . 0.0 108.155 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.857 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.16 -179.14 0.53 Allowed Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.024 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.6 mt 68.56 52.02 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -139.24 78.11 1.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.239 -1.538 . . . . 0.0 108.867 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -82.09 18.5 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.075 0.94 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.627 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 24.8 p -45.17 171.99 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.397 179.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -71.09 -55.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.282 1.675 . . . . 0.0 108.879 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 97.9 mttt -160.49 -15.11 0.05 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.05 27.22 7.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -128.73 159.25 69.15 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.42 104.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.798 1.42 . . . . 0.0 110.058 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -64.85 -34.07 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -126.07 163.65 22.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -68.19 156.48 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.948 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -59.61 133.51 56.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.813 . . . . 0.0 110.486 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 727' ' ' LEU . 6.6 mp -73.3 -34.08 65.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 109.926 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 728' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 729' ' ' LYS . . . -109.13 155.87 20.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 728' ' ' ALA . 17.1 mttp 58.75 44.51 16.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.537 -0.727 . . . . 0.0 110.558 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 730' ' ' VAL . 12.8 p -110.39 116.35 53.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 126.67 13.58 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.32 1.168 . . . . 0.0 110.317 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.56 74.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.182 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 16.7 m -79.62 84.45 5.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -87.31 178.87 47.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.53 -35.01 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -1.14 . . . . 0.0 110.098 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 162.2 -114.33 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 128.67 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.093 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -153.08 171.66 18.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.3 119.71 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -0.945 . . . . 0.0 110.096 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 60.0 m -79.22 -36.68 39.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 110.382 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.4 m -65.81 159.71 24.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.775 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -93.82 126.33 38.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.54 -0.725 . . . . 0.0 109.91 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.83 119.43 25.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.367 -0.833 . . . . 0.0 110.464 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.44 109.87 3.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 33.8 t -145.49 157.01 44.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -1.061 . . . . 0.0 110.232 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.3 m -115.88 148.02 40.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.442 -0.786 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.288 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 150.58 95.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 110.167 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.86 150.51 73.6 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.75 1.395 . . . . 0.0 110.262 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.9 137.23 33.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.868 . . . . 0.0 110.363 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -141.97 161.42 38.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 89.57 -52.24 3.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 63.6 p -70.58 -19.87 62.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -1.04 . . . . 0.0 110.119 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -117.14 144.22 44.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -82.76 150.42 26.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 111.019 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 -111.0 150.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.711 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 38.1 m-70 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.824 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.954 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 4' ' ' LEU . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.704 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HD21 ' A' ' 84' ' ' LEU . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.795 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.879 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.577 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.804 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 165' ' ' TYR . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.562 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.479 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.48 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.804 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.79 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 167' ' ' LEU . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.79 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.4 mttm -50.23 144.39 7.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.36 -18.64 44.17 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.727 1.383 . . . . 0.0 110.8 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.3 142.69 27.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.155 -0.966 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 86.64 -171.09 42.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 14.9 p -147.07 68.2 1.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -1.082 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 11.3 t -136.01 160.73 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 110.387 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.8 150.09 20.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 110.048 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.6 138.51 57.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.365 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.7 118.88 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.412 -0.805 . . . . 0.0 110.04 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.7 tp -98.86 122.01 41.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -137.08 148.03 46.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 110.056 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -158.08 162.77 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 699' ' ' ALA . . . . . 0.842 ' HB3' ' CG2' ' B' ' 702' ' ' THR . . . -151.07 150.94 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 110.131 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 31.6 p-10 -141.1 111.95 7.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 702' ' ' THR . . . . . 0.842 ' CG2' ' HB3' ' B' ' 699' ' ' ALA . 54.4 p -122.63 156.59 33.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.72 136.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.251 -0.905 . . . . 0.0 110.596 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.1 m -119.23 147.23 44.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -145.26 154.67 42.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.584 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -143.17 93.27 2.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -125.43 87.86 55.05 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.408 -0.808 . . . . 0.0 110.291 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 137.16 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.736 1.388 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -72.26 147.12 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -99.57 142.52 30.95 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.838 0.828 . . . . 0.0 111.791 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 55.9 m -65.25 -39.09 92.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.859 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 -174.66 177.28 0.63 Allowed Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.954 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.1 mt 74.65 41.36 0.34 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.492 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.5 t -133.0 85.34 2.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.476 -1.39 . . . . 0.0 107.588 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -78.99 15.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.79 0.805 . . . . 0.0 110.299 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.587 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -48.78 170.26 0.13 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.905 -0.497 . . . . 0.0 111.294 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 35.8 Cg_endo -68.05 -53.21 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.054 1.555 . . . . 0.0 108.134 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 26.2 mtmt -164.7 -15.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.412 ' H ' ' H ' ' B' ' 719' ' ' LYS . 20.8 m 53.82 26.48 6.13 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 721' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -132.73 168.22 18.93 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.544 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' B' ' 723' ' ' ALA . 44.3 Cg_endo -75.86 -59.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.825 1.434 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 723' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 722' ' ' PRO . . . 177.88 44.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.191 -0.943 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -104.8 133.06 50.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 0.0 110.589 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -112.95 154.1 26.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.478 -0.764 . . . . 0.0 110.051 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -86.42 152.35 22.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.994 . . . . 0.0 110.537 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' B' ' 729' ' ' LYS . 21.3 tp -100.11 125.94 46.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.384 -0.822 . . . . 0.0 109.771 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.54 29.72 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 110.499 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' B' ' 727' ' ' LEU . 25.0 mttt -93.11 145.05 24.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.852 . . . . 0.0 110.153 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.431 HG22 ' H ' ' B' ' 730' ' ' VAL . 35.3 m -100.18 160.33 27.38 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.842 . . . . 0.0 110.489 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.32 159.54 53.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.62 147.97 17.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.8 t -74.41 146.72 42.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.434 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -177.98 69.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.32 136.42 34.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -1.1 . . . . 0.0 110.299 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.23 -32.44 76.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -129.84 144.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -1.102 . . . . 0.0 110.287 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -99.99 131.32 46.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.357 -0.839 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.15 138.24 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 31.7 m -77.26 131.59 38.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.8 m -128.91 149.56 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.422 -0.799 . . . . 0.0 110.316 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 51.12 73.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.321 -0.862 . . . . 0.0 110.654 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.45 -38.2 74.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.99 47.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 13.7 t -170.01 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.38 -1.071 . . . . 0.0 110.261 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -122.01 144.24 49.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 0.0 110.168 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.179 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.91 85.64 60.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.076 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.97 -23.16 47.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.586 1.308 . . . . 0.0 110.138 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.68 -20.62 65.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.46 -0.775 . . . . 0.0 110.055 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -50.65 -41.67 55.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 111.064 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 177.81 -82.84 0.07 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.407 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 57.9 m -69.33 137.71 53.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.354 -1.086 . . . . 0.0 110.897 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -89.67 146.34 24.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -67.8 133.55 49.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.322 -0.861 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 52.24 108.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.672 . . . . 0.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.563 ' HA ' HD23 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.699 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.436 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.9 m-70 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.436 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.575 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.786 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.918 HD23 HD13 ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.7 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 4' ' ' LEU . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.746 ' HB2' HG22 ' A' ' 3' ' ' VAL . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.84 HG22 HD21 ' A' ' 84' ' ' LEU . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.493 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.419 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.786 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.882 HD11 ' CD1' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.774 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.765 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 172' ' ' VAL . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.765 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm -50.11 -34.38 21.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.617 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.78 -17.94 42.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.808 1.425 . . . . 0.0 110.532 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.83 145.64 26.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 0.0 110.104 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 138.82 -24.56 2.86 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 47.3 m -118.27 146.85 43.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -1.114 . . . . 0.0 110.024 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 73.3 p -83.69 127.29 33.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.398 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -69.58 -35.12 75.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.82 -178.47 4.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 110.259 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.34 143.81 48.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.72 -174.86 4.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 56.66 47.7 17.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.48 -0.763 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.07 -38.44 76.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -171.09 67.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.22 -0.925 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.8 -29.22 68.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -58.93 -32.93 70.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.407 -0.808 . . . . 0.0 110.879 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 13.8 t -129.64 157.03 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.37 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.59 133.14 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.7 m -123.56 145.84 48.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.747 . . . . 0.0 109.874 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.75 38.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 706' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 719' ' ' LYS . . . -73.42 142.85 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.828 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.53 156.27 91.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.7 -20.97 45.89 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.73 1.384 . . . . 0.0 110.486 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.1 150.64 20.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.358 -0.839 . . . . 0.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.87 139.91 44.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 111.427 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 45.3 m -74.05 -39.78 63.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.122 0.963 . . . . 0.0 108.849 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER -171.21 -178.74 0.5 Allowed Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.918 HD13 HD23 ' A' ' 26' ' ' LEU . 9.4 mt 74.18 44.04 0.26 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.585 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.99 80.86 1.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.288 -1.507 . . . . 0.0 109.261 178.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.94 17.76 2.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.093 0.949 . . . . 0.0 109.353 178.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.62 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 27.8 p -45.59 170.69 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.79 -55.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.518 1.799 . . . . 0.0 108.817 175.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' B' ' 706' ' ' ALA . 51.0 mtmt -159.43 -13.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.598 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.9 m 59.47 27.36 16.49 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -175.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 721' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -75.66 171.11 12.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.852 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 41.7 Cg_endo -67.87 121.77 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.593 1.312 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -75.86 -19.94 58.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 110.661 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -70.53 142.48 51.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.867 . . . . 0.0 110.734 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -103.31 159.85 15.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.902 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -114.87 144.17 43.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.16 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 72.4 mt -99.17 138.3 36.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 110.067 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -90.67 109.49 20.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.095 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -131.79 147.16 52.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.45 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 730' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.1 m -97.0 164.08 18.65 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.429 -0.794 . . . . 0.0 109.64 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 731' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 43.9 Cg_endo -71.25 57.03 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.523 1.275 . . . . 0.0 110.651 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.48 64.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.1 t -55.3 -35.82 65.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -58.7 -34.1 75.5 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.0 tp -103.94 130.25 51.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.438 -1.036 . . . . 0.0 110.2 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -126.97 42.71 1.43 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.8 145.22 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -1.11 . . . . 0.0 110.323 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.36 135.13 57.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.376 -0.828 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 137.92 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.827 . . . . 0.0 110.179 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 55.7 p -118.45 164.28 15.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 0.0 110.352 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 32.8 t -110.66 151.32 27.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.469 -0.77 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -127.96 159.38 35.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 110.285 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.97 116.65 22.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.455 -0.778 . . . . 0.0 110.44 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -129.71 -64.57 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.9 t -124.69 143.58 50.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -1.08 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 53.5 p -70.17 161.53 30.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.121 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 -179.987 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -8' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -103.25 -64.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.829 -179.83 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' -7' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.6 Cg_endo -70.64 133.76 24.65 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 O-C-N 123.225 1.118 . . . . 0.0 110.711 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -68.53 -31.49 70.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.18 157.74 25.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.533 -0.73 . . . . 0.0 110.495 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 175.95 -127.0 1.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 48.3 m -58.24 -36.04 72.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.047 . . . . 0.0 110.966 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.07 146.22 48.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 156' ' ' GLN . 27.3 t70 -97.29 113.67 25.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.447 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 -132.59 134.77 45.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.446 -0.783 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.683 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' CD1' ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.013 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.496 HD11 HD11 ' B' ' 714' ' ' LEU . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.817 HG22 HD21 ' A' ' 84' ' ' LEU . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.605 HD23 ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 160' ' ' VAL . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 155' ' ' ILE . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.7 mttm -50.55 -34.37 25.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.185 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.83 161.63 45.21 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.794 1.418 . . . . 0.0 110.395 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.5 mt -74.04 144.25 45.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -71.27 136.25 24.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.0 t -126.57 142.52 51.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.474 -1.015 . . . . 0.0 109.648 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 45.2 m -122.98 137.18 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.92 169.64 10.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 109.561 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.11 137.06 56.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 109.961 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.64 119.76 29.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.653 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.79 142.28 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.463 -0.773 . . . . 0.0 109.702 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.02 141.68 33.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 55.2 t0 49.5 37.81 13.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 110.721 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -124.4 -85.46 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.414 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -123.79 144.88 49.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.435 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -125.12 173.63 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.802 . . . . 0.0 110.205 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.0 m -76.06 134.4 40.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 703' ' ' VAL . . . . . 0.43 HG12 ' O ' ' B' ' 705' ' ' ALA . 47.2 t -122.62 131.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.141 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 23.2 t -61.17 -38.61 87.11 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.17 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 705' ' ' ALA . . . . . 0.43 ' O ' HG12 ' B' ' 703' ' ' VAL . . . -149.58 154.69 39.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.459 -0.775 . . . . 0.0 109.975 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.04 94.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.242 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.59 80.82 18.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 110.504 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.44 -171.09 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.714 1.376 . . . . 0.0 110.251 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -55.01 147.73 15.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -100.99 131.12 47.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 111.595 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.61 -41.11 76.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.26 1.029 . . . . 0.0 108.703 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.909 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -167.17 -176.63 0.49 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.909 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.013 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.6 mt 69.48 45.48 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.21 80.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.189 -1.57 . . . . 0.0 108.888 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -82.92 17.16 2.0 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.034 0.921 . . . . 0.0 109.673 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.624 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.64 172.18 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.6 179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -72.49 -55.47 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.398 1.736 . . . . 0.0 108.842 175.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 97.6 mttt -160.5 -14.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 55.49 27.28 10.02 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 721' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -107.1 164.85 13.93 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 41.7 Cg_endo -68.59 143.69 57.79 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.705 1.371 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -90.95 145.44 24.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.263 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 724' ' ' GLN . . . . . 0.429 HE21 HD23 ' B' ' 727' ' ' LEU . 63.4 tt0 -94.12 128.17 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.927 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -79.92 132.99 36.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 110.628 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 46.89 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 111.184 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.429 HD23 HE21 ' B' ' 724' ' ' GLN . 28.5 tp 50.43 64.01 1.98 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.467 -0.771 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -102.82 143.86 31.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -82.23 132.7 35.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.5 t -70.47 139.7 86.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.07 104.17 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.654 1.344 . . . . 0.0 110.287 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -175.8 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.392 -0.817 . . . . 0.0 110.154 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.5 m -58.48 -36.31 73.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.299 -0.875 . . . . 0.0 110.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.2 36.22 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.35 142.0 30.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -1.055 . . . . 0.0 109.989 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -156.99 -178.14 30.77 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.0 t -120.41 137.88 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.394 -1.062 . . . . 0.0 110.04 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -101.41 136.03 41.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.67 137.92 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.389 -0.819 . . . . 0.0 109.97 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 69.2 p -101.67 149.23 24.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.204 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 52.6 p -93.47 -3.57 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -115.24 146.53 41.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.653 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -172.39 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -120.74 89.68 0.45 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 46.6 t -82.93 -0.45 48.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -1.046 . . . . 0.0 110.666 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.2 t -57.24 -34.78 68.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 92.7 m95 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 179.97 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.87 64.17 6.91 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.251 -1.147 . . . . 0.0 110.485 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 159.75 52.55 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.813 1.428 . . . . 0.0 110.575 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.29 148.12 15.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.52 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -63.55 155.64 28.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -0.817 . . . . 0.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.69 22.63 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -3' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' -1' ' ' ASP . 38.3 m -89.49 147.04 24.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.429 -1.042 . . . . 0.0 110.688 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -56.65 -27.91 59.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.521 -0.737 . . . . 0.0 110.514 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' -3' ' ' THR . 93.1 m-20 -52.8 -35.72 57.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.694 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 -81.79 128.79 34.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.448 -0.782 . . . . 0.0 109.182 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 31' ' ' ILE . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.6 m-70 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.824 HD23 HD13 ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.923 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 HD11 HD11 ' B' ' 714' ' ' LEU . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 HD21 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.424 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 49' ' ' LEU . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.509 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.808 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.723 HD21 HD11 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 160' ' ' VAL . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.694 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 155' ' ' ILE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.49 HG21 ' HE1' ' A' ' 128' ' ' PHE . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.774 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 167' ' ' LEU . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.777 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm -50.17 -34.32 22.13 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.248 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.35 -26.45 35.18 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.769 1.405 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.42 -36.33 75.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 0.0 110.364 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 142.58 58.62 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 29.3 t -110.42 146.22 36.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -1.024 . . . . 0.0 110.058 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.9 m -107.85 136.03 48.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.0 150.04 39.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.122 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 694' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' B' ' 728' ' ' ALA . 96.9 mt-10 -62.28 139.43 58.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.026 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -142.69 141.37 31.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.384 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 21.2 tp -105.73 126.72 52.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -127.11 123.87 37.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.394 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.19 -29.52 67.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.208 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.14 68.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 110.969 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -104.6 149.83 25.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.127 -0.983 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -138.25 171.84 13.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 14.9 t -133.8 141.67 47.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 111.355 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.88 140.69 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.7 . . . . 0.0 109.352 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 82.5 p -147.72 162.46 39.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.081 -1.012 . . . . 0.0 111.063 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.01 44.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.679 . . . . 0.0 109.715 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -97.04 136.07 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.172 -0.955 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -162.7 129.38 2.45 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.69 -18.58 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.612 1.322 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -96.44 168.22 10.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.129 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 710' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 7.6 m-30 -46.89 156.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.049 0.928 . . . . 0.0 112.007 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 57.0 m -56.69 -36.14 69.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.826 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.13 -179.03 0.53 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.826 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.923 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt 71.39 44.71 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -135.57 81.22 1.88 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.241 -1.537 . . . . 0.0 108.733 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.466 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 11.9 mp0 -82.49 18.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.088 0.947 . . . . 0.0 109.757 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.583 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.2 p -46.25 169.62 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.254 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.5 Cg_endo -70.3 -55.04 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.313 1.691 . . . . 0.0 108.672 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 73.8 mttt -160.89 -15.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.569 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.54 26.81 7.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.99 39.41 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.812 -178.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.77 153.97 59.0 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.791 1.416 . . . . 0.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 723' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' B' ' 724' ' ' GLN . . . -152.19 -147.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.078 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 724' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 723' ' ' ALA . 92.3 mt-30 58.58 48.59 11.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.311 -0.868 . . . . 0.0 110.543 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -73.26 125.03 26.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.259 -0.901 . . . . 0.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -137.74 141.75 40.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.844 . . . . 0.0 110.038 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 77.8 mt -88.07 8.33 27.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.794 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 728' ' ' ALA . . . . . 0.419 ' HB3' ' OE2' ' B' ' 694' ' ' GLU . . . -63.23 -21.82 66.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.657 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -66.53 142.63 57.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.173 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.0 t -123.44 77.22 54.25 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.81 156.48 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.781 1.411 . . . . 0.0 110.299 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -56.55 148.73 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 87.3 p -103.48 154.14 19.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -149.9 -138.31 2.89 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.14 134.56 41.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -1.049 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -81.84 -174.16 49.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.16 130.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.291 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -168.39 132.89 1.64 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.474 -0.766 . . . . 0.0 110.086 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.18 153.42 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.2 m -124.82 137.53 54.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.196 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 27.2 t -132.38 148.08 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 125.3 34.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.949 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -165.66 174.45 9.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.082 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.52 9.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 29.2 t -108.75 87.38 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -1.202 . . . . 0.0 109.993 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 74.1 m -86.55 5.52 35.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.348 -0.845 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.247 -179.835 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.36 142.8 31.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.204 -1.174 . . . . 0.0 110.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.53 168.02 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.708 1.373 . . . . 0.0 110.462 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.15 146.63 18.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -90.14 135.5 33.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.563 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 86.63 178.49 49.33 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 64.1 p -99.99 -0.38 39.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -1.033 . . . . 0.0 110.6 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -127.02 152.65 46.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.84 172.03 15.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 110.144 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -110.34 150.69 28.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 31' ' ' ILE . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.8 m-70 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.779 HD23 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 4' ' ' LEU . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.806 HG22 HD21 ' A' ' 84' ' ' LEU . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.81 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.43 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.806 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.81 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.67 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 25' ' ' LEU . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.079 HD11 HD22 ' B' ' 714' ' ' LEU . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.411 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 152' ' ' LEU . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.67 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.803 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 46.9 mttm -50.04 144.38 6.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.216 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.63 149.64 73.94 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.751 1.395 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.52 138.59 32.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -0.81 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 94.68 -167.89 27.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 56.3 p -70.29 161.61 30.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -1.078 . . . . 0.0 110.55 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 55.6 m -119.16 141.04 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 0.0 109.894 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.04 141.75 55.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.293 -0.879 . . . . 0.0 110.569 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.31 149.5 27.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.772 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.25 136.6 58.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 79.3 mt -92.49 3.96 54.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.811 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.99 141.99 54.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.02 -1.05 . . . . 0.0 110.207 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -133.49 164.53 26.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 110.202 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -112.28 148.16 34.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 700' ' ' GLU . . . . . 0.806 ' HG3' HG23 ' B' ' 702' ' ' THR . 22.7 pt-20 -108.57 164.6 12.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.475 -0.766 . . . . 0.0 109.828 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 23.8 p-10 -81.72 100.38 9.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.21 -0.931 . . . . 0.0 111.451 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 702' ' ' THR . . . . . 0.806 HG23 ' HG3' ' B' ' 700' ' ' GLU . 34.0 p -126.87 142.39 51.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.88 123.64 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.625 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 53.0 p -97.45 -3.09 40.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.409 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.04 72.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 0.0 110.903 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.82 136.02 57.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.246 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -157.16 72.69 4.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 110.39 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.2 154.18 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.632 1.333 . . . . 0.0 110.329 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -55.96 146.46 22.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 710' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 8.6 m-30 -110.44 149.53 30.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.226 1.012 . . . . 0.0 112.478 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 83.6 m -60.34 -34.14 73.4 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.818 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -175.63 179.87 0.41 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.193 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 152' ' ' LEU . 5.5 mp 74.46 36.09 0.66 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -137.3 77.4 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.418 -1.426 . . . . 0.0 107.411 177.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 716' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 27.8 mp0 -76.67 18.39 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.879 0.847 . . . . 0.0 110.091 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.515 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.7 p -52.62 167.4 0.38 Allowed Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.552 ' O ' ' HG3' ' B' ' 719' ' ' LYS . 36.7 Cg_endo -70.22 -51.47 0.34 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.143 1.601 . . . . 0.0 108.641 176.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 10.3 mtmt -164.38 -14.53 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.2 m 56.89 26.52 11.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -175.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -138.57 161.84 56.46 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.742 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.7 126.09 11.73 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.545 1.287 . . . . 0.0 109.896 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -113.7 143.56 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.55 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -120.49 139.31 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.81 . . . . 0.0 110.01 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -130.63 148.76 52.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.95 126.86 51.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.857 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 727' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' B' ' 728' ' ' ALA . 27.4 tp -60.46 -38.8 85.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.514 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 728' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' B' ' 727' ' ' LEU . . . 57.56 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.362 -0.836 . . . . 0.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 729' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' B' ' 727' ' ' LEU . 60.1 tttp -130.24 139.91 50.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.98 140.19 86.98 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.376 -0.828 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.91 -36.66 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.992 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.01 140.14 56.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 95.8 p -122.14 151.35 41.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.35 96.98 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.6 tp -111.51 128.39 56.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.232 -1.158 . . . . 0.0 110.403 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -90.34 178.91 43.34 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.26 153.34 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -1.143 . . . . 0.0 110.234 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -115.89 147.83 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.171 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.29 153.89 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 35.6 m -125.24 138.69 54.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 93.8 p -126.26 153.71 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.08 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -58.67 -37.44 76.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.362 -0.837 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.84 -36.4 74.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -64.48 145.63 49.69 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.4 m -121.32 150.45 41.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.994 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.9 t -111.95 142.76 43.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.822 . . . . 0.0 110.035 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.17 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -65.01 141.7 98.46 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.094 . . . . 0.0 110.223 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.65 137.43 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.686 1.361 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -113.41 131.52 55.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 110.208 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -115.0 137.83 51.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 171.05 37.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.319 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -3' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 78' ' ' GLY . 30.5 m -58.4 -40.79 83.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.996 -1.296 . . . . 0.0 109.54 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -58.11 -35.58 71.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 109.661 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -75.67 134.05 40.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.664 -0.648 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 0' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 -53.39 145.98 13.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.29 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HB3' HG12 ' A' ' 34' ' ' ILE . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' PRO . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' CE1' ' NH1' ' A' ' 14' ' ' ARG . 37.7 m-70 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 25' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 HD13 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.995 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 HD11 ' B' ' 714' ' ' LEU . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.823 HG22 ' CD2' ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 49' ' ' LEU . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD23 ' O ' ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' -3' ' ' THR . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.823 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.811 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.893 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.893 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.573 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HG3' HG12 ' A' ' 5' ' ' VAL . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.756 HD11 HD12 ' B' ' 714' ' ' LEU . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.573 HG21 ' HE1' ' A' ' 128' ' ' PHE . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.799 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.715 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.734 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.801 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 172' ' ' VAL . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.801 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -49.81 -34.67 20.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.19 -179.987 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 149.65 68.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.791 1.417 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.7 tp -94.7 127.71 40.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.075 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.35 -122.61 29.84 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.6 p -68.54 166.58 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -1.099 . . . . 0.0 109.545 179.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 65.1 p -63.64 146.91 52.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.832 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.18 -56.49 2.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -113.26 128.24 56.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 695' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' B' ' 695' ' ' ASP . 26.8 p-10 -67.42 -33.22 74.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 110.545 179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.81 147.02 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.46 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.85 140.61 45.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 110.167 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -110.01 149.07 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.475 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -71.22 158.32 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.928 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.64 142.68 32.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.3 -0.875 . . . . 0.0 110.185 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -143.42 170.06 16.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.433 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.9 p -123.29 161.38 24.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.83 141.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.025 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 54.7 p -78.62 155.15 29.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 110.351 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -111.78 143.29 42.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.092 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -167.82 30.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.338 -0.851 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 75.87 78.33 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.47 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.48 -21.29 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.756 1.398 . . . . 0.0 110.004 179.532 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.35 168.68 11.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.988 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -49.59 139.2 12.82 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.69 0.757 . . . . 0.0 111.587 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 47.5 m -71.46 -38.29 71.29 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.037 0.922 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -174.0 -176.26 0.29 Allowed Pre-proline 0 C--N 1.301 -1.528 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 714' ' ' LEU . . . . . 0.995 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.5 mt 68.02 46.22 1.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 715' ' ' CYS . . . . . 0.53 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.84 77.02 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.186 -1.571 . . . . 0.0 108.964 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -82.86 18.63 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.217 1.008 . . . . 0.0 109.238 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 717' ' ' CYS . . . . . 0.593 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.0 p -46.14 170.12 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.692 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 718' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -72.83 -54.31 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.529 1.805 . . . . 0.0 108.972 176.147 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 52.0 mtpt -160.75 -14.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 720' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.6 m 58.22 27.47 15.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 721' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -95.38 168.47 10.91 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.006 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 722' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 42.3 Cg_endo -68.8 145.4 62.67 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.645 1.34 . . . . 0.0 110.549 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -141.95 151.67 42.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.138 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -85.25 -1.84 57.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.358 -0.839 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -79.39 141.86 36.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -138.73 161.05 38.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.442 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 75.8 mt -84.13 150.57 25.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.783 . . . . 0.0 109.927 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -58.17 140.68 52.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 110.339 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -96.48 147.05 24.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 110.104 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.2 m -54.84 149.9 21.08 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.271 -0.893 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 -21.14 43.79 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.739 1.389 . . . . 0.0 110.859 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.51 127.22 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 83.9 p -142.88 158.6 43.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.25 -169.9 43.04 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 735' ' ' LEU . . . . . 0.577 ' O ' HG21 ' B' ' 739' ' ' VAL . 9.1 tt -93.1 125.41 37.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -1.009 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.29 -169.16 52.48 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 737' ' ' VAL . . . . . 0.805 ' O ' HG13 ' B' ' 739' ' ' VAL . 32.7 m -129.88 149.08 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 110.013 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 21.3 m120 53.26 38.56 27.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.369 -0.832 . . . . 0.0 109.98 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 739' ' ' VAL . . . . . 0.805 HG13 ' O ' ' B' ' 737' ' ' VAL . 33.0 m -132.28 172.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 59.8 p -62.48 148.61 45.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 43.5 t -142.51 125.45 16.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.623 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -140.91 154.03 45.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 110.051 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -84.91 138.89 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 85.14 -173.39 48.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 745' ' ' SER . . . . . 0.465 ' HG ' ' HD1' ' B' ' 747' ' ' TRP . 1.8 t -128.12 141.24 51.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.005 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 31.0 t -75.59 -84.19 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.068 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 747' ' ' TRP . . . . . 0.465 ' HD1' ' HG ' ' B' ' 745' ' ' SER . 98.0 m95 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.562 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.022 0.439 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 33' ' ' HIS . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.933 HD23 HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.704 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.81 HD11 HD21 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.729 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 84' ' ' LEU . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.769 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 12' ' ' PRO . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 49' ' ' LEU . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' HB2' HD23 ' A' ' 35' ' ' LEU . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 84' ' ' LEU . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.734 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.769 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.409 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.954 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.589 ' CG1' HG23 ' A' ' 160' ' ' VAL . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.589 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 152' ' ' LEU . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.656 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.834 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.834 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 152' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.456 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 34' ' ' ILE . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.701 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.802 HD23 HD13 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.99 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.472 HD11 HD11 ' B' ' 714' ' ' LEU . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.946 HG22 HD21 ' A' ' 84' ' ' LEU . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 84' ' ' LEU . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.946 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.766 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.887 HD11 HD12 ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.497 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 128' ' ' PHE . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.763 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' A' ' 152' ' ' LEU . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.813 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.813 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.867 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.99 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.5 mt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 31' ' ' ILE . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.694 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.898 HD23 HD23 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.798 HD11 HD21 ' B' ' 714' ' ' LEU . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.409 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.824 HG22 HD21 ' A' ' 84' ' ' LEU . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG13 HD13 ' A' ' 84' ' ' LEU . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.43 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.808 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.654 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.875 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.941 HD11 HD22 ' B' ' 714' ' ' LEU . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.541 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.541 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.784 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.784 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.823 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.823 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.941 HD22 HD11 ' A' ' 152' ' ' LEU . 3.3 mp . . . . . 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.422 ' HB3' HG12 ' A' ' 34' ' ' ILE . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.661 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.822 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.864 HD23 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.887 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.709 HG22 ' CD2' ' A' ' 84' ' ' LEU . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.776 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.602 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 84' ' ' LEU . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.776 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.888 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.888 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.624 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.822 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.99 HD11 HD12 ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.772 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.624 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.78 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.78 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.87 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.99 HD12 HD11 ' A' ' 152' ' ' LEU . 10.7 mt . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.573 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 120.48 0.181 . . . . 0.0 111.188 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.702 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.952 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.548 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.927 HD11 HD21 ' B' ' 714' ' ' LEU . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD21 ' A' ' 84' ' ' LEU . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.428 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.918 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.622 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.901 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.044 HD11 HD22 ' B' ' 714' ' ' LEU . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 160' ' ' VAL . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 155' ' ' ILE . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.667 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 152' ' ' LEU . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.768 HD12 HG12 ' A' ' 172' ' ' VAL . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 167' ' ' LEU . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 152' ' ' LEU . 2.5 mp . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 HD23 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.719 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.839 HD23 HD23 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.692 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 714' ' ' LEU . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 3' ' ' VAL . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.832 HG22 HD21 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.812 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.541 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.812 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.886 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.977 HD11 HD22 ' B' ' 714' ' ' LEU . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.531 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.44 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 152' ' ' LEU . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.799 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.861 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.861 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 152' ' ' LEU . 4.3 mp . . . . . 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.451 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.864 0.364 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.703 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 26' ' ' LEU . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.034 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 714' ' ' LEU . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.717 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.527 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.436 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.518 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.74 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.714 HD11 ' CD1' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.537 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.518 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 152' ' ' LEU . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.696 HG12 HD12 ' A' ' 167' ' ' LEU . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.034 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.5 mt . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.077 0.465 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 31' ' ' ILE . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.654 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.936 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.901 HD23 HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 30' ' ' LYS . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.839 HD11 HD21 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.75 HG22 ' CD2' ' A' ' 84' ' ' LEU . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.777 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.55 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.75 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.777 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.658 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.936 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.948 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 160' ' ' VAL . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.669 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.669 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.848 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.948 HD22 ' CD1' ' A' ' 152' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 31' ' ' ILE . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 132' ' ' PRO . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.727 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.84 HD23 HD23 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 30' ' ' LYS . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.677 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 HD21 ' B' ' 714' ' ' LEU . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 57' ' ' HIS . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.4 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 HD21 ' A' ' 84' ' ' LEU . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.837 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.895 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.557 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.511 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 131' ' ' ASN . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.769 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.716 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.973 HD11 HD22 ' B' ' 714' ' ' LEU . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.571 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.511 HG21 ' HE1' ' A' ' 128' ' ' PHE . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.795 ' CE2' HD12 ' A' ' 152' ' ' LEU . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.769 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.807 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.595 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.807 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.973 HD22 HD11 ' A' ' 152' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.48 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.995 0.426 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.426 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.67 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.803 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.73 HD23 HD13 ' B' ' 714' ' ' LEU . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.9 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.739 ' HB2' HG22 ' A' ' 3' ' ' VAL . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 84' ' ' LEU . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.536 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.498 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.673 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.803 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.84 HD21 ' CD1' ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.48 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.408 HG21 ' HE1' ' A' ' 128' ' ' PHE . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.673 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.773 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.773 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.905 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.905 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.9 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.5 mt . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 34' ' ' ILE . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.687 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.919 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HD11 ' B' ' 714' ' ' LEU . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.762 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.787 HG22 ' CD2' ' A' ' 84' ' ' LEU . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.498 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 HD13 ' A' ' 84' ' ' LEU . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.432 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.787 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.643 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.688 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.745 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.813 HD11 HD12 ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 155' ' ' ILE . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.418 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.75 ' CE2' HD12 ' A' ' 152' ' ' LEU . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.663 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.663 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' B' ' 712' ' ' HIS . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.919 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.0 mt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.696 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.821 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.861 HD23 HD13 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 27' ' ' VAL . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.904 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HD11 ' B' ' 714' ' ' LEU . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.518 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.679 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.821 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.98 HD11 HD12 ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.572 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.572 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.402 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.744 ' CE2' HD12 ' A' ' 152' ' ' LEU . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.679 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.659 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 167' ' ' LEU . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.659 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.847 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 152' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.911 0.386 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 713' ' ' PRO . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.606 HD13 HD21 ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.693 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.788 HD23 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.703 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.405 HD13 HD22 ' A' ' 4' ' ' LEU . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.696 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 HD21 ' A' ' 84' ' ' LEU . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.592 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 45' ' ' SER . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' HD22 ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 49' ' ' LEU . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.512 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.83 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.05 HD11 HD22 ' B' ' 714' ' ' LEU . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.542 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.542 HG23 HG12 ' A' ' 155' ' ' ILE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 173' ' ' LYS . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 167' ' ' LEU . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.69 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.05 HD22 HD11 ' A' ' 152' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.749 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.764 HG22 ' CD2' ' A' ' 84' ' ' LEU . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.449 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.764 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.779 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.622 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.419 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.863 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.055 HD11 HD22 ' B' ' 714' ' ' LEU . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 155' ' ' ILE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.428 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.732 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.797 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.782 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.782 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.494 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.8 mttm . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.805 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.805 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 152' ' ' LEU . 1.6 mp . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.83 0.348 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.723 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.856 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.853 HD23 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 26' ' ' LEU . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.947 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.508 HD11 HD11 ' B' ' 714' ' ' LEU . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' HD22 ' A' ' 40' ' ' LEU . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.866 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.766 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.836 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.915 HD11 HD12 ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.456 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.754 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.737 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.634 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' B' ' 712' ' ' HIS . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.851 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.947 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.8 mt . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.3 ptt85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.849 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.947 HD23 HD23 ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HD21 ' B' ' 714' ' ' LEU . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.75 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 HD21 ' A' ' 84' ' ' LEU . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.804 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.023 HD11 HD22 ' B' ' 714' ' ' LEU . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 160' ' ' VAL . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.56 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.703 ' CE1' HD12 ' A' ' 152' ' ' LEU . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.714 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.804 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 167' ' ' LEU . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.804 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.4 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.845 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.023 HD22 HD11 ' A' ' 152' ' ' LEU . 2.2 mp . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.09 0.471 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.945 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.955 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.848 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.792 HG22 HD21 ' A' ' 84' ' ' LEU . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.495 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.435 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.792 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.7 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.876 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.958 HD11 HD22 ' B' ' 714' ' ' LEU . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 160' ' ' VAL . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 155' ' ' ILE . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.683 ' CE1' HD12 ' A' ' 152' ' ' LEU . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.7 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.783 HD12 ' HD2' ' A' ' 173' ' ' LYS . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.872 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 152' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.442 ' HB2' HG21 ' A' ' 31' ' ' ILE . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.4 m80 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.712 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.902 ' HE2' HD23 ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.442 HG21 ' HB2' ' A' ' 4' ' ' LEU . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.72 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HD21 ' A' ' 84' ' ' LEU . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.807 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.578 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 25' ' ' LEU . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' B' ' 714' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.441 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.534 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.416 HG21 ' HE1' ' A' ' 128' ' ' PHE . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.67 ' CE2' HD12 ' A' ' 152' ' ' LEU . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.45 HG21 ' HE1' ' A' ' 22' ' ' PHE . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 160' ' ' VAL . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.896 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.896 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.902 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.391 0.615 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.696 HD23 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.024 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 HD11 ' B' ' 714' ' ' LEU . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.842 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.516 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.842 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.537 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.805 HD11 HD12 ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 155' ' ' ILE . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.425 HG21 ' HE1' ' A' ' 128' ' ' PHE . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.719 ' CE2' HD12 ' A' ' 152' ' ' LEU . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 172' ' ' VAL . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.673 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.857 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.024 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.6 mt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.711 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.824 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.954 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 4' ' ' LEU . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.704 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HD21 ' A' ' 84' ' ' LEU . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.879 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.577 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.804 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 165' ' ' TYR . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.562 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.479 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.48 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.804 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.79 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 167' ' ' LEU . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.79 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.4 mttm . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.859 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.954 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.1 mt . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 . . . . . 0 N--CA 1.498 1.953 0 CA-C-O 120.989 0.423 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.563 ' HA ' HD23 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.699 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.575 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.786 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.918 HD23 HD13 ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.7 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 4' ' ' LEU . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.746 ' HB2' HG22 ' A' ' 3' ' ' VAL . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.84 HG22 HD21 ' A' ' 84' ' ' LEU . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.493 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.419 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.786 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.882 HD11 ' CD1' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.774 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.765 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 172' ' ' VAL . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.765 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.918 HD13 HD23 ' A' ' 26' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.447 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.683 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.738 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' CD1' ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.013 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.496 HD11 HD11 ' B' ' 714' ' ' LEU . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.817 HG22 HD21 ' A' ' 84' ' ' LEU . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.605 HD23 ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 160' ' ' VAL . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 155' ' ' ILE . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.7 mttm . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.909 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.909 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.013 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.6 mt . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.694 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 31' ' ' ILE . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.824 HD23 HD13 ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.923 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 HD11 HD11 ' B' ' 714' ' ' LEU . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 HD21 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.424 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.509 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.808 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.723 HD21 HD11 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 160' ' ' VAL . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.694 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 155' ' ' ILE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.49 HG21 ' HE1' ' A' ' 128' ' ' PHE . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.774 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 167' ' ' LEU . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.777 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.826 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.826 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.923 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.191 0.52 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 31' ' ' ILE . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.68 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.779 HD23 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 4' ' ' LEU . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.806 HG22 HD21 ' A' ' 84' ' ' LEU . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.81 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.43 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.806 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.81 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.67 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 25' ' ' LEU . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.079 HD11 HD22 ' B' ' 714' ' ' LEU . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.411 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 152' ' ' LEU . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.67 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.803 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 46.9 mttm . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.818 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 152' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 0' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HB3' HG12 ' A' ' 34' ' ' ILE . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' PRO . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 HD13 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.995 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 HD11 ' B' ' 714' ' ' LEU . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.823 HG22 ' CD2' ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.811 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.823 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.811 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.893 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.893 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.573 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HG3' HG12 ' A' ' 5' ' ' VAL . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.756 HD11 HD12 ' B' ' 714' ' ' LEU . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.573 HG21 ' HE1' ' A' ' 128' ' ' PHE . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.799 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.715 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.734 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.801 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 172' ' ' VAL . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.801 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 714' ' ' LEU . . . . . 0.995 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.5 mt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.0 p -117.71 157.84 46.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -1.099 . . . . 0.0 110.244 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.96 136.57 32.8 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.768 1.404 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -62.99 -38.53 91.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.878 . . . . 0.0 110.358 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . 0.443 ' CD2' ' N ' ' A' ' -4' ' ' GLY . 30.2 t80 -137.2 161.59 35.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.409 -0.807 . . . . 0.0 110.047 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' -5' ' ' PHE . . . -66.82 -69.96 1.24 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' -5' ' ' PHE . 63.9 p -122.72 163.16 20.66 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -115.77 133.38 56.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 0.0 110.417 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -117.32 18.06 14.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.476 -0.765 . . . . 0.0 110.33 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 36.2 ptt180 -54.84 140.25 37.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -0.891 . . . . 0.0 110.916 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp -141.24 137.44 32.55 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.349 -0.844 . . . . 0.0 110.338 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' B' ' 713' ' ' PRO . 28.4 tp -95.13 135.95 36.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.9 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 33' ' ' HIS . 39.5 t -121.51 138.89 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.292 -0.88 . . . . 0.0 110.422 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 48.9 tp -98.56 132.55 43.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.2 130.12 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.455 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -168.18 -175.75 2.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.9 -175.68 34.36 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.4 40.76 13.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.757 -0.849 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.51 -35.73 65.65 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.35 42.05 30.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.688 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.19 136.89 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 109.026 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.43 25.27 19.76 Favored 'Cis proline' 0 C--N 1.316 -1.142 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.209 -1.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.9 -48.0 83.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 111.979 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.5 -21.85 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.058 -1.026 . . . . 0.0 111.047 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.69 158.41 43.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.085 -1.009 . . . . 0.0 110.169 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.7 15.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 111.074 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 178.97 2.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 110.62 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.47 162.69 67.82 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.91 142.0 86.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.1 -59.96 2.34 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -56.25 -35.93 67.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.83 -1.169 . . . . 0.0 111.779 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.39 -40.42 95.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.99 -1.068 . . . . 0.0 111.01 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -56.03 -36.92 68.52 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.71 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.59 -35.46 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.664 . . . . 0.0 109.522 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -65.8 -39.0 90.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.251 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.933 HD23 HD23 ' B' ' 714' ' ' LEU . 84.5 mt -84.87 134.98 34.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.228 -0.92 . . . . 0.0 111.509 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.4 m -151.53 145.93 18.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.741 -0.599 . . . . 0.0 110.046 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.86 149.89 54.52 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.477 1.251 . . . . 0.0 111.017 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.09 81.45 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.704 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -109.02 -27.58 9.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.276 -1.132 . . . . 0.0 110.926 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.81 HD11 HD21 ' B' ' 714' ' ' LEU . 72.5 mt -111.03 130.18 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 110.662 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -99.42 -20.28 16.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.677 . . . . 0.0 110.493 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.729 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.5 m-70 -138.06 138.21 38.56 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.925 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.1 mt -129.48 123.0 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.9 128.4 55.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 108.887 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -119.44 129.57 54.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -0.977 . . . . 0.0 110.556 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.734 HG22 ' CD2' ' A' ' 84' ' ' LEU . 55.8 p -102.8 -66.47 0.93 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.75 . . . . 0.0 110.611 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.769 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.03 162.11 2.6 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.7 p30 -72.28 148.95 44.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.597 -0.943 . . . . 0.0 110.412 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -55.8 -62.89 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.354 -0.841 . . . . 0.0 111.438 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -99.45 -23.34 15.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.835 -1.791 . . . . 0.0 110.104 -0.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 12' ' ' PRO . 11.3 t -67.41 143.48 56.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.32 -0.863 . . . . 0.0 110.918 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -59.58 -27.67 66.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 0.0 110.148 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -51.93 -41.06 61.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.74 -34.3 77.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.878 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.6 t80 -59.63 -43.08 93.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.9 -40.41 88.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.379 -0.826 . . . . 0.0 109.633 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.35 -44.8 95.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 110.028 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 49' ' ' LEU . 81.0 mt -62.75 -38.69 91.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.372 -0.83 . . . . 0.0 110.128 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.2 -32.29 72.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.708 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.3 m -63.55 -43.58 96.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.47 -0.769 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.66 -36.94 84.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.183 -0.948 . . . . 0.0 110.601 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.3 154.69 36.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -0.917 . . . . 0.0 110.44 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.15 12.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -86.06 109.11 18.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.239 -1.153 . . . . 0.0 110.324 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.68 133.45 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.341 -0.849 . . . . 0.0 110.242 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' HB2' HD23 ' A' ' 35' ' ' LEU . 95.0 m-70 -115.91 124.63 51.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.3 mt -130.8 150.06 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 111.338 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 84' ' ' LEU . 28.0 m -116.82 150.5 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.53 130.78 43.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.771 -1.205 . . . . 0.0 111.018 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.39 -175.49 38.87 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.27 0.51 36.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.122 -1.222 . . . . 0.0 110.807 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -0.999 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.22 133.01 35.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.65 -46.03 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.227 -0.92 . . . . 0.0 110.027 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.78 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.432 0.634 . . . . 0.0 110.139 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.59 -1.11 57.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.625 -0.672 . . . . 0.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.55 -3.89 36.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.218 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.71 80.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.85 -1.156 . . . . 0.0 109.512 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.42 21.05 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.89 1.468 . . . . 0.0 110.964 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.37 80.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.33 29.31 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.78 34.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.841 -1.162 . . . . 0.0 111.54 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.81 113.3 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.41 131.8 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.51 37.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 109.16 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.83 -119.21 5.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.3 -6.09 51.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -1.16 . . . . 0.0 110.879 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 137.39 36.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 113.207 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.57 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.02 140.55 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.308 -0.87 . . . . 0.0 112.195 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.29 16.27 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.734 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.855 -1.379 . . . . 0.0 111.902 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.57 149.08 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.455 -0.778 . . . . 0.0 109.503 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.769 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.33 3.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.845 -1.159 . . . . 0.0 110.499 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.65 3.4 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.75 -17.32 55.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.966 -1.314 . . . . 0.0 110.02 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.69 -5.96 59.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.843 . . . . 0.0 109.986 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.13 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.192 -0.942 . . . . 0.0 109.699 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.27 154.94 97.22 Favored 'Cis proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.744 -2.19 . . . . 0.0 111.668 -0.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.07 5.72 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.027 -1.559 . . . . 0.0 112.539 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.09 36.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.704 -1.468 . . . . 0.0 110.341 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.48 63.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.69 86.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 109.532 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.13 -42.01 85.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.341 -0.85 . . . . 0.0 109.165 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.7 -42.14 98.01 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.451 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.25 94.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.61 67.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.11 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.95 -35.36 69.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.5 85.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.826 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.04 12.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.457 -0.777 . . . . 0.0 110.199 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.56 70.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.661 -0.65 . . . . 0.0 110.689 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.12 -28.98 63.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.448 -0.783 . . . . 0.0 111.437 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.36 48.05 10.54 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.163 -0.96 . . . . 0.0 109.901 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.96 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.435 -0.791 . . . . 0.0 110.302 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.15 -31.98 33.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.809 . . . . 0.0 109.071 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.16 140.51 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.46 42.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.06 131.58 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.158 -0.964 . . . . 0.0 109.938 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.51 160.75 38.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 110.229 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.56 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.935 -0.744 . . . . 0.0 111.589 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.3 p -87.96 -9.62 52.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.845 -1.159 . . . . 0.0 111.447 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 25.03 7.6 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.074 -1.016 . . . . 0.0 110.773 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.71 114.2 19.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.343 -0.848 . . . . 0.0 109.263 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.49 137.92 41.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.96 122.38 7.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 110.32 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.76 3.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 109.827 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.58 21.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.92 . . . . 0.0 111.035 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.18 145.43 37.27 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.285 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.54 117.56 7.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.186 -0.946 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.87 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.722 . . . . 0.0 111.428 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.25 15.31 6.31 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.758 -0.589 . . . . 0.0 112.393 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.75 154.84 38.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.888 -1.133 . . . . 0.0 109.845 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.27 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 111.187 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.25 53.48 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.001 . . . . 0.0 111.941 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.42 108.97 14.78 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.04 -29.98 48.01 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.538 1.283 . . . . 0.0 111.467 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.39 14.82 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.86 111.69 19.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.56 -20.58 47.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.34 -0.85 . . . . 0.0 110.442 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.53 13.14 18.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -0.898 . . . . 0.0 110.552 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.54 64.41 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.95 4.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.957 . . . . 0.0 110.787 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.16 46.36 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.736 0.779 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 116.0 5.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.11 11.21 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.19 -28.77 48.16 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.619 -1.301 . . . . 0.0 112.353 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.36 22.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.891 -1.131 . . . . 0.0 109.87 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.86 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.489 -0.757 . . . . 0.0 111.274 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.2 4.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.055 -1.028 . . . . 0.0 110.049 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.03 121.12 39.01 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.44 135.99 41.49 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.424 1.223 . . . . 0.0 109.734 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.409 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 95.5 p -169.15 154.45 5.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.572 -1.33 . . . . 0.0 112.2 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.792 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.8 p90 -137.98 160.77 38.44 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.28 137.77 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.069 -1.019 . . . . 0.0 113.43 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.954 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.2 mt -107.96 135.71 48.88 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -116.33 122.88 46.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.303 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -100.27 118.02 35.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.433 -0.792 . . . . 0.0 109.75 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.589 ' CG1' HG23 ' A' ' 160' ' ' VAL . 94.0 mt -115.63 109.14 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 111.25 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -41.32 27.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.759 0.79 . . . . 0.0 108.896 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.21 -106.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 8.48 17.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.68 -1.263 . . . . 0.0 110.132 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.1 m -124.18 139.8 53.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.731 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.589 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -130.89 139.58 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.022 . . . . 0.0 111.213 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.22 126.52 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.0 p -107.56 136.11 47.88 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.635 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.704 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.56 127.24 55.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.87 132.95 57.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 152' ' ' LEU . 58.8 m-85 -111.64 115.8 29.73 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.348 -0.845 . . . . 0.0 109.793 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -109.38 137.86 46.6 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.362 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -94.04 82.17 4.18 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.656 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -100.1 118.6 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.48 53.99 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.4 -43.92 65.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.263 . . . . 0.0 110.783 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -75.3 157.5 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.262 -0.899 . . . . 0.0 110.958 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 60.3 t -104.81 129.28 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 0.0 109.722 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.656 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -98.33 147.65 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.459 -0.776 . . . . 0.0 109.965 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.6 p -131.47 141.13 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.954 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.1 tt0 -120.97 150.6 40.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.583 -0.698 . . . . 0.0 109.33 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.69 126.63 54.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.004 . . . . 0.0 111.624 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.07 141.67 47.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.959 -1.088 . . . . 0.0 111.432 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.9 t80 -140.01 142.55 36.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.0 109.992 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -140.24 147.23 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.1 mttm -50.61 -34.34 25.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.334 -0.854 . . . . 0.0 110.619 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.176 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.48 148.19 66.36 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.789 1.415 . . . . 0.0 110.532 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.72 -35.84 77.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 0.0 110.28 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -96.57 119.58 6.37 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 88.3 p -62.24 -25.87 68.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -1.108 . . . . 0.0 110.334 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 76.4 p -65.33 133.13 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.3 -32.92 72.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -0.806 . . . . 0.0 110.75 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -98.48 136.81 38.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.711 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -169.85 28.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.424 -0.797 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.1 mt -100.52 125.58 46.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.165 -0.959 . . . . 0.0 110.347 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.74 -38.48 73.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.364 -0.835 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -132.51 123.8 27.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.33 -0.856 . . . . 0.0 110.24 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -67.8 -40.15 83.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.418 -0.802 . . . . 0.0 110.726 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -127.92 149.31 50.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -0.934 . . . . 0.0 110.87 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 48.6 p30 -100.58 170.26 8.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.0 110.22 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 43.0 p -117.6 161.59 19.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.9 152.64 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.423 -0.798 . . . . 0.0 110.39 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 84.7 p -148.24 157.21 43.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -76.06 -58.46 3.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.313 -0.867 . . . . 0.0 110.215 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -153.89 152.4 30.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.39 74.61 80.82 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.17 144.42 51.78 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.784 1.412 . . . . 0.0 110.544 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -110.6 149.19 30.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -109.61 132.6 53.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 111.646 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.0 m -90.17 -46.29 8.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.294 1.045 . . . . 0.0 108.44 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.834 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -159.77 -178.74 0.94 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.834 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.02 143.09 99.95 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 122.766 0.877 . . . . 0.0 110.292 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.954 HD22 ' CD1' ' A' ' 152' ' ' LEU . 3.5 mp 68.72 37.57 2.41 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.73 77.9 1.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.539 -1.35 . . . . 0.0 108.54 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.423 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 17.6 mp0 -81.6 16.85 1.58 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.968 0.89 . . . . 0.0 109.796 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.626 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.9 p -45.69 171.56 0.05 OUTLIER Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.394 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.05 -54.99 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.34 1.705 . . . . 0.0 108.767 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 18.9 mttp -160.9 -14.08 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.727 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' H ' ' H ' ' B' ' 719' ' ' LYS . 19.7 m 56.98 26.8 12.3 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -70.63 151.2 95.45 Favored Pre-proline 0 N--CA 1.487 1.39 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.4 -8.06 22.72 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.886 1.466 . . . . 0.0 111.243 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.71 114.85 2.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.087 -1.008 . . . . 0.0 110.3 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -146.51 -174.06 4.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 0.0 109.843 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -55.85 -37.67 69.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.198 -0.939 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -58.94 -35.25 72.82 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.839 . . . . 0.0 110.208 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.32 131.16 35.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.097 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -99.66 137.94 37.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -0.832 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -99.33 146.6 26.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 63.3 t -63.51 129.62 93.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.979 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.36 148.47 61.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.674 1.355 . . . . 0.0 110.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -159.84 41.63 0.2 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.307 -0.87 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.4 t -117.39 140.16 49.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.321 -0.862 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -79.3 -61.54 2.33 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.1 tp -99.84 133.17 44.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.422 -1.046 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -162.35 -168.45 24.28 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.82 -29.01 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -1.084 . . . . 0.0 110.411 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -54.9 -30.83 59.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.378 -0.826 . . . . 0.0 110.355 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.75 135.33 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 110.317 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.6 p -120.95 161.48 21.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 109.941 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.7 p -118.92 148.95 42.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.521 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -125.91 147.53 49.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.999 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -81.56 114.03 19.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.69 97.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 91.2 p -63.7 -36.18 83.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.267 -1.137 . . . . 0.0 110.242 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -63.75 -34.91 78.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.317 -0.864 . . . . 0.0 110.17 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.5 t90 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.277 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.98 74.49 66.36 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.356 -1.085 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.13 60.16 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.714 1.376 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -112.09 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.387 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.23 133.46 51.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.425 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -136.95 170.96 23.26 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 50.8 m -89.81 132.56 35.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.238 -1.154 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -121.54 20.57 11.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.737 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -53.49 -36.16 61.39 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.198 -0.939 . . . . 0.0 110.125 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.456 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 35.8 ptt-85 -119.49 149.64 41.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 109.037 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.23 136.42 48.21 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.447 -1.301 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.0 tp -91.74 131.97 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.486 -0.759 . . . . 0.0 111.017 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.9 t -119.07 137.12 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.334 -0.853 . . . . 0.0 110.066 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 34' ' ' ILE . 55.9 tp -97.95 131.79 44.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.284 -0.885 . . . . 0.0 110.526 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -122.8 129.9 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 110.162 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.97 -176.81 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 109.812 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.54 -175.4 34.9 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.305 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.701 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.09 40.76 14.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.871 -0.782 . . . . 0.0 109.912 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.43 -35.78 65.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.37 42.07 30.48 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.658 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.21 136.88 19.96 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 108.973 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.45 25.27 19.74 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.843 -1.316 . . . . 0.0 110.133 -1.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -60.83 -48.08 83.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.311 -0.868 . . . . 0.0 112.027 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.46 -21.77 4.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.951 -1.093 . . . . 0.0 111.014 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.1 m -133.78 158.42 43.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.95 -18.68 15.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 111.023 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.98 179.02 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.116 -0.99 . . . . 0.0 110.579 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.49 162.62 68.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.64 145.37 91.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.44 1.232 . . . . 0.0 110.532 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.22 -55.8 11.38 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.23 -36.98 73.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.851 -1.156 . . . . 0.0 111.764 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.21 -40.08 95.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.95 -1.094 . . . . 0.0 111.14 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -56.51 -39.02 72.6 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.702 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -68.19 -35.5 78.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 1.0 OUTLIER -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.817 . . . . 0.0 110.348 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.802 HD23 HD13 ' B' ' 714' ' ' LEU . 91.8 mt -89.27 134.85 33.88 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.177 -0.952 . . . . 0.0 111.857 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.6 m -149.57 148.04 24.75 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.627 -0.671 . . . . 0.0 109.739 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.36 151.39 59.84 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.561 1.295 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.99 85.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.99 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -110.05 -27.51 9.16 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.259 -1.142 . . . . 0.0 110.996 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.472 HD11 HD11 ' B' ' 714' ' ' LEU . 70.6 mt -112.38 132.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 110.787 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -99.41 -23.62 15.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.546 -0.721 . . . . 0.0 110.771 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 62.6 m-70 -135.89 139.72 43.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.144 -0.973 . . . . 0.0 111.085 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -130.0 123.87 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.801 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -111.31 129.16 56.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.03 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 4.4 t -120.78 129.36 53.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.013 . . . . 0.0 110.437 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.946 HG22 HD21 ' A' ' 84' ' ' LEU . 44.4 p -102.71 -56.4 2.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.46 -0.775 . . . . 0.0 110.731 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.792 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.32 161.3 30.41 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.268 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -71.91 147.01 47.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.811 -0.817 . . . . 0.0 110.047 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.597 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.8 mt -54.1 -62.67 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.356 -0.84 . . . . 0.0 111.574 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.93 -20.52 16.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.809 -1.807 . . . . 0.0 110.162 -0.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.31 142.21 54.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.308 -0.87 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -59.51 -27.7 66.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.511 -0.743 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.05 -40.66 61.46 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 40' ' ' LEU . 54.2 m -66.36 -35.0 79.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.52 -0.738 . . . . 0.0 109.961 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.26 -42.91 92.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.37 88.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.685 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -62.2 -45.01 95.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.445 -0.784 . . . . 0.0 110.036 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.9 mt -62.72 -38.8 91.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -0.84 . . . . 0.0 110.084 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -62.23 -32.59 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.3 m -63.38 -43.44 97.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -62.68 -36.85 84.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.2 -0.937 . . . . 0.0 110.604 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.71 153.99 35.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.267 -0.895 . . . . 0.0 110.41 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.38 -43.2 13.16 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 41.9 t0 -86.38 110.0 19.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -1.153 . . . . 0.0 110.226 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.21 134.15 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 0.0 110.34 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.3 m-70 -116.96 127.48 54.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 109.618 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 76.2 mt -132.01 150.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 111.527 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 84' ' ' LEU . 30.4 m -119.78 157.03 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.68 130.98 39.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.846 -1.158 . . . . 0.0 111.732 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.55 -175.5 38.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.273 . . . . 0.0 110.818 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.71 3.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.13 35.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.23 -0.919 . . . . 0.0 110.362 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.02 70.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.636 -0.665 . . . . 0.0 110.2 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.12 57.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 110.562 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.51 -3.95 37.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.034 -1.041 . . . . 0.0 111.215 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.07 147.75 80.55 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.945 -1.097 . . . . 0.0 109.446 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.74 140.47 20.9 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.894 1.471 . . . . 0.0 110.916 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -39.38 80.83 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 0.0 109.159 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.34 29.35 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.768 -1.207 . . . . 0.0 111.57 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.85 113.35 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.44 131.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.441 -0.787 . . . . 0.0 109.996 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.9 t -121.52 86.83 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.444 -0.785 . . . . 0.0 109.206 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.02 -119.28 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.2 -6.42 50.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -1.11 . . . . 0.0 110.896 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.62 137.39 36.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.034 -1.041 . . . . 0.0 113.257 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.35 107.6 18.67 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.99 140.55 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.895 . . . . 0.0 112.142 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.3 16.22 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.946 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.7 27.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.926 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.5 149.11 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.457 -0.777 . . . . 0.0 109.517 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.792 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.96 -60.37 3.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.876 -1.14 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.56 3.41 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.364 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.82 -17.24 55.53 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.968 -1.313 . . . . 0.0 110.063 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -6.0 59.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.16 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.26 154.93 97.2 Favored 'Cis proline' 0 C--N 1.319 -0.996 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.674 -0.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 27.1 m0 -39.05 -57.48 1.27 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.36 34.07 5.73 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 118.976 -1.583 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.11 36.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.775 -1.426 . . . . 0.0 110.315 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.87 -40.51 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.482 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.55 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.11 -42.06 85.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.856 . . . . 0.0 109.186 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.497 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.31 -45.18 94.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.505 -0.747 . . . . 0.0 109.475 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.16 -35.6 67.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.52 -0.738 . . . . 0.0 109.093 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.96 -35.42 69.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.57 -0.706 . . . . 0.0 109.709 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.43 86.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.96 -57.1 12.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.483 -0.761 . . . . 0.0 110.208 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.66 -45.62 70.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.632 -0.668 . . . . 0.0 110.684 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -29.0 63.61 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.389 -0.819 . . . . 0.0 111.39 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.3 48.07 10.63 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.08 -1.013 . . . . 0.0 109.929 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.93 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.295 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.1 -31.96 34.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.0 109.11 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.19 140.55 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.542 -0.724 . . . . 0.0 110.055 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.43 42.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.799 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.6 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.04 131.71 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.26 -0.9 . . . . 0.0 109.954 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.66 38.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 110.285 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.79 1.97 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.64 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.907 -0.761 . . . . 0.0 111.588 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.06 -9.6 52.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.855 -1.153 . . . . 0.0 111.402 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.74 24.93 7.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.052 -1.03 . . . . 0.0 110.775 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.71 114.31 19.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.408 -0.807 . . . . 0.0 109.258 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.59 137.9 42.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 0.0 110.239 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.36 7.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.72 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.887 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.99 167.63 21.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.23 -0.919 . . . . 0.0 111.026 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.21 145.44 37.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.598 -0.689 . . . . 0.0 110.288 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.176 -0.953 . . . . 0.0 110.993 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.96 58.05 5.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.607 -0.683 . . . . 0.0 111.413 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.23 6.26 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.847 -0.533 . . . . 0.0 112.412 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.65 154.94 38.66 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.904 -1.122 . . . . 0.0 109.821 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.97 47.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 111.16 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.05 134.34 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.93 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.11 -0.994 . . . . 0.0 111.951 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.33 109.01 14.9 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.08 -30.0 47.7 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.487 1.256 . . . . 0.0 111.501 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.44 14.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.68 19.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -1.128 . . . . 0.0 110.528 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.57 47.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.447 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.53 13.12 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.194 -0.941 . . . . 0.0 110.475 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.58 63.9 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.63 -0.924 . . . . 0.0 110.748 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.87 151.18 46.22 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.711 0.767 . . . . 0.0 111.453 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.92 115.88 5.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.1 11.08 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.8 48.29 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.586 -1.321 . . . . 0.0 112.345 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.22 22.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.851 -1.156 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.88 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.511 -0.743 . . . . 0.0 111.283 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.55 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 110.073 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.54 139.76 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.529 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.86 121.04 39.43 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.8 Cg_endo -65.63 133.61 34.96 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.468 1.246 . . . . 0.0 109.661 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 90.4 p -167.49 154.03 8.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.883 -1.136 . . . . 0.0 111.948 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.766 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.2 p90 -137.04 160.31 39.3 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.47 138.07 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.035 -1.04 . . . . 0.0 113.47 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.887 HD11 HD12 ' B' ' 714' ' ' LEU . 10.6 mt -109.61 137.51 47.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.7 mtp -115.97 123.62 48.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.0 110.365 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -99.19 116.91 32.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.497 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.09 122.53 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 111.179 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.04 -55.34 2.66 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.636 0.731 . . . . 0.0 109.3 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.17 106.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 m 60.08 10.72 2.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.268 -0.895 . . . . 0.0 110.287 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 40.6 m -138.8 131.49 29.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 108.885 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.5 p -132.69 138.54 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.574 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 89.4 t -119.06 125.16 74.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 128' ' ' PHE . 26.7 p -105.66 139.18 40.66 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.583 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.763 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.97 128.0 56.2 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.7 p -111.03 131.4 62.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' A' ' 152' ' ' LEU . 52.8 m-85 -110.4 112.11 23.83 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.672 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -106.06 136.52 45.6 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.394 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.7 tp -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.326 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.813 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.5 mt -108.09 124.9 64.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.65 -131.55 31.75 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -99.29 -49.98 4.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -1.149 . . . . 0.0 110.311 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -70.29 156.97 38.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.37 128.37 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.806 . . . . 0.0 109.725 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.813 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.5 mttt -96.37 147.86 23.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.733 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.482 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 14.4 p -132.69 141.35 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 111.32 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.0 tt0 -121.66 149.9 42.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.705 . . . . 0.0 109.361 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.49 126.41 54.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.058 -1.026 . . . . 0.0 111.634 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.4 mm -126.01 131.81 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.55 140.97 48.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.986 -1.071 . . . . 0.0 111.636 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.0 t80 -138.83 141.93 38.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.662 -0.649 . . . . 0.0 110.044 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.3 147.2 41.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.15 -34.47 22.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.846 . . . . 0.0 110.645 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.549 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.22 -27.61 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.735 1.387 . . . . 0.0 110.421 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.57 143.14 31.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.392 -0.818 . . . . 0.0 109.926 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.69 -176.4 51.42 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 44.3 m -63.16 152.41 37.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -1.084 . . . . 0.0 110.284 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 44.6 m -59.09 -38.4 79.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 110.28 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.85 152.65 30.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.399 -0.813 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.87 129.34 55.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -65.22 -35.84 82.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.375 -0.828 . . . . 0.0 110.5 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 67.8 mt -59.36 -34.76 72.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.385 -0.822 . . . . 0.0 110.959 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -109.11 151.5 26.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.147 -0.971 . . . . 0.0 110.587 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 50.0 p30 -141.72 173.06 11.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 110.041 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -98.91 134.89 41.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.319 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -105.11 139.25 40.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 109.652 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -104.61 165.42 11.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 111.051 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 68.8 p -109.12 -146.69 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.633 -0.667 . . . . 0.0 109.503 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.71 145.32 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.982 -1.074 . . . . 0.0 110.383 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 28.5 m -59.48 -28.36 66.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.18 47.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.856 . . . . 0.0 110.691 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.65 146.04 37.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.34 162.5 31.86 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.351 -0.843 . . . . 0.0 110.406 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.95 152.59 68.39 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.907 1.477 . . . . 0.0 110.51 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -104.2 153.85 20.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 0.0 110.469 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -97.31 134.63 40.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.78 . . . . 0.0 111.425 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 46.8 m -76.45 -38.08 55.97 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.994 0.902 . . . . 0.0 108.921 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.867 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.5 p80 -171.05 -177.08 0.41 Allowed Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -58.99 137.84 82.11 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 122.869 0.931 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.99 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.5 mt 70.2 39.47 1.31 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.572 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -131.45 77.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.371 -1.456 . . . . 0.0 108.392 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -80.74 18.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.004 0.907 . . . . 0.0 109.721 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.608 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -49.21 170.81 0.13 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.275 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -73.15 -54.04 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.367 1.72 . . . . 0.0 108.919 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 32.4 mttt -161.17 -14.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.873 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.7 m 57.35 27.4 13.73 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -118.59 151.33 49.66 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.95 131.46 18.26 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.663 1.349 . . . . 0.0 110.485 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -156.67 146.88 21.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 110.186 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -131.68 156.42 45.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.394 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -59.55 -35.18 73.74 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.372 -0.83 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -77.26 157.57 30.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.513 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.542 ' C ' HD23 ' B' ' 727' ' ' LEU . 7.8 tt -84.71 131.02 34.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.369 -0.832 . . . . 0.0 109.805 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . 0.481 ' N ' HD23 ' B' ' 727' ' ' LEU . . . -143.65 158.88 43.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -91.12 146.75 23.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -0.842 . . . . 0.0 109.98 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.31 155.7 46.62 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.34 150.44 58.6 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.836 1.44 . . . . 0.0 110.457 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.97 147.86 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.386 -0.822 . . . . 0.0 109.974 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.9 p -64.82 161.68 17.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . 0.466 ' HA2' ' ND2' ' B' ' 738' ' ' ASN . . . 124.63 38.71 0.5 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 25.7 tp -100.22 133.47 44.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -1.063 . . . . 0.0 109.96 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.84 -105.08 2.16 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -128.24 139.12 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -1.152 . . . . 0.0 110.402 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . 0.466 ' ND2' ' HA2' ' B' ' 734' ' ' GLY . 11.8 p-10 -171.51 -152.47 0.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.66 138.27 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 0.0 109.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 14.9 t -128.42 161.95 28.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.263 -0.898 . . . . 0.0 110.5 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 29.5 t -75.58 133.88 40.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.67 -36.28 83.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.442 -0.786 . . . . 0.0 110.399 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -153.14 160.08 42.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -135.2 16.67 4.13 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.8 t -139.06 139.51 37.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.164 -1.198 . . . . 0.0 110.427 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 43.9 m -129.23 149.2 51.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.357 -0.84 . . . . 0.0 110.337 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.209 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 12.3 p -112.52 149.23 40.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.32 -1.106 . . . . 0.0 110.34 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -70.8 -17.97 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.868 1.457 . . . . 0.0 110.502 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -101.41 151.83 21.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 0.0 110.494 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.49 155.41 40.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -70.35 176.47 34.58 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 43.7 m -116.91 126.73 53.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -1.198 . . . . 0.0 110.546 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . 0.462 ' HB3' ' OE1' ' A' ' 156' ' ' GLN . 97.8 mtt180 -144.78 151.84 39.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 156' ' ' GLN . 58.1 t0 -86.6 115.98 24.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.188 -0.945 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -135.42 155.56 50.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.861 . . . . 0.0 109.845 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.27 135.68 18.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.054 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.7 tp -92.48 131.1 37.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.506 -0.746 . . . . 0.0 110.4 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.07 139.3 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.42 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 31' ' ' ILE . 48.6 tp -98.82 131.56 44.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 110.559 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -123.47 129.49 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.469 -0.77 . . . . 0.0 110.317 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.73 -176.59 3.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.764 . . . . 0.0 109.74 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.01 -175.52 35.22 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.218 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 61.18 40.76 14.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.797 -0.825 . . . . 0.0 109.83 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.41 -35.81 65.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.12 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.2 136.85 19.97 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 109.044 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.47 25.33 19.64 Favored 'Cis proline' 0 C--N 1.316 -1.145 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.169 -1.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.88 -48.02 83.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.0 111.995 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.54 -21.79 4.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.0 111.028 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.6 m -133.71 158.4 43.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.1 -1.0 . . . . 0.0 110.147 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.62 15.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 111.059 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.97 179.11 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.075 -1.016 . . . . 0.0 110.653 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.64 162.71 67.26 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.43 144.4 90.61 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.391 1.206 . . . . 0.0 110.435 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.91 -56.97 6.33 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -57.5 -36.68 71.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.804 -1.185 . . . . 0.0 111.806 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.42 -39.74 95.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.917 -1.114 . . . . 0.0 111.042 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.48 -37.89 70.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 108.824 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.19 -35.5 76.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.685 -0.634 . . . . 0.0 109.469 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.896 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.69 -40.75 92.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.32 -0.862 . . . . 0.0 110.227 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.898 HD23 HD23 ' B' ' 714' ' ' LEU . 85.8 mt -82.97 133.73 35.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.202 -0.936 . . . . 0.0 111.286 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.1 p -150.64 143.91 16.84 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.627 -0.67 . . . . 0.0 109.833 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.0 Cg_endo -70.24 148.77 62.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.516 1.271 . . . . 0.0 110.858 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.2 -8.51 75.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.3 mmmt -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -1.144 . . . . 0.0 110.911 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.798 HD11 HD21 ' B' ' 714' ' ' LEU . 75.4 mt -112.6 131.56 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.881 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.94 -21.19 15.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.476 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.7 m-70 -137.36 138.22 39.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.906 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.2 123.31 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.856 . . . . 0.0 110.753 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -110.09 128.31 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 108.928 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.409 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.17 129.46 55.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 110.363 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.824 HG22 HD21 ' A' ' 84' ' ' LEU . 69.3 p -102.33 -62.29 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.483 -0.761 . . . . 0.0 110.759 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.808 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.27 163.49 11.74 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -73.56 148.45 42.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.673 -0.898 . . . . 0.0 110.215 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.97 -62.64 1.52 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.341 -0.85 . . . . 0.0 111.553 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.89 -20.34 16.87 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 119.813 -1.805 . . . . 0.0 110.151 -0.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -69.02 143.24 54.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.36 -0.837 . . . . 0.0 110.89 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 69.3 tttt -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.58 -41.32 61.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.217 -0.927 . . . . 0.0 110.143 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.452 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.3 m -66.31 -34.36 77.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -0.792 . . . . 0.0 109.937 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 79.4 t80 -59.67 -43.0 94.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 110.083 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.32 89.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.822 . . . . 0.0 109.648 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.32 -44.63 96.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.107 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.79 -38.67 91.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.889 . . . . 0.0 110.106 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.15 -32.57 73.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.57 -43.48 96.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.955 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.64 -36.67 83.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.511 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.568 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.22 154.05 35.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.461 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.94 -44.0 12.98 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.33 110.01 19.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -1.166 . . . . 0.0 110.359 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -125.75 134.08 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 110.282 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.59 126.33 53.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.573 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.67 149.82 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 111.368 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG13 HD13 ' A' ' 84' ' ' LEU . 27.8 m -118.42 155.15 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.26 130.6 40.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.694 -1.254 . . . . 0.0 111.616 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.47 -175.5 38.75 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.47 37.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.225 . . . . 0.0 110.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.82 25.75 3.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.082 -1.011 . . . . 0.0 111.1 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.4 133.09 35.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.07 -1.019 . . . . 0.0 110.311 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.67 -46.02 70.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.3 119.67 19.72 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.468 0.652 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.42 -1.17 57.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.547 -0.72 . . . . 0.0 110.551 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.54 -3.83 36.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 0.0 111.271 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.7 80.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.174 . . . . 0.0 109.517 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.65 140.46 21.13 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.837 1.44 . . . . 0.0 110.889 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.83 -39.26 80.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.172 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.79 150.27 29.19 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.53 147.75 34.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.856 -1.152 . . . . 0.0 111.572 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.8 113.29 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.637 -0.664 . . . . 0.0 109.224 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.7 p -115.37 131.82 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.79 130.51 37.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.905 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.511 -0.743 . . . . 0.0 109.233 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.18 5.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.43 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.24 -6.47 50.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.191 -1.182 . . . . 0.0 110.88 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.43 137.28 36.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.967 -1.083 . . . . 0.0 113.317 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.93 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.207 -0.933 . . . . 0.0 112.197 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.37 159.23 16.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.824 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.11 131.78 27.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.87 -1.371 . . . . 0.0 111.908 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.6 149.13 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.444 -0.785 . . . . 0.0 109.464 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.808 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.41 3.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.87 -1.144 . . . . 0.0 110.496 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.312 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.72 -17.34 55.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.98 -1.306 . . . . 0.0 110.096 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.07 59.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 109.931 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.654 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.35 113.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.735 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.52 24.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.272 -0.892 . . . . 0.0 110.157 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.32 155.0 97.32 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.764 -2.182 . . . . 0.0 111.664 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.06 -57.55 1.26 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.05 5.74 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 119.023 -1.561 . . . . 0.0 112.511 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.13 36.65 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.689 -1.477 . . . . 0.0 110.31 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.98 -40.45 62.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.437 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.72 86.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.528 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -42.05 85.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 109.191 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.65 -42.08 98.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 0.0 109.487 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.24 94.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 109.121 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.89 -35.48 69.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.569 -0.707 . . . . 0.0 109.688 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.77 -45.47 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 0.0 109.834 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -53.99 -56.97 12.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.458 -0.776 . . . . 0.0 110.26 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.79 -45.55 70.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.729 -0.607 . . . . 0.0 110.66 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.93 63.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.465 -0.772 . . . . 0.0 111.443 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.35 48.08 10.51 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 0.0 109.839 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.04 155.93 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.364 -0.835 . . . . 0.0 110.313 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.09 -32.05 34.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.773 . . . . 0.0 109.067 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.16 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.68 -0.638 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.38 42.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -0.954 . . . . 0.0 109.842 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.97 131.64 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.199 -0.938 . . . . 0.0 109.993 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.58 160.71 38.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 110.213 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.71 1.97 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.5 -34.14 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.865 -0.785 . . . . 0.0 111.628 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.99 -9.52 53.21 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.864 -1.147 . . . . 0.0 111.426 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.55 24.94 7.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.057 -1.027 . . . . 0.0 110.82 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.69 114.27 19.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.42 137.82 41.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.042 -1.036 . . . . 0.0 110.286 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 110.349 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.71 3.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.748 . . . . 0.0 109.862 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.57 21.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 111.004 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.13 145.43 37.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.773 . . . . 0.0 110.313 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.208 -0.933 . . . . 0.0 110.924 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.92 58.12 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.746 . . . . 0.0 111.441 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.806 -0.559 . . . . 0.0 112.4 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.91 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.891 -1.131 . . . . 0.0 109.812 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.08 134.25 53.43 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.04 136.0 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 112.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.33 109.07 14.92 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.1 -30.03 47.42 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.566 1.298 . . . . 0.0 111.428 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.39 14.81 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.92 111.75 19.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.419 -1.047 . . . . 0.0 110.458 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.69 48.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.43 13.17 18.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.881 . . . . 0.0 110.609 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.55 63.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.98 4.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.759 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.22 46.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.705 0.764 . . . . 0.0 111.477 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.8 5.63 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.76 -29.17 10.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.84 48.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.603 -1.31 . . . . 0.0 112.278 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.27 22.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.817 -1.177 . . . . 0.0 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.9 -15.86 60.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.496 -0.753 . . . . 0.0 111.338 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.59 94.24 4.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.091 -1.006 . . . . 0.0 110.036 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.73 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.538 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.9 121.02 39.42 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.98 135.29 40.31 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.471 1.248 . . . . 0.0 109.829 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -169.11 154.6 6.11 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.725 -1.234 . . . . 0.0 112.116 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.875 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.4 p90 -137.28 161.18 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.9 t -126.44 137.26 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.107 -1.037 . . . . 0.0 113.584 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.941 HD11 HD22 ' B' ' 714' ' ' LEU . 15.2 mt -107.13 136.41 47.02 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -115.91 121.85 43.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 110.291 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.46 117.74 33.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.464 -0.772 . . . . 0.0 109.76 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.541 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.73 122.75 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.902 . . . . 0.0 111.064 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' -2' ' ' ARG . 0.0 OUTLIER -100.1 -54.67 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.605 0.717 . . . . 0.0 109.349 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.2 m 60.42 9.47 2.03 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.329 -0.857 . . . . 0.0 110.458 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 73.0 m -138.94 132.96 31.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.541 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.6 p -131.74 138.88 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.488 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.28 124.91 73.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 p -105.54 136.48 45.05 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.801 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.629 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.91 126.03 54.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.56 131.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.9 m-85 -111.05 112.49 24.34 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.824 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.59 137.42 45.64 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.507 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.667 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 40.2 tp -95.01 95.16 8.42 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.218 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.784 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.5 126.09 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.26 -128.58 30.86 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -103.76 -47.66 4.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.238 -1.154 . . . . 0.0 110.287 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.03 158.77 35.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.438 -0.789 . . . . 0.0 110.521 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 98.7 t -102.36 128.04 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.081 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.784 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.9 mttt -98.54 145.07 27.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.504 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.8 p -131.49 139.95 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.178 -0.952 . . . . 0.0 111.007 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.1 tt0 -119.21 149.92 40.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.665 -0.647 . . . . 0.0 109.281 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.25 127.01 55.2 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.064 -1.023 . . . . 0.0 111.637 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.23 132.26 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.98 140.96 48.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.997 -1.065 . . . . 0.0 111.433 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.412 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.7 t80 -139.14 141.63 38.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.658 -0.651 . . . . 0.0 110.055 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.31 147.56 41.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.296 -0.877 . . . . 0.0 110.118 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.21 144.56 7.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.346 -0.846 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.336 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.12 -17.18 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.81 1.426 . . . . 0.0 110.691 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.1 145.29 27.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.086 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -83.24 179.38 52.74 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.9 m -76.82 158.36 30.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.539 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 5.1 m -98.79 157.19 16.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.777 . . . . 0.0 109.735 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.16 147.15 7.92 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.905 . . . . 0.0 110.127 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.96 -37.22 73.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -109.09 105.61 15.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 109.999 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.32 -38.46 91.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.28 -0.888 . . . . 0.0 110.519 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -107.08 148.63 28.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.806 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -52.89 -36.34 59.17 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.268 -0.895 . . . . 0.0 110.451 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -89.77 137.53 32.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.206 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.08 -32.35 73.7 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -127.35 -174.66 3.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.952 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 52.1 p -119.74 151.81 38.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.927 . . . . 0.0 110.418 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 13.3 p -138.9 143.7 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.131 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 4.9 m -131.37 49.77 2.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.53 45.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.875 . . . . 0.0 110.458 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.12 73.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.12 72.16 70.6 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.375 -0.828 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 169.22 22.51 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.743 1.391 . . . . 0.0 110.177 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -54.74 146.88 15.94 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -107.67 134.39 50.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 111.83 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 62.4 m -79.4 -47.67 15.32 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.231 1.015 . . . . 0.0 108.666 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.823 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.8 OUTLIER -155.54 -178.93 0.97 Allowed Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.823 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.6 Cg_endo -58.62 137.13 78.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 122.745 0.866 . . . . 0.0 110.057 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.941 HD22 HD11 ' A' ' 152' ' ' LEU . 3.3 mp 71.88 41.69 0.66 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -134.23 79.38 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.352 -1.467 . . . . 0.0 108.479 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.66 16.83 1.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.942 0.877 . . . . 0.0 109.835 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.607 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.2 p -47.54 170.51 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.324 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.19 -54.26 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.403 1.739 . . . . 0.0 108.904 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 18.5 mttp -161.7 -13.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.859 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.3 m 56.92 27.64 13.4 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -123.95 161.4 47.04 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.033 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -77.06 -65.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.667 1.351 . . . . 0.0 110.496 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -165.4 141.6 5.41 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -115.43 137.01 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 110.202 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.37 142.27 27.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 110.288 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -65.21 156.92 30.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.482 -0.761 . . . . 0.0 109.925 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.97 129.89 36.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -174.69 135.27 0.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.428 -0.795 . . . . 0.0 109.943 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -93.69 -68.14 0.82 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 110.148 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.556 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -147.51 122.39 5.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.53 144.71 56.17 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.523 1.275 . . . . 0.0 110.65 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -171.05 94.03 0.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.422 -0.799 . . . . 0.0 110.189 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 29.7 t -124.25 143.53 50.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.911 . . . . 0.0 110.389 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -154.6 123.51 1.38 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.9 -39.65 82.13 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.372 -1.075 . . . . 0.0 110.28 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.49 -29.62 69.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.3 129.53 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.303 -1.116 . . . . 0.0 110.541 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -125.17 19.7 8.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.517 -0.739 . . . . 0.0 110.174 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 60.8 t -113.71 142.61 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.295 -0.878 . . . . 0.0 110.103 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 57.1 p -68.45 157.76 35.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.372 -0.83 . . . . 0.0 110.02 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 83.9 p -141.01 167.41 22.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.445 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' B' ' 741' ' ' SER . 92.2 mt-30 57.82 43.78 21.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.442 -0.786 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -123.23 119.65 30.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.174 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 91.77 4.7 67.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 49.1 m -121.97 148.05 45.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -1.228 . . . . 0.0 110.184 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 93.9 p -134.0 158.35 43.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.279 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.118 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 6.4 m 53.5 64.48 6.78 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.333 -1.098 . . . . 0.0 110.4 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 144.14 49.87 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.782 1.412 . . . . 0.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.28 -27.98 67.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.211 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -58.3 148.94 25.76 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.412 -0.805 . . . . 0.0 110.361 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 118.57 114.79 2.62 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 61.9 m -120.39 135.93 54.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 110.718 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.78 123.96 48.42 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.416 ' OD2' ' O ' ' A' ' -1' ' ' ASP . 53.5 p30 -116.64 148.0 41.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 27.5 ttt85 -113.2 121.71 45.3 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.26 136.05 46.69 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.8 -1.16 . . . . 0.0 110.519 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.6 tp -92.62 131.97 37.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 110.515 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.65 138.43 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 110.329 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' HB3' HG12 ' A' ' 34' ' ' ILE . 47.8 tp -98.73 131.6 44.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.801 . . . . 0.0 110.324 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.7 128.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.43 -175.49 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.5 -0.75 . . . . 0.0 109.863 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.05 -175.51 33.78 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.661 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.37 40.67 13.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.83 -0.806 . . . . 0.0 109.879 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.41 -35.7 65.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.34 42.02 30.61 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.701 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.17 136.84 19.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.83 . . . . 0.0 108.992 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.4 Cg_endo -98.46 25.29 19.71 Favored 'Cis proline' 0 C--N 1.316 -1.154 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.219 -1.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.234 -0.916 . . . . 0.0 111.966 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.8 4.79 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.076 -1.015 . . . . 0.0 111.045 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.9 m -133.76 158.38 43.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.153 -0.967 . . . . 0.0 110.172 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.56 15.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.231 -0.918 . . . . 0.0 111.076 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -174.0 179.12 2.0 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.037 -1.039 . . . . 0.0 110.623 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.76 67.09 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.07 141.91 85.28 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.218 1.115 . . . . 0.0 110.193 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.04 3.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -57.17 -36.53 70.88 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.828 -1.17 . . . . 0.0 111.848 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -64.02 -39.43 94.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.169 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -57.07 -38.23 72.98 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.004 -1.078 . . . . 0.0 108.877 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.43 -35.93 78.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.661 -0.649 . . . . 0.0 109.593 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.822 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.61 -40.51 95.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 110.278 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.864 HD23 HD13 ' B' ' 714' ' ' LEU . 89.8 mt -84.66 135.04 34.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.314 -0.866 . . . . 0.0 111.771 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.5 p -150.81 144.89 17.67 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.753 -0.592 . . . . 0.0 109.516 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.5 Cg_endo -70.07 150.54 66.47 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.515 1.271 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.95 -4.69 81.75 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.887 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.6 OUTLIER -109.21 -26.0 10.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.195 -1.179 . . . . 0.0 110.974 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.63 131.84 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.872 . . . . 0.0 110.746 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.709 . . . . 0.0 110.538 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -136.87 139.21 41.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.205 -0.934 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.5 mt -129.91 122.6 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.762 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.4 127.87 54.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 108.828 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -118.76 128.84 54.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.132 -0.98 . . . . 0.0 110.6 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.709 HG22 ' CD2' ' A' ' 84' ' ' LEU . 48.4 p -102.35 -67.08 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.511 -0.743 . . . . 0.0 110.377 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.776 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -51.96 162.68 1.74 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.2 p30 -73.76 149.51 41.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.581 -0.952 . . . . 0.0 110.357 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.96 -63.18 1.26 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -0.789 . . . . 0.0 111.422 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.602 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.23 -22.2 15.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 119.813 -1.804 . . . . 0.0 110.106 -0.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.17 143.11 55.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 110.849 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.63 -27.82 66.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.515 -0.74 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -51.81 -40.67 60.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.0 m -66.66 -34.47 77.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 110.0 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.39 -43.09 93.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.395 -0.816 . . . . 0.0 110.141 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.2 -40.19 89.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 109.609 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -62.54 -44.44 96.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.103 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.6 mt -63.24 -38.35 90.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.23 -0.918 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -62.32 -32.75 73.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.443 -0.785 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.2 m -63.39 -43.23 98.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.439 -0.788 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.59 -36.74 83.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.175 -0.953 . . . . 0.0 110.586 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.05 35.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.35 -0.844 . . . . 0.0 110.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.21 -43.46 13.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -87.0 109.52 19.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.327 -1.102 . . . . 0.0 110.328 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.27 133.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.251 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -115.71 124.23 50.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 0.0 109.482 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.8 mt -130.36 148.65 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 111.241 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 84' ' ' LEU . 29.1 m -115.72 149.03 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -68.25 130.92 44.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.715 -1.241 . . . . 0.0 110.896 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.31 -175.56 39.0 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 86' ' ' HIS . 15.1 p-10 -81.26 0.46 36.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.84 25.76 3.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.32 133.02 35.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.119 -0.988 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.66 -46.01 70.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.29 119.68 19.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 110.21 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.09 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.702 -0.624 . . . . 0.0 110.529 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -75.63 -3.79 36.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.025 . . . . 0.0 111.229 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.13 147.77 80.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.919 -1.113 . . . . 0.0 109.467 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.37 20.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.795 1.419 . . . . 0.0 110.92 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.61 -39.47 80.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.915 . . . . 0.0 109.176 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.34 29.38 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.74 34.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.866 -1.147 . . . . 0.0 111.583 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.82 113.31 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.82 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.77 130.45 37.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.956 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.74 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.262 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.2 4.99 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -5.95 51.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -1.167 . . . . 0.0 110.958 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.02 137.26 37.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 0.0 113.225 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.26 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.99 140.51 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 112.205 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.06 131.8 27.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.939 -1.33 . . . . 0.0 111.92 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.574 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.776 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.86 -60.38 3.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.923 -1.111 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.66 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.33 55.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.944 -1.327 . . . . 0.0 110.05 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.69 -6.03 59.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.39 113.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.888 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.4 Cg_endo -71.28 155.0 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.811 -2.162 . . . . 0.0 111.647 -0.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.09 -57.53 1.28 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.31 34.04 5.75 Favored Glycine 0 N--CA 1.501 2.969 0 C-N-CA 119.022 -1.561 . . . . 0.0 112.562 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.888 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.18 36.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.724 -1.457 . . . . 0.0 110.355 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.91 -40.55 63.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.79 -38.8 86.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.763 . . . . 0.0 109.541 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.12 -41.99 85.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.173 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.79 -42.04 97.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.19 94.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.506 -0.746 . . . . 0.0 109.457 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.52 67.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.752 . . . . 0.0 109.118 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.38 69.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 109.716 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.78 -45.46 85.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.543 -0.723 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.03 -57.06 12.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.58 70.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.93 63.56 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.447 -0.783 . . . . 0.0 111.469 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.37 48.02 10.54 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.17 -0.956 . . . . 0.0 109.95 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.03 155.94 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.457 -0.777 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.95 33.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.23 140.58 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.68 . . . . 0.0 109.999 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.77 123.44 42.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 109.817 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.01 131.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.204 -0.935 . . . . 0.0 109.98 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.77 38.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.82 1.97 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.65 -34.22 0.24 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.813 -0.816 . . . . 0.0 111.621 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.96 -9.61 53.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.816 -1.177 . . . . 0.0 111.472 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 m170 55.59 25.04 7.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.067 -1.021 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.7 114.3 19.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.402 -0.811 . . . . 0.0 109.265 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.46 137.87 41.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.353 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.52 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.62 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.31 -0.869 . . . . 0.0 110.991 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -110.24 145.44 37.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.496 -0.753 . . . . 0.0 110.263 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.58 117.53 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.217 -0.927 . . . . 0.0 110.872 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.96 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.526 -0.734 . . . . 0.0 111.408 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.32 6.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.75 -0.594 . . . . 0.0 112.415 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.9 38.83 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.871 -1.143 . . . . 0.0 109.754 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.29 140.99 47.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 111.173 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.26 53.39 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.08 136.03 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.115 -0.99 . . . . 0.0 111.94 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.39 108.96 14.82 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.5 Cg_endo -66.07 -30.04 47.73 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.524 1.276 . . . . 0.0 111.435 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.88 -139.41 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.83 19.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 110.475 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.51 13.26 18.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 110.524 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.36 36.64 63.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.89 4.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.617 -0.931 . . . . 0.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.92 151.19 46.36 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 111.401 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.86 5.65 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.14 11.05 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.76 48.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.654 -1.279 . . . . 0.0 112.313 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.24 116.28 22.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.859 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.553 -0.717 . . . . 0.0 111.3 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.12 -0.987 . . . . 0.0 110.082 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 43.0 mm -101.6 139.79 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.323 -0.86 . . . . 0.0 110.491 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.11 39.15 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.624 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.07 134.58 37.39 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.501 1.264 . . . . 0.0 109.701 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 89.2 p -169.2 154.7 6.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.732 -1.23 . . . . 0.0 111.943 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.822 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 21.4 p90 -137.87 160.43 39.31 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.49 138.03 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.98 -1.075 . . . . 0.0 113.491 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.99 HD11 HD12 ' B' ' 714' ' ' LEU . 15.4 mt -108.66 139.74 43.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.4 mtp -119.37 119.52 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.344 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 0' ' ' ARG . 23.8 t70 -96.62 117.45 31.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -115.02 111.6 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 111.311 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -81.61 -40.77 22.48 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.892 0.854 . . . . 0.0 108.831 178.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -106.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.7 m -84.67 8.29 17.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.652 -1.28 . . . . 0.0 110.042 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -124.37 140.11 53.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.85 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.3 p -131.53 139.65 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.05 . . . . 0.0 111.265 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.98 126.97 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 50.3 p -107.78 136.82 46.87 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.68 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.04 126.34 55.0 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.0 p -109.04 131.78 58.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.175 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.772 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.1 m-85 -111.42 114.51 27.68 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.963 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -109.91 138.66 45.96 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.606 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.624 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.4 tp -96.51 95.63 8.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.161 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.78 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.1 mt -110.03 125.94 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.64 -127.38 31.23 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -103.28 -50.85 3.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -1.166 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.55 156.11 39.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.359 -0.838 . . . . 0.0 110.368 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.6 t -101.4 127.58 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.846 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.78 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -95.83 146.14 24.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.492 -0.755 . . . . 0.0 109.718 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.3 p -131.75 139.82 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -119.55 150.8 39.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.547 -0.721 . . . . 0.0 109.406 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -115.6 126.72 54.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.971 -1.081 . . . . 0.0 111.719 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -125.98 132.84 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.01 141.33 48.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.003 -1.06 . . . . 0.0 111.496 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.25 142.0 37.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.776 -0.577 . . . . 0.0 109.946 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.51 146.24 39.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -50.48 -34.58 25.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.444 -0.785 . . . . 0.0 110.643 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.338 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.33 -23.5 38.37 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.728 1.383 . . . . 0.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.1 -37.42 74.5 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -56.75 -25.46 51.74 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 23.7 m -55.13 -34.23 63.56 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -1.058 . . . . 0.0 110.709 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 64.4 p -82.98 156.84 23.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.262 -0.899 . . . . 0.0 110.212 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -121.04 153.63 37.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.388 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.12 143.17 57.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.362 -0.836 . . . . 0.0 110.49 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.36 167.69 21.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.0 110.158 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 82.0 mt -71.17 147.8 47.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.843 . . . . 0.0 110.098 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.16 140.26 53.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.274 -0.891 . . . . 0.0 110.409 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -92.48 5.08 52.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.433 -0.792 . . . . 0.0 110.805 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.02 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.108 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -167.94 42.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.843 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -78.39 94.03 4.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.297 -0.877 . . . . 0.0 110.348 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.6 m -122.24 149.16 44.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.117 -0.989 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 34.6 m -54.96 152.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.456 -0.778 . . . . 0.0 110.212 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' B' ' 705' ' ' ALA . 21.7 m -54.95 -39.53 69.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 110.747 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' B' ' 704' ' ' SER . . . 178.61 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.149 -0.97 . . . . 0.0 111.122 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.67 150.32 13.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.069 . . . . 0.0 110.457 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . 0.429 ' N ' ' CD ' ' B' ' 708' ' ' PRO . 4.0 p30 -130.38 53.84 12.89 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' B' ' 707' ' ' ASP . 48.7 Cg_endo -74.24 141.84 29.61 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.629 1.331 . . . . 0.0 110.364 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.61 144.17 56.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 109.83 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' B' ' 708' ' ' PRO . 41.9 m-85 -122.5 136.11 54.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 111.368 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 34.9 m -92.79 -44.03 8.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.87 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -161.9 -177.88 0.77 Allowed Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.52 136.6 72.42 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 122.595 0.787 . . . . 0.0 110.913 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.99 HD12 HD11 ' A' ' 152' ' ' LEU . 10.7 mt 70.07 43.54 0.88 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -129.95 79.01 1.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.256 -1.528 . . . . 0.0 109.643 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.491 ' NE2' HG11 ' A' ' 27' ' ' VAL . 7.8 mp0 -84.14 19.35 1.84 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.106 0.955 . . . . 0.0 108.94 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.585 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.6 p -42.73 169.34 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.921 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.89 -55.62 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.564 1.823 . . . . 0.0 108.955 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.421 ' H ' ' H ' ' B' ' 720' ' ' CYS . 46.3 mttt -159.38 -14.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.624 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.421 ' H ' ' H ' ' B' ' 719' ' ' LYS . 18.9 m 56.57 26.99 11.7 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -79.09 158.92 74.12 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.277 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.18 138.95 40.96 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.769 1.405 . . . . 0.0 110.795 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -85.41 1.4 48.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 0.0 110.648 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -57.84 -34.09 69.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -85.56 140.71 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -123.61 145.85 48.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.816 . . . . 0.0 110.246 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 86.7 mt -61.35 -36.1 79.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.81 148.0 29.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.411 -0.806 . . . . 0.0 110.193 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -85.88 144.7 27.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 109.973 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -65.38 131.42 94.95 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.996 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.31 140.87 41.59 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.708 1.372 . . . . 0.0 110.584 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -150.97 153.75 35.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.401 -0.812 . . . . 0.0 109.914 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 20.1 m -59.22 -39.24 82.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 52.27 -137.84 32.88 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 737' ' ' VAL . 86.5 mt -63.14 -32.17 73.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.452 -1.028 . . . . 0.0 110.258 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.45 55.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 735' ' ' LEU . 34.2 m -111.42 20.43 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -1.168 . . . . 0.0 110.465 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -73.88 157.17 36.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.887 . . . . 0.0 110.388 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.5 161.01 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 62.7 m -78.65 135.21 37.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.0 110.542 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -85.56 167.5 15.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.75 . . . . 0.0 110.017 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -85.03 107.8 17.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -94.75 122.42 37.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.297 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 141.74 64.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 22.7 t -58.42 -34.29 70.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -1.084 . . . . 0.0 110.268 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.5 t -117.94 138.76 51.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 110.258 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.114 179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.1 m -125.61 74.82 69.85 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.307 -1.113 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.96 152.62 73.34 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.779 1.41 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -94.47 144.83 25.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.49 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.98 168.66 19.23 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 88.25 39.47 6.84 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 80.9 p -109.71 -167.52 1.21 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.428 -1.043 . . . . 0.0 109.985 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -50.24 141.91 10.75 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -168.25 178.36 4.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.082 . . . . 0.0 111.649 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.573 ' HG3' ' C ' ' A' ' 155' ' ' ILE 0.252 58.8 ttp180 -45.93 139.48 4.28 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.188 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 136.47 54.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.745 -1.222 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.9 tp -92.48 130.78 38.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.449 -0.782 . . . . 0.0 110.389 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.7 t -118.21 138.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.1 tp -98.83 131.86 44.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.372 -0.83 . . . . 0.0 110.536 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.4 t -123.37 129.3 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.217 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.58 -177.43 4.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.61 -175.83 35.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.702 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.04 40.74 14.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.834 -0.803 . . . . 0.0 109.889 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.42 -35.82 65.87 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.04 30.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.682 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.16 136.9 19.98 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.354 -0.841 . . . . 0.0 108.953 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.0 Cg_endo -98.42 25.26 19.8 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.19 -1.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.83 -48.04 83.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.283 -0.886 . . . . 0.0 112.001 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.46 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.981 -1.074 . . . . 0.0 111.002 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.8 m -133.58 158.39 43.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.069 -1.02 . . . . 0.0 110.167 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.77 15.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 111.04 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.9 p -173.94 179.0 2.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.095 -1.003 . . . . 0.0 110.592 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.44 162.63 68.1 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.1 Cg_endo -62.86 141.97 86.72 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.37 1.195 . . . . 0.0 110.384 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.57 -56.69 5.64 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -57.53 -36.21 71.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.806 -1.184 . . . . 0.0 111.606 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.55 -39.82 94.46 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.944 -1.097 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.26 -38.87 71.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.79 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.55 -35.04 76.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.615 -0.678 . . . . 0.0 109.328 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -40.6 92.42 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.389 -0.819 . . . . 0.0 110.281 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.952 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -84.4 132.91 34.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.089 -1.007 . . . . 0.0 111.42 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -147.84 145.25 20.58 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.608 -0.682 . . . . 0.0 109.916 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.91 147.98 56.64 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.51 -9.91 73.5 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.548 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.8 mmmt -104.31 -25.04 13.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -1.114 . . . . 0.0 110.886 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.927 HD11 HD21 ' B' ' 714' ' ' LEU . 74.2 mt -113.59 132.14 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 110.803 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -101.36 -21.59 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.618 -0.676 . . . . 0.0 110.462 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.755 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.93 138.91 41.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.17 -0.956 . . . . 0.0 110.93 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.68 123.64 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.83 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.6 mt -111.05 128.88 56.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.114 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -120.6 129.12 53.61 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.379 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD21 ' A' ' 84' ' ' LEU . 51.8 p -102.35 -58.34 1.89 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.44 -0.788 . . . . 0.0 110.628 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -60.63 163.67 18.06 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -74.4 148.7 40.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.885 . . . . 0.0 110.115 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.52 -62.35 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.327 -0.858 . . . . 0.0 111.618 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.1 p -98.88 -20.81 16.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.878 -1.764 . . . . 0.0 110.189 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 t -69.26 143.11 53.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.74 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -59.55 -28.36 67.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 110.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.27 -40.73 59.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.232 -0.918 . . . . 0.0 110.314 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.0 m -66.66 -34.56 78.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.64 -43.18 93.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.303 -0.873 . . . . 0.0 110.132 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.94 -40.1 87.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 109.601 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.57 -44.61 95.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.495 -0.753 . . . . 0.0 110.063 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.63 -38.7 91.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.16 -32.61 73.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.6 m -63.45 -43.32 97.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.428 -0.795 . . . . 0.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.0 -36.73 84.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.581 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.06 154.28 35.63 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.448 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.51 12.2 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -85.97 109.92 19.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -1.168 . . . . 0.0 110.363 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.08 134.21 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.358 -0.839 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.99 127.14 53.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -132.06 151.58 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.239 -0.913 . . . . 0.0 111.492 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -120.63 156.36 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.11 130.72 39.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.718 -1.239 . . . . 0.0 111.701 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.52 -175.53 38.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.51 36.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.079 -1.248 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.73 3.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.066 -1.022 . . . . 0.0 111.132 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.05 35.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.142 -0.974 . . . . 0.0 110.379 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.67 -46.06 70.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.16 119.64 19.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.19 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.09 57.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.612 -0.68 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.56 -3.87 36.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 0.0 111.266 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.428 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.15 147.76 80.28 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.925 -1.109 . . . . 0.0 109.419 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.74 140.41 20.83 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.896 1.471 . . . . 0.0 110.916 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.59 -39.49 80.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.232 -0.917 . . . . 0.0 109.169 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.36 29.37 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.7 34.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.839 -1.163 . . . . 0.0 111.577 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.81 113.34 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.89 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.0 110.217 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.83 130.45 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.0 t -121.49 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.137 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.2 5.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.28 -6.19 50.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -1.15 . . . . 0.0 110.924 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.36 36.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.094 -1.004 . . . . 0.0 113.29 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.39 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.93 140.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 112.222 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.3 159.32 16.31 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.918 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.891 -1.358 . . . . 0.0 111.876 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.09 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.506 -0.746 . . . . 0.0 109.514 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.31 3.98 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.111 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.72 3.39 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.373 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.66 -17.33 55.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.001 -1.293 . . . . 0.0 110.129 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.68 -6.07 59.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.929 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.34 113.06 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.145 -0.972 . . . . 0.0 109.754 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.52 24.46 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.136 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 154.99 97.25 Favored 'Cis proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.752 -2.187 . . . . 0.0 111.701 -0.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.47 1.28 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.38 34.06 5.73 Favored Glycine 0 N--CA 1.5 2.937 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.563 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.7 t70 -79.3 135.05 36.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.734 -1.451 . . . . 0.0 110.427 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.83 -40.58 63.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.79 86.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.421 -0.799 . . . . 0.0 109.552 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.03 -42.06 85.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.197 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.09 98.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.468 -0.77 . . . . 0.0 109.418 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.533 -0.73 . . . . 0.0 109.392 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.761 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.23 -35.56 67.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.491 -0.756 . . . . 0.0 109.128 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.9 -35.42 69.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.749 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.77 -45.43 85.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.407 -0.808 . . . . 0.0 109.802 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.01 12.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.529 -0.732 . . . . 0.0 110.212 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.43 70.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 110.728 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.473 -0.767 . . . . 0.0 111.421 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.12 10.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.187 -0.946 . . . . 0.0 109.93 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.463 -0.773 . . . . 0.0 110.27 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.16 -31.97 33.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 109.1 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.613 -0.679 . . . . 0.0 110.065 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.37 42.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.843 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.622 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.59 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.206 -0.934 . . . . 0.0 110.004 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.59 160.72 38.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.98 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 121.92 -0.753 . . . . 0.0 111.64 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.95 -9.6 53.09 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.806 -1.183 . . . . 0.0 111.457 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.64 24.96 7.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.974 -1.079 . . . . 0.0 110.789 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.68 114.28 19.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.427 -0.796 . . . . 0.0 109.244 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.55 137.94 42.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.088 -1.007 . . . . 0.0 110.279 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.6 97.68 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.717 . . . . 0.0 109.821 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.9 167.62 21.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 111.033 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.24 145.42 37.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.477 -0.764 . . . . 0.0 110.3 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -146.51 117.58 7.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.538 -0.726 . . . . 0.0 111.433 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.15 15.34 6.23 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.91 38.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.943 -1.098 . . . . 0.0 109.819 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.28 140.94 47.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 111.209 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.12 134.24 53.4 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.07 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.086 -1.009 . . . . 0.0 111.927 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.48 109.02 14.72 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.07 -29.97 47.75 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.48 1.253 . . . . 0.0 111.456 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.46 14.86 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.87 111.74 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -1.13 . . . . 0.0 110.441 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.477 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.3 p -113.49 13.07 18.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.59 63.71 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.97 4.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.567 -0.96 . . . . 0.0 110.81 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 151.11 46.24 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.691 0.758 . . . . 0.0 111.46 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.89 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.18 11.18 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.22 -28.71 48.03 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.567 -1.333 . . . . 0.0 112.327 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.18 22.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.823 -1.173 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.9 60.12 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.559 -0.713 . . . . 0.0 111.255 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.26 4.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.051 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.64 139.77 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.93 121.05 39.32 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.709 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.5 Cg_endo -66.14 135.55 40.78 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.48 1.253 . . . . 0.0 109.765 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.8 p -169.12 154.01 5.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.712 -1.243 . . . . 0.0 112.01 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.901 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.2 p90 -138.09 159.95 40.67 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.85 136.63 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.029 . . . . 0.0 113.691 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.044 HD11 HD22 ' B' ' 714' ' ' LEU . 16.0 mt -106.55 134.22 50.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 63.4 mtp -114.28 120.14 39.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.893 -1.13 . . . . 0.0 110.375 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' OD1' ' HG2' ' A' ' 0' ' ' ARG . 58.7 t0 -98.2 117.4 32.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 160' ' ' VAL . 96.1 mt -114.34 111.57 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 111.194 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -41.04 24.55 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.832 0.825 . . . . 0.0 108.919 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 -105.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.35 8.31 19.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.74 -1.225 . . . . 0.0 110.115 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.2 m -124.03 139.55 53.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 109.759 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 155' ' ' ILE . 11.3 p -130.02 139.88 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.072 -1.017 . . . . 0.0 111.128 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.69 127.81 74.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -109.56 136.13 49.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 110.762 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.667 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.87 127.29 55.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -112.09 131.63 62.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.708 ' CE2' HD12 ' A' ' 152' ' ' LEU . 36.9 m-85 -110.14 116.09 30.91 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.244 -0.91 . . . . 0.0 110.015 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -108.33 136.95 47.12 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.238 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.768 HD12 HG12 ' A' ' 172' ' ' VAL . 37.7 tp -92.5 80.56 4.86 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.694 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.0 mt -98.3 117.48 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.94 -161.31 54.26 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -71.27 -44.38 65.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.208 -1.172 . . . . 0.0 110.759 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -76.99 157.73 31.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.329 -0.857 . . . . 0.0 110.765 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.768 HG12 HD12 ' A' ' 167' ' ' LEU . 19.7 m -105.89 131.4 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.76 148.79 23.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.007 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.7 p -130.52 140.58 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 111.007 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.31 149.71 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.543 -0.723 . . . . 0.0 109.333 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.38 126.88 54.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.052 -1.03 . . . . 0.0 111.707 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.39 132.37 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.49 141.07 48.56 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.049 -1.032 . . . . 0.0 111.494 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.4 t80 -139.25 142.27 37.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.586 -0.696 . . . . 0.0 109.904 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.62 146.87 40.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.934 . . . . 0.0 110.118 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -50.55 -34.33 25.16 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.322 -0.861 . . . . 0.0 110.657 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.138 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.43 -17.69 43.9 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.843 1.444 . . . . 0.0 110.725 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.6 tp -55.96 -37.9 69.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.261 -0.9 . . . . 0.0 110.438 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 130.29 172.82 13.22 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.9 m -122.32 150.29 42.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.386 -1.067 . . . . 0.0 110.321 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 56.6 p -116.38 167.12 11.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.364 -0.835 . . . . 0.0 109.902 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.43 -36.13 75.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 0.0 110.191 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.9 135.08 51.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.402 -0.811 . . . . 0.0 110.22 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -105.01 145.1 30.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 110.293 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -102.44 139.12 38.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.232 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.72 -33.94 76.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -85.35 121.92 28.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -132.28 156.62 46.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -93.3 146.45 23.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.812 . . . . 0.0 110.037 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' B' ' 701' ' ' ASP . 31.4 p-10 -61.19 132.96 55.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 110.387 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 38.8 m -61.07 -34.61 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.538 HG12 ' H ' ' B' ' 705' ' ' ALA . 48.5 t -102.81 133.42 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 110.423 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 24.1 t -59.88 -29.97 68.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.461 -0.775 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.538 ' H ' HG12 ' B' ' 703' ' ' VAL . . . -56.46 144.52 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.426 -0.797 . . . . 0.0 110.445 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -162.05 -130.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.468 -0.77 . . . . 0.0 109.745 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.75 140.46 85.76 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.2 119.91 6.62 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.624 1.328 . . . . 0.0 110.872 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -132.87 148.01 52.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.425 -0.797 . . . . 0.0 109.866 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.44 141.14 51.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.297 -0.877 . . . . 0.0 111.489 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.68 -40.09 12.77 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.115 0.96 . . . . 0.0 108.627 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.883 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 3.1 p80 -166.45 -175.44 0.43 Allowed Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.3 Cg_endo -60.25 138.85 83.88 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 122.694 0.839 . . . . 0.0 110.163 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 152' ' ' LEU . 2.5 mp 67.1 44.15 1.98 Allowed 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.586 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -135.26 78.74 1.75 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.196 -1.565 . . . . 0.0 109.187 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -85.34 17.76 2.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.181 0.991 . . . . 0.0 109.401 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.63 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 26.5 p -44.33 172.41 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.914 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.8 Cg_endo -73.06 -55.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.406 1.74 . . . . 0.0 108.844 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 41.4 mtmt -159.74 -13.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.741 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.3 m 58.19 27.72 15.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.72 142.9 25.28 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.19 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.11 149.53 64.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.635 1.334 . . . . 0.0 110.335 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.25 58.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.095 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -134.24 161.83 33.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -79.05 147.65 32.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 0.0 109.916 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 63.9 mtp85 -60.76 142.56 55.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.276 -0.89 . . . . 0.0 110.735 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 50.3 tp -112.68 130.66 55.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.732 . . . . 0.0 110.164 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -81.2 136.39 35.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -96.28 141.13 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.067 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.546 HG23 ' O ' ' B' ' 730' ' ' VAL . 34.4 m -126.74 69.71 71.78 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.441 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.52 145.8 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.702 1.369 . . . . 0.0 110.471 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -143.33 148.6 36.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.9 m 49.67 21.08 0.59 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 111.131 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.28 24.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.2 tp -58.19 -38.46 76.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.5 -1.0 . . . . 0.0 110.582 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 142.91 -167.67 26.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.44 129.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -1.137 . . . . 0.0 110.167 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -172.33 164.85 5.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.142 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 50.5 t -120.64 130.5 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.4 m -65.14 -36.87 85.62 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.367 -0.833 . . . . 0.0 110.47 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 33.0 t -85.39 151.13 24.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.435 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -94.7 115.26 27.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 109.994 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -89.27 136.58 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -86.53 -178.23 49.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.2 t -59.28 -35.83 74.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.336 -1.096 . . . . 0.0 110.138 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.9 m -121.79 148.07 45.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.063 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 64.3 t90 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.208 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 60.6 p -123.01 161.2 45.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.407 -1.055 . . . . 0.0 110.227 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 145.16 59.19 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.77 1.405 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -62.07 144.5 55.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.8 . . . . 0.0 110.309 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.28 130.24 52.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.37 -0.831 . . . . 0.0 110.174 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -91.66 -178.05 42.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 39.2 m -60.93 -30.54 70.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.549 -0.971 . . . . 0.0 110.228 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -49.51 -23.75 1.74 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.41 -36.7 6.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.327 -0.858 . . . . 0.0 111.158 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.2 ptt180 -65.02 142.93 58.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.092 -1.005 . . . . 0.0 109.577 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.88 136.15 42.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.43 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' B' ' 713' ' ' PRO . 34.1 tp -93.51 133.57 36.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.489 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.713 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -118.3 139.54 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 110.535 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.515 HD12 HD23 ' A' ' 152' ' ' LEU . 45.4 tp -96.09 129.88 43.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.391 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.6 t -123.7 127.69 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -0.778 . . . . 0.0 110.141 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.23 -176.47 4.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.39 -175.13 34.85 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.23 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.719 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 60.88 40.75 15.3 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.829 -0.806 . . . . 0.0 109.865 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.79 65.75 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.41 42.05 30.42 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.678 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.19 136.87 19.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.374 -0.828 . . . . 0.0 109.029 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.7 Cg_endo -98.49 25.38 19.56 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.729 -1.363 . . . . 0.0 110.163 -1.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.92 -48.01 83.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.232 -0.917 . . . . 0.0 112.014 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.45 -21.91 4.79 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.028 -1.045 . . . . 0.0 110.982 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.66 158.32 43.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.086 -1.009 . . . . 0.0 110.2 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.69 15.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 111.079 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.92 179.09 2.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.992 . . . . 0.0 110.657 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.7 67.25 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.62 145.23 91.31 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.37 1.195 . . . . 0.0 110.412 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.13 -56.01 10.49 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -57.86 -36.72 72.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.813 -1.18 . . . . 0.0 111.886 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.73 -39.32 94.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.974 -1.079 . . . . 0.0 111.199 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -56.62 -38.34 71.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 108.936 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -68.51 -35.23 77.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.538 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.02 -37.35 85.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.457 -0.777 . . . . 0.0 110.55 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.839 HD23 HD23 ' B' ' 714' ' ' LEU . 88.3 mt -89.01 132.6 34.66 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.19 -0.944 . . . . 0.0 111.484 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.7 m -149.17 147.89 25.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.592 -0.692 . . . . 0.0 109.854 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.04 149.86 59.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.615 1.324 . . . . 0.0 110.967 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.53 -4.95 82.58 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.692 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.3 mmmt -108.09 -27.42 10.12 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.249 -1.148 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 714' ' ' LEU . 71.1 mt -113.01 132.23 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.845 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -99.82 -22.31 15.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.619 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 3' ' ' VAL . 59.9 m-70 -136.27 138.88 42.23 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.286 -0.884 . . . . 0.0 110.961 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.0 mt -129.13 123.25 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.404 -0.81 . . . . 0.0 110.749 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -110.53 128.53 55.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.888 . . . . 0.0 109.061 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.23 129.42 55.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.964 . . . . 0.0 110.293 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.832 HG22 HD21 ' A' ' 84' ' ' LEU . 70.7 p -102.03 -57.24 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.747 . . . . 0.0 111.075 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.812 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -65.6 165.66 36.32 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.311 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -74.49 147.47 41.86 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.767 -0.843 . . . . 0.0 110.098 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.65 -61.72 2.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.0 111.576 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.64 -19.08 17.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 119.759 -1.838 . . . . 0.0 110.132 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.95 143.23 52.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.276 -0.89 . . . . 0.0 110.776 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.85 -28.02 67.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -51.66 -41.06 61.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -0.918 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.8 m -66.54 -34.31 77.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 0.0 109.854 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.7 t80 -59.94 -43.05 95.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.368 -0.832 . . . . 0.0 110.049 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.12 -40.14 88.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.577 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -62.38 -44.78 95.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.131 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.74 -38.53 90.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.245 -0.909 . . . . 0.0 110.059 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.16 -32.66 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.565 -0.709 . . . . 0.0 109.753 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.32 97.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.967 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.78 -36.88 84.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.568 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.91 154.6 36.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.263 -0.898 . . . . 0.0 110.396 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.54 -43.62 12.01 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.51 110.22 19.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.78 134.16 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 110.244 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.541 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.6 m-70 -116.8 126.55 53.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -130.43 149.76 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -0.871 . . . . 0.0 111.344 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -119.47 157.33 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.26 130.67 38.51 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.834 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.62 -175.51 38.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.33 0.5 36.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.27 . . . . 0.0 110.784 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 0.0 111.206 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.31 133.14 35.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.72 -46.09 69.82 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.286 -0.884 . . . . 0.0 110.025 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.17 119.68 19.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.592 -0.692 . . . . 0.0 110.203 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.12 57.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.53 -3.79 36.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.71 80.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.86 -1.15 . . . . 0.0 109.465 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.0 Cg_endo -76.64 140.35 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.917 1.483 . . . . 0.0 110.899 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.62 -39.47 80.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.235 -0.916 . . . . 0.0 109.159 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.29 29.28 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.79 34.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.879 -1.138 . . . . 0.0 111.518 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.89 113.25 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.36 131.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.55 37.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.395 -0.816 . . . . 0.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.57 86.93 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.523 -0.736 . . . . 0.0 109.195 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.26 -6.28 50.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.276 -1.132 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.65 137.32 36.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.004 -1.06 . . . . 0.0 113.282 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.27 107.55 18.59 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.48 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.965 . . . . 0.0 112.235 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.27 16.31 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.832 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.914 -1.345 . . . . 0.0 111.896 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.09 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.5 -0.75 . . . . 0.0 109.568 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.812 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.874 -1.141 . . . . 0.0 110.499 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.97 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.848 -1.168 . . . . 0.0 110.307 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.76 -17.32 55.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.929 -1.336 . . . . 0.0 110.041 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.877 . . . . 0.0 109.943 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.46 113.13 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.18 129.43 24.57 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.1 Cg_endo -71.27 154.92 97.22 Favored 'Cis proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.793 -2.169 . . . . 0.0 111.745 -0.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.03 -57.48 1.26 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 33.98 5.78 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 119.09 -1.529 . . . . 0.0 112.543 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.707 -1.466 . . . . 0.0 110.323 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.89 -40.51 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.85 -38.71 86.44 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.507 -0.746 . . . . 0.0 109.516 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.1 -42.11 85.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 109.139 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.94 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.426 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.18 94.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.431 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.59 67.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.541 -0.725 . . . . 0.0 109.107 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.93 -35.38 69.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.76 -45.49 85.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.0 109.892 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.98 -57.0 12.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.43 70.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.636 -0.665 . . . . 0.0 110.704 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.31 -28.9 63.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 0.0 111.384 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.33 48.06 10.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.155 -0.965 . . . . 0.0 109.835 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.787 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.13 -32.02 33.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.056 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.2 140.49 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.612 -0.68 . . . . 0.0 109.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.45 42.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 109.855 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.534 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.98 131.64 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.59 160.74 38.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 110.225 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.8 1.97 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.5 t60 75.59 -34.17 0.24 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.893 -0.769 . . . . 0.0 111.609 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -87.91 -9.71 52.83 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.852 -1.155 . . . . 0.0 111.419 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.62 25.02 7.6 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.058 -1.026 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.75 114.27 19.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.418 -0.801 . . . . 0.0 109.291 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 164' ' ' VAL . 40.1 t80 -54.47 137.88 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.978 -1.076 . . . . 0.0 110.255 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.48 7.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 110.265 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.7 3.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.512 -0.743 . . . . 0.0 109.884 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.57 21.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.56 37.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.472 -0.767 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.67 117.51 7.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.183 -0.948 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.82 58.19 5.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 111.443 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.31 6.25 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.768 -0.582 . . . . 0.0 112.342 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.92 38.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.923 -1.111 . . . . 0.0 109.824 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.99 47.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.887 . . . . 0.0 111.184 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.11 134.26 53.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.122 -0.986 . . . . 0.0 111.968 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.99 14.82 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.04 -29.96 48.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.523 1.275 . . . . 0.0 111.525 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.77 -139.43 14.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.83 111.81 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.4 -1.059 . . . . 0.0 110.431 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.73 48.6 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.329 -0.857 . . . . 0.0 110.397 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.53 13.23 18.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 110.506 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.35 36.64 63.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.05 146.94 4.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.952 . . . . 0.0 110.783 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.95 151.2 46.43 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.701 0.762 . . . . 0.0 111.445 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.92 5.67 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.17 11.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.14 -28.74 48.49 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.524 -1.36 . . . . 0.0 112.4 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.603 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.26 116.17 22.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.922 -1.111 . . . . 0.0 109.903 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.82 -15.98 60.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.482 -0.761 . . . . 0.0 111.311 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.43 94.19 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.6 139.7 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.04 39.38 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.82 134.33 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.4 1.21 . . . . 0.0 109.71 -178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.0 p -168.49 154.84 7.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.777 -1.202 . . . . 0.0 112.141 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.886 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 18.6 p90 -137.08 159.88 40.6 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.12 138.68 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.066 -1.022 . . . . 0.0 113.53 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.977 HD11 HD22 ' B' ' 714' ' ' LEU . 83.6 mt -107.98 139.92 41.89 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -118.36 110.14 17.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.029 -1.044 . . . . 0.0 109.978 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.97 117.4 29.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.426 -0.796 . . . . 0.0 109.479 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.531 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -113.9 126.12 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -55.19 2.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.58 0.705 . . . . 0.0 109.319 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.6 108.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.685 -0.634 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.7 m 59.65 10.21 1.89 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.5 m -139.51 133.45 30.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 108.778 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.531 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -131.0 139.13 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.842 -1.161 . . . . 0.0 111.564 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.16 126.52 74.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.44 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -108.71 135.66 49.58 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.725 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.88 126.14 54.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.0 p -112.03 132.26 61.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.695 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.635 ' OH ' HD12 ' A' ' 152' ' ' LEU . 46.9 m-85 -111.34 114.71 28.07 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.791 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -106.25 133.26 51.23 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.19 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -89.47 91.98 8.93 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.395 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -107.23 124.92 63.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.95 -131.13 30.76 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -100.48 -48.57 4.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.137 -1.214 . . . . 0.0 110.379 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.08 157.55 38.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.282 -0.886 . . . . 0.0 110.408 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 167' ' ' LEU . 60.2 t -102.31 128.15 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.801 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.799 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.0 mttt -96.24 147.74 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.37 -0.831 . . . . 0.0 109.784 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.9 p -131.29 140.97 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 111.197 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.66 149.57 43.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.79 126.81 54.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 0.0 111.702 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.17 132.34 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.64 141.09 48.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.028 -1.045 . . . . 0.0 111.526 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.19 142.35 37.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.644 -0.66 . . . . 0.0 109.988 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.5 146.86 40.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.5 mttm -49.99 144.46 6.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.396 -0.815 . . . . 0.0 110.564 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.27 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.99 146.93 66.61 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.729 1.384 . . . . 0.0 110.528 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.6 tp -98.95 129.19 45.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.355 -0.841 . . . . 0.0 110.264 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 179.31 177.36 47.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 26.3 m -61.59 -29.48 70.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.456 -1.026 . . . . 0.0 110.505 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 50.1 p -71.31 162.35 29.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 0.0 110.378 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.23 154.15 17.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.24 147.53 35.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.479 -0.763 . . . . 0.0 110.449 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.59 159.85 4.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.433 -0.792 . . . . 0.0 110.237 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 22.6 tp -80.27 128.79 33.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.286 -0.884 . . . . 0.0 110.291 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -117.75 161.91 18.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.487 -0.758 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 699' ' ' ALA . 53.0 p30 -88.13 10.78 18.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -0.817 . . . . 0.0 110.704 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 698' ' ' ASP . . . 63.88 13.26 7.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.289 -0.882 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.03 145.9 50.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 110.11 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -109.69 123.02 48.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 0.0 110.335 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 50.9 m -124.34 135.65 53.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.236 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.718 HG22 ' H ' ' B' ' 705' ' ' ALA . 12.0 p -134.19 136.87 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -0.839 . . . . 0.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 71.4 m -91.82 4.49 52.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.718 ' H ' HG22 ' B' ' 703' ' ' VAL . . . -101.62 138.97 37.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 0.0 110.555 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -102.59 8.87 39.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.387 -0.82 . . . . 0.0 110.421 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -126.94 80.37 71.38 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.192 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 149.16 72.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.754 1.397 . . . . 0.0 110.709 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -88.8 149.1 23.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.434 -0.791 . . . . 0.0 109.874 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -113.17 137.4 51.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.875 . . . . 0.0 111.986 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 72.2 m -102.55 -55.43 2.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.861 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -144.53 -177.97 0.73 Allowed Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.861 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 32.2 Cg_endo -57.25 135.45 70.37 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 122.625 0.803 . . . . 0.0 110.358 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 152' ' ' LEU . 4.3 mp 72.1 39.72 0.77 Allowed 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.576 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -133.24 78.62 1.79 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.424 -1.423 . . . . 0.0 108.876 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.447 ' NE2' HG21 ' A' ' 27' ' ' VAL . 14.1 mp0 -83.84 17.79 2.22 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.123 0.963 . . . . 0.0 109.548 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.66 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.22 172.24 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.643 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.16 -55.25 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 124.495 1.787 . . . . 0.0 109.067 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.3 mttm -160.54 -13.8 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.885 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.5 m 56.92 26.84 12.22 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.56 148.6 49.57 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.628 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.38 163.34 39.42 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.742 1.391 . . . . 0.0 110.553 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -68.81 114.56 7.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -65.25 -33.88 77.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.423 -0.798 . . . . 0.0 111.014 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -91.56 150.5 21.16 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.907 . . . . 0.0 111.243 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -119.28 168.98 10.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 31.1 tp -81.15 120.5 24.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.207 -0.933 . . . . 0.0 109.886 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.13 58.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.408 -0.808 . . . . 0.0 111.129 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -72.87 140.8 47.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.121 -0.987 . . . . 0.0 110.572 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.9 m -122.42 162.57 37.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.533 -0.729 . . . . 0.0 109.994 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 42.4 Cg_endo -68.44 143.2 56.79 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.72 1.379 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -111.01 160.06 17.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.4 t -100.24 141.22 33.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.05 127.13 0.95 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.4 mt -97.39 144.79 26.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.301 -1.117 . . . . 0.0 110.23 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -153.82 -170.16 19.55 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.63 165.42 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.088 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -56.68 120.93 8.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 110.202 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 84.6 t -67.3 -44.99 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.459 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 12.5 t -141.17 152.78 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 110.622 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 178.22 4.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.826 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.72 153.8 35.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -52.56 -41.08 63.24 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.153 -0.967 . . . . 0.0 110.319 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 50.55 -136.33 27.62 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 79.4 p -151.06 167.47 27.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.47 -1.018 . . . . 0.0 110.065 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 29.4 t -78.69 144.5 35.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -0.864 . . . . 0.0 109.974 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.292 -179.873 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 15.4 p -124.31 158.45 61.16 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.357 -1.084 . . . . 0.0 110.237 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.44 -13.77 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.924 1.487 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -88.43 141.98 28.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.0 110.333 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.66 129.38 45.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 159.68 -113.44 0.57 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 44.4 m -57.16 -35.88 70.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -1.061 . . . . 0.0 109.937 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -114.52 139.67 49.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.463 -0.773 . . . . 0.0 109.756 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -157.73 178.92 9.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.0 110.639 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.451 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.7 ptt180 -59.3 145.53 42.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.432 -0.793 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.86 138.77 53.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 110.425 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.0 tp -94.85 133.04 39.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.482 -0.761 . . . . 0.0 110.74 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -119.95 138.4 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.816 . . . . 0.0 110.201 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 51.5 tp -99.48 131.61 45.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.507 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.23 128.9 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.783 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.08 -177.67 4.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.452 -0.78 . . . . 0.0 109.562 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.45 -175.26 35.59 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.199 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 60.9 40.8 15.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.903 -0.763 . . . . 0.0 109.872 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.77 65.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.03 30.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.716 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.14 136.9 19.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.1 Cg_endo -98.47 25.36 19.6 Favored 'Cis proline' 0 C--N 1.316 -1.153 0 C-N-CA 123.764 -1.348 . . . . 0.0 110.154 -1.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -60.9 -48.01 83.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 0.0 112.025 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.51 -21.81 4.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.102 -0.999 . . . . 0.0 111.009 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.37 43.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.063 -1.023 . . . . 0.0 110.142 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.93 -18.65 15.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -0.847 . . . . 0.0 111.062 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -174.01 179.04 2.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.132 -0.98 . . . . 0.0 110.505 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.37 Favored Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.22 89.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.269 1.142 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.51 -56.16 9.06 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -57.85 -36.99 73.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.78 -1.2 . . . . 0.0 111.808 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.3 m-30 -63.88 -39.51 94.36 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 111.102 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.44 -37.13 69.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.014 -1.053 . . . . 0.0 108.81 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -69.49 -36.59 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.724 -0.61 . . . . 0.0 109.806 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.814 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.26 -37.88 88.58 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.244 -0.91 . . . . 0.0 110.367 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.703 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.2 mt -86.84 133.9 33.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -0.98 . . . . 0.0 111.624 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 26' ' ' LEU . 26.9 m -149.51 146.68 21.31 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.55 149.92 56.47 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.668 1.352 . . . . 0.0 111.027 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.29 -6.87 80.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.034 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.1 mmmt -107.75 -26.46 10.79 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.287 -1.125 . . . . 0.0 110.981 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 714' ' ' LEU . 69.0 mt -111.95 132.9 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.876 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -101.03 -22.16 14.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.717 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.25 139.21 42.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.105 -0.997 . . . . 0.0 111.113 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -130.09 123.06 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -0.841 . . . . 0.0 110.792 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.0 mt -110.13 129.46 55.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 0.0 109.008 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.1 t -118.89 130.11 55.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.127 -0.983 . . . . 0.0 110.419 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.845 HG22 HD21 ' A' ' 84' ' ' LEU . 75.4 p -102.98 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.505 -0.747 . . . . 0.0 110.884 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.78 164.08 31.72 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.245 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -73.38 147.72 44.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.854 -0.792 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.9 mt -54.7 -62.1 1.88 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.342 -0.849 . . . . 0.0 111.471 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.69 -20.69 16.81 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 119.838 -1.789 . . . . 0.0 110.034 -0.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.74 142.97 54.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.295 -0.878 . . . . 0.0 110.83 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -59.56 -28.13 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.833 . . . . 0.0 110.228 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -51.58 -41.14 60.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.231 -0.918 . . . . 0.0 110.238 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.9 m -66.24 -34.54 78.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.907 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.3 t80 -59.83 -43.21 94.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.433 -0.792 . . . . 0.0 110.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -59.85 -40.26 87.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 109.68 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.47 -44.53 96.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.442 -0.786 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.0 mt -62.84 -38.42 90.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.28 -32.69 73.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -63.45 -43.58 96.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.97 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.66 -36.64 83.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.142 -0.974 . . . . 0.0 110.59 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.14 154.34 35.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.257 -0.902 . . . . 0.0 110.453 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.69 12.17 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.42 110.12 19.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -1.187 . . . . 0.0 110.394 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.97 134.39 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 0.0 110.355 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.527 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -116.94 126.98 53.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 109.587 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.14 150.34 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 111.406 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.7 m -120.16 157.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -76.46 130.64 38.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.0 111.916 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.65 -175.45 38.47 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.44 0.57 37.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.073 -1.251 . . . . 0.0 110.801 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.75 3.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.008 . . . . 0.0 111.189 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 0.0 110.37 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.67 -46.08 70.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -0.863 . . . . 0.0 110.068 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.2 119.68 19.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.663 -0.648 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.48 -1.08 57.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.564 -0.71 . . . . 0.0 110.564 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.62 -3.78 36.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.056 -1.027 . . . . 0.0 111.295 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.17 147.75 80.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.904 -1.122 . . . . 0.0 109.427 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.61 140.4 21.17 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.94 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.73 -39.39 80.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.251 -0.906 . . . . 0.0 109.177 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.63 150.35 29.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.72 34.8 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.863 -1.148 . . . . 0.0 111.548 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.31 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.69 130.49 37.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.424 -0.798 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.53 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 109.154 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.17 4.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.436 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.29 -6.35 50.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -1.115 . . . . 0.0 110.87 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.36 36.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 113.318 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.24 107.51 18.54 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 112.185 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.42 159.27 16.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.845 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.14 131.71 27.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.885 -1.362 . . . . 0.0 111.928 -179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 109.534 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.47 3.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.078 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.65 3.39 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.358 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.74 -17.3 55.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.001 -1.293 . . . . 0.0 110.111 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.71 -6.01 59.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.335 -0.853 . . . . 0.0 109.937 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.06 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.07 129.48 24.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 110.184 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 154.94 97.2 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.675 -0.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.05 -57.52 1.27 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.96 5.8 Favored Glycine 0 N--CA 1.501 2.981 0 C-N-CA 119.06 -1.543 . . . . 0.0 112.569 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.26 135.07 36.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.783 -1.422 . . . . 0.0 110.37 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.52 63.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.472 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.75 -38.94 86.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.499 -0.751 . . . . 0.0 109.49 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -66.93 -42.18 85.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.177 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.59 -42.13 98.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.509 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.63 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.0 109.146 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.94 -35.38 69.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.595 -0.691 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.62 85.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.512 -0.742 . . . . 0.0 109.802 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.01 12.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.48 -0.763 . . . . 0.0 110.222 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.77 -45.6 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.715 -0.616 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -28.96 63.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.421 -0.799 . . . . 0.0 111.429 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.0 10.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.2 -0.937 . . . . 0.0 109.879 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.89 155.98 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.384 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.17 -31.97 33.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.076 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.691 -0.631 . . . . 0.0 110.054 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.69 123.31 42.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 109.893 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.94 131.63 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.53 160.78 38.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.62 -34.18 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.922 -0.752 . . . . 0.0 111.593 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.92 -9.69 52.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.828 -1.17 . . . . 0.0 111.404 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.97 7.63 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.16 -0.963 . . . . 0.0 110.734 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.63 114.3 19.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.842 . . . . 0.0 109.261 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.8 t80 -54.53 137.93 41.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 110.254 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.93 122.4 7.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.741 . . . . 0.0 110.333 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.72 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.472 -0.768 . . . . 0.0 109.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.97 167.58 21.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.287 -0.883 . . . . 0.0 111.034 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.52 37.14 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.585 -0.697 . . . . 0.0 110.224 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.68 117.53 7.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.282 -0.886 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.94 58.12 5.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.503 -0.748 . . . . 0.0 111.425 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.35 6.26 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.803 -0.561 . . . . 0.0 112.402 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.7 154.96 38.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.801 -1.187 . . . . 0.0 109.813 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.518 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.41 141.0 47.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 111.156 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.07 134.3 53.42 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.1 136.04 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.096 -1.003 . . . . 0.0 112.018 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.43 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.05 -29.98 47.97 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.546 1.288 . . . . 0.0 111.451 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.42 14.83 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.504 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.52 -20.61 47.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.316 -0.865 . . . . 0.0 110.443 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.54 13.17 18.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.267 -0.895 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.48 36.59 64.23 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.824 -1.711 . . . . 0.0 108.824 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.19 146.92 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.491 -1.005 . . . . 0.0 110.733 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 151.12 46.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.686 0.755 . . . . 0.0 111.452 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.87 115.89 5.67 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.79 -29.22 11.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.24 -28.68 47.88 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.6 -1.313 . . . . 0.0 112.39 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.25 22.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.849 -1.157 . . . . 0.0 109.908 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.78 60.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.501 -0.75 . . . . 0.0 111.331 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.58 94.34 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.093 -1.004 . . . . 0.0 110.02 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.64 139.67 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.539 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.81 121.0 39.59 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.74 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.62 134.32 37.69 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.443 1.233 . . . . 0.0 109.767 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.8 p -167.25 154.26 8.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.581 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -136.87 160.55 38.55 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.27 135.54 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.476 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.714 HD11 ' CD1' ' B' ' 714' ' ' LEU . 14.6 mt -107.55 135.14 49.52 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.5 mtp -114.11 122.5 47.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.909 -1.119 . . . . 0.0 110.448 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -99.13 118.19 35.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.643 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.537 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.79 124.21 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.57 -55.89 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.639 0.733 . . . . 0.0 109.3 178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.85 107.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.18 9.53 1.93 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.357 -0.84 . . . . 0.0 110.514 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.7 m -138.9 133.37 31.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 108.756 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.07 139.32 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.76 124.4 72.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.518 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -105.83 134.42 48.99 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.532 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.872 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.56 129.24 56.6 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.36 132.91 58.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.709 ' CE2' HD12 ' A' ' 152' ' ' LEU . 64.0 m-85 -111.77 112.03 23.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.375 -0.828 . . . . 0.0 109.789 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.82 138.8 42.3 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.587 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.74 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -95.26 81.39 3.62 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.594 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.95 117.69 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 -161.43 54.29 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.32 -44.48 65.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.061 -1.258 . . . . 0.0 110.692 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.57 154.98 34.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.865 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.696 HG12 HD12 ' A' ' 167' ' ' LEU . 34.5 m -102.63 128.05 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.842 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.44 148.98 21.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.912 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.1 p -133.03 141.8 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 111.061 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.477 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.6 tt0 -121.55 151.49 40.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -116.07 127.23 54.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.07 -1.019 . . . . 0.0 111.687 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.59 132.45 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.5 141.15 48.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.0 t80 -139.46 141.96 37.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.62 -0.675 . . . . 0.0 109.983 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.09 147.2 41.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.02 -34.37 21.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.356 -0.84 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.161 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.47 -25.46 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.867 1.457 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.8 tp -104.29 129.3 52.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 110.222 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -148.64 25.37 1.34 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.5 t -125.37 145.25 50.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.366 -1.079 . . . . 0.0 110.22 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.1 m -78.61 136.11 37.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.936 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -112.72 151.95 29.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.593 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.25 -25.12 68.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.477 -0.764 . . . . 0.0 110.141 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -50.94 -32.92 22.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.6 mt -75.63 134.01 40.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.192 -0.942 . . . . 0.0 110.143 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -143.06 -39.72 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.447 -0.783 . . . . 0.0 110.431 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.31 145.52 55.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . 0.52 ' HB3' ' OD2' ' B' ' 701' ' ' ASP . . . -99.37 162.04 13.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 0.0 110.112 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.27 -30.11 66.33 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.52 ' OD2' ' HB3' ' B' ' 699' ' ' ALA . 50.1 p30 -71.15 169.75 14.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 110.293 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 5.7 m -127.92 50.27 2.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.56 -39.52 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 31.8 t -118.54 141.71 48.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.148 -0.97 . . . . 0.0 110.547 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -71.71 153.61 41.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 110.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -58.94 146.13 39.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -66.93 148.66 98.8 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.439 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.66 144.08 53.39 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.771 1.406 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.93 156.62 30.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.754 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -69.12 150.92 47.03 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.545 0.688 . . . . 0.0 111.559 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 56.2 m -64.66 -38.35 90.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.9 p80 -175.02 179.74 0.44 Allowed Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.814 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -59.14 140.58 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.051 1.027 . . . . 0.0 110.617 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.034 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.5 mt 68.67 46.49 0.95 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.575 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -139.15 78.53 1.68 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.217 -1.552 . . . . 0.0 108.845 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -82.26 17.41 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.167 0.984 . . . . 0.0 109.808 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.681 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.258 28.5 p -47.62 173.58 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.269 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.73 -54.49 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.359 1.715 . . . . 0.0 108.884 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 81.5 mttt -161.88 -13.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.928 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.0 m 58.22 26.9 14.4 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -103.87 125.68 33.92 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.283 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.75 145.51 51.61 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.683 1.36 . . . . 0.0 110.424 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -166.48 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.0 110.271 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -98.42 157.84 15.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -115.79 147.56 40.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.301 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 80.0 mt -90.57 53.38 2.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.72 -21.75 66.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.0 110.466 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -59.51 138.63 57.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.366 -0.833 . . . . 0.0 110.226 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 730' ' ' VAL . 9.2 p -87.12 113.31 53.05 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.449 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.13 -19.47 29.7 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.556 1.292 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 730' ' ' VAL . . . -99.98 149.77 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.417 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.3 m -117.64 150.13 39.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 110.169 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -63.9 148.76 50.8 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 22.8 tp -104.46 128.67 52.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -1.083 . . . . 0.0 110.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 52.92 89.25 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.98 -34.24 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -1.062 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -107.48 149.11 28.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.429 -0.794 . . . . 0.0 110.246 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.8 137.45 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.363 -0.836 . . . . 0.0 110.183 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 42.1 m -115.65 134.81 54.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 20.7 m -61.03 -35.47 76.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.816 . . . . 0.0 110.506 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -83.67 3.63 32.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 110.866 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.79 46.76 25.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.163 -0.961 . . . . 0.0 110.256 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -54.17 -26.0 34.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 34.1 m -57.04 154.2 10.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -1.093 . . . . 0.0 110.386 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 44.6 m -118.35 148.85 42.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.224 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.17 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 94.0 p -120.35 160.56 43.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.357 -1.084 . . . . 0.0 109.911 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.76 -28.85 29.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.761 1.401 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -138.21 112.39 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.173 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -61.88 -40.5 95.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.264 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.9 0.56 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 69.4 p -68.58 -9.83 52.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.401 -1.058 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -53.69 147.02 12.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 110.389 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -127.22 143.35 51.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.404 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 32.4 ptt180 -69.67 147.28 50.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -0.805 . . . . 0.0 110.606 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 137.55 35.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 110.447 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' B' ' 713' ' ' PRO . 44.5 tp -93.86 132.14 38.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.535 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.4 t -118.92 139.16 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.283 -0.886 . . . . 0.0 110.45 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 31' ' ' ILE . 59.2 tp -99.31 132.26 44.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.6 t -123.18 129.07 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.277 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? -166.1 -175.06 3.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.859 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.22 -175.34 33.22 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.124 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.654 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.41 40.63 13.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.849 -0.795 . . . . 0.0 109.861 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.47 -35.77 65.73 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.0 m80 55.39 42.13 30.38 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.594 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.28 136.9 19.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 108.963 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.8 Cg_endo -98.45 25.21 19.82 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.797 -1.334 . . . . 0.0 110.152 -1.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.8 -48.16 83.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 111.991 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.39 -21.75 4.85 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.07 -1.019 . . . . 0.0 111.099 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.72 158.34 43.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.009 . . . . 0.0 110.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.71 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.327 -0.858 . . . . 0.0 111.061 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.8 p -173.94 179.12 2.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.045 -1.034 . . . . 0.0 110.578 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.66 162.68 67.33 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.2 143.22 89.31 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.341 1.18 . . . . 0.0 110.263 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.52 -57.77 4.41 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -57.41 -36.66 71.61 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.808 -1.182 . . . . 0.0 111.878 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -63.88 -39.91 95.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.943 -1.098 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.27 -38.35 71.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 108.925 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.76 -35.27 76.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.615 -0.678 . . . . 0.0 109.528 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.936 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -65.45 -39.42 92.02 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.305 -0.872 . . . . 0.0 110.496 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.901 HD23 HD23 ' B' ' 714' ' ' LEU . 86.3 mt -85.05 133.5 34.23 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.158 -0.964 . . . . 0.0 111.369 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 30' ' ' LYS . 31.3 m -148.74 145.33 19.66 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.39 148.76 55.37 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.509 1.268 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.84 -7.99 76.65 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.38 -25.64 11.82 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.244 -1.151 . . . . 0.0 111.056 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.839 HD11 HD21 ' B' ' 714' ' ' LEU . 72.2 mt -112.66 130.89 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.741 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -99.95 -21.66 15.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.512 -0.743 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -137.03 138.47 40.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.925 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.4 mt -129.43 122.54 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.866 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -109.37 127.98 54.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 108.841 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -118.84 128.65 54.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 110.594 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.75 HG22 ' CD2' ' A' ' 84' ' ' LEU . 59.3 p -102.33 -66.05 0.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.498 -0.751 . . . . 0.0 110.544 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.777 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -53.26 160.67 3.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 8.8 p30 -71.69 149.37 45.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.551 -0.97 . . . . 0.0 110.332 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 111.539 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -99.12 -21.86 15.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 119.751 -1.843 . . . . 0.0 110.144 -0.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -68.43 143.46 55.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.342 -0.849 . . . . 0.0 110.912 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.5 tttt -59.68 -28.23 67.1 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.205 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -51.41 -40.94 60.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -0.858 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.0 m -66.74 -34.35 77.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.349 -0.844 . . . . 0.0 109.878 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.9 t80 -59.74 -43.09 94.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.815 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.2 -40.28 89.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.37 -44.97 95.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 110.06 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.4 mt -62.44 -38.53 90.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.33 -0.857 . . . . 0.0 110.166 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.28 -32.69 73.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.55 -0.719 . . . . 0.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.6 m -63.46 -42.99 98.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.98 -36.67 84.26 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.187 -0.946 . . . . 0.0 110.522 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.18 154.25 35.45 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.15 -44.12 12.23 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -86.33 109.39 18.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -1.148 . . . . 0.0 110.373 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.18 133.83 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.374 -0.828 . . . . 0.0 110.285 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.55 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.4 m-70 -115.95 124.6 50.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 0.0 109.451 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.7 mt -130.26 149.35 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 111.424 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.5 m -116.84 150.38 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.57 131.03 44.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 111.079 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.3 -175.46 39.01 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.33 0.42 37.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.045 -1.267 . . . . 0.0 110.795 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.83 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.124 -0.985 . . . . 0.0 111.104 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.97 35.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.096 -1.002 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.63 -46.1 70.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 109.95 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.63 19.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.613 -0.68 . . . . 0.0 110.135 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.1 57.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.579 -0.7 . . . . 0.0 110.523 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.61 -3.82 36.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.09 147.82 80.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.864 -1.147 . . . . 0.0 109.436 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.8 Cg_endo -76.71 140.45 20.94 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.886 1.466 . . . . 0.0 110.906 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.34 80.81 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.64 150.33 29.37 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.75 34.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.823 -1.173 . . . . 0.0 111.519 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.78 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.32 131.82 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 110.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.83 130.54 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.382 -0.824 . . . . 0.0 109.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.53 86.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.47 -0.769 . . . . 0.0 109.189 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.06 -119.23 4.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.3 -6.0 51.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -1.163 . . . . 0.0 110.97 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.94 137.27 37.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 113.244 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.55 18.6 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.94 140.51 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.276 -0.89 . . . . 0.0 112.149 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.47 159.31 16.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.75 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.74 27.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.929 -1.336 . . . . 0.0 111.896 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.6 149.03 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.485 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.777 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.81 -60.43 3.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.499 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.63 3.41 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.298 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.73 -17.25 55.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.945 -1.326 . . . . 0.0 110.101 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.75 -6.0 59.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.323 -0.861 . . . . 0.0 109.941 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.43 113.11 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.214 -0.929 . . . . 0.0 109.743 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.56 24.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 110.128 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.02 97.28 Favored 'Cis proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.748 -2.189 . . . . 0.0 111.666 -0.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.53 1.25 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.0 5.76 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.004 -1.569 . . . . 0.0 112.524 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.3 135.04 36.63 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.735 -1.45 . . . . 0.0 110.357 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.5 ttp -73.86 -40.59 63.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.446 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.7 -38.78 86.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.498 -0.751 . . . . 0.0 109.576 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.19 85.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.072 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.07 97.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.477 -0.764 . . . . 0.0 109.421 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.23 94.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.451 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.18 -35.57 67.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.505 -0.747 . . . . 0.0 109.105 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.587 -0.696 . . . . 0.0 109.742 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.88 -45.4 86.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.759 . . . . 0.0 109.882 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -56.96 13.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -0.8 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.54 70.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.691 -0.63 . . . . 0.0 110.65 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -28.97 63.48 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.463 -0.773 . . . . 0.0 111.354 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.37 48.09 10.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.123 -0.985 . . . . 0.0 109.889 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -114.05 155.95 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.284 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.2 -31.95 33.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.789 . . . . 0.0 109.072 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.21 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.667 -0.646 . . . . 0.0 110.005 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.39 42.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.823 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.659 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.0 131.64 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.176 -0.953 . . . . 0.0 109.972 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.51 160.76 38.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.77 1.97 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.6 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.916 -0.756 . . . . 0.0 111.671 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.2 p -87.99 -9.61 52.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.836 -1.165 . . . . 0.0 111.383 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 24.95 7.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.01 -1.056 . . . . 0.0 110.775 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.58 137.87 42.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.061 -1.024 . . . . 0.0 110.276 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.41 7.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.5 -0.75 . . . . 0.0 110.32 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.834 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.212 -0.93 . . . . 0.0 111.035 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.11 145.49 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.507 -0.746 . . . . 0.0 110.244 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.65 117.61 7.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 0.0 110.91 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.82 58.11 5.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.432 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.29 6.34 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.78 -0.575 . . . . 0.0 112.316 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.98 38.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.892 -1.13 . . . . 0.0 109.857 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.36 140.96 47.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 0.0 111.158 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.06 134.3 53.43 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.08 135.97 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.005 . . . . 0.0 111.97 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.41 109.04 14.8 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.6 Cg_endo -66.12 -29.96 47.35 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.57 1.3 . . . . 0.0 111.462 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.83 -139.41 14.83 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 45.9 t -117.84 111.82 19.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -1.116 . . . . 0.0 110.426 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.53 48.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.19 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.75 63.17 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.96 . . . . 0.0 110.793 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.2 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.95 115.9 5.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.18 10.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.18 -28.82 48.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.612 -1.305 . . . . 0.0 112.322 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.31 22.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.855 -1.153 . . . . 0.0 109.875 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.0 -15.89 60.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.483 -0.761 . . . . 0.0 111.295 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.45 94.22 4.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.045 -1.035 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.67 139.8 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.453 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.9 mt -113.03 121.07 39.12 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.658 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -65.93 134.21 36.43 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.475 1.25 . . . . 0.0 109.612 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.403 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.8 p -168.89 154.36 6.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.654 -1.279 . . . . 0.0 112.009 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.936 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 24.8 p90 -137.78 161.08 37.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.21 137.73 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.156 -1.017 . . . . 0.0 113.572 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.948 ' CD1' HD22 ' B' ' 714' ' ' LEU . 13.1 mt -107.74 137.75 45.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.5 mtp -117.12 121.57 41.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.936 -1.102 . . . . 0.0 110.213 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.82 117.97 33.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.8 . . . . 0.0 109.62 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 160' ' ' VAL . 96.9 mt -115.5 122.88 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 111.084 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.1 -54.67 2.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.624 0.726 . . . . 0.0 109.378 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.77 107.37 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.2 m 59.63 10.19 1.87 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.368 -0.833 . . . . 0.0 110.465 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.8 m -139.7 132.97 29.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 108.851 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.99 139.23 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.923 -1.111 . . . . 0.0 111.506 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.45 125.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -106.87 137.31 45.17 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.8 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.68 126.7 55.18 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -109.79 132.22 58.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.389 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.791 ' CE2' HD12 ' A' ' 152' ' ' LEU . 59.3 m-85 -110.76 112.84 24.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.862 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.21 137.2 45.71 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.583 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 41.7 tp -93.64 84.08 4.58 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.669 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -102.03 118.73 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.72 -161.0 53.86 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -72.63 -43.99 62.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.111 -1.229 . . . . 0.0 110.839 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -75.44 157.81 33.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.31 -0.869 . . . . 0.0 110.988 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 167' ' ' LEU . 53.5 t -104.66 128.79 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.823 . . . . 0.0 109.725 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.669 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -97.26 147.58 23.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.865 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.8 p -131.88 141.55 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 111.065 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.8 tt0 -121.57 150.73 41.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.597 -0.689 . . . . 0.0 109.375 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -116.32 127.32 54.58 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.081 -1.012 . . . . 0.0 111.538 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.28 132.96 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.11 141.06 48.52 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.025 -1.047 . . . . 0.0 111.448 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.12 141.7 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.983 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.42 146.12 39.73 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.272 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -50.28 141.04 12.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.328 -0.858 . . . . 0.0 110.627 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.499 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.55 139.87 42.03 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.744 1.392 . . . . 0.0 110.579 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . 0.401 HD11 ' OE1' ' B' ' 694' ' ' GLU . 22.5 tp -105.97 131.75 52.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 0.0 110.046 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.82 -86.65 0.08 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.0 m -123.0 147.77 46.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.407 -1.055 . . . . 0.0 110.341 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 62.6 p -71.23 -16.36 62.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.427 -0.796 . . . . 0.0 110.435 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.21 -31.74 70.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.448 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.401 ' OE1' HD11 ' B' ' 689' ' ' LEU . 1.0 OUTLIER -62.23 -25.53 67.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.304 -0.872 . . . . 0.0 110.209 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -57.62 -33.98 68.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.351 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.6 mt -77.77 148.11 34.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.851 . . . . 0.0 110.186 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.76 153.81 21.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.363 -0.835 . . . . 0.0 110.377 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -148.17 175.26 11.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -63.08 147.0 52.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.84 151.86 27.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -110.05 172.16 7.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.46 -0.775 . . . . 0.0 110.38 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 48.4 p -80.58 162.3 24.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.336 -0.853 . . . . 0.0 110.029 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.71 132.31 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -0.855 . . . . 0.0 110.412 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 91.2 p -137.92 155.92 48.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.395 -0.816 . . . . 0.0 109.91 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.747 ' HB1' ' HG3' ' B' ' 708' ' ' PRO . . . -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -95.59 -66.7 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.504 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.61 59.74 47.91 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.604 -0.685 . . . . 0.0 109.586 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.747 ' HG3' ' HB1' ' B' ' 705' ' ' ALA . 47.4 Cg_endo -74.6 62.86 5.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.843 1.444 . . . . 0.0 110.361 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.08 148.19 33.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 110.328 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -104.65 136.66 43.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 111.629 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 43.7 m -67.4 -36.36 81.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.848 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -176.7 -178.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.5 Cg_endo -59.27 144.17 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 122.799 0.894 . . . . 0.0 110.375 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.948 HD22 ' CD1' ' A' ' 152' ' ' LEU . 4.1 mp 66.78 41.42 2.89 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.36 75.41 1.53 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.337 -1.477 . . . . 0.0 108.955 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.439 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 24.5 mp0 -82.59 18.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.221 1.01 . . . . 0.0 109.029 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.501 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.6 p -44.51 167.31 0.1 Allowed Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.011 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -74.09 -54.18 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.593 1.839 . . . . 0.0 108.702 176.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 53.2 mttp -158.55 -12.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.475 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.3 m 61.6 28.58 17.75 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . 0.637 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -89.38 171.73 8.43 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.449 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.637 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 42.0 Cg_endo -67.65 130.7 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.595 1.313 . . . . 0.0 110.364 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -154.71 160.75 41.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -91.03 136.75 32.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.36 -0.838 . . . . 0.0 110.118 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.84 151.17 25.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -115.67 153.47 31.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.452 -0.78 . . . . 0.0 110.064 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.8 tp -93.36 133.39 36.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 110.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.33 150.59 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.846 . . . . 0.0 110.28 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -80.12 148.3 31.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 0.0 110.114 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.6 HG12 ' O ' ' B' ' 732' ' ' ALA . 60.3 t -65.9 113.39 11.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.24 -23.1 28.99 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.647 1.341 . . . . 0.0 110.631 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . 0.6 ' O ' HG12 ' B' ' 730' ' ' VAL . . . -102.53 151.95 21.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 54.4 p -65.69 162.57 18.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 110.277 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.65 -171.63 29.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . 0.493 ' C ' HD23 ' B' ' 735' ' ' LEU . 9.3 tt -95.69 129.15 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -1.09 . . . . 0.0 110.247 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 145.13 164.29 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.3 t -121.8 136.86 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -1.043 . . . . 0.0 110.057 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.01 112.63 25.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.155 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 48.4 t -125.78 131.96 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 8.5 m -107.26 -10.91 15.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 110.549 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 59.5 p -86.67 158.91 19.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.428 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -108.63 137.89 45.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.698 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -89.63 15.0 10.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.276 -0.89 . . . . 0.0 111.034 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -79.19 -177.12 49.55 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.4 t -112.82 147.5 36.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.406 -1.055 . . . . 0.0 110.24 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 23.2 t -56.92 -33.76 67.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.447 -0.783 . . . . 0.0 110.371 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.11 179.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.0 p -127.94 70.57 78.0 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.57 -24.74 30.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.721 1.38 . . . . 0.0 110.275 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 148.53 41.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 0.0 110.379 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.11 135.09 35.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 142.73 58.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.7 t -131.47 162.48 30.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.476 -1.014 . . . . 0.0 110.038 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -93.84 126.36 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.04 -35.94 80.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.451 -0.78 . . . . 0.0 110.691 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 34.7 ttm180 -102.48 123.98 47.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 110.565 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.15 137.41 23.36 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.505 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' B' ' 713' ' ' PRO . 36.0 tp -94.63 133.58 38.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.446 -0.784 . . . . 0.0 110.547 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -119.9 139.04 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 31' ' ' ILE . 57.2 tp -98.54 130.74 45.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.402 HG12 ' HG3' ' A' ' 132' ' ' PRO . 93.4 t -122.56 130.3 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.791 . . . . 0.0 110.118 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.619 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -166.29 -177.7 4.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.437 -0.79 . . . . 0.0 109.787 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.55 -174.92 34.99 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.258 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.727 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 60.78 40.75 15.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.906 -0.761 . . . . 0.0 109.88 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.69 65.75 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.27 42.1 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.713 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.21 136.84 19.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.047 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.53 25.32 19.58 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.193 -1.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.89 -48.06 83.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.285 -0.884 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.49 -21.85 4.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.062 -1.024 . . . . 0.0 111.006 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.57 158.38 43.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.132 -0.98 . . . . 0.0 110.199 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.94 -18.63 15.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.927 . . . . 0.0 111.1 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.94 179.07 2.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.169 -0.957 . . . . 0.0 110.611 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.67 162.69 67.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.34 143.56 89.23 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.347 1.183 . . . . 0.0 110.181 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.34 -55.93 9.42 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -57.73 -36.13 71.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.78 -1.2 . . . . 0.0 111.805 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.541 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.85 -39.2 93.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.905 -1.122 . . . . 0.0 111.105 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.53 -38.17 71.48 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.936 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.66 -35.11 76.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.613 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.792 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -66.34 -39.15 89.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.349 -0.844 . . . . 0.0 110.539 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD23 HD23 ' B' ' 714' ' ' LEU . 88.9 mt -84.39 133.42 34.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -0.984 . . . . 0.0 111.263 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 30' ' ' LYS . 7.8 p -148.98 143.94 17.58 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 110.069 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -70.62 148.69 60.05 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.526 1.277 . . . . 0.0 110.744 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -7.37 78.14 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.677 ' HE2' HD12 ' B' ' 714' ' ' LEU . 0.0 OUTLIER -106.74 -26.75 11.16 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.287 -1.125 . . . . 0.0 110.979 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD11 HD21 ' B' ' 714' ' ' LEU . 74.1 mt -112.44 131.66 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 110.778 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -100.18 -21.45 15.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 110.586 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -137.04 138.83 40.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.19 -0.944 . . . . 0.0 111.002 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -129.75 123.29 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.793 . . . . 0.0 110.751 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 57' ' ' HIS . 76.6 mt -110.11 129.1 55.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.12 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.4 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.3 t -118.32 129.69 55.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 110.208 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 HD21 ' A' ' 84' ' ' LEU . 73.1 p -102.91 -56.73 2.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 111.039 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.22 165.59 38.85 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.325 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.48 147.12 44.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.857 -0.79 . . . . 0.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.5 mt -54.71 -61.95 1.98 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 111.44 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.74 -19.98 17.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 119.914 -1.741 . . . . 0.0 110.022 -1.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.41 143.53 53.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 110.779 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.27 -28.31 67.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.51 -0.744 . . . . 0.0 110.143 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.3 -41.06 60.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -0.88 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.7 -34.76 78.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 109.822 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.9 t80 -59.43 -42.76 92.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.32 -40.16 89.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.579 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -62.29 -44.76 95.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.075 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.9 mt -63.0 -38.3 90.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -62.24 -32.63 73.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.535 -0.728 . . . . 0.0 109.78 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.2 m -63.4 -43.67 96.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.6 -36.79 83.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.596 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.85 36.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.177 -0.952 . . . . 0.0 110.372 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.78 -43.09 11.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.02 110.35 20.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -1.134 . . . . 0.0 110.384 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 134.51 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.38 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.487 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.22 127.63 54.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.406 -0.808 . . . . 0.0 109.563 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.59 151.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.6 m -121.75 157.51 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -76.28 130.82 38.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.724 -1.235 . . . . 0.0 111.744 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.4 38.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.44 37.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.097 -1.237 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.105 -0.997 . . . . 0.0 111.119 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.15 35.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.129 -0.982 . . . . 0.0 110.374 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.69 -46.12 69.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 110.006 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.22 119.76 19.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.66 -0.65 . . . . 0.0 110.151 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.16 57.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.62 -0.675 . . . . 0.0 110.579 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.52 -3.82 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 111.323 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.19 147.74 80.13 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.862 -1.149 . . . . 0.0 109.443 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.68 140.5 21.07 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.859 1.452 . . . . 0.0 110.903 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.79 -39.36 80.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 109.171 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.31 29.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.57 147.76 34.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.833 -1.167 . . . . 0.0 111.526 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -113.82 113.41 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.48 131.81 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.42 37.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.4 -0.813 . . . . 0.0 109.983 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.46 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.494 -0.754 . . . . 0.0 109.188 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.97 -119.24 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.33 -6.08 50.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.261 -1.14 . . . . 0.0 110.848 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.89 137.24 37.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 113.261 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.53 18.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.9 140.45 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 112.201 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.33 159.24 16.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.837 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.76 27.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.355 . . . . 0.0 111.896 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.56 149.02 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.739 . . . . 0.0 109.537 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.95 -60.41 3.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.893 -1.129 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.06 -26.55 3.4 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.333 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.81 -17.28 55.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.95 -1.323 . . . . 0.0 110.103 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.74 -5.95 59.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.983 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.46 113.21 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.926 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.23 129.54 24.48 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.833 . . . . 0.0 110.155 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.4 Cg_endo -71.23 155.01 97.19 Favored 'Cis proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.691 -0.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.19 -57.39 1.34 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 33.99 5.78 Favored Glycine 0 N--CA 1.5 2.955 0 C-N-CA 119.055 -1.545 . . . . 0.0 112.48 -177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.895 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.15 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.736 -1.449 . . . . 0.0 110.317 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.03 -40.47 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.89 -38.72 86.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.548 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.04 -42.09 85.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.15 98.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.419 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.2 -45.27 94.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.53 -0.731 . . . . 0.0 109.417 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.57 67.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 109.116 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.89 -35.49 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.73 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.72 -45.48 85.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -54.02 -56.98 12.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.221 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.49 70.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.732 -0.605 . . . . 0.0 110.742 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -28.98 63.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.438 -0.789 . . . . 0.0 111.372 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.9 t70 59.4 48.0 10.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.18 -0.95 . . . . 0.0 109.882 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.94 155.93 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.796 . . . . 0.0 110.278 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.06 -32.06 34.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.149 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.19 140.58 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.39 42.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.225 -0.922 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.557 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.94 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.908 . . . . 0.0 109.989 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.0 110.221 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.03 -120.85 1.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.7 -34.16 0.24 Allowed 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.868 -0.783 . . . . 0.0 111.582 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -88.02 -9.59 52.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.898 -1.126 . . . . 0.0 111.429 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.66 24.99 7.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.166 -0.959 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.79 114.35 19.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.215 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.56 137.88 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.995 -1.065 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.34 7.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 110.355 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.79 3.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.44 -0.788 . . . . 0.0 109.807 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.65 21.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.309 -0.869 . . . . 0.0 111.007 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -110.28 145.45 37.38 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.553 -0.717 . . . . 0.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.58 117.52 7.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 110.941 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 53.02 58.06 5.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.537 -0.727 . . . . 0.0 111.388 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.16 15.33 6.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.798 -0.564 . . . . 0.0 112.417 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.63 154.96 38.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.511 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.5 t80 -113.34 140.97 47.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 111.262 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.09 134.3 53.41 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.09 136.02 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -0.981 . . . . 0.0 111.935 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 108.98 14.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 131' ' ' ASN . 40.7 Cg_endo -66.05 -30.04 47.88 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.509 1.268 . . . . 0.0 111.47 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.37 14.8 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.94 111.73 19.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.61 -20.47 47.7 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.88 . . . . 0.0 110.444 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.58 13.12 18.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.309 -0.87 . . . . 0.0 110.521 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.61 63.8 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 147.01 4.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.57 -0.959 . . . . 0.0 110.767 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.99 151.18 46.62 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.733 0.777 . . . . 0.0 111.477 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.95 115.98 5.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.1 10.88 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.25 -28.82 47.83 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.606 -1.309 . . . . 0.0 112.268 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.25 22.42 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.79 60.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 111.267 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.16 4.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.09 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.9 mm -101.61 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -0.889 . . . . 0.0 110.447 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.87 120.92 39.68 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.769 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -65.7 134.74 39.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.504 1.265 . . . . 0.0 109.843 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.1 p -167.78 154.58 8.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.824 -1.173 . . . . 0.0 112.255 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.716 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 26.6 p90 -135.45 160.79 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 99.5 t -126.97 137.12 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.557 -177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.973 HD11 HD22 ' B' ' 714' ' ' LEU . 21.9 mt -107.73 137.14 46.29 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 57.6 mtp -116.81 117.88 30.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -95.43 117.09 29.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 0.0 109.599 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.94 110.53 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -0.977 . . . . 0.0 111.413 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.26 -41.19 22.57 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.894 0.854 . . . . 0.0 108.874 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.31 -106.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.9 m -85.06 8.25 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.689 -1.257 . . . . 0.0 110.148 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.9 m -124.21 140.34 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.398 -0.814 . . . . 0.0 109.789 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.571 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.86 139.18 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 111.265 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.13 127.41 73.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.511 HG21 ' HE1' ' A' ' 128' ' ' PHE . 73.3 p -107.72 137.06 46.42 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.054 -1.029 . . . . 0.0 110.602 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.703 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.59 127.38 55.75 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.2 131.73 60.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.262 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.795 ' CE2' HD12 ' A' ' 152' ' ' LEU . 71.1 m-85 -111.26 111.11 21.94 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.4 -0.813 . . . . 0.0 109.932 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -106.97 139.32 41.56 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.674 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.769 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.7 tp -96.61 94.85 7.58 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.28 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.807 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.9 mt -109.2 125.55 66.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.72 -131.58 31.57 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -99.38 -48.86 4.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.185 -1.185 . . . . 0.0 110.225 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -71.19 155.4 40.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.384 -0.823 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.595 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.8 t -101.25 128.04 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.711 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.807 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.69 147.4 23.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -0.763 . . . . 0.0 109.797 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.7 p -131.71 140.33 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 79.0 tt0 -120.36 150.57 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.514 -0.741 . . . . 0.0 109.421 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -115.46 127.02 55.03 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.088 -1.008 . . . . 0.0 111.722 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.4 132.76 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.556 -0.715 . . . . 0.0 109.113 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.72 141.72 47.7 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.006 -1.059 . . . . 0.0 111.656 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.4 t80 -139.53 143.16 37.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.707 -0.621 . . . . 0.0 109.823 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -140.04 145.62 37.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.963 . . . . 0.0 110.249 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -50.39 -34.51 24.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.386 -0.821 . . . . 0.0 110.61 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.238 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.38 140.75 44.9 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.71 1.374 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.16 -31.01 72.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -52.96 145.5 20.72 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 25.4 t -142.84 162.11 36.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.468 -1.019 . . . . 0.0 110.025 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 14.3 t -128.74 152.55 48.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.68 137.91 58.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.375 -0.828 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -76.28 -33.1 59.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.97 -42.42 89.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.313 -0.867 . . . . 0.0 110.746 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.14 142.93 45.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.892 . . . . 0.0 110.597 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -113.26 161.17 17.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.473 -0.767 . . . . 0.0 110.121 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -136.32 171.83 13.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.864 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -50.57 145.95 6.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.837 . . . . 0.0 110.243 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.21 141.71 45.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.452 -0.78 . . . . 0.0 110.638 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -104.65 173.5 6.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 71.9 p -115.2 167.81 10.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.364 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.87 143.75 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 46.3 m -112.0 150.08 31.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.862 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -74.54 126.99 31.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.436 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.06 65.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.456 -0.777 . . . . 0.0 110.382 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.85 153.69 5.69 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.438 -0.788 . . . . 0.0 110.534 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.66 154.38 71.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.837 1.441 . . . . 0.0 110.456 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.16 147.89 26.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.602 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -110.09 138.13 46.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 49.9 m -75.73 -37.62 59.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.843 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.7 OUTLIER -176.01 -178.7 0.33 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.3 Cg_endo -59.67 146.97 93.93 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 122.805 0.898 . . . . 0.0 110.015 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.973 HD22 HD11 ' A' ' 152' ' ' LEU . 3.5 mp 67.38 36.48 3.87 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.543 -0.723 . . . . 0.0 112.766 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.646 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.95 74.94 1.49 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.642 -1.286 . . . . 0.0 108.199 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.42 ' NE2' ' HG3' ' A' ' 30' ' ' LYS . 27.1 mp0 -80.08 17.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.048 0.928 . . . . 0.0 109.797 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.557 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 28.3 p -48.01 169.79 0.12 Allowed Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.224 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.0 Cg_endo -72.83 -54.46 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.439 1.757 . . . . 0.0 108.518 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 40.9 mtmt -160.22 -12.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.51 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.1 m 61.68 28.52 17.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.95 122.71 53.78 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.09 -39.9 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.673 1.354 . . . . 0.0 110.528 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -177.54 -32.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -95.89 154.57 17.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -58.09 -21.27 45.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.706 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -39.12 107.77 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.495 -0.753 . . . . 0.0 111.552 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.35 146.43 29.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.655 -0.653 . . . . 0.0 109.71 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -50.6 140.78 13.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.229 -0.92 . . . . 0.0 110.301 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -90.46 129.91 36.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.863 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.26 87.57 53.36 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.492 -0.755 . . . . 0.0 109.59 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 114.96 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.655 1.345 . . . . 0.0 110.679 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -160.27 155.18 24.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 109.914 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -120.5 146.2 46.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -107.12 141.17 15.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.7 -35.51 78.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -1.095 . . . . 0.0 110.321 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 137.81 -167.27 24.9 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 55.9 t -111.97 133.49 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.385 -1.067 . . . . 0.0 110.089 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.04 -154.18 0.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.446 -0.784 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.14 152.66 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.892 . . . . 0.0 110.181 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 81.6 p -95.58 1.41 53.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.818 . . . . 0.0 110.848 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 53.8 p -68.54 152.26 45.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -110.0 -66.33 1.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 110.556 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -57.18 -40.58 77.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.381 -0.825 . . . . 0.0 110.594 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.58 67.93 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 53.7 p -66.97 159.36 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -1.073 . . . . 0.0 110.421 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -62.76 -27.43 69.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.477 -0.764 . . . . 0.0 110.229 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.272 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 17.8 p -66.39 146.64 99.06 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 110.165 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.96 147.78 62.32 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.65 1.342 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -101.26 143.22 31.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.022 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.68 -6.71 39.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -161.64 51.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 58.9 p -120.95 154.48 35.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -1.145 . . . . 0.0 110.04 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -134.77 155.93 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -134.72 157.15 47.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.426 -0.796 . . . . 0.0 110.177 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.48 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 33.1 ptt180 -113.06 144.7 42.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.962 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.99 134.84 40.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.45 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.8 tp -93.06 131.07 38.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.739 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.1 t -117.28 141.5 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.179 -0.951 . . . . 0.0 110.797 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.3 tp -99.84 133.23 44.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.432 -0.793 . . . . 0.0 110.664 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.06 129.94 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.847 . . . . 0.0 110.249 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.63 -175.93 3.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.017 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.1 -175.55 33.8 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.67 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.36 40.75 13.83 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.758 -0.848 . . . . 0.0 109.857 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.66 65.66 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.24 42.11 30.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.712 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.92 19.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 108.983 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.26 19.79 Favored 'Cis proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.791 -1.337 . . . . 0.0 110.141 -1.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.93 -47.98 83.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.295 -0.878 . . . . 0.0 111.971 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.48 -21.87 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.965 -1.084 . . . . 0.0 111.034 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.3 m -133.7 158.42 43.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.072 -1.018 . . . . 0.0 110.164 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.87 -18.79 15.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 111.047 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.86 179.03 2.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 0.0 110.6 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.62 162.72 67.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.13 142.75 88.28 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.371 1.195 . . . . 0.0 110.212 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.27 -56.13 7.35 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -58.02 -36.71 73.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.758 -1.214 . . . . 0.0 111.772 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -63.95 -40.03 95.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 111.227 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -56.66 -38.93 72.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.972 -1.08 . . . . 0.0 108.925 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.56 -34.98 76.78 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.681 . . . . 0.0 109.669 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.803 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 1.1 tt -65.25 -38.89 91.73 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.465 -0.772 . . . . 0.0 110.583 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.73 HD23 HD13 ' B' ' 714' ' ' LEU . 92.3 mt -88.14 134.68 33.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.853 . . . . 0.0 111.578 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 26' ' ' LEU . 27.6 m -148.05 147.85 27.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.57 149.34 55.37 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.51 1.268 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.0 81.38 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.9 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.4 mmmt -107.79 -25.96 11.01 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.321 -1.105 . . . . 0.0 110.997 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.8 mt -113.09 132.31 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.912 . . . . 0.0 110.692 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -100.5 -21.63 15.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 110.745 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.739 ' HB2' HG22 ' A' ' 3' ' ' VAL . 64.8 m-70 -136.74 139.14 41.66 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.139 -0.975 . . . . 0.0 111.06 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.3 mt -129.86 122.52 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.38 -0.825 . . . . 0.0 110.789 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.4 mt -109.74 128.46 55.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.341 -0.849 . . . . 0.0 108.915 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.29 129.6 54.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 110.521 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 84' ' ' LEU . 64.8 p -103.02 -63.84 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.616 -0.677 . . . . 0.0 110.651 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.794 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -56.25 161.48 6.82 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.62 149.61 45.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.599 -0.942 . . . . 0.0 110.2 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.2 mt -55.8 -62.62 1.57 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.399 -0.813 . . . . 0.0 111.632 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 27.9 p -99.06 -22.12 15.86 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.801 -1.812 . . . . 0.0 110.226 -0.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 t -68.58 143.25 54.94 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.308 -0.87 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -59.62 -28.6 67.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.449 -0.782 . . . . 0.0 110.15 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -51.63 -40.69 60.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.192 -0.943 . . . . 0.0 110.143 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' HD22 ' A' ' 40' ' ' LEU . 57.1 m -66.05 -34.71 78.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.796 . . . . 0.0 109.913 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -59.79 -43.0 94.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.355 -0.841 . . . . 0.0 110.17 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.84 -40.28 87.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.434 -0.791 . . . . 0.0 109.686 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.35 -44.75 95.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 0.0 110.118 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.5 mt -62.85 -38.23 89.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.164 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.4 tptt -62.26 -32.6 73.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.474 -0.766 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -63.4 -43.47 97.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.353 -0.842 . . . . 0.0 110.966 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.64 -36.82 84.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.912 . . . . 0.0 110.626 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.12 154.86 36.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.905 . . . . 0.0 110.454 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.0 -43.08 11.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -86.21 110.07 19.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.34 -1.094 . . . . 0.0 110.287 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.61 134.04 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.339 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.481 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.78 126.41 53.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.428 -0.795 . . . . 0.0 109.578 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.9 mt -131.65 151.57 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 0.0 111.491 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.536 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.04 152.89 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -71.73 130.94 42.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.748 -1.22 . . . . 0.0 111.239 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.57 38.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.23 0.51 36.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.078 -1.248 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.72 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.118 -0.989 . . . . 0.0 111.101 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.334 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.73 -46.0 70.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.235 -0.916 . . . . 0.0 110.024 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.32 119.7 19.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.695 -0.628 . . . . 0.0 110.169 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.14 57.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.583 -0.698 . . . . 0.0 110.58 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.62 -3.82 36.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.078 -1.014 . . . . 0.0 111.219 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.498 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.17 147.77 80.27 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.866 -1.146 . . . . 0.0 109.435 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.6 Cg_endo -76.66 140.39 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.857 1.451 . . . . 0.0 110.944 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.35 80.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.261 -0.9 . . . . 0.0 109.165 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.28 29.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.59 147.68 34.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 111.544 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.35 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.275 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.76 130.46 37.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.406 -0.809 . . . . 0.0 109.941 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.1 t -121.49 86.84 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.491 -0.755 . . . . 0.0 109.229 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.42 -5.76 51.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -1.124 . . . . 0.0 110.918 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.18 137.29 37.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.09 -1.006 . . . . 0.0 113.225 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.53 18.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.95 140.46 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 112.188 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.32 159.3 16.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.77 27.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.365 . . . . 0.0 111.863 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.59 149.14 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.525 -0.734 . . . . 0.0 109.483 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.794 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.94 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.833 -1.167 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.56 3.41 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.32 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.83 -17.21 55.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.958 -1.319 . . . . 0.0 110.107 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.02 59.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.942 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.37 113.08 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 0.0 109.748 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.11 129.51 24.47 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.266 -0.896 . . . . 0.0 110.199 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.21 154.94 97.13 Favored 'Cis proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.79 -2.171 . . . . 0.0 111.717 -0.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.08 -57.41 1.29 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.46 34.11 5.69 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.003 -1.57 . . . . 0.0 112.489 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.1 36.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.749 -1.442 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ttp -73.89 -40.56 63.11 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.205 -0.934 . . . . 0.0 109.483 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.86 -38.75 86.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.443 -0.785 . . . . 0.0 109.524 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.06 -42.08 85.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.141 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.19 98.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 109.347 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.16 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.507 -0.746 . . . . 0.0 109.464 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.26 -35.58 67.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.778 . . . . 0.0 109.091 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.94 -35.42 69.61 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.546 -0.721 . . . . 0.0 109.748 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.81 -45.38 86.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 109.884 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -56.97 12.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.509 -0.744 . . . . 0.0 110.277 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.51 70.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.646 -0.659 . . . . 0.0 110.721 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.2 -29.0 63.55 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.313 -0.867 . . . . 0.0 111.394 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.32 48.12 10.52 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.124 -0.985 . . . . 0.0 109.826 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.97 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.1 -32.04 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.089 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.2 140.54 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.011 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.74 123.49 42.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.183 -0.948 . . . . 0.0 109.779 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.665 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.11 131.64 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.52 160.74 38.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.214 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.84 1.98 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.17 0.24 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.886 -0.773 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.62 53.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.835 -1.166 . . . . 0.0 111.484 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.66 24.96 7.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.117 -0.99 . . . . 0.0 110.783 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -123.72 114.26 19.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 109.28 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.52 137.99 41.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -152.0 122.32 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.528 -0.732 . . . . 0.0 110.32 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.72 3.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.526 -0.734 . . . . 0.0 109.848 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.64 21.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.318 -0.864 . . . . 0.0 111.062 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -110.19 145.42 37.3 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.527 -0.733 . . . . 0.0 110.292 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.56 117.53 7.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.85 58.12 5.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.497 -0.752 . . . . 0.0 111.381 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.28 6.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.826 -0.546 . . . . 0.0 112.352 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.76 154.96 38.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.966 -1.084 . . . . 0.0 109.85 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 111.21 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.03 134.3 53.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.05 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.015 -1.053 . . . . 0.0 111.916 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.45 109.02 14.75 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.04 -30.08 47.95 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.582 1.306 . . . . 0.0 111.449 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.48 14.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.87 111.71 19.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 0.0 110.488 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.59 47.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.27 -0.894 . . . . 0.0 110.475 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.51 13.17 18.79 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 110.552 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 63.97 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.04 146.92 4.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.603 -0.94 . . . . 0.0 110.747 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.9 151.21 46.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.763 0.792 . . . . 0.0 111.477 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.83 5.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.8 -29.16 10.92 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.22 -28.73 47.99 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.532 -1.355 . . . . 0.0 112.343 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.31 22.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.831 -1.168 . . . . 0.0 109.867 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.78 60.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.23 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.081 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.58 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.0 mt -112.91 121.09 39.23 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.673 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.98 133.73 34.54 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.372 1.196 . . . . 0.0 109.436 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.3 p -167.84 154.53 7.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.735 -1.228 . . . . 0.0 111.851 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.803 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.6 p90 -138.37 162.46 34.36 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 84.8 t -124.57 140.39 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.84 HD21 ' CD1' ' B' ' 714' ' ' LEU . 0.1 OUTLIER -107.73 131.59 54.26 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.8 mtp -114.61 124.44 51.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.658 -1.276 . . . . 0.0 110.458 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -101.32 117.11 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 109.915 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -116.22 108.08 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 111.169 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.48 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -81.15 -41.0 23.08 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.829 0.823 . . . . 0.0 108.895 178.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.43 -105.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 68.2 m -85.41 8.58 18.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 110.16 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.9 m -125.01 138.33 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.995 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.1 p -131.58 139.11 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 0.0 111.187 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.15 128.8 74.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.408 HG21 ' HE1' ' A' ' 128' ' ' PHE . 63.8 p -107.14 138.62 42.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.844 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.14 128.91 56.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.1 p -112.99 132.41 61.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.621 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 49.3 m-85 -109.89 113.62 26.51 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.311 -0.868 . . . . 0.0 109.768 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -108.49 135.54 49.6 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.432 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.673 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 39.0 tp -93.94 93.96 8.2 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.773 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.2 mt -108.78 125.69 65.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.1 32.7 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -99.19 -48.84 4.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -1.198 . . . . 0.0 110.287 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -70.66 156.83 38.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.3 t -102.15 127.8 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.8 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.773 ' HD2' HD12 ' A' ' 168' ' ' ILE . 98.6 mttt -96.87 146.69 24.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 109.861 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.3 p -132.42 140.51 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.907 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.5 tt0 -119.48 150.52 40.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.617 -0.677 . . . . 0.0 109.45 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -115.16 126.54 54.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.04 -1.037 . . . . 0.0 111.647 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.04 132.95 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.9 141.33 48.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.017 -1.052 . . . . 0.0 111.554 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.3 t80 -139.25 142.02 37.82 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.732 -0.605 . . . . 0.0 109.812 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.96 145.74 38.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.215 -0.928 . . . . 0.0 110.352 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -50.32 144.41 7.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.392 -0.817 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.454 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.89 148.53 70.85 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.789 1.415 . . . . 0.0 110.525 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.54 -32.59 71.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.758 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 90.08 -163.57 30.54 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 41.9 m -60.27 150.56 29.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.378 -1.072 . . . . 0.0 110.311 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 41.2 m -60.65 -39.21 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.516 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.47 148.05 38.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.314 -0.867 . . . . 0.0 110.43 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -101.43 -62.02 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.109 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -134.09 163.57 29.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.803 . . . . 0.0 109.759 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 26.0 tp -100.43 111.82 24.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -74.59 -29.46 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.736 . . . . 0.0 110.427 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.56 141.32 58.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.732 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -147.29 159.73 43.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.563 -0.711 . . . . 0.0 109.63 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -89.56 128.83 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -172.94 169.84 4.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.403 -0.811 . . . . 0.0 110.102 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 87.5 m -103.27 142.45 34.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 0.0 109.494 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.9 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.767 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 26.1 t -119.11 153.27 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.605 -0.684 . . . . 0.0 109.819 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -56.21 -27.33 54.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.24 -0.912 . . . . 0.0 110.399 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.04 -26.5 67.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.55 153.74 48.85 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' B' ' 718' ' ' PRO . 43.6 Cg_endo -68.91 139.65 43.8 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.756 1.398 . . . . 0.0 110.714 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -122.82 157.66 31.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.468 -0.77 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -74.26 137.88 43.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.444 -0.785 . . . . 0.0 111.398 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 35.8 m -83.42 -37.8 22.76 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.821 0.82 . . . . 0.0 109.048 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.905 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -173.63 -175.11 0.26 Allowed Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.905 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -59.56 138.84 86.08 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 122.724 0.855 . . . . 0.0 110.58 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.9 HD23 ' HE2' ' A' ' 30' ' ' LYS . 6.5 mt 70.29 40.95 1.09 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.57 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -136.98 78.36 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.833 -1.547 . . . . 0.0 109.269 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -83.78 18.35 2.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.121 0.962 . . . . 0.0 109.21 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.552 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.1 p -47.29 168.91 0.12 Allowed Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.829 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -74.42 -54.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.484 1.781 . . . . 0.0 108.542 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 31.1 mttt -159.21 -12.1 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.515 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.6 m 62.51 28.13 16.59 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -97.64 138.65 21.09 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.566 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' B' ' 723' ' ' ALA . 43.6 Cg_endo -69.88 119.35 6.31 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.478 1.252 . . . . 0.0 110.688 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' B' ' 722' ' ' PRO . . . 176.55 141.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.457 -0.777 . . . . 0.0 110.203 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 55.42 50.83 13.97 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.275 -0.891 . . . . 0.0 110.614 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -61.58 142.38 57.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -0.916 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -54.36 -37.02 64.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 0.0 110.868 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 56.5 mt -86.51 141.14 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.472 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -167.72 68.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -58.52 -32.69 69.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.393 -0.817 . . . . 0.0 110.61 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.41 141.04 96.56 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.232 -0.917 . . . . 0.0 110.022 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.09 58.77 5.69 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.633 1.333 . . . . 0.0 110.491 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.07 91.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.28 -0.887 . . . . 0.0 110.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.3 t -139.57 148.7 42.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.822 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.16 -176.13 37.71 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.44 143.4 34.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.399 -1.06 . . . . 0.0 110.461 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.49 157.65 31.43 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.3 m -133.9 159.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.455 -1.026 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -106.32 144.36 33.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 0.0 110.198 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . 0.494 HG22 ' O ' ' B' ' 739' ' ' VAL . 10.6 p -104.32 4.51 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.679 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 7.2 m 56.64 111.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.833 . . . . 0.0 111.39 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' B' ' 742' ' ' GLN . 51.0 m -123.51 152.59 41.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.68 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' B' ' 741' ' ' SER . 93.7 mt-30 58.18 54.41 5.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.268 -0.895 . . . . 0.0 110.163 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' B' ' 743' ' ' ASP . 24.5 p-10 -54.84 -33.88 62.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.338 -0.851 . . . . 0.0 110.639 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -80.19 -176.74 50.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.2 t -112.69 141.63 46.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -1.128 . . . . 0.0 110.086 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 28.3 t -124.13 144.4 49.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.247 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.9 m95 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.188 179.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -170.71 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.346 -1.091 . . . . 0.0 110.431 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.3 Cg_endo -68.72 153.12 73.78 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.435 1.229 . . . . 0.0 110.628 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -87.48 144.46 26.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.255 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.97 155.37 39.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.865 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 97.69 -174.35 29.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.6 p -118.95 159.91 22.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.287 -1.125 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -107.2 2.32 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.25 -39.7 73.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.919 -1.113 . . . . 0.0 109.524 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 31.2 ttm180 -130.56 132.68 45.68 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.87 136.82 50.96 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.611 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.0 tp -92.69 132.17 37.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.539 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.1 t -119.28 138.64 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.272 -0.893 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 34' ' ' ILE . 50.5 tp -99.58 131.4 45.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.488 -0.758 . . . . 0.0 110.437 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.96 128.86 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 110.291 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -165.43 -176.24 3.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.733 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.11 -175.44 34.58 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.687 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.3 40.65 14.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.862 -0.787 . . . . 0.0 109.857 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.4 -35.78 65.93 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.32 42.09 30.58 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.689 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.87 19.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.03 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.7 Cg_endo -98.53 25.38 19.51 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.143 -1.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.91 -47.99 83.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.291 -0.881 . . . . 0.0 111.996 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.54 -21.76 4.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 111.043 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.0 m -133.75 158.43 43.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.8 15.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.25 -0.906 . . . . 0.0 111.046 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.87 179.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.105 -0.997 . . . . 0.0 110.671 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.64 162.74 67.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.35 143.67 89.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.265 1.139 . . . . 0.0 110.427 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.79 -57.25 5.84 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -57.42 -36.45 71.37 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.779 -1.201 . . . . 0.0 111.754 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.06 -39.45 94.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.942 -1.098 . . . . 0.0 110.996 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.55 -37.73 70.92 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.133 -1.027 . . . . 0.0 108.816 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -68.83 -36.16 77.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.667 -0.645 . . . . 0.0 109.628 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.812 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -64.83 -42.02 95.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 714' ' ' LEU . 95.4 mt -82.59 134.59 35.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.273 -0.892 . . . . 0.0 111.52 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 28' ' ' PRO . 6.6 p -151.17 144.82 17.44 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.707 -0.621 . . . . 0.0 109.724 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.522 ' HD2' HG23 ' A' ' 27' ' ' VAL . 44.3 Cg_endo -69.95 149.58 65.89 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.442 1.233 . . . . 0.0 110.922 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.91 -4.98 82.02 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.919 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.4 mmmt -108.54 -26.83 10.22 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.269 -1.136 . . . . 0.0 110.976 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HD11 ' B' ' 714' ' ' LEU . 73.6 mt -112.81 132.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.788 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.51 -23.65 15.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.71 . . . . 0.0 110.655 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.762 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.9 m-70 -135.6 139.47 43.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.0 mt -129.75 122.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.828 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.5 mt -109.78 128.79 55.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.01 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -119.15 129.84 55.23 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.431 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.787 HG22 ' CD2' ' A' ' 84' ' ' LEU . 60.3 p -103.08 -63.16 1.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.693 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.76 162.42 9.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.46 148.83 44.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.686 -0.891 . . . . 0.0 110.41 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.6 mt -55.21 -62.75 1.46 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.307 -0.871 . . . . 0.0 111.568 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.97 -21.08 16.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 119.821 -1.799 . . . . 0.0 110.22 -0.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -68.98 143.5 54.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.247 -0.908 . . . . 0.0 110.878 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -59.87 -28.33 67.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.776 . . . . 0.0 110.172 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.55 -40.99 60.77 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 0.0 110.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.4 m -66.28 -34.63 78.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.899 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.8 t80 -59.75 -43.11 94.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -0.819 . . . . 0.0 110.055 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.34 88.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.0 109.69 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -62.43 -44.57 96.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 110.048 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -62.91 -38.45 91.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.277 -0.889 . . . . 0.0 110.134 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.25 -32.65 73.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 109.77 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.7 m -63.35 -43.29 98.13 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.775 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.86 -36.87 84.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.173 -0.955 . . . . 0.0 110.571 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.16 154.27 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.31 -43.41 13.06 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.55 109.85 19.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 110.388 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.82 134.47 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.373 -0.829 . . . . 0.0 110.304 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.498 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.86 126.74 53.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 109.522 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.56 151.2 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 111.445 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG13 HD13 ' A' ' 84' ' ' LEU . 27.3 m -119.78 154.26 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.18 130.76 40.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.757 -1.215 . . . . 0.0 111.447 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.42 -175.52 38.82 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.59 36.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.08 -1.247 . . . . 0.0 110.842 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.74 3.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 111.194 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 132.93 35.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.43 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.02 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.305 -0.872 . . . . 0.0 110.088 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.28 119.7 19.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.619 -0.676 . . . . 0.0 110.109 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.49 -1.12 57.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 110.544 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.6 -3.81 36.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 111.255 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.432 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.23 147.76 80.05 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.7 Cg_endo -76.68 140.41 20.99 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.876 1.461 . . . . 0.0 110.883 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.67 -39.44 80.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.284 -0.885 . . . . 0.0 109.175 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.27 29.31 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.73 34.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.85 -1.156 . . . . 0.0 111.544 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.73 113.23 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.644 -0.66 . . . . 0.0 109.258 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.74 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.75 130.5 37.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 109.967 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.53 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.18 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.25 5.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.28 -6.02 51.18 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.312 -1.111 . . . . 0.0 110.902 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.9 137.28 36.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 113.246 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.27 107.5 18.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.95 140.5 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 112.233 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.2 16.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.787 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.13 131.79 27.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.841 -1.388 . . . . 0.0 111.875 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.64 149.11 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.541 -0.724 . . . . 0.0 109.468 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.99 -60.31 4.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.945 -1.097 . . . . 0.0 110.525 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.72 3.39 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.282 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.7 -17.27 54.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.977 -1.308 . . . . 0.0 110.14 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -5.93 59.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.967 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.52 113.24 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.17 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.231 -0.918 . . . . 0.0 110.172 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.23 154.95 97.17 Favored 'Cis proline' 0 C--N 1.32 -0.956 0 C-N-CA 121.697 -2.21 . . . . 0.0 111.727 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.0 -57.52 1.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.4 34.08 5.72 Favored Glycine 0 N--CA 1.5 2.931 0 C-N-CA 118.954 -1.593 . . . . 0.0 112.532 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.35 135.06 36.61 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.732 -1.451 . . . . 0.0 110.296 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.41 63.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.84 -38.81 86.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 109.498 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.09 -42.16 85.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.092 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.61 -42.08 98.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 109.524 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -45.14 94.57 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.472 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.22 -35.59 67.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.079 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.48 69.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.7 -45.42 85.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.419 -0.801 . . . . 0.0 109.904 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.02 12.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.418 -0.801 . . . . 0.0 110.181 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.53 70.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.684 -0.635 . . . . 0.0 110.734 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.16 -29.08 63.67 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 111.384 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.43 48.0 10.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.085 -1.01 . . . . 0.0 109.875 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.96 155.97 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.455 -0.778 . . . . 0.0 110.271 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.17 -31.99 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.116 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.18 140.55 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.674 . . . . 0.0 110.034 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.643 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.03 131.63 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.933 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.52 160.72 38.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.449 -0.782 . . . . 0.0 110.215 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.01 -120.8 1.98 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.6 t60 75.67 -34.28 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.884 -0.774 . . . . 0.0 111.611 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.6 p -87.95 -9.55 53.24 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.915 -1.115 . . . . 0.0 111.509 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.95 7.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.089 -1.007 . . . . 0.0 110.761 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.29 19.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.58 137.93 42.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.156 -0.965 . . . . 0.0 110.29 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.33 7.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.5 97.73 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.427 -0.796 . . . . 0.0 109.922 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -0.892 . . . . 0.0 111.082 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.15 145.43 37.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.449 -0.782 . . . . 0.0 110.305 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.6 117.54 7.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.97 58.04 5.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 111.44 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.36 6.29 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.808 -0.557 . . . . 0.0 112.373 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.836 -1.165 . . . . 0.0 109.805 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.95 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.0 111.231 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.06 134.27 53.44 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.08 135.99 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.983 . . . . 0.0 111.936 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.32 108.95 14.9 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -30.08 48.56 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.627 1.33 . . . . 0.0 111.444 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.89 -139.36 14.79 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.91 111.84 19.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -1.097 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.64 -20.58 49.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -0.906 . . . . 0.0 110.379 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.14 18.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.552 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.38 36.63 63.6 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.89 4.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.978 . . . . 0.0 110.758 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.18 46.19 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.67 0.748 . . . . 0.0 111.499 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.88 115.95 5.68 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.11 11.05 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.17 -28.84 48.33 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.592 -1.318 . . . . 0.0 112.349 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.18 116.28 22.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.98 -15.87 60.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.569 -0.707 . . . . 0.0 111.208 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.18 4.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 110.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.56 139.74 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.289 -0.882 . . . . 0.0 110.525 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.88 121.02 39.44 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.688 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.97 134.21 36.32 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.519 1.273 . . . . 0.0 109.592 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.5 p -167.62 154.71 8.38 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.994 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.745 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.3 p90 -137.07 160.26 39.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.53 137.03 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.0 113.352 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.813 HD11 HD12 ' B' ' 714' ' ' LEU . 18.6 mt -108.34 137.56 46.11 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.3 mtp -117.06 120.27 37.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 110.308 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -97.04 117.78 31.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.411 -0.806 . . . . 0.0 109.638 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 97.0 mt -114.4 123.62 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.195 -0.941 . . . . 0.0 111.124 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 -54.79 2.73 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.62 0.724 . . . . 0.0 109.309 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.91 106.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 60.02 9.94 2.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.805 . . . . 0.0 110.5 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.0 m -139.41 132.99 30.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 108.813 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.511 HG23 HG12 ' A' ' 155' ' ' ILE . 9.6 p -132.37 138.79 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.469 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.43 124.95 72.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.418 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.1 p -105.46 135.88 46.04 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.668 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.743 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.61 126.46 55.3 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.8 p -109.0 132.02 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.243 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.75 ' CE2' HD12 ' A' ' 152' ' ' LEU . 69.5 m-85 -111.3 113.11 25.35 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.35 -0.844 . . . . 0.0 109.904 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -108.13 139.7 42.41 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.688 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.6 tp -96.48 83.11 3.46 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.645 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.663 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.1 mt -100.68 119.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.8 -161.56 53.9 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -71.83 -44.23 64.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.113 -1.227 . . . . 0.0 110.791 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.57 157.36 33.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 110.863 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.556 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.68 128.63 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.663 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.13 147.54 23.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' B' ' 712' ' ' HIS . 8.7 p -132.38 140.66 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.936 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.7 tt0 -120.32 151.15 39.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.8 ttt-85 -115.89 127.04 54.7 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.087 -1.008 . . . . 0.0 111.585 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.39 132.96 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.24 141.23 48.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.0 -1.062 . . . . 0.0 111.513 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.2 t80 -139.38 141.59 37.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.682 -0.636 . . . . 0.0 109.965 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.02 146.92 41.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -50.57 144.36 8.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.608 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.176 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.62 149.95 68.44 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.752 1.396 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . 0.632 ' O ' HD23 ' B' ' 689' ' ' LEU . 7.4 tt 51.26 80.22 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -0.837 . . . . 0.0 110.383 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -145.7 95.64 0.17 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 50.5 m -121.32 147.86 45.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -1.063 . . . . 0.0 109.786 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.9 t -133.82 152.08 51.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -92.44 4.52 53.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 0.0 110.457 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.5 mt-10 -60.31 149.12 34.52 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.173 -0.954 . . . . 0.0 110.555 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 81.8 m-20 57.48 50.93 10.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.872 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.1 -37.22 71.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -107.7 134.46 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -112.49 168.14 9.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -81.41 108.41 14.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -36.74 85.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.436 -0.79 . . . . 0.0 110.313 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -169.63 -177.9 2.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 110.52 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . 0.485 HG22 ' H ' ' B' ' 703' ' ' VAL . 1.5 m -86.54 179.49 6.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.455 -0.778 . . . . 0.0 109.729 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.485 ' H ' HG22 ' B' ' 702' ' ' THR . 14.7 p -120.47 136.98 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 110.301 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 9.3 p -170.05 -75.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.512 -0.743 . . . . 0.0 109.867 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.08 83.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -0.828 . . . . 0.0 109.858 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -70.2 146.75 50.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 110.042 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.5 133.44 94.32 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.424 ' HB2' ' O ' ' B' ' 717' ' ' CYS . 42.9 Cg_endo -70.17 145.7 55.51 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.605 1.319 . . . . 0.0 110.595 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -60.88 145.21 51.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.89 . . . . 0.0 110.032 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -113.62 133.28 55.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.818 . . . . 0.0 111.354 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -102.42 -56.37 2.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.173 0.987 . . . . 0.0 108.633 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.4 p80 -143.82 -178.33 0.77 Allowed Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.2 Cg_endo -58.68 136.96 77.36 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 122.732 0.859 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.919 HD23 ' HE2' ' A' ' 30' ' ' LYS . 9.0 mt 72.24 42.49 0.56 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.539 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -136.04 80.44 1.83 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.425 -1.422 . . . . 0.0 109.214 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -84.41 18.33 2.28 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.139 0.971 . . . . 0.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.642 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 25.6 p -44.77 171.91 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.699 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -71.92 -55.73 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.339 1.704 . . . . 0.0 109.003 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 44.8 mttp -160.37 -14.52 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.8 m 55.38 27.01 9.39 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -89.28 159.23 45.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.674 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.33 143.67 53.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.803 1.423 . . . . 0.0 110.445 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 111.016 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -126.65 156.37 41.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 0.0 110.959 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -122.85 130.37 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.435 -0.79 . . . . 0.0 110.035 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . 0.762 ' C ' HD12 ' B' ' 727' ' ' LEU . 94.9 mtt-85 -132.19 142.38 49.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 110.309 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.762 HD12 ' C ' ' B' ' 726' ' ' ARG . 5.7 mp -138.1 72.13 1.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -152.0 157.59 41.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 0.0 110.226 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -118.53 123.86 46.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.157 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 61.5 t -139.89 89.51 11.36 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 0.0 110.156 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.99 -25.18 38.53 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.743 1.391 . . . . 0.0 110.636 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' B' ' 735' ' ' LEU . . . -74.14 134.29 42.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.339 -0.851 . . . . 0.0 110.005 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 50.2 m -126.41 150.96 48.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.573 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 91.71 10.37 61.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' B' ' 732' ' ' ALA . 50.1 mt -96.92 133.73 41.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.274 . . . . 0.0 110.1 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.99 -179.44 53.63 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.25 136.25 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -1.103 . . . . 0.0 110.2 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -130.38 -162.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.836 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.64 137.27 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 47.4 m -113.09 140.26 48.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 48.3 m -64.5 153.25 39.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.471 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -126.91 161.78 27.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.439 -0.788 . . . . 0.0 110.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -53.96 -38.46 65.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 110.567 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 61.08 -123.41 32.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 27.1 t -120.59 141.32 50.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 90.5 p -137.66 159.39 42.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.297 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -124.58 83.12 58.53 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.518 -0.989 . . . . 0.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.34 144.59 62.57 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.862 1.454 . . . . 0.0 110.363 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.94 111.89 23.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -74.24 -32.74 63.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 110.128 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 122.92 131.89 3.91 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 13.3 m -98.52 -12.38 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.165 -1.197 . . . . 0.0 111.228 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.23 139.17 45.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.063 -1.023 . . . . 0.0 109.959 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -146.05 103.98 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.521 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.487 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 43.9 ptt85 -122.96 152.71 40.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.397 -0.815 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.48 137.65 35.71 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.391 -1.324 . . . . 0.0 110.526 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' B' ' 713' ' ' PRO . 42.2 tp -93.74 132.52 38.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.668 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.2 t -119.44 138.06 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 58.9 tp -98.58 131.84 44.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.22 129.0 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.219 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.66 -176.19 3.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 0.0 109.732 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.06 -175.37 34.56 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.18 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.696 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.19 40.75 14.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.813 -0.816 . . . . 0.0 109.824 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.5 -35.69 65.67 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.04 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.7 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.18 136.85 19.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.879 . . . . 0.0 109.066 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 51.6 Cg_endo -98.48 25.36 19.59 Favored 'Cis proline' 0 C--N 1.316 -1.155 0 C-N-CA 123.76 -1.35 . . . . 0.0 110.121 -1.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -61.04 -47.97 83.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 111.921 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.82 4.81 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.015 -1.053 . . . . 0.0 111.072 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.0 m -133.66 158.39 43.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.99 -18.58 15.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.262 -0.899 . . . . 0.0 111.104 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.98 179.07 2.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.104 -0.998 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.62 162.68 67.47 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.4 144.25 90.45 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.307 1.162 . . . . 0.0 110.505 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.32 -56.88 6.94 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -57.62 -36.71 72.16 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.724 -1.235 . . . . 0.0 111.828 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.5 m-30 -64.04 -39.42 94.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.62 -37.27 70.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 108.74 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -69.58 -36.71 76.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 109.729 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.821 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -64.23 -40.47 96.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.178 -0.951 . . . . 0.0 110.212 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.861 HD23 HD13 ' B' ' 714' ' ' LEU . 92.6 mt -84.07 134.46 34.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.38 -0.825 . . . . 0.0 111.551 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 28' ' ' PRO . 7.7 p -150.84 144.12 16.95 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.759 -0.588 . . . . 0.0 109.619 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 27' ' ' VAL . 43.4 Cg_endo -69.62 150.57 69.26 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.487 1.257 . . . . 0.0 111.007 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -4.15 81.61 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.904 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.9 OUTLIER -109.84 -27.35 9.33 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 110.958 -179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HD11 ' B' ' 714' ' ' LEU . 74.5 mt -111.94 132.5 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.748 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -100.62 -22.42 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 110.66 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.8 m-70 -136.22 138.87 42.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.182 -0.948 . . . . 0.0 110.981 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.5 mt -129.61 123.34 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.757 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.05 128.82 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.026 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -118.99 129.66 55.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.167 -0.958 . . . . 0.0 110.393 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -102.85 -62.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.477 -0.765 . . . . 0.0 110.762 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.08 162.86 11.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.76 148.57 44.48 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.748 -0.854 . . . . 0.0 110.267 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.8 mt -55.13 -62.62 1.55 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 111.426 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.98 -21.61 16.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.806 -1.809 . . . . 0.0 110.076 -0.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.7 t -68.39 142.49 55.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.328 -0.857 . . . . 0.0 110.801 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.25 -28.24 66.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.436 -0.79 . . . . 0.0 110.499 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -51.45 -40.59 59.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.282 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.9 m -66.56 -34.57 78.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.66 -43.06 94.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.0 110.137 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.86 -40.4 88.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.42 -44.62 96.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.2 mt -62.72 -38.43 90.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.15 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.469 -0.769 . . . . 0.0 109.789 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.46 -43.39 97.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.372 -0.83 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.73 -36.67 83.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.586 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.08 35.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.243 -0.911 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.14 -43.52 13.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -86.06 110.07 19.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -1.149 . . . . 0.0 110.338 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.04 133.74 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.398 -0.813 . . . . 0.0 110.282 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.518 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -116.53 126.36 53.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 109.547 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.5 mt -130.86 150.19 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 111.409 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -119.1 155.13 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.09 130.59 40.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.205 . . . . 0.0 111.552 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.47 38.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.45 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.108 -1.231 . . . . 0.0 110.778 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.8 3.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.0 . . . . 0.0 111.148 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.02 35.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.148 -0.97 . . . . 0.0 110.399 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -45.99 70.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.256 -0.903 . . . . 0.0 110.115 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.27 119.66 19.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 0.0 110.111 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.53 -1.1 57.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.629 -0.669 . . . . 0.0 110.545 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -3.81 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.028 . . . . 0.0 111.296 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.407 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.04 147.75 80.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.93 -1.106 . . . . 0.0 109.46 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.47 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.841 1.443 . . . . 0.0 110.947 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.4 80.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.116 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.28 29.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.67 34.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.777 -1.202 . . . . 0.0 111.541 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.76 113.26 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.625 -0.672 . . . . 0.0 109.225 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.34 131.79 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.75 130.43 37.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.51 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.215 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.99 -119.29 5.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.23 -6.17 51.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -1.143 . . . . 0.0 110.905 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.81 137.34 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.065 -1.022 . . . . 0.0 113.2 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.58 18.64 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -108.04 140.54 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 112.127 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.19 16.3 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.78 27.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.907 -1.349 . . . . 0.0 111.906 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.63 149.03 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.5 -0.75 . . . . 0.0 109.505 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.92 -60.39 3.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.64 3.39 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.334 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.7 -17.34 55.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.918 -1.342 . . . . 0.0 110.056 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.67 -6.0 59.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.6 t -98.49 113.15 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.665 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.49 24.48 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.351 -0.843 . . . . 0.0 110.19 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.22 155.06 97.15 Favored 'Cis proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.755 -2.186 . . . . 0.0 111.722 -0.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.47 1.32 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.35 34.05 5.74 Favored Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.016 -1.564 . . . . 0.0 112.567 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.25 135.09 36.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.717 -1.461 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.88 -40.55 63.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.78 86.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.556 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -66.99 -42.16 85.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.321 -0.862 . . . . 0.0 109.124 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.08 97.93 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.419 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.19 94.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.542 -0.723 . . . . 0.0 109.464 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.62 67.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.96 -35.38 69.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.641 -0.662 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.85 -45.41 86.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.426 -0.796 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.0 -57.06 12.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.492 -0.755 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.74 -45.53 70.58 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.672 -0.643 . . . . 0.0 110.71 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.14 -29.02 63.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.414 -0.803 . . . . 0.0 111.432 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 47.98 10.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.148 -0.97 . . . . 0.0 109.939 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.92 155.99 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.472 -0.767 . . . . 0.0 110.292 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.2 -31.89 33.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.077 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.22 140.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.695 -0.628 . . . . 0.0 110.044 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.65 123.42 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.888 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -106.0 131.65 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.77 38.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.225 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.1 -120.77 1.97 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.67 -34.2 0.24 Allowed 'General case' 0 N--CA 1.509 2.515 0 O-C-N 121.888 -0.772 . . . . 0.0 111.595 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.8 p -88.03 -9.64 52.76 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.821 -1.174 . . . . 0.0 111.422 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.65 24.95 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.092 -1.005 . . . . 0.0 110.804 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -123.72 114.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.815 . . . . 0.0 109.243 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.56 137.95 42.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.03 -1.044 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.38 7.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.338 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.62 3.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.427 -0.795 . . . . 0.0 109.874 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.88 167.61 21.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.909 . . . . 0.0 111.014 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.48 37.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.545 -0.722 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.5 7.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.86 58.15 5.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 111.411 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.28 6.26 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.81 -0.556 . . . . 0.0 112.393 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.71 154.95 38.72 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.953 -1.092 . . . . 0.0 109.778 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.31 140.9 47.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 111.224 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -123.97 134.29 53.51 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.07 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.114 -0.991 . . . . 0.0 111.969 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.3 t-20 -131.45 108.94 14.74 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.02 -30.03 48.14 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.543 1.286 . . . . 0.0 111.454 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.94 -139.39 14.8 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.59 47.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.839 . . . . 0.0 110.428 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.11 18.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.54 63.87 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.946 . . . . 0.0 110.721 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.08 46.45 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.685 0.755 . . . . 0.0 111.482 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.85 115.96 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.24 11.45 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.07 -28.85 48.93 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.633 -1.292 . . . . 0.0 112.372 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.15 116.3 22.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.177 . . . . 0.0 109.885 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.05 -15.79 60.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.543 -0.723 . . . . 0.0 111.307 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.52 94.32 4.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.038 -1.039 . . . . 0.0 110.071 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.59 139.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.547 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.9 121.12 39.18 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.679 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.9 Cg_endo -65.82 133.83 35.29 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.446 1.235 . . . . 0.0 109.632 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 92.2 p -167.47 154.48 8.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 111.906 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.821 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.47 160.32 39.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.1 t -126.51 137.39 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.979 -1.076 . . . . 0.0 113.537 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.98 HD11 HD12 ' B' ' 714' ' ' LEU . 16.3 mt -108.64 138.56 44.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.8 mtp -118.18 119.37 34.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 110.336 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -97.11 117.44 31.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.424 -0.798 . . . . 0.0 109.529 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.572 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.5 mt -114.62 112.55 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.913 . . . . 0.0 111.412 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.1 OUTLIER -82.07 -41.18 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.86 -106.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.7 m -85.15 8.73 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.618 -1.302 . . . . 0.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.5 m -124.34 139.54 53.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.572 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.8 p -130.69 140.18 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.961 -1.087 . . . . 0.0 111.274 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.01 127.45 74.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.402 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.5 p -108.63 137.3 46.8 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.713 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.699 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -115.0 127.57 55.75 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.494 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -110.69 132.13 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.223 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.744 ' CE2' HD12 ' A' ' 152' ' ' LEU . 62.3 m-85 -111.62 113.21 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.282 -0.886 . . . . 0.0 109.897 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.21 138.75 42.81 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.439 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.679 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.4 tp -94.96 81.26 3.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.669 -0.813 . . . . 0.0 109.627 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.659 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.9 mt -98.93 118.42 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.29 -161.29 54.17 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -72.02 -44.48 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.25 . . . . 0.0 110.736 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.38 156.79 35.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.351 -0.843 . . . . 0.0 110.919 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 167' ' ' LEU . 54.7 t -104.47 128.88 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.516 -0.74 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.659 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.77 148.07 23.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.36 -0.838 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.4 p -131.53 140.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.918 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.78 150.14 41.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.499 -0.751 . . . . 0.0 109.387 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -115.45 126.92 54.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.035 -1.04 . . . . 0.0 111.693 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.21 132.69 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.07 141.17 48.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.979 -1.076 . . . . 0.0 111.491 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 160' ' ' VAL . 73.1 t80 -139.28 142.19 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.649 -0.657 . . . . 0.0 109.919 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.8 146.85 39.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.5 mttm -50.23 -34.38 22.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.306 -0.871 . . . . 0.0 110.613 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 -18.24 42.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.707 1.372 . . . . 0.0 110.646 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 94.8 mt -59.15 -38.14 78.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.212 -0.93 . . . . 0.0 110.352 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 80.43 -171.43 54.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 90.4 p -63.82 -30.38 71.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.19 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 48.2 p -124.64 158.11 33.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.95 143.04 57.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.898 . . . . 0.0 110.218 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -108.84 142.51 39.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.037 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -88.54 114.21 24.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 36.1 tp -172.68 -99.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.0 110.061 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' B' ' 697' ' ' GLU . 78.4 tt0 50.84 26.47 2.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.907 -1.121 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -84.38 -1.09 54.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.24 -0.913 . . . . 0.0 110.809 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.31 -36.86 81.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.02 -1.05 . . . . 0.0 110.296 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.94 143.17 50.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 110.264 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.5 p30 -100.22 169.62 9.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.7 m -117.29 138.88 51.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.9 t -118.05 141.34 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.467 -0.771 . . . . 0.0 109.785 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.3 m -101.59 140.16 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.342 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -165.86 164.44 18.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -59.61 143.53 50.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 0.0 109.989 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -70.41 113.92 21.98 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.37 145.69 48.73 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.634 1.334 . . . . 0.0 110.491 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -108.57 150.0 28.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 110.135 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -117.3 144.57 44.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.365 -0.834 . . . . 0.0 111.385 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.75 -58.33 2.29 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.266 1.031 . . . . 0.0 108.36 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.847 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.2 p80 -140.73 -179.02 0.9 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.847 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -58.54 135.59 68.57 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 122.664 0.823 . . . . 0.0 110.725 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 152' ' ' LEU . 10.2 mt 69.84 46.76 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.475 ' HB2' ' ND1' ' B' ' 712' ' ' HIS . 5.4 t -130.63 82.31 2.05 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.281 -1.512 . . . . 0.0 109.349 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.429 ' NE2' HG11 ' A' ' 27' ' ' VAL . 11.6 mp0 -85.32 18.64 2.58 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.086 0.946 . . . . 0.0 109.385 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.641 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.255 24.2 p -43.94 172.33 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.724 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.4 Cg_endo -69.87 -57.08 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.454 1.765 . . . . 0.0 108.84 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 4.3 mtmp? -159.67 -15.39 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.686 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 53.47 27.55 6.61 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.24 122.71 88.32 Favored Pre-proline 0 N--CA 1.488 1.441 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.814 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 154.14 35.57 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.867 1.456 . . . . 0.0 110.443 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -97.22 131.99 43.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.6 121.43 44.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -136.83 135.37 37.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -0.861 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -69.38 153.91 42.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.794 . . . . 0.0 109.922 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.1 mt -76.27 142.78 41.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -104.56 146.72 28.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -59.73 -34.46 72.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 110.539 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 730' ' ' VAL . 35.5 m -109.69 106.86 58.89 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.327 -0.858 . . . . 0.0 110.731 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' B' ' 730' ' ' VAL . 44.0 Cg_endo -70.17 160.26 50.2 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.642 1.338 . . . . 0.0 110.547 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.45 152.48 8.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.369 -0.832 . . . . 0.0 110.535 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 8.0 t -129.81 -163.89 1.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.478 -0.764 . . . . 0.0 110.29 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -52.24 164.44 1.5 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.7 tp -56.09 -40.41 73.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.305 -1.115 . . . . 0.0 110.641 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 51.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.77 130.89 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -1.132 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -90.57 -57.63 2.76 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.541 -0.724 . . . . 0.0 109.98 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.24 143.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 110.125 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 45.4 m -92.74 137.53 32.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.382 -0.824 . . . . 0.0 110.487 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . 0.465 ' O ' ' N ' ' B' ' 743' ' ' ASP . 5.4 t -148.94 -55.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.03 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' B' ' 741' ' ' SER . 62.9 tt0 61.61 -72.13 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.616 -0.678 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' B' ' 741' ' ' SER . 93.1 m-20 -55.25 -37.47 67.27 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.063 -1.023 . . . . 0.0 110.405 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -137.91 175.12 21.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.7 t -124.7 127.36 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -1.198 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.4 m -63.0 -34.61 77.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 83.1 t90 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.157 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 92.7 p -121.34 96.0 48.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.379 -1.071 . . . . 0.0 110.162 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.01 136.23 40.4 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.709 1.373 . . . . 0.0 110.6 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -63.71 -27.32 69.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.462 -0.774 . . . . 0.0 110.593 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -98.18 135.11 40.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.625 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -139.72 -117.03 1.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 45.3 m -118.46 138.09 52.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -1.117 . . . . 0.0 110.094 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -71.47 140.86 50.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 110.359 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -165.48 163.32 19.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -0.787 . . . . 0.0 109.949 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.5 ptt180 -121.65 147.66 45.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.913 . . . . 0.0 110.024 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.88 137.13 16.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.257 -0.902 . . . . 0.0 110.478 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 713' ' ' PRO . 27.5 tp -95.71 134.49 38.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.4 -0.812 . . . . 0.0 110.608 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.1 t -118.59 139.23 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.341 -0.849 . . . . 0.0 110.546 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.606 HD13 HD21 ' A' ' 152' ' ' LEU . 51.1 tp -97.57 131.59 44.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.02 128.7 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.407 -0.808 . . . . 0.0 110.272 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.56 -177.07 4.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.493 -0.754 . . . . 0.0 109.642 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.8 -175.04 35.16 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.164 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.693 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.07 40.75 14.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.775 -0.838 . . . . 0.0 109.816 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.52 -35.69 65.62 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.3 42.14 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.624 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.22 136.9 19.95 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 109.062 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.45 25.31 19.69 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.731 -1.362 . . . . 0.0 110.156 -1.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.95 -47.88 84.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 112.023 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.57 -21.79 4.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.973 -1.079 . . . . 0.0 111.052 -178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.6 m -133.71 158.34 43.53 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.125 -0.984 . . . . 0.0 110.227 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.62 15.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 111.061 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -174.04 178.99 2.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.12 -0.988 . . . . 0.0 110.569 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.65 67.69 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.52 144.73 90.94 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.329 1.173 . . . . 0.0 110.321 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.98 -56.25 9.47 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -58.02 -36.77 73.17 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.792 -1.193 . . . . 0.0 111.854 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.7 m-30 -63.27 -39.49 94.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 111.07 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -56.12 -37.72 69.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.121 -0.987 . . . . 0.0 108.803 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -69.82 -35.45 74.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.626 -0.671 . . . . 0.0 109.239 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' B' ' 714' ' ' LEU . 0.6 OUTLIER -66.36 -33.11 75.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.342 -0.848 . . . . 0.0 110.626 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.788 HD23 ' CD2' ' B' ' 714' ' ' LEU . 93.7 mt -93.74 131.51 39.01 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.133 -0.979 . . . . 0.0 111.011 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.0 m -148.42 148.39 28.53 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.46 -0.775 . . . . 0.0 110.015 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.73 149.2 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.531 1.28 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.75 -8.22 78.64 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.703 ' HE2' HD12 ' B' ' 714' ' ' LEU . 3.9 mmmt -105.09 -26.17 12.22 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.261 -1.141 . . . . 0.0 110.892 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 HD13 HD22 ' A' ' 4' ' ' LEU . 70.4 mt -114.23 132.4 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 110.946 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -100.48 -21.96 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.474 -0.767 . . . . 0.0 110.516 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.696 ' HB2' HG22 ' A' ' 3' ' ' VAL . 58.4 m-70 -136.56 139.24 42.04 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 0.0 110.95 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.8 123.21 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 110.879 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.26 128.86 55.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 108.992 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.2 t -118.79 129.62 55.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.501 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 HD21 ' A' ' 84' ' ' LEU . 71.2 p -102.52 -60.4 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.753 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -61.38 163.43 22.29 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.186 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -72.89 147.89 44.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.749 -0.854 . . . . 0.0 110.141 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -54.76 -62.29 1.75 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.231 -0.918 . . . . 0.0 111.53 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.592 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.4 p -98.9 -20.62 16.72 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.797 -1.814 . . . . 0.0 110.118 -1.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 45' ' ' SER . 11.4 t -69.01 142.9 54.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.248 -0.908 . . . . 0.0 110.871 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.6 tttt -59.75 -28.78 67.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.51 -40.65 60.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' HD22 ' A' ' 40' ' ' LEU . 59.4 m -66.4 -34.65 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -0.796 . . . . 0.0 109.855 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.5 t80 -59.92 -43.06 95.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.4 -0.813 . . . . 0.0 110.155 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.83 -40.13 87.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.49 -44.65 95.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 0.0 110.076 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 49' ' ' LEU . 77.8 mt -62.69 -38.87 92.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -62.23 -32.2 72.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.496 -0.752 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 m -62.8 -43.75 97.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.501 -0.749 . . . . 0.0 110.946 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.27 -36.74 84.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -0.927 . . . . 0.0 110.665 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.8 154.62 36.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.58 -43.26 12.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -86.33 110.33 19.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.319 -1.107 . . . . 0.0 110.265 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.17 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -0.85 . . . . 0.0 110.368 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.512 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.31 126.72 53.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -0.819 . . . . 0.0 109.5 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.1 151.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 111.446 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.1 m -120.45 156.28 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.05 130.75 39.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.806 -1.184 . . . . 0.0 111.749 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.58 -175.43 38.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.39 0.53 37.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.037 -1.272 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.73 3.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.048 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 133.05 35.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.146 -0.971 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.59 -46.12 70.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.219 -0.926 . . . . 0.0 110.082 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.64 19.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.633 -0.667 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.47 -1.14 57.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.489 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.52 -3.83 36.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 111.277 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.14 147.75 80.31 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.952 -1.093 . . . . 0.0 109.487 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.71 140.36 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.839 1.442 . . . . 0.0 110.923 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.4 80.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.59 150.36 29.44 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.72 34.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.85 -1.156 . . . . 0.0 111.534 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 109.226 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.84 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.84 130.51 37.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -0.836 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -121.56 86.8 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.242 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.22 5.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.3 -6.09 50.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.364 -1.08 . . . . 0.0 110.907 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.88 137.33 36.89 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.035 -1.04 . . . . 0.0 113.199 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.62 18.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.96 140.5 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 112.176 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.3 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.83 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.64 26.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.876 -1.367 . . . . 0.0 111.898 -179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.54 149.09 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.433 -0.792 . . . . 0.0 109.559 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.38 3.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.931 -1.105 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.6 3.41 Favored Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.8 -17.25 55.46 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.888 -1.36 . . . . 0.0 110.032 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.98 59.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.329 -0.857 . . . . 0.0 109.951 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.43 113.17 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.18 -0.95 . . . . 0.0 109.662 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.09 129.48 24.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.316 -0.865 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.26 155.05 97.21 Favored 'Cis proline' 0 C--N 1.319 -1.002 0 C-N-CA 121.703 -2.207 . . . . 0.0 111.717 -0.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.54 1.27 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.99 5.79 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.045 -1.55 . . . . 0.0 112.519 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.32 135.09 36.63 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.749 -1.442 . . . . 0.0 110.357 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.54 63.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.429 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.77 -38.81 86.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.538 -0.726 . . . . 0.0 109.517 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.0 m -67.0 -42.12 85.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.87 . . . . 0.0 109.176 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.66 -42.06 98.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.518 -0.739 . . . . 0.0 109.458 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.508 -0.745 . . . . 0.0 109.416 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.63 67.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.537 -0.727 . . . . 0.0 109.202 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.92 -35.36 69.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.59 -0.694 . . . . 0.0 109.746 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.8 -45.49 86.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.47 -0.769 . . . . 0.0 109.884 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 12.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 110.136 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.56 70.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.762 -0.586 . . . . 0.0 110.683 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.17 -28.96 63.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.377 -0.827 . . . . 0.0 111.366 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.26 48.09 10.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.224 -0.922 . . . . 0.0 109.992 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.99 155.93 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.484 -0.76 . . . . 0.0 110.27 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.07 -32.03 34.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.145 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.5 mt -129.17 140.57 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.43 42.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 109.779 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.98 131.61 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.17 -0.956 . . . . 0.0 109.973 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.52 160.7 38.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.424 -0.798 . . . . 0.0 110.17 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.97 -120.73 1.97 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.6 -34.24 0.24 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.96 -0.729 . . . . 0.0 111.618 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 p -87.91 -9.6 53.16 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.797 -1.189 . . . . 0.0 111.442 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.88 7.49 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.113 -0.992 . . . . 0.0 110.752 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.62 114.33 19.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 109.245 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.58 137.87 42.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.086 -1.009 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.91 122.41 7.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.345 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.55 97.64 3.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.507 -0.746 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.86 167.6 21.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.235 -0.915 . . . . 0.0 110.98 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.24 145.48 37.26 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.432 -0.792 . . . . 0.0 110.222 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.58 117.51 7.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.92 58.11 5.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.733 . . . . 0.0 111.414 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.22 15.35 6.31 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.841 -0.537 . . . . 0.0 112.349 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.92 38.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.824 -1.172 . . . . 0.0 109.81 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.7 t80 -113.38 141.01 47.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 111.16 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.08 134.28 53.43 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 136.08 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.937 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.47 108.95 14.72 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.96 -30.05 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.508 1.268 . . . . 0.0 111.483 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.9 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.85 111.75 19.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -1.112 . . . . 0.0 110.455 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.62 -20.52 48.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.52 13.07 18.75 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.174 -0.954 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.53 36.6 64.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.95 4.47 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.515 -0.991 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.13 46.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.792 0.806 . . . . 0.0 111.454 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.92 115.9 5.65 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.13 11.0 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.25 -28.7 47.84 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.619 -1.3 . . . . 0.0 112.302 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.27 116.26 22.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.858 -1.151 . . . . 0.0 109.909 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.87 60.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 111.236 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.5 94.24 4.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.58 139.7 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 110.606 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.91 121.08 39.27 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.713 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.3 Cg_endo -66.08 135.52 40.88 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.473 1.249 . . . . 0.0 109.688 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 80.5 p -167.58 154.56 8.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.712 -1.242 . . . . 0.0 112.3 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' CZ ' ' CD1' ' A' ' 165' ' ' TYR . 24.9 p90 -136.18 160.93 37.17 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 93.5 t -128.33 136.4 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.023 -1.048 . . . . 0.0 113.432 -177.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.05 HD11 HD22 ' B' ' 714' ' ' LEU . 82.1 mt -106.84 135.45 48.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.83 115.31 26.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -95.13 117.76 30.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.76 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.542 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -114.05 125.23 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 111.174 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -55.36 2.62 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.609 0.719 . . . . 0.0 109.371 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.93 107.96 0.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 m 59.82 9.49 1.7 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.293 -0.879 . . . . 0.0 110.57 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.2 m -139.05 133.0 31.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.918 . . . . 0.0 108.814 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.542 HG23 HG12 ' A' ' 155' ' ' ILE . 9.8 p -131.47 139.1 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 111.532 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.29 125.01 73.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.9 p -105.77 134.77 48.35 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.653 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.68 127.6 56.1 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.2 p -112.66 133.24 59.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 109.695 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.625 ' OH ' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.18 116.84 31.75 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.349 -0.844 . . . . 0.0 109.774 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -108.86 136.32 48.6 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 109.39 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 45.3 tp -91.69 72.77 5.85 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.469 -0.769 . . . . 0.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.69 HD12 ' HD2' ' A' ' 173' ' ' LYS . 72.1 mt -91.53 117.34 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.37 -162.04 54.48 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -71.59 -43.99 65.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.184 -1.186 . . . . 0.0 110.779 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' B' ' 723' ' ' ALA . 89.5 m-20 -76.11 157.66 32.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.314 -0.866 . . . . 0.0 110.955 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 167' ' ' LEU . 52.5 t -104.56 128.76 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.437 -0.79 . . . . 0.0 109.651 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.69 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.4 mttt -96.74 147.77 23.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 10.7 p -130.54 139.7 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.894 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.6 tt0 -120.42 149.85 41.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.302 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -115.77 126.66 54.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 111.752 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.2 132.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -114.89 141.14 48.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.7 t80 -139.18 141.91 37.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.678 -0.639 . . . . 0.0 110.009 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.35 146.86 40.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 110.193 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -50.51 144.32 7.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.301 -0.874 . . . . 0.0 110.633 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.176 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.6 -30.2 28.82 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.712 1.375 . . . . 0.0 110.296 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.71 -31.64 70.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.456 -0.777 . . . . 0.0 110.208 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 111.1 3.45 27.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 45.7 m -117.33 150.02 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . 0.548 HG22 ' H ' ' B' ' 694' ' ' GLU . 24.7 m -108.5 132.53 53.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.601 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.0 -18.33 64.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.556 -0.715 . . . . 0.0 110.49 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.548 ' H ' HG22 ' B' ' 692' ' ' THR . 97.2 mt-10 -54.56 -30.82 55.26 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.303 -0.873 . . . . 0.0 110.618 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -62.83 135.59 57.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 109.805 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.9 tp -105.64 130.69 53.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.816 . . . . 0.0 110.525 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.6 143.87 55.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 110.089 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . 0.507 ' OD2' HG23 ' B' ' 703' ' ' VAL . 50.1 p30 -76.43 175.85 8.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.354 -0.841 . . . . 0.0 110.522 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -61.15 155.12 21.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.389 -0.819 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.16 -33.55 53.03 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.204 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.77 169.74 10.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 110.035 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 35.3 m 50.66 59.32 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.253 -0.904 . . . . 0.0 110.476 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.507 HG23 ' OD2' ' B' ' 698' ' ' ASP . 12.3 p -125.7 147.05 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.297 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.5 m -109.36 146.53 34.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.197 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.14 77.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 110.965 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -146.22 159.67 43.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.0 169.82 7.49 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.575 -0.703 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.12 132.9 10.67 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.683 1.36 . . . . 0.0 111.088 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -127.54 152.12 48.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.361 -0.837 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -105.42 132.32 51.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.306 -0.872 . . . . 0.0 111.716 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' B' ' 720' ' ' CYS . 75.5 m -80.56 -43.09 21.21 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.345 1.069 . . . . 0.0 109.367 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.2 OUTLIER -172.22 -174.13 0.26 Allowed Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.4 Cg_endo -59.24 138.47 84.99 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 N-CA-C 108.456 -1.401 . . . . 0.0 108.456 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.05 HD22 HD11 ' A' ' 152' ' ' LEU . 10.4 mp 66.23 63.06 0.56 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.578 -0.701 . . . . 0.0 111.263 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 86.06 3.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.125 -0.985 . . . . 0.0 109.164 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.438 ' OE1' HD23 ' A' ' 25' ' ' LEU . 25.9 mp0 -96.02 7.83 45.34 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.08 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.91 144.14 54.81 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.91 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.26 -55.21 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 125.069 2.089 . . . . 0.0 113.784 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.47 -11.52 48.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.406 ' HB3' ' SG ' ' B' ' 711' ' ' CYS . 98.4 m 49.37 29.13 2.64 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -117.72 152.53 49.96 Favored Pre-proline 0 N--CA 1.485 1.296 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.278 -177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.12 148.01 30.57 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.938 1.493 . . . . 0.0 110.186 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . . . -114.12 20.67 15.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.662 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -123.55 156.29 35.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.964 . . . . 0.0 110.722 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -84.7 154.25 22.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 110.177 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -60.56 143.09 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.38 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 71.5 mt -107.83 139.78 41.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.395 -0.816 . . . . 0.0 110.265 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.91 -68.76 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.155 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -129.71 131.49 46.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.0 109.567 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.606 ' O ' HG13 ' B' ' 730' ' ' VAL . 7.2 p -127.81 79.17 74.05 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 111.122 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.1 148.15 49.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.634 1.334 . . . . 0.0 110.129 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.94 71.55 10.26 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 22.9 m -59.89 -36.51 77.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.409 -0.807 . . . . 0.0 110.967 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -103.36 118.46 6.06 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.337 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -114.64 129.32 56.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.4 -1.059 . . . . 0.0 109.877 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.11 8.32 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.22 -38.29 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.407 -1.055 . . . . 0.0 110.487 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -90.89 121.78 33.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.184 -0.947 . . . . 0.0 110.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.1 t -118.69 135.36 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.259 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 41.8 p -122.57 165.64 16.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 0.0 109.715 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 69.1 m -106.02 124.74 50.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -69.22 -34.91 75.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -83.63 121.25 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.251 -0.905 . . . . 0.0 110.992 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.92 -146.86 15.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.3 m -114.18 145.61 41.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.28 -1.13 . . . . 0.0 110.181 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' B' ' 747' ' ' TRP . 23.0 m -59.43 -36.9 76.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . 0.425 ' CG ' ' O ' ' B' ' 746' ' ' SER . 99.3 m95 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.221 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 20.7 t -103.52 113.83 65.31 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.364 -1.08 . . . . 0.0 110.12 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.61 54.3 3.88 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.58 1.306 . . . . 0.0 110.85 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -125.58 142.1 51.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -62.9 -31.63 72.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -0.819 . . . . 0.0 110.172 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 124.41 40.12 0.45 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 37.9 m -57.39 -37.15 72.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -1.108 . . . . 0.0 110.237 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . 0.409 ' O ' ' OE1' ' A' ' 156' ' ' GLN . 55.7 ttt85 -55.39 -34.34 64.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.452 -0.78 . . . . 0.0 110.562 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -80.01 147.08 31.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.459 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 37.7 ptt-85 -117.84 152.04 36.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.368 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.21 136.38 51.96 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.538 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.3 tp -92.29 131.11 37.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.413 -0.804 . . . . 0.0 110.456 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.2 t -118.34 138.8 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.316 -0.865 . . . . 0.0 110.451 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.2 tp -99.09 132.08 44.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -0.803 . . . . 0.0 110.494 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.41 128.6 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.246 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.12 -175.02 3.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 155.77 -175.16 33.68 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.656 ' N ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.35 40.69 13.92 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.716 0.77 . . . . 0.0 109.917 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.5 mt -73.46 -35.77 65.78 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.17 30.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.596 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.33 136.84 19.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.366 -0.834 . . . . 0.0 108.995 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.51 25.34 19.58 Favored 'Cis proline' 0 C--N 1.316 -1.133 0 C-N-CA 123.777 -1.343 . . . . 0.0 110.212 -1.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.97 -48.01 83.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.244 -0.91 . . . . 0.0 111.962 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.4 -21.92 4.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.6 158.36 43.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.063 -1.023 . . . . 0.0 110.18 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.91 -18.66 15.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.266 -0.896 . . . . 0.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.055 -1.028 . . . . 0.0 110.628 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.59 162.72 67.38 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.51 144.88 91.34 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.338 1.178 . . . . 0.0 110.458 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.39 -57.35 6.18 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -57.51 -37.22 72.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.777 -1.202 . . . . 0.0 111.916 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.72 -39.56 94.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.89 -1.132 . . . . 0.0 111.128 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.41 -37.06 69.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 108.805 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.51 -35.91 75.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 109.675 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -65.42 -40.8 93.78 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.304 -0.872 . . . . 0.0 110.237 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.835 HD23 HD23 ' B' ' 714' ' ' LEU . 91.0 mt -83.42 133.37 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.12 -0.987 . . . . 0.0 111.5 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -149.23 146.48 21.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.682 -0.636 . . . . 0.0 110.054 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.64 147.82 51.96 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.537 1.282 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.17 -10.61 73.29 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -103.39 -25.1 13.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.291 -1.123 . . . . 0.0 110.989 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.749 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.82 132.18 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.865 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -100.95 -22.18 14.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 110.544 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -136.54 138.55 41.43 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.261 -0.899 . . . . 0.0 110.898 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.28 123.07 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.406 -0.809 . . . . 0.0 110.766 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.6 mt -109.96 128.31 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 108.829 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -118.96 129.09 54.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -0.972 . . . . 0.0 110.621 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.764 HG22 ' CD2' ' A' ' 84' ' ' LEU . 58.4 p -102.55 -65.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.587 -0.696 . . . . 0.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.779 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -54.49 161.24 4.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB3' ' HA3' ' A' ' 61' ' ' GLY . 9.7 p30 -72.21 149.21 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.592 -0.946 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.5 mt -56.01 -63.05 1.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.788 . . . . 0.0 111.466 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -99.18 -21.28 16.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.743 -1.848 . . . . 0.0 110.143 -0.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -68.58 143.43 54.88 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.329 -0.857 . . . . 0.0 110.965 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.86 -28.24 67.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.563 -0.71 . . . . 0.0 110.124 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.52 -41.0 60.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.296 -0.877 . . . . 0.0 110.251 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.0 m -66.56 -34.53 78.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.874 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -59.64 -42.95 93.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.038 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -60.19 -40.26 89.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.337 -0.852 . . . . 0.0 109.655 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -62.5 -44.81 95.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 110.046 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.7 mt -62.56 -38.63 90.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.232 -0.917 . . . . 0.0 110.101 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -62.19 -32.64 73.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.748 . . . . 0.0 109.736 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -63.5 -43.41 97.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.71 -36.47 83.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.186 -0.946 . . . . 0.0 110.585 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.38 154.36 35.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.3 -43.66 12.67 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -86.18 109.95 19.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -1.144 . . . . 0.0 110.343 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.83 133.61 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.0 110.198 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.2 m-70 -116.25 124.96 51.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 109.5 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.2 mt -130.38 149.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 111.378 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 84' ' ' LEU . 28.9 m -116.95 151.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.65 130.69 42.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.796 -1.19 . . . . 0.0 111.139 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 39' ' ' ASN . . . -94.28 -175.48 39.03 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.3 0.53 36.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.195 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.9 25.83 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.002 . . . . 0.0 111.111 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 132.95 35.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 0.0 110.357 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.59 -46.1 70.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.237 -0.914 . . . . 0.0 110.044 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.26 119.76 19.81 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.45 0.643 . . . . 0.0 110.118 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.52 -1.12 57.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.59 -0.693 . . . . 0.0 110.612 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.79 36.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.06 -1.025 . . . . 0.0 111.29 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.449 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.08 147.76 80.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.076 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.64 140.37 21.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.946 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.7 -39.32 80.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.922 . . . . 0.0 109.224 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.72 150.31 29.3 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.73 34.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.824 -1.173 . . . . 0.0 111.525 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.38 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.605 -0.684 . . . . 0.0 109.18 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.42 131.79 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.328 -0.858 . . . . 0.0 110.181 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.77 130.49 37.54 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.949 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -121.56 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.189 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.23 5.01 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.3 -6.2 50.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.21 -1.17 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.78 137.24 36.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.056 -1.028 . . . . 0.0 113.262 -177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.23 107.5 18.52 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.89 140.52 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.942 . . . . 0.0 112.18 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.23 16.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.764 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.15 131.71 27.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.881 -1.364 . . . . 0.0 111.918 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.09 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.483 -0.761 . . . . 0.0 109.532 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.779 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.4 t-80 -60.95 -60.26 4.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.868 -1.145 . . . . 0.0 110.494 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.9 -26.65 3.41 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.349 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.8 p-80 -61.7 -17.35 55.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.977 -1.307 . . . . 0.0 110.067 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.97 59.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.893 . . . . 0.0 109.999 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.41 113.14 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.14 129.43 24.56 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.25 -0.907 . . . . 0.0 110.236 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.33 155.01 97.34 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.758 -2.184 . . . . 0.0 111.659 0.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.07 -57.5 1.27 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.37 34.07 5.72 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 118.966 -1.588 . . . . 0.0 112.518 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.1 36.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.764 -1.433 . . . . 0.0 110.284 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.82 -40.53 63.28 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.495 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.82 86.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.545 -0.722 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.07 -42.05 85.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.157 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.6 mt -63.73 -42.11 97.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 109.364 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.18 94.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.21 -35.5 67.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.97 -35.39 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.514 -0.741 . . . . 0.0 109.732 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.79 -45.42 86.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.765 . . . . 0.0 109.858 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.08 -57.09 12.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.367 -0.833 . . . . 0.0 110.059 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.48 70.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.666 -0.646 . . . . 0.0 110.71 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.18 -28.99 63.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.447 -0.783 . . . . 0.0 111.407 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.05 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.113 -0.992 . . . . 0.0 109.933 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.484 -0.76 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -81.12 -31.99 33.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.22 140.52 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 110.019 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.59 123.38 42.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 109.863 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.657 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.99 131.62 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.153 -0.967 . . . . 0.0 110.018 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.5 160.7 38.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -0.844 . . . . 0.0 110.218 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.02 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.19 0.24 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.984 -0.715 . . . . 0.0 111.656 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.94 -9.62 53.02 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.828 -1.17 . . . . 0.0 111.451 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.67 25.0 7.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.055 -1.028 . . . . 0.0 110.753 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.68 114.19 19.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.262 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 39.9 t80 -54.54 137.96 41.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.035 . . . . 0.0 110.251 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.95 122.3 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.44 97.67 3.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.6 21.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.307 -0.87 . . . . 0.0 111.069 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.16 145.45 37.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.526 -0.734 . . . . 0.0 110.327 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.56 117.48 7.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.9 58.11 5.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.567 -0.708 . . . . 0.0 111.425 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.31 15.22 6.3 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.783 -0.573 . . . . 0.0 112.329 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.88 38.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.912 -1.117 . . . . 0.0 109.889 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.34 140.92 47.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 111.217 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.03 134.27 53.46 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.06 135.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 111.913 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 40.8 Cg_endo -66.03 -30.01 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.53 1.279 . . . . 0.0 111.492 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.43 14.82 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.83 111.7 19.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -1.098 . . . . 0.0 110.512 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.67 47.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.419 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.7 p -113.49 13.14 18.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.161 -0.962 . . . . 0.0 110.587 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.6 63.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.91 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.551 -0.97 . . . . 0.0 110.814 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.84 151.11 46.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.751 0.786 . . . . 0.0 111.409 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.82 115.94 5.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.17 11.3 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.19 -28.68 48.17 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.569 -1.332 . . . . 0.0 112.361 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.28 116.26 22.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.821 -1.174 . . . . 0.0 109.829 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.81 60.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.433 -0.792 . . . . 0.0 111.296 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.56 94.15 4.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.993 -1.067 . . . . 0.0 110.023 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.57 139.7 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.314 -0.866 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.1 mt -112.91 121.12 39.18 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.622 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.1 Cg_endo -66.0 134.02 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.439 1.231 . . . . 0.0 109.563 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.419 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 92.9 p -167.35 154.96 8.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.631 -1.293 . . . . 0.0 112.134 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.863 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 25.5 p90 -137.96 161.54 36.42 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.6 136.13 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.038 -1.039 . . . . 0.0 113.567 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.055 HD11 HD22 ' B' ' 714' ' ' LEU . 21.0 mt -106.48 134.63 49.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.6 mtp -114.29 120.76 41.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.903 -1.123 . . . . 0.0 110.257 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -98.56 117.93 34.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.364 -0.835 . . . . 0.0 109.669 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 160' ' ' VAL . 96.6 mt -115.07 124.22 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.212 -0.93 . . . . 0.0 111.048 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.65 -55.09 2.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.62 107.43 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.0 m 59.99 9.62 1.85 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.276 -0.89 . . . . 0.0 110.474 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 68.8 m -139.28 132.74 30.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 108.84 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 155' ' ' ILE . 10.0 p -131.87 138.74 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.92 -1.112 . . . . 0.0 111.488 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.08 124.76 72.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.428 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.4 p -105.03 135.85 45.6 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.732 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.86 125.7 54.36 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -109.29 132.55 57.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.797 ' CE2' HD12 ' A' ' 152' ' ' LEU . 63.5 m-85 -111.43 113.04 25.22 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.731 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -107.76 138.61 43.68 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.635 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 42.8 tp -95.71 94.45 7.71 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.358 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.782 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.8 mt -109.28 125.69 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.07 -131.15 33.28 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -100.22 -48.78 4.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -1.155 . . . . 0.0 110.301 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -71.2 156.95 38.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.414 -0.804 . . . . 0.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 167' ' ' LEU . 48.9 t -102.18 128.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.782 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -96.69 146.93 24.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.494 HG21 ' CD2' ' B' ' 712' ' ' HIS . 10.6 p -131.53 140.32 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.889 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.3 tt0 -120.03 149.99 41.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.531 -0.731 . . . . 0.0 109.359 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -115.32 126.62 54.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.105 -0.997 . . . . 0.0 111.739 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.07 132.26 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -114.82 141.23 48.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.962 -1.086 . . . . 0.0 111.463 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.408 ' O ' HG12 ' A' ' 160' ' ' VAL . 69.9 t80 -139.35 141.72 37.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.714 -0.616 . . . . 0.0 109.906 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.33 146.65 40.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.8 mttm -50.02 -34.59 21.76 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.641 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.92 150.62 73.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.756 1.398 . . . . 0.0 110.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 82.9 mt -59.55 -35.28 73.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.397 -0.814 . . . . 0.0 110.168 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -135.6 159.19 24.08 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 86.5 p -64.21 -31.03 72.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -1.077 . . . . 0.0 110.304 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 m -126.42 138.27 53.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.838 . . . . 0.0 110.31 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.73 139.9 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.853 . . . . 0.0 109.962 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.19 -88.73 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.569 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -105.81 18.44 22.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.552 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.99 -36.22 70.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.291 -0.88 . . . . 0.0 110.528 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.4 143.1 56.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.252 -0.905 . . . . 0.0 109.919 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -166.53 -151.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.222 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -54.4 167.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.286 -0.884 . . . . 0.0 110.475 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -55.03 138.57 43.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.425 -0.797 . . . . 0.0 110.25 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -63.99 -35.17 79.82 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.372 -0.83 . . . . 0.0 111.012 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 34.7 m -90.66 143.31 26.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 110.558 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.699 HG23 ' H ' ' B' ' 706' ' ' ALA . 34.9 m -125.63 154.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.467 -0.77 . . . . 0.0 110.208 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 25.7 m -59.64 -36.04 75.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.429 -0.795 . . . . 0.0 111.012 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.88 -57.09 11.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.396 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . 0.699 ' H ' HG23 ' B' ' 703' ' ' VAL . . . 46.43 26.14 0.46 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.486 -0.759 . . . . 0.0 111.298 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.46 148.09 21.55 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.03 -1.044 . . . . 0.0 110.797 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.67 158.28 47.34 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.852 1.449 . . . . 0.0 110.623 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.07 152.78 24.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.667 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -100.74 142.0 32.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.414 -0.804 . . . . 0.0 111.849 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 37.4 m -74.57 -43.73 54.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.02 0.915 . . . . 0.0 108.911 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.805 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -167.14 -179.94 0.88 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.805 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.9 Cg_endo -58.88 141.48 98.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 122.865 0.929 . . . . 0.0 109.881 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.055 HD22 HD11 ' A' ' 152' ' ' LEU . 1.6 mp 68.34 44.92 1.26 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.587 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.66 79.34 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.243 -1.536 . . . . 0.0 109.153 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -83.93 18.99 1.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.027 0.918 . . . . 0.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.62 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 24.5 p -44.12 171.33 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.797 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.743 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.72 -56.12 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.468 1.772 . . . . 0.0 108.833 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 23.6 mttp -160.18 -15.28 0.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.693 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 54.38 26.76 7.33 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -88.05 137.18 31.46 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.557 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.22 148.22 55.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.662 1.349 . . . . 0.0 110.399 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -84.42 129.35 34.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.149 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -121.41 144.38 48.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.329 -0.857 . . . . 0.0 110.292 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 726' ' ' ARG . 98.4 mttt -132.14 111.47 11.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 110.105 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' B' ' 725' ' ' LYS . 66.9 mtm180 52.56 165.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.473 -0.767 . . . . 0.0 111.123 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.51 -36.13 82.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.145 -0.972 . . . . 0.0 110.911 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.72 157.15 43.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.994 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -115.84 134.74 54.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.577 -0.702 . . . . 0.0 109.815 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 730' ' ' VAL . 35.9 m -62.36 112.1 5.85 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.298 -0.876 . . . . 0.0 110.351 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.42 ' HG3' ' HA3' ' B' ' 736' ' ' GLY . 49.1 Cg_endo -75.66 144.42 28.12 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.646 1.34 . . . . 0.0 110.419 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.81 85.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.722 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.3 t -153.71 152.74 31.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.523 -0.736 . . . . 0.0 110.17 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 96.61 168.37 33.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.26 -35.8 81.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.38 -1.071 . . . . 0.0 110.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' B' ' 731' ' ' PRO . . . 100.43 78.02 1.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.12 163.08 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -1.031 . . . . 0.0 110.334 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -82.92 129.28 35.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.029 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . 0.489 HG13 ' N ' ' B' ' 740' ' ' THR . 14.2 p -61.23 -39.91 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.39 -0.819 . . . . 0.0 110.686 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . 0.489 ' N ' HG13 ' B' ' 739' ' ' VAL . 46.7 m -131.04 137.42 49.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.898 . . . . 0.0 110.262 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 36.3 t -165.39 24.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.691 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -122.29 140.91 52.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 0.0 110.462 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -137.65 160.17 39.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.432 -0.792 . . . . 0.0 109.971 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -159.87 53.97 0.35 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 83.7 p -62.6 -26.99 68.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -1.078 . . . . 0.0 110.409 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 91.3 p -121.45 156.82 31.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.248 -0.907 . . . . 0.0 110.405 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 86.5 m95 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' -7' ' ' PRO . 0.3 OUTLIER -51.59 -55.28 30.93 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.374 -1.074 . . . . 0.0 110.707 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' -8' ' ' SER . 42.8 Cg_endo -70.28 145.04 53.04 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.597 1.314 . . . . 0.0 110.57 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -113.72 168.35 9.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.163 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -55.28 -36.05 65.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 110.454 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 84.61 20.29 58.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 56.4 m -120.72 143.13 48.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 109.943 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -59.79 138.75 57.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 110.069 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -108.65 149.39 29.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -0.832 . . . . 0.0 110.263 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 58.2 ttp180 50.46 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.439 -0.788 . . . . 0.0 110.929 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.19 137.56 53.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.982 -1.073 . . . . 0.0 110.478 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' B' ' 713' ' ' PRO . 45.9 tp -92.92 131.05 38.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.537 -0.727 . . . . 0.0 110.658 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -118.65 138.35 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.0 tp -99.46 131.06 45.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.545 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -122.92 128.79 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 110.247 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -163.95 -178.27 5.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.5 -0.75 . . . . 0.0 109.696 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.44 -175.53 36.32 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.41 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.723 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.7 m-20 60.66 40.82 15.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.833 -0.804 . . . . 0.0 109.957 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.51 -35.73 65.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.39 41.99 30.53 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.14 136.97 19.97 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.03 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.43 25.34 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.143 0 C-N-CA 123.719 -1.367 . . . . 0.0 110.165 -1.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.87 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.322 -0.861 . . . . 0.0 111.988 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.41 -21.81 4.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.032 -1.043 . . . . 0.0 111.003 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.71 158.38 43.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.116 -0.99 . . . . 0.0 110.188 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.77 15.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 111.074 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.72 67.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.5 Cg_endo -63.34 144.33 90.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.278 1.146 . . . . 0.0 110.437 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.76 -55.6 11.02 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -57.98 -36.67 72.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.712 -1.243 . . . . 0.0 111.701 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.559 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.95 -40.2 95.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.49 -38.32 71.58 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.812 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -68.73 -35.91 77.74 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.672 -0.642 . . . . 0.0 109.473 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.856 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.4 OUTLIER -64.74 -41.95 95.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.841 . . . . 0.0 110.165 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.853 HD23 HD13 ' B' ' 714' ' ' LEU . 93.7 mt -83.67 135.1 34.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.214 -0.928 . . . . 0.0 111.834 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 26' ' ' LEU . 29.7 m -150.72 147.15 20.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.631 -0.668 . . . . 0.0 109.861 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.53 150.61 57.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.443 1.233 . . . . 0.0 111.027 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.44 -4.39 82.39 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.947 ' HE2' HD23 ' B' ' 714' ' ' LEU . 0.7 OUTLIER -110.02 -26.82 9.52 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.294 -1.121 . . . . 0.0 110.948 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.508 HD11 HD11 ' B' ' 714' ' ' LEU . 70.4 mt -112.35 132.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.738 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -101.22 -20.54 15.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.497 -0.752 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.2 m-70 -137.73 138.69 39.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -0.996 . . . . 0.0 111.084 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.6 mt -129.83 123.8 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.74 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.83 129.05 55.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.0 109.072 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -117.93 129.84 55.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.233 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.866 HG22 HD21 ' A' ' 84' ' ' LEU . 75.1 p -102.58 -54.76 2.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.444 -0.785 . . . . 0.0 111.175 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -68.61 167.56 44.43 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.34 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -75.56 146.61 40.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.795 -0.827 . . . . 0.0 110.051 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.1 mt -54.07 -61.54 2.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.373 -0.83 . . . . 0.0 111.383 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 29.0 p -98.54 -19.34 17.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 119.811 -1.806 . . . . 0.0 110.024 -1.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.9 t -69.74 142.89 53.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.838 . . . . 0.0 110.761 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.74 -27.7 66.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.505 -0.747 . . . . 0.0 110.196 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.75 -41.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.239 -0.913 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' HD22 ' A' ' 40' ' ' LEU . 69.0 m -66.5 -34.62 78.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.56 -42.91 93.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -40.11 88.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.576 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.56 -44.98 94.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 110.051 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.0 mt -62.59 -38.43 90.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.141 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.3 -32.52 73.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.43 -0.794 . . . . 0.0 109.739 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.0 m -63.5 -43.38 97.39 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.99 -36.58 84.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.256 -0.903 . . . . 0.0 110.546 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.11 154.23 35.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.217 -0.927 . . . . 0.0 110.469 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.14 13.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -86.86 110.15 19.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -1.158 . . . . 0.0 110.332 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.99 134.51 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.352 -0.843 . . . . 0.0 110.398 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.1 m-70 -117.21 127.57 54.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.66 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.0 mt -131.04 151.01 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.437 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -121.0 159.05 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -78.05 130.66 36.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.771 -1.206 . . . . 0.0 112.074 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.7 -175.46 38.4 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.066 -1.255 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.79 3.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.218 -0.927 . . . . 0.0 111.153 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.35 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.099 -1.001 . . . . 0.0 110.36 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.63 -46.02 70.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.34 119.72 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.692 . . . . 0.0 110.137 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.23 57.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 110.527 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.54 -3.81 36.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 111.274 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.16 147.78 80.29 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.113 . . . . 0.0 109.501 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.64 140.34 21.03 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.894 1.47 . . . . 0.0 110.882 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.35 80.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.283 -0.886 . . . . 0.0 109.185 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.37 29.35 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.61 147.67 34.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.853 -1.154 . . . . 0.0 111.575 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.43 131.84 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.76 130.48 37.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.977 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.2 t -121.56 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.175 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.13 4.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.56 50.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.807 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.37 137.35 36.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.978 -1.076 . . . . 0.0 113.352 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.33 107.49 18.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.95 140.52 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 112.181 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.28 16.26 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.866 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.74 27.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.902 -1.352 . . . . 0.0 111.903 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.09 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.756 . . . . 0.0 109.564 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.37 3.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.848 -1.157 . . . . 0.0 110.542 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.7 3.38 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.24 55.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.95 -1.324 . . . . 0.0 110.131 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.76 -6.05 59.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.296 -0.878 . . . . 0.0 109.898 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.38 113.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.975 . . . . 0.0 109.72 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.55 24.45 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.122 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.9 Cg_endo -71.27 155.03 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.931 0 C-N-CA 121.673 -2.219 . . . . 0.0 111.668 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.08 -57.46 1.28 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.44 34.1 5.7 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 118.951 -1.595 . . . . 0.0 112.495 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.33 135.06 36.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.775 -1.426 . . . . 0.0 110.355 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.85 -40.53 63.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.885 . . . . 0.0 109.435 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.81 86.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.499 -0.751 . . . . 0.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.06 -42.09 85.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.852 . . . . 0.0 109.11 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.69 -42.13 98.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.494 -0.754 . . . . 0.0 109.453 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.22 94.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.66 67.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.48 -0.763 . . . . 0.0 109.116 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.91 -35.38 69.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.581 -0.7 . . . . 0.0 109.757 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.78 -45.42 86.04 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 109.903 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.05 -56.93 13.35 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.405 -0.81 . . . . 0.0 110.233 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -53.91 -45.38 71.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.692 -0.63 . . . . 0.0 110.668 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.02 63.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.401 -0.812 . . . . 0.0 111.387 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.33 48.01 10.65 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.049 -1.032 . . . . 0.0 109.958 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.92 155.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.486 -0.759 . . . . 0.0 110.328 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.2 -32.01 33.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.418 -0.801 . . . . 0.0 109.029 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.16 140.54 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.628 . . . . 0.0 110.079 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.61 123.32 42.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.904 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.533 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -105.97 131.66 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.23 -0.919 . . . . 0.0 109.974 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.79 38.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.329 -0.857 . . . . 0.0 110.234 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.12 -120.73 1.96 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.55 -34.16 0.24 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 121.902 -0.764 . . . . 0.0 111.668 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.5 p -87.95 -9.6 53.08 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.786 -1.196 . . . . 0.0 111.42 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.61 24.98 7.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.103 -0.998 . . . . 0.0 110.801 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.69 114.24 19.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.35 -0.844 . . . . 0.0 109.225 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.51 137.88 41.9 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.44 7.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.567 -0.708 . . . . 0.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.79 3.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.52 -0.737 . . . . 0.0 109.847 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.95 167.54 21.94 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.22 -0.925 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.21 145.47 37.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.734 . . . . 0.0 110.259 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.51 7.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.204 -0.935 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.97 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.496 -0.753 . . . . 0.0 111.402 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.26 15.22 6.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.741 -0.599 . . . . 0.0 112.39 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.973 -1.079 . . . . 0.0 109.862 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.94 47.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 111.2 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.02 134.27 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 135.97 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.118 -0.988 . . . . 0.0 111.945 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 109.02 14.89 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.11 -30.04 47.37 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.536 1.282 . . . . 0.0 111.423 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.1 t -117.87 111.75 19.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -1.118 . . . . 0.0 110.466 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.48 -20.68 47.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.317 -0.864 . . . . 0.0 110.448 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.16 18.75 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.459 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.47 36.5 63.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.1 146.97 4.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.99 . . . . 0.0 110.727 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.09 46.43 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.724 0.773 . . . . 0.0 111.45 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.91 115.87 5.65 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.73 -29.2 10.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.21 -28.78 48.09 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.582 -1.324 . . . . 0.0 112.351 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.2 116.27 22.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.918 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 -15.87 60.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 111.282 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.48 94.1 4.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 110.101 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.57 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.284 -0.885 . . . . 0.0 110.517 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.8 121.07 39.43 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.766 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.9 Cg_endo -65.58 134.47 38.32 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.373 1.196 . . . . 0.0 109.808 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -168.08 154.5 7.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.099 . . . . 0.0 112.009 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.836 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 23.8 p90 -137.65 160.69 38.51 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.0 t -125.62 137.34 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.573 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.915 HD11 HD12 ' B' ' 714' ' ' LEU . 10.9 mt -108.72 135.66 49.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.8 mtp -114.34 123.52 49.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.96 -1.087 . . . . 0.0 110.471 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -99.34 117.33 33.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 0.0 109.598 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.3 mt -115.29 123.58 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 111.136 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -54.9 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.624 0.725 . . . . 0.0 109.275 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.78 107.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.3 m 60.43 9.2 1.92 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.386 -0.821 . . . . 0.0 110.457 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.7 m -138.7 133.76 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 108.83 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.533 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.7 p -131.56 139.15 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.937 -1.102 . . . . 0.0 111.532 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.56 125.01 72.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.456 HG21 ' HE1' ' A' ' 128' ' ' PHE . 65.4 p -106.91 135.57 48.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.985 -1.072 . . . . 0.0 110.674 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.754 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.15 127.38 55.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -110.39 132.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.405 -0.81 . . . . 0.0 109.398 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.737 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.2 m-85 -111.68 111.53 22.58 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.865 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -106.51 137.44 44.51 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.459 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 44.4 tp -94.23 84.13 4.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.674 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.6 mt -101.53 117.98 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.1 54.33 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -71.12 -43.74 67.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -1.223 . . . . 0.0 110.712 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -76.41 156.3 33.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.865 . . . . 0.0 110.85 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.634 HG22 ' CD1' ' A' ' 167' ' ' LEU . 47.3 t -104.27 129.49 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.674 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.14 148.36 23.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 109.98 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' B' ' 712' ' ' HIS . 12.1 p -132.0 140.52 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 110.912 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.1 tt0 -120.5 150.8 40.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.73 . . . . 0.0 109.422 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 111.629 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.6 mm -126.41 132.7 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.44 141.39 48.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 111.46 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.1 t80 -139.4 141.96 37.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.609 -0.682 . . . . 0.0 110.074 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.19 147.47 41.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.121 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 48.4 mttm -49.98 -34.82 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.351 -0.843 . . . . 0.0 110.673 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.263 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 -20.58 37.73 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.795 1.418 . . . . 0.0 110.736 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 1.3 mp -91.37 141.15 29.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 144.39 148.97 4.96 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 87.1 p -63.12 -28.24 69.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -1.075 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 13.0 t -135.87 156.8 48.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 110.408 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.2 143.09 44.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 110.196 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -132.04 169.54 16.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.039 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -58.64 150.25 23.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.743 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 69.7 mt -83.82 125.43 31.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.925 . . . . 0.0 110.523 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.74 -6.56 14.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.88 -38.14 72.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 0.0 111.012 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -141.63 32.54 1.64 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 111.019 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -99.75 127.44 45.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.99 . . . . 0.0 110.121 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.797 ' OD2' HG22 ' B' ' 702' ' ' THR . 2.7 p30 -177.37 -46.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.398 -0.813 . . . . 0.0 110.433 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . 0.797 HG22 ' OD2' ' B' ' 701' ' ' ASP . 12.7 t -146.09 155.83 43.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.97 138.16 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.504 -0.748 . . . . 0.0 109.685 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 99.5 p -111.83 145.47 39.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.63 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -69.06 -29.74 67.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.795 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.06 44.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.25 160.51 52.24 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.444 -0.785 . . . . 0.0 110.46 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.65 156.28 57.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.887 1.467 . . . . 0.0 110.635 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' B' ' 710' ' ' PHE . 76.8 mm-40 -105.2 156.91 17.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.423 -0.798 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' B' ' 709' ' ' GLU . 34.1 m-85 53.59 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.903 0.858 . . . . 0.0 112.295 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 39.5 m -65.75 -40.25 91.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.091 0.948 . . . . 0.0 108.912 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.851 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -168.56 -177.45 0.51 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -59.14 139.28 89.72 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 122.824 0.907 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.947 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.8 mt 67.8 45.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.561 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.32 80.89 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.383 -1.448 . . . . 0.0 109.26 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -84.65 17.63 2.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.102 0.953 . . . . 0.0 109.414 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.664 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.256 27.9 p -45.95 172.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.664 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.4 Cg_endo -74.55 -55.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.546 1.814 . . . . 0.0 108.923 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 14.2 mtpp -159.21 -14.58 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.657 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.8 m 57.31 25.83 11.66 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.99 131.87 80.75 Favored Pre-proline 0 C--N 1.305 -1.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.962 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.02 148.59 70.21 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.601 1.316 . . . . 0.0 110.559 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -114.09 -85.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -121.86 122.23 38.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.093 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -57.71 149.26 22.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.371 -0.83 . . . . 0.0 110.512 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.0 tp -92.9 128.63 38.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.411 -0.805 . . . . 0.0 109.995 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -72.49 143.18 48.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.4 -0.812 . . . . 0.0 110.54 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -80.49 145.61 31.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 109.867 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.77 104.99 20.37 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.345 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.55 151.34 58.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.617 1.325 . . . . 0.0 110.297 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -93.05 132.47 37.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 30.1 t -137.86 142.4 40.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.308 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -95.97 134.78 12.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 71.8 mt -102.48 139.49 38.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -122.08 76.88 0.34 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 34.2 m -128.15 161.71 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -1.127 . . . . 0.0 110.472 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -82.66 133.49 35.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 110.066 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.78 147.89 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.344 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 13.5 t -126.89 160.12 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.436 -0.79 . . . . 0.0 110.237 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.0 m -114.28 152.61 31.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -91.22 123.11 34.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.467 -0.771 . . . . 0.0 109.953 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -98.99 161.81 13.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.46 -0.775 . . . . 0.0 110.376 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 98.15 17.74 28.76 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 23.3 t -75.25 137.08 40.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.163 -1.198 . . . . 0.0 109.965 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 46.1 m -124.73 150.62 46.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.386 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.463 179.748 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -125.79 73.52 69.94 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.336 -1.097 . . . . 0.0 110.084 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.89 -23.32 35.09 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.724 1.381 . . . . 0.0 110.706 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.08 -35.5 80.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.873 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.01 156.76 34.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.285 -0.884 . . . . 0.0 110.257 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -88.92 176.06 43.83 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 30.1 p -144.0 45.46 1.46 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -1.062 . . . . 0.0 110.263 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -115.73 149.75 37.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.241 -0.912 . . . . 0.0 110.177 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.544 ' O ' ' O ' ' A' ' 156' ' ' GLN . 64.9 t0 -145.94 97.38 2.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.574 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 37.3 ptt85 -157.49 159.21 37.01 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.086 -1.009 . . . . 0.0 109.668 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 136.15 7.97 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.459 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.1 tp -92.54 131.49 37.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.3 t -118.39 138.85 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 57.8 tp -99.23 131.58 45.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.397 -0.814 . . . . 0.0 110.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.07 129.29 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.437 -0.789 . . . . 0.0 110.304 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.54 -176.43 3.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.497 -0.752 . . . . 0.0 109.855 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.29 -175.65 34.66 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 61.21 40.73 14.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.835 . . . . 0.0 109.861 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.49 -35.74 65.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.38 42.07 30.46 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.22 136.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.9 . . . . 0.0 109.019 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.49 25.31 19.64 Favored 'Cis proline' 0 C--N 1.317 -1.129 0 C-N-CA 123.726 -1.364 . . . . 0.0 110.195 -1.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.87 -48.01 83.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.259 -0.901 . . . . 0.0 112.001 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.49 -21.84 4.79 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.03 -1.044 . . . . 0.0 111.01 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.5 m -133.68 158.37 43.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.045 -1.035 . . . . 0.0 110.22 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.89 -18.68 15.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.239 -0.913 . . . . 0.0 111.098 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -174.02 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.013 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.63 162.74 67.18 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.19 143.58 90.17 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.283 1.149 . . . . 0.0 110.399 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.19 -56.18 8.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.73 -36.59 72.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.778 -1.201 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.3 -39.65 94.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.102 . . . . 0.0 111.03 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -56.32 -39.02 72.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 108.827 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.7 -34.93 76.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.67 -0.644 . . . . 0.0 109.275 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.849 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.7 -38.12 86.1 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.947 HD23 HD23 ' B' ' 714' ' ' LEU . 91.5 mt -86.56 132.86 33.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.153 -0.967 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 30' ' ' LYS . 27.6 m -148.35 146.21 22.36 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.638 -0.664 . . . . 0.0 110.078 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.59 148.34 53.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.536 1.282 . . . . 0.0 110.667 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.72 -11.79 70.54 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.5 mmmt -102.86 -24.23 13.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.264 -1.139 . . . . 0.0 111.005 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HD21 ' B' ' 714' ' ' LEU . 74.0 mt -114.4 132.26 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 110.895 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -101.44 -22.02 14.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.565 -0.709 . . . . 0.0 110.482 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.75 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.4 m-70 -136.55 138.3 41.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.234 -0.917 . . . . 0.0 110.931 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.13 123.28 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.797 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -110.1 128.58 55.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.831 . . . . 0.0 108.937 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.0 t -118.63 130.09 55.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.114 -0.991 . . . . 0.0 110.526 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 HD21 ' A' ' 84' ' ' LEU . 67.3 p -103.25 -62.02 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.484 -0.76 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.12 162.56 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -72.47 149.28 44.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.688 -0.889 . . . . 0.0 110.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.66 -62.73 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.285 -0.884 . . . . 0.0 111.502 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.83 -20.79 16.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 119.891 -1.755 . . . . 0.0 110.191 -0.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -69.13 142.89 54.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.379 -0.825 . . . . 0.0 110.812 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -59.74 -28.51 67.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -0.785 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -51.38 -41.03 60.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 40' ' ' LEU . 65.3 m -66.21 -34.53 78.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.931 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.72 -43.21 94.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 110.116 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.49 -39.95 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -62.6 -44.84 95.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.0 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.5 mt -62.57 -38.92 91.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 110.034 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -62.22 -32.06 72.68 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.517 -0.74 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 m -63.09 -43.94 97.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.544 -0.723 . . . . 0.0 111.01 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.07 -36.82 84.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.241 -0.912 . . . . 0.0 110.651 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.75 155.13 37.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.222 -0.923 . . . . 0.0 110.477 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.79 -43.61 11.31 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.54 110.55 19.87 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -1.147 . . . . 0.0 110.387 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.59 133.94 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.376 -0.828 . . . . 0.0 110.33 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.28 127.23 54.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.337 -0.852 . . . . 0.0 109.627 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.7 mt -131.72 151.33 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 111.455 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.18 155.66 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -74.53 130.65 39.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.754 -1.216 . . . . 0.0 111.623 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.43 -175.52 38.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.38 0.61 36.59 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.264 . . . . 0.0 110.78 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.92 25.76 3.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.29 133.02 35.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.154 -0.966 . . . . 0.0 110.445 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.6 -46.11 70.18 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.341 -0.849 . . . . 0.0 110.066 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.25 119.7 19.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.571 -0.706 . . . . 0.0 110.192 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.5 -1.13 57.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.539 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -75.59 -3.72 35.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 111.284 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.1 m-30 -76.23 147.77 80.06 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.72 140.37 20.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.879 1.463 . . . . 0.0 110.974 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.58 -39.38 80.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.255 -0.903 . . . . 0.0 109.245 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.76 150.26 29.21 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.56 147.74 34.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.867 -1.146 . . . . 0.0 111.557 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.78 113.27 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.72 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.341 -0.849 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.64 130.51 37.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.6 t -121.58 86.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.438 -0.789 . . . . 0.0 109.163 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.15 5.0 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.35 -6.12 50.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.306 -1.114 . . . . 0.0 110.858 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -97.82 137.33 36.84 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 113.209 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.31 107.52 18.55 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 54.0 mt -107.95 140.57 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 112.167 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.19 16.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.12 131.72 27.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.955 -1.321 . . . . 0.0 111.91 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.544 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.804 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.97 -60.31 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.887 -1.133 . . . . 0.0 110.515 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.0 -26.62 3.4 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.369 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.4 p-80 -61.76 -17.25 55.22 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.969 -1.312 . . . . 0.0 110.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.8 -5.95 59.17 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.47 113.2 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.19 129.57 24.44 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.89 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.28 155.01 97.26 Favored 'Cis proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.76 -2.184 . . . . 0.0 111.636 -0.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -39.07 -57.52 1.27 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.48 34.23 5.62 Favored Glycine 0 N--CA 1.5 2.947 0 C-N-CA 118.919 -1.61 . . . . 0.0 112.446 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.89 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.08 36.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.726 -1.455 . . . . 0.0 110.367 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.86 -40.48 63.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.74 86.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 109.517 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.11 -42.06 85.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.131 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.05 97.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -0.794 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.22 94.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.504 -0.748 . . . . 0.0 109.426 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.67 67.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.464 -0.772 . . . . 0.0 109.112 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 tp -71.84 -35.5 69.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.592 -0.692 . . . . 0.0 109.726 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.72 -45.45 85.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.877 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.04 12.52 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.515 -0.741 . . . . 0.0 110.197 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.76 -45.43 70.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.25 -29.01 63.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.386 -0.821 . . . . 0.0 111.388 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.01 10.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.162 -0.962 . . . . 0.0 109.899 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.98 155.95 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 0.0 110.308 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -32.05 33.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.034 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.9 mt -129.16 140.54 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.679 . . . . 0.0 110.013 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.72 123.47 42.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.793 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 37' ' ' THR . 36.3 mm -106.08 131.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.226 -0.921 . . . . 0.0 109.965 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.6 p -157.57 160.69 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.0 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.7 t60 75.61 -34.23 0.24 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.806 -0.82 . . . . 0.0 111.609 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.66 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.84 -1.162 . . . . 0.0 111.491 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.69 24.89 7.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.065 -1.022 . . . . 0.0 110.806 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.36 19.85 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.216 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.52 137.84 42.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.105 -0.997 . . . . 0.0 110.331 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.89 122.45 7.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.542 -0.723 . . . . 0.0 110.278 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.68 3.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.466 -0.771 . . . . 0.0 109.865 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.96 167.58 21.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.192 -0.942 . . . . 0.0 111.056 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.16 145.47 37.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.492 -0.755 . . . . 0.0 110.292 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.6 117.57 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.0 110.931 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.83 58.19 5.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 111.394 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.17 15.29 6.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.849 -0.532 . . . . 0.0 112.357 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.93 38.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.93 -1.107 . . . . 0.0 109.839 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.6 t80 -113.26 140.9 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.24 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.01 134.3 53.48 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.12 136.03 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 111.917 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 108.93 14.8 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.02 -30.01 48.17 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.517 1.272 . . . . 0.0 111.457 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.37 14.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.93 111.79 19.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -1.091 . . . . 0.0 110.429 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.62 48.31 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.378 -0.826 . . . . 0.0 110.473 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.203 -0.935 . . . . 0.0 110.542 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.44 36.57 63.92 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.09 146.91 4.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.517 -0.99 . . . . 0.0 110.793 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 151.17 46.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.77 0.795 . . . . 0.0 111.428 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.91 5.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.17 11.03 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.8 48.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.668 -1.27 . . . . 0.0 112.333 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.19 116.32 22.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.1 . . . . 0.0 109.954 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.99 -15.82 60.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 111.255 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.57 94.31 4.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.023 -1.048 . . . . 0.0 110.062 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.63 139.75 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.513 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.0 mt -112.96 121.01 39.38 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.714 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.06 134.93 38.69 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.528 1.278 . . . . 0.0 109.65 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.402 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . 88.4 p -168.53 154.09 6.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.744 -1.223 . . . . 0.0 111.987 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 15.4 p90 -137.9 159.43 42.03 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.2 136.13 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.027 -1.046 . . . . 0.0 113.618 -176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.023 HD11 HD22 ' B' ' 714' ' ' LEU . 15.4 mt -106.48 134.03 50.25 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.3 mtp -113.54 120.96 42.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.379 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -98.01 117.25 31.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 109.767 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 160' ' ' VAL . 96.8 mt -114.2 123.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 111.082 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -99.95 -55.43 2.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.597 0.713 . . . . 0.0 109.371 178.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.2 108.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 59.65 9.77 1.72 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.269 -0.894 . . . . 0.0 110.557 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.2 m -139.18 133.05 30.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG23 HG12 ' A' ' 155' ' ' ILE . 9.3 p -131.23 138.65 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.365 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.88 126.08 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.2 p -107.37 135.73 48.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.853 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.21 127.28 55.82 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.5 p -112.47 131.36 64.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.836 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.703 ' CE1' HD12 ' A' ' 152' ' ' LEU . 34.7 m-85 -109.72 115.15 29.33 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -107.61 136.76 46.83 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.449 -0.782 . . . . 0.0 109.309 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.714 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.3 tp -93.16 93.31 8.2 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.28 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.804 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.8 mt -108.3 124.31 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.97 -132.02 31.03 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -99.24 -49.46 4.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.275 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -70.43 156.84 38.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 110.491 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 167' ' ' LEU . 55.4 t -102.23 128.02 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.804 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.8 147.79 23.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.519 HG21 ' CD2' ' B' ' 712' ' ' HIS . 14.1 p -131.05 140.88 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 111.09 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.3 tt0 -121.25 149.91 42.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.572 -0.705 . . . . 0.0 109.306 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.4 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 73.1 ttt-85 -116.21 126.86 54.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.132 -0.98 . . . . 0.0 111.721 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.42 132.19 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -115.03 141.11 48.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.395 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 73.7 t80 -139.24 141.74 37.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 109.974 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.23 147.1 41.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 110.078 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -50.51 -34.51 25.45 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.368 -0.833 . . . . 0.0 110.59 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.229 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.71 -19.15 41.85 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.859 1.452 . . . . 0.0 110.693 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.22 -172.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.261 -0.899 . . . . 0.0 110.603 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -89.61 49.46 3.41 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 83.9 p -60.76 -28.22 68.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.303 -1.116 . . . . 0.0 110.227 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.1 m -86.25 134.57 33.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -138.0 -54.94 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 110.473 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.87 -36.63 81.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.815 . . . . 0.0 110.634 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -92.85 111.4 23.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 73.9 mt -119.1 131.79 55.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.355 -0.84 . . . . 0.0 109.888 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.06 131.95 44.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.491 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -116.25 142.12 47.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.985 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -108.67 136.62 47.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.78 127.36 47.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -102.62 6.71 39.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.849 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 47.1 m -122.46 139.61 53.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.166 -0.958 . . . . 0.0 110.325 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 52.4 t -120.44 138.04 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.101 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.9 m -114.64 149.73 36.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.192 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.7 52.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.432 -0.792 . . . . 0.0 110.539 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -66.37 156.55 34.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.492 -0.755 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' B' ' 708' ' ' PRO . 1.7 m-20 -104.04 96.89 10.21 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.81 . . . . 0.0 110.076 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' B' ' 707' ' ' ASP . 44.2 Cg_endo -70.03 156.24 63.11 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.776 1.409 . . . . 0.0 110.568 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.94 153.99 17.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.389 -0.819 . . . . 0.0 110.289 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.25 146.72 28.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.485 -0.759 . . . . 0.0 111.321 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.09 -40.88 95.39 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.173 0.987 . . . . 0.0 108.622 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.845 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 2.2 p80 -165.54 -178.05 0.69 Allowed Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.2 Cg_endo -60.56 133.32 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.023 HD22 HD11 ' A' ' 152' ' ' LEU . 2.2 mp 67.74 59.54 0.47 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.537 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -138.74 76.74 1.59 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.152 -1.593 . . . . 0.0 109.068 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -84.44 19.87 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.224 1.011 . . . . 0.0 109.055 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.626 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.254 21.9 p -43.05 171.36 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.073 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.7 Cg_endo -71.37 -56.7 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.488 1.783 . . . . 0.0 108.874 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 21.2 mttp -158.91 -15.15 0.07 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.3 m 55.21 26.99 9.03 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -73.59 150.45 88.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.311 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.99 -17.46 41.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.78 1.41 . . . . 0.0 110.793 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -59.55 145.59 43.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.285 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -108.99 161.11 15.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.12 148.18 42.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 110.38 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -115.9 154.44 29.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.465 -0.772 . . . . 0.0 110.256 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 25.4 tp -93.16 122.2 35.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 0.0 109.98 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -163.43 156.95 19.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.463 ' C ' HG13 ' B' ' 730' ' ' VAL . 9.5 tptp -126.63 119.19 26.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.992 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.463 HG13 ' C ' ' B' ' 729' ' ' LYS . 30.2 m -151.63 134.85 9.11 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.338 -0.851 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.04 146.78 53.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.607 1.32 . . . . 0.0 110.688 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -67.23 139.08 57.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.069 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . 0.466 ' O ' ' O ' ' B' ' 736' ' ' GLY . 28.6 p -118.25 30.37 7.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.462 -0.774 . . . . 0.0 110.351 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.5 25.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.12 -36.55 80.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.169 -1.195 . . . . 0.0 111.011 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' B' ' 733' ' ' SER . . . -140.1 165.86 25.87 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.94 132.3 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.084 -1.245 . . . . 0.0 110.574 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -136.14 74.73 1.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 109.879 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 160.71 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.811 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . 0.589 HG22 ' O ' ' B' ' 740' ' ' THR . 45.8 m 51.0 26.1 2.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.416 -0.802 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 26.5 t -147.76 147.99 30.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.953 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -98.91 104.81 16.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 109.976 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -136.09 140.54 43.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.434 -0.791 . . . . 0.0 110.212 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -90.16 -175.23 45.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 60.5 p -66.75 166.27 13.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.343 -1.093 . . . . 0.0 109.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.0 m -54.7 -33.83 61.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.298 -0.876 . . . . 0.0 110.172 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 1.3 m95 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.073 179.733 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.8 m -109.51 113.87 57.73 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.378 -1.072 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.99 141.27 52.69 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.506 1.267 . . . . 0.0 110.144 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.58 127.2 53.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 0.0 110.705 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -79.29 -44.31 21.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.317 -0.864 . . . . 0.0 110.495 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -177.56 179.5 48.18 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 46.7 p -131.07 165.26 23.62 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.369 -1.077 . . . . 0.0 110.546 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -114.17 129.83 56.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.358 -0.839 . . . . 0.0 109.978 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -64.61 -36.0 82.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.314 -0.866 . . . . 0.0 110.999 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 42.7 ptt85 -70.59 146.66 49.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.229 -0.919 . . . . 0.0 110.878 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.53 135.75 42.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.318 -0.864 . . . . 0.0 110.479 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.0 tp -92.31 130.86 37.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.0 t -117.85 139.52 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 110.432 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 34' ' ' ILE . 57.3 tp -99.21 131.58 45.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.411 -0.806 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -123.01 129.08 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.207 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.4 -176.67 4.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.833 . . . . 0.0 109.88 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.18 -175.54 34.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.24 40.81 14.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.817 -0.813 . . . . 0.0 109.857 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.71 65.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.31 42.1 30.61 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.672 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -100.23 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 108.966 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.45 25.24 19.78 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.839 -1.317 . . . . 0.0 110.158 -1.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.05 83.56 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 0.0 111.982 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.4 mtt180 -124.47 -21.82 4.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.031 -1.043 . . . . 0.0 111.059 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.7 m -133.7 158.39 43.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.085 -1.009 . . . . 0.0 110.156 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -102.0 -18.58 15.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -0.857 . . . . 0.0 111.034 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.6 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.21 -0.931 . . . . 0.0 110.567 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.6 162.68 67.5 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -63.13 142.92 89.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.299 1.157 . . . . 0.0 110.291 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 -56.25 7.62 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -57.67 -36.57 72.1 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.885 -1.134 . . . . 0.0 111.715 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.21 -39.54 94.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.953 -1.092 . . . . 0.0 111.066 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.43 -38.92 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 108.814 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.8 -34.43 75.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.609 -0.682 . . . . 0.0 109.304 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.945 HD23 ' HB3' ' B' ' 714' ' ' LEU . 0.2 OUTLIER -66.36 -39.48 89.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.401 -0.812 . . . . 0.0 110.304 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.955 HD23 HD23 ' B' ' 714' ' ' LEU . 89.6 mt -85.6 132.67 34.13 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.06 -1.025 . . . . 0.0 111.357 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 30' ' ' LYS . 34.3 m -148.08 145.58 21.19 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.618 -0.676 . . . . 0.0 109.941 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.28 148.4 55.26 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.569 1.299 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -10.59 72.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.636 ' HE2' HD12 ' B' ' 714' ' ' LEU . 2.6 mmmt -104.03 -24.56 13.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.241 -1.152 . . . . 0.0 110.968 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.848 HD11 HD21 ' B' ' 714' ' ' LEU . 74.4 mt -113.84 132.37 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 110.858 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.39 -22.38 14.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.5 138.6 41.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.246 -0.909 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.0 mt -129.39 123.16 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.359 -0.838 . . . . 0.0 110.79 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.7 mt -109.94 128.54 55.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 108.975 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.5 t -119.18 129.24 54.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.495 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.792 HG22 HD21 ' A' ' 84' ' ' LEU . 69.9 p -102.46 -62.9 1.21 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.557 -0.714 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.63 162.46 8.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.96 149.02 43.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.907 . . . . 0.0 110.238 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -55.23 -62.84 1.4 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.4 -0.813 . . . . 0.0 111.6 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.6 -21.41 16.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 119.862 -1.774 . . . . 0.0 110.164 -0.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -68.56 142.99 55.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.848 . . . . 0.0 110.926 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -59.94 -27.73 67.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 110.15 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.9 -40.73 61.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.218 -0.926 . . . . 0.0 110.092 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 66.5 m -66.85 -34.37 77.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.42 -0.8 . . . . 0.0 109.943 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -59.35 -43.35 92.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.042 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.09 -40.14 88.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.592 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -62.3 -44.63 96.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.457 -0.777 . . . . 0.0 110.021 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.3 mt -63.11 -38.48 91.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.05 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.21 -32.65 73.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.1 m -63.55 -43.09 98.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.319 -0.863 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.95 -36.85 84.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.189 -0.944 . . . . 0.0 110.548 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.1 154.89 36.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.298 -0.876 . . . . 0.0 110.387 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.71 -43.4 11.82 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.31 110.09 19.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.98 133.96 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.317 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.495 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.78 126.51 53.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.48 151.4 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.194 -0.941 . . . . 0.0 111.451 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -120.26 154.29 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.11 130.74 40.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.741 -1.225 . . . . 0.0 111.47 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.46 -175.52 38.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.59 36.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.085 -1.244 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.63 3.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.23 132.99 35.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.65 -45.98 70.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.253 -0.904 . . . . 0.0 110.084 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.25 119.68 19.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.682 -0.636 . . . . 0.0 110.181 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.55 -1.03 57.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.67 . . . . 0.0 110.531 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.68 -3.78 36.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.005 . . . . 0.0 111.184 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.435 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.11 147.77 80.43 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.67 140.4 21.0 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.914 1.481 . . . . 0.0 110.955 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.37 80.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.25 -0.906 . . . . 0.0 109.158 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.65 150.29 29.32 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.54 147.75 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.846 -1.158 . . . . 0.0 111.549 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.77 113.32 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.4 131.81 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 110.208 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.72 130.44 37.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.56 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.476 -0.765 . . . . 0.0 109.192 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.87 -119.21 5.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -92.33 -5.95 51.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.293 -1.122 . . . . 0.0 110.961 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -98.03 137.29 37.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.051 -1.031 . . . . 0.0 113.181 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.3 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.52 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 112.219 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.22 16.28 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.792 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.16 131.68 27.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.851 -1.382 . . . . 0.0 111.923 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.56 149.03 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.85 -60.38 3.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.854 -1.154 . . . . 0.0 110.553 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.96 -26.58 3.41 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.321 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.78 -17.29 55.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.889 -1.359 . . . . 0.0 110.035 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.73 -5.96 59.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.247 -0.908 . . . . 0.0 109.961 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.4 t -98.53 113.2 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 0.0 109.665 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.5 24.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.154 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.31 155.1 97.27 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.746 -2.189 . . . . 0.0 111.635 -0.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.6 m0 -39.24 -57.44 1.35 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.01 5.77 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.068 -1.539 . . . . 0.0 112.58 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.09 36.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.676 -1.485 . . . . 0.0 110.369 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.43 63.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.519 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.91 -38.72 86.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.05 -42.08 85.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.88 . . . . 0.0 109.146 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.03 97.91 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.408 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.18 94.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.464 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.56 67.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.147 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.94 -35.45 69.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.535 -0.728 . . . . 0.0 109.727 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.478 -0.764 . . . . 0.0 109.897 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.94 -57.06 12.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.438 -0.789 . . . . 0.0 110.178 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.86 -45.43 70.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.673 -0.642 . . . . 0.0 110.661 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -29.0 63.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.373 -0.83 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.35 48.07 10.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.01 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.2 -31.95 33.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.064 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.48 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.666 -0.646 . . . . 0.0 110.056 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.44 42.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.871 . . . . 0.0 109.851 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.98 131.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.188 -0.945 . . . . 0.0 110.026 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.7 p -157.52 160.68 38.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.312 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.69 1.96 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.64 -34.26 0.24 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.949 -0.736 . . . . 0.0 111.631 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.9 p -87.93 -9.67 52.93 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.785 -1.197 . . . . 0.0 111.405 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.6 25.06 7.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.028 -1.045 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -123.74 114.28 19.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.349 -0.845 . . . . 0.0 109.209 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.3 t80 -54.56 137.89 42.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.316 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.9 122.37 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.49 97.67 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 109.868 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.65 21.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.0 110.949 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.26 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.55 117.56 7.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.287 -0.883 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.87 58.17 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 111.418 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.18 15.29 6.21 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.797 -0.565 . . . . 0.0 112.369 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.91 38.73 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.116 . . . . 0.0 109.82 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.36 140.95 47.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 111.233 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.11 134.33 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.7 mm -134.05 136.1 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.955 . . . . 0.0 111.94 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.52 108.94 14.65 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -65.98 -30.04 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.53 1.279 . . . . 0.0 111.47 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.96 -139.44 14.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.9 111.74 19.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -1.133 . . . . 0.0 110.469 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.55 47.34 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.332 -0.855 . . . . 0.0 110.506 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.57 13.18 18.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.307 -0.871 . . . . 0.0 110.475 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.66 63.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.15 146.93 4.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.513 -0.992 . . . . 0.0 110.725 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.86 151.1 46.4 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.731 0.776 . . . . 0.0 111.482 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.83 115.88 5.68 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.89 -29.12 11.12 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.22 -28.64 48.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.595 -1.316 . . . . 0.0 112.402 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.36 116.3 22.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.814 -1.178 . . . . 0.0 109.875 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.95 -15.89 60.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.482 -0.761 . . . . 0.0 111.254 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.5 94.15 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.029 -1.045 . . . . 0.0 110.092 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.7 mm -101.59 139.71 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.93 121.07 39.26 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.7 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.6 Cg_endo -66.07 134.8 38.2 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.479 1.252 . . . . 0.0 109.587 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -168.71 153.67 6.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.715 -1.241 . . . . 0.0 111.994 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.876 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 17.8 p90 -137.35 159.55 41.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.67 136.83 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.045 -1.035 . . . . 0.0 113.662 -176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.958 HD11 HD22 ' B' ' 714' ' ' LEU . 18.9 mt -106.12 135.36 47.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 62.8 mtp -114.68 119.94 38.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.074 . . . . 0.0 110.146 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -96.94 117.74 31.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 160' ' ' VAL . 97.1 mt -114.73 122.94 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 111.063 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -55.09 2.72 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.592 0.71 . . . . 0.0 109.239 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.57 107.12 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 m 60.17 9.78 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.366 -0.834 . . . . 0.0 110.5 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.2 m -138.93 133.2 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 108.76 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 155' ' ' ILE . 9.1 p -131.68 138.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.446 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.78 126.38 74.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 p -107.19 135.57 48.49 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.778 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.34 125.6 54.45 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.9 p -110.73 130.53 63.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.347 -0.845 . . . . 0.0 109.727 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.683 ' CE1' HD12 ' A' ' 152' ' ' LEU . 45.0 m-85 -108.94 114.16 27.68 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.245 -0.909 . . . . 0.0 109.968 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -107.98 136.57 47.46 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.303 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.7 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 36.3 tp -93.85 95.92 9.41 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.209 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.783 HD12 ' HD2' ' A' ' 173' ' ' LYS . 68.6 mt -110.22 125.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.25 32.59 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.08 -50.89 3.84 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.226 -1.161 . . . . 0.0 110.363 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.11 156.76 38.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.396 -0.815 . . . . 0.0 110.363 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.596 HG22 ' CD1' ' A' ' 167' ' ' LEU . 56.5 t -103.01 129.06 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.753 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.783 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.6 mttt -96.41 147.86 23.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' B' ' 712' ' ' HIS . 13.8 p -130.85 140.39 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 111.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.5 tt0 -120.42 149.28 42.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.296 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -114.99 126.33 54.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.006 -1.059 . . . . 0.0 111.69 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -125.82 132.52 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.97 140.73 48.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.926 -1.109 . . . . 0.0 111.55 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 71.0 t80 -138.64 142.05 39.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.686 -0.634 . . . . 0.0 109.898 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.61 145.84 39.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.226 -0.921 . . . . 0.0 110.304 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -50.22 -34.44 22.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.326 -0.859 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.451 179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.7 148.41 71.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.789 1.415 . . . . 0.0 110.462 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 24.7 tp -57.66 -37.01 72.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.303 -0.873 . . . . 0.0 110.347 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.08 126.43 33.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 80.6 p -149.39 167.82 25.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -1.06 . . . . 0.0 109.997 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 49.3 p -75.49 154.58 36.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.806 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.84 134.79 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -0.86 . . . . 0.0 110.259 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.81 -73.37 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.431 -0.793 . . . . 0.0 110.114 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -153.26 -61.59 0.14 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.464 -0.773 . . . . 0.0 110.208 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 17.5 mt 52.78 19.94 1.43 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.364 -0.835 . . . . 0.0 111.047 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.17 -35.18 80.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -78.57 138.74 38.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.444 -0.785 . . . . 0.0 110.159 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -106.28 142.15 36.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.271 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -116.17 146.58 42.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.339 -0.85 . . . . 0.0 110.127 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 47.8 p30 -135.58 176.78 8.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.567 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . 0.721 HG22 ' HE3' ' B' ' 729' ' ' LYS . 43.1 p -80.69 164.05 23.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.865 . . . . 0.0 110.193 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 93.9 t -59.7 -41.71 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.6 p -142.0 157.28 45.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.839 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -124.48 42.17 3.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . 53.88 -173.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.357 -0.84 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.27 112.0 5.17 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.162 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.98 143.6 45.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.639 1.336 . . . . 0.0 110.627 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.22 150.91 36.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.386 -0.821 . . . . 0.0 110.092 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -104.82 132.26 51.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.7 m -69.24 -43.41 74.07 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.023 0.916 . . . . 0.0 109.111 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.872 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -163.21 -177.25 0.66 Allowed Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.872 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 34.4 Cg_endo -59.15 133.18 51.34 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 122.668 0.825 . . . . 0.0 110.102 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.958 HD22 HD11 ' A' ' 152' ' ' LEU . 3.9 mp 71.04 48.06 0.39 Allowed 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.569 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -133.57 77.79 1.74 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.271 -1.518 . . . . 0.0 108.848 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -82.81 18.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.104 0.954 . . . . 0.0 109.3 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.586 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 24.2 p -43.58 169.67 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.736 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -70.95 -55.81 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.396 1.735 . . . . 0.0 108.97 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' B' ' 718' ' ' PRO . 14.2 mtpp -159.76 -15.04 0.06 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.71 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.4 m 55.25 27.18 9.4 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -91.55 154.48 44.22 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.555 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.79 -16.42 33.24 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.813 1.428 . . . . 0.0 111.039 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -57.82 140.12 52.5 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.119 -0.988 . . . . 0.0 110.35 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -87.1 -77.6 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.857 . . . . 0.0 110.538 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.03 28.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.238 -0.914 . . . . 0.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -61.37 -33.79 74.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.071 -1.018 . . . . 0.0 110.544 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 727' ' ' LEU . 9.1 tt -95.5 124.73 39.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.097 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -159.59 158.73 32.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.477 -0.764 . . . . 0.0 110.069 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.721 ' HE3' HG22 ' B' ' 702' ' ' THR . 91.2 mttt -83.98 147.74 27.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.014 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' B' ' 731' ' ' PRO . 71.5 t -115.48 97.4 48.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 110.346 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' B' ' 730' ' ' VAL . 43.3 Cg_endo -69.97 151.67 67.96 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.741 1.39 . . . . 0.0 110.177 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -60.64 89.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.188 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.7 m -59.33 -35.18 73.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -57.01 -33.58 64.26 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 32.2 tp -100.87 128.3 46.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.47 -1.018 . . . . 0.0 110.148 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 66.13 124.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.24 137.57 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -1.084 . . . . 0.0 110.063 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -100.24 141.79 32.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 110.266 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.19 143.79 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.7 m -120.78 137.29 54.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.365 -0.834 . . . . 0.0 110.455 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 94.4 p -134.12 156.58 48.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.44 -0.787 . . . . 0.0 109.901 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -115.37 138.65 50.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.3 -0.875 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -102.96 11.56 37.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 110.321 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 117.01 -73.97 0.28 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 26.6 t -124.39 139.5 53.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -1.107 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -35.38 73.58 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.187 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 25.8 p -66.57 155.61 88.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.42 -1.047 . . . . 0.0 110.397 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.96 139.67 47.9 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.841 1.443 . . . . 0.0 110.417 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -63.56 -36.11 82.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.256 -0.902 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -111.3 133.91 53.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 172.87 149.58 6.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 12.4 t -140.29 156.77 46.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.406 -1.055 . . . . 0.0 110.557 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -101.3 6.0 42.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.308 -0.87 . . . . 0.0 110.51 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -73.51 156.04 38.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.9 ptt180 -51.54 149.96 4.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.363 -0.836 . . . . 0.0 109.693 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.43 135.82 25.53 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.51 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.2 tp -90.7 127.45 36.32 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.8 t -115.9 139.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.215 -0.928 . . . . 0.0 110.333 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' HB2' HG21 ' A' ' 31' ' ' ILE . 51.9 tp -100.33 131.25 46.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.435 -0.79 . . . . 0.0 110.731 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -123.37 128.92 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.078 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.13 -176.73 4.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.37 -0.831 . . . . 0.0 109.797 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.99 -175.39 35.23 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.219 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.06 40.7 14.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.873 -0.781 . . . . 0.0 109.882 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.51 -35.72 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.4 m80 55.39 42.04 30.48 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.681 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.89 19.96 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 109.064 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.47 25.4 19.56 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.745 -1.356 . . . . 0.0 110.222 -1.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.99 83.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.977 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.47 -21.79 4.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.086 -1.009 . . . . 0.0 111.092 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.65 158.34 43.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.08 -1.013 . . . . 0.0 110.176 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.83 -18.78 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 111.077 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.91 179.13 2.03 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.51 162.66 67.82 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.35 144.28 90.8 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.28 1.147 . . . . 0.0 110.53 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.02 -54.96 13.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -58.49 -36.97 74.58 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.781 -1.2 . . . . 0.0 111.578 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.61 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.0 m-30 -64.1 -40.26 95.84 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.009 -1.057 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -56.02 -39.48 71.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.962 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.66 -37.83 79.95 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.712 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 21.0 tp -64.16 -35.88 82.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' B' ' 714' ' ' LEU . 97.0 mt -89.61 134.07 34.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.631 -1.293 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -147.78 144.91 19.8 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.504 -0.747 . . . . 0.0 110.523 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.02 157.06 51.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.707 1.372 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.27 -0.91 86.0 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.902 ' HE2' HD23 ' B' ' 714' ' ' LEU . 12.1 tptt -111.27 -55.26 2.52 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.433 -1.039 . . . . 0.0 111.305 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.442 HG21 ' HB2' ' A' ' 4' ' ' LEU . 22.5 mt -86.15 130.9 35.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.517 0.675 . . . . 0.0 111.061 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -97.55 -21.57 17.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.643 -0.661 . . . . 0.0 110.657 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.72 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.7 m-70 -135.01 138.46 43.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.964 . . . . 0.0 111.161 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.6 mt -129.51 123.06 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.315 -0.866 . . . . 0.0 110.701 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.9 mt -109.91 129.62 55.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 109.032 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.0 t -119.4 130.38 55.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.435 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HD21 ' A' ' 84' ' ' LEU . 72.3 p -103.43 -59.54 1.7 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 110.941 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.807 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.36 162.96 27.79 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.113 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -72.4 148.5 45.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.719 -0.871 . . . . 0.0 110.013 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.337 -0.852 . . . . 0.0 111.431 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.52 -22.51 15.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.822 -1.799 . . . . 0.0 110.149 -0.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.3 t -67.11 142.37 57.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.371 -0.831 . . . . 0.0 110.803 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.63 -27.74 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.87 -40.39 60.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.33 -0.856 . . . . 0.0 110.186 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.8 m -67.14 -33.84 76.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.831 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' N ' HD22 ' A' ' 40' ' ' LEU . 73.3 t80 -60.24 -43.48 96.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.77 -39.68 85.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -63.09 -44.54 95.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 49' ' ' LEU . 77.1 mt -62.75 -38.75 91.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 110.105 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -62.26 -32.17 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.473 -0.767 . . . . 0.0 109.576 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.3 m -62.82 -43.96 97.4 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.798 . . . . 0.0 110.992 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.26 -36.23 82.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.211 -0.931 . . . . 0.0 110.621 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.67 155.12 36.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.257 -0.902 . . . . 0.0 110.547 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 -42.78 11.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -86.49 109.5 19.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.219 -1.166 . . . . 0.0 110.373 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.89 134.25 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 110.364 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.1 m-70 -117.1 127.69 54.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.4 mt -131.83 151.56 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 111.471 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.0 m -121.11 157.64 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.48 130.76 38.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.763 -1.211 . . . . 0.0 111.889 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.67 -175.47 38.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.36 0.5 37.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.041 -1.27 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.89 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.053 -1.03 . . . . 0.0 111.121 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.37 133.11 35.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.12 -0.988 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.74 -45.91 70.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.32 -0.863 . . . . 0.0 110.099 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.32 119.69 19.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.638 -0.663 . . . . 0.0 110.132 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.11 57.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 110.521 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.55 -3.93 36.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 111.195 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.06 147.68 80.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.857 -1.152 . . . . 0.0 109.444 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.61 140.44 21.21 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.928 1.488 . . . . 0.0 110.914 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.77 -39.36 80.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 0.0 109.151 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.75 34.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.792 -1.192 . . . . 0.0 111.608 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.79 113.29 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.38 131.8 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.0 110.299 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.79 130.52 37.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.959 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -121.54 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.172 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.92 -119.29 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.27 -6.26 50.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.313 -1.11 . . . . 0.0 110.837 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.6 m-85 -97.64 137.33 36.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.03 -1.044 . . . . 0.0 113.249 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.32 107.55 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.98 140.52 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 112.242 -176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.38 159.15 16.32 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.76 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.86 -1.376 . . . . 0.0 111.876 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.58 149.07 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.408 -0.807 . . . . 0.0 109.547 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.807 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.94 -60.35 3.93 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.901 -1.125 . . . . 0.0 110.478 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.99 -26.76 3.39 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.312 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.68 -17.23 54.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.907 -1.349 . . . . 0.0 110.074 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.79 -5.96 59.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.331 -0.856 . . . . 0.0 109.904 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.45 113.11 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.147 -0.971 . . . . 0.0 109.733 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.53 24.46 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.167 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.6 Cg_endo -71.34 155.0 97.35 Favored 'Cis proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.731 -2.195 . . . . 0.0 111.63 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.01 -57.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.3 33.97 5.79 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 119.048 -1.549 . . . . 0.0 112.54 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.14 36.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.719 -1.459 . . . . 0.0 110.318 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.49 63.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.467 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.81 -38.83 86.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.516 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.02 -42.09 85.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.131 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.75 -42.0 97.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.495 -0.753 . . . . 0.0 109.452 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.22 94.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.524 -0.735 . . . . 0.0 109.444 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.64 67.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.094 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.36 69.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.569 -0.707 . . . . 0.0 109.75 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.07 -56.89 13.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.426 -0.797 . . . . 0.0 110.223 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.83 -45.55 70.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.664 -0.647 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.21 -28.85 63.45 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.33 -0.856 . . . . 0.0 111.434 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.22 48.04 10.85 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.14 -0.975 . . . . 0.0 109.996 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.97 155.95 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.485 -0.759 . . . . 0.0 110.251 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -32.0 33.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.39 -0.819 . . . . 0.0 109.061 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.61 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.599 -0.688 . . . . 0.0 110.046 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.76 123.37 42.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.578 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -106.05 131.63 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.52 160.77 38.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.222 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.66 1.96 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.58 -34.22 0.24 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.896 -0.767 . . . . 0.0 111.62 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.95 -9.62 53.04 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.826 -1.171 . . . . 0.0 111.439 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.5 m170 55.63 24.95 7.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.053 -1.029 . . . . 0.0 110.79 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.65 114.31 19.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.58 137.89 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.294 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.85 122.41 7.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.488 -0.757 . . . . 0.0 110.343 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.61 97.81 3.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -0.763 . . . . 0.0 109.813 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.03 167.65 21.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 111.023 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.27 145.44 37.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 0.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -146.55 117.52 7.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.239 -0.913 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.84 58.13 5.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.525 -0.734 . . . . 0.0 111.439 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.3 15.21 6.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.865 -0.522 . . . . 0.0 112.406 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.68 154.89 38.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.876 -1.14 . . . . 0.0 109.882 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.34 140.89 47.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 111.213 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.04 134.36 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 136.02 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.002 . . . . 0.0 111.949 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.36 108.97 14.86 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.98 -30.07 48.48 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.472 1.249 . . . . 0.0 111.495 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.37 14.81 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.9 111.68 19.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -1.093 . . . . 0.0 110.492 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.5 -20.65 47.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.6 p -113.52 13.21 18.79 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.225 -0.922 . . . . 0.0 110.534 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.37 36.62 63.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.13 146.96 4.45 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.639 -0.918 . . . . 0.0 110.734 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.88 151.14 46.37 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.75 0.786 . . . . 0.0 111.444 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.93 115.92 5.66 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.9 -29.12 11.19 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.23 -28.7 47.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.526 -1.359 . . . . 0.0 112.376 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.25 116.31 22.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.86 -1.15 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.89 60.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 111.265 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.47 94.27 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.063 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.65 139.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.477 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.89 121.15 39.11 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.721 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.79 134.25 36.95 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.426 1.224 . . . . 0.0 109.725 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.9 p -167.75 154.89 8.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.844 -1.16 . . . . 0.0 112.223 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 25' ' ' LEU . 17.3 p90 -138.43 160.06 40.49 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 87.8 t -125.02 136.08 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.062 . . . . 0.0 113.63 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.703 HD11 ' CD1' ' B' ' 714' ' ' LEU . 28.4 mt -105.91 135.89 46.54 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.1 mtp -116.89 117.05 28.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.441 ' HB3' ' CG1' ' A' ' 161' ' ' VAL . 21.2 t70 -97.56 118.23 33.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 109.531 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.534 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.7 mt -114.19 113.55 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.2 -0.938 . . . . 0.0 111.358 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -81.44 -42.1 20.86 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.819 0.819 . . . . 0.0 108.792 178.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -168.44 -106.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m -85.6 8.33 19.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 0.0 110.202 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.2 m -124.26 138.28 54.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.534 HG23 ' CG1' ' A' ' 155' ' ' ILE . 11.0 p -132.54 141.88 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 154' ' ' ASP . 14.6 p -121.67 131.96 71.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.416 HG21 ' HE1' ' A' ' 128' ' ' PHE . 60.8 p -109.34 138.1 46.2 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.79 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.706 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.09 128.41 56.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 119' ' ' PHE . 6.3 p -113.72 134.56 56.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.67 ' CE2' HD12 ' A' ' 152' ' ' LEU . 61.0 m-85 -112.83 114.29 26.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.025 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.84 133.45 51.47 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.152 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.721 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.5 tp -90.14 82.75 6.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.2 mt -100.0 118.73 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.42 -161.44 54.19 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -71.14 -45.17 64.1 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.085 -1.244 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -75.02 160.58 30.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 0.0 110.554 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.45 HG21 ' HE1' ' A' ' 22' ' ' PHE . 11.8 p -110.21 130.96 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.397 -0.814 . . . . 0.0 109.475 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.1 mttt -98.14 149.54 22.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.518 -0.739 . . . . 0.0 110.123 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 11.0 p -131.82 141.59 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 111.021 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.459 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.2 tt0 -121.19 149.44 42.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.485 -0.759 . . . . 0.0 109.501 179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 73.0 ttt-85 -114.43 127.44 55.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.129 -0.982 . . . . 0.0 111.564 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.43 132.14 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.03 140.14 49.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.966 -1.083 . . . . 0.0 111.456 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 160' ' ' VAL . 70.7 t80 -139.26 142.16 37.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.693 -0.629 . . . . 0.0 109.952 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.65 147.85 41.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 0.0 110.24 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.9 mttm -50.55 144.37 7.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.311 -0.868 . . . . 0.0 110.666 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.469 179.896 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.37 -20.94 41.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.797 1.419 . . . . 0.0 110.606 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.16 -37.34 79.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 73.31 27.81 67.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 27.3 t -120.03 145.68 46.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -1.124 . . . . 0.0 110.456 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 60.6 m -74.93 133.48 41.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 0.0 110.197 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.73 144.42 57.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.762 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' B' ' 695' ' ' ASP . 96.9 mt-10 -62.73 -23.32 67.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.091 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' B' ' 694' ' ' GLU . 85.5 m-20 57.57 39.14 27.95 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.513 -0.742 . . . . 0.0 110.176 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.26 130.59 56.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 109.526 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.55 132.35 38.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 110.314 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -79.59 136.32 36.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.813 . . . . 0.0 110.319 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -90.77 129.84 36.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.376 -0.827 . . . . 0.0 110.147 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.33 138.36 58.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.41 -0.806 . . . . 0.0 110.403 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' B' ' 704' ' ' SER . 4.5 p30 -93.27 7.42 44.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.504 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 41.9 m -66.46 -37.33 84.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.64 -40.95 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.364 -0.835 . . . . 0.0 111.159 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . 0.409 ' O ' ' O ' ' B' ' 701' ' ' ASP . 92.3 p -120.09 153.53 35.99 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.049 -1.032 . . . . 0.0 110.878 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.517 ' HB1' ' OD1' ' B' ' 707' ' ' ASP . . . -82.15 136.82 35.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.303 -0.873 . . . . 0.0 110.361 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -67.23 -32.11 72.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.542 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . 0.517 ' OD1' ' HB1' ' B' ' 705' ' ' ALA . 4.1 p30 -66.72 127.97 93.66 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.3 -0.875 . . . . 0.0 110.495 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' B' ' 709' ' ' GLU . 44.4 Cg_endo -71.71 -15.0 30.3 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.678 1.357 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' B' ' 708' ' ' PRO . 94.7 mt-10 60.0 146.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.5 -0.75 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -105.82 132.0 52.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.408 -0.808 . . . . 0.0 111.731 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 78.3 m -73.55 -38.78 65.11 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.157 0.98 . . . . 0.0 109.059 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.896 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.6 OUTLIER -173.4 -174.42 0.25 Allowed Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.896 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.7 Cg_endo -60.36 136.2 66.51 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 N-CA-C 109.516 -0.994 . . . . 0.0 109.516 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.902 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt 74.88 41.96 0.29 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.607 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.1 t -139.15 81.68 1.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 119.814 -1.804 . . . . 0.0 109.154 178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -84.37 17.2 2.69 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.143 0.973 . . . . 0.0 109.505 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.636 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.6 p -46.12 172.07 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.818 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.749 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.9 Cg_endo -72.95 -55.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.497 1.788 . . . . 0.0 108.936 175.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 41.1 mttt -160.52 -14.94 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.76 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 55.33 25.96 8.12 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -93.45 126.7 49.26 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.234 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.35 133.46 24.54 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.556 1.292 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -125.14 26.58 6.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -99.51 121.72 41.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 110.526 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -168.76 62.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.484 -0.76 . . . . 0.0 110.048 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -93.19 5.57 51.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.322 -0.861 . . . . 0.0 110.91 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.39 -31.79 69.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.093 -1.004 . . . . 0.0 110.088 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -61.32 150.25 35.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 110.074 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.42 ' HG2' ' HD3' ' B' ' 731' ' ' PRO . 42.0 tttp -74.77 129.98 38.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.621 ' O ' HG13 ' B' ' 730' ' ' VAL . 7.1 p -126.12 76.71 71.98 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.402 -0.812 . . . . 0.0 109.885 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 729' ' ' LYS . 46.3 Cg_endo -72.5 146.74 44.91 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.862 1.453 . . . . 0.0 110.847 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.65 161.57 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.482 -0.761 . . . . 0.0 109.701 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 27.8 m -110.72 143.52 41.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.487 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -162.72 26.7 0.23 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.46 -33.24 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -1.13 . . . . 0.0 110.356 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 70.47 -118.66 7.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . 0.529 ' O ' HG23 ' B' ' 739' ' ' VAL . 48.1 t -107.01 137.11 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -1.12 . . . . 0.0 110.109 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -54.44 -37.32 65.03 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 737' ' ' VAL . 57.4 t 51.19 95.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 43.3 p -80.04 158.31 26.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.353 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.3 m -122.26 150.64 42.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 110.143 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -100.91 136.44 40.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.86 117.11 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -102.75 29.98 11.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 20.8 t -57.01 -35.35 69.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -1.122 . . . . 0.0 110.53 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 85.3 p -138.96 160.91 38.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.872 . . . . 0.0 110.227 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.087 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 4.6 m -123.98 76.61 58.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.389 -1.065 . . . . 0.0 110.07 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.78 142.91 49.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.824 1.434 . . . . 0.0 110.507 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -112.24 155.02 24.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.423 -0.798 . . . . 0.0 110.034 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.72 141.33 45.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 110.233 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -86.45 -174.16 49.32 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 33.1 m -112.92 137.76 50.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 109.989 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -65.59 148.73 51.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.514 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -57.89 -34.86 70.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.629 -0.67 . . . . 0.0 110.767 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 35.2 ptt-85 -106.97 148.93 28.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.109 -0.994 . . . . 0.0 110.609 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.4 139.4 20.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.736 . . . . 0.0 110.476 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 713' ' ' PRO . 39.8 tp -95.28 132.96 39.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 110.734 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 33' ' ' HIS . 42.8 t -119.64 138.72 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' HB3' HG12 ' A' ' 34' ' ' ILE . 53.0 tp -99.59 131.25 45.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 0.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.6 t -122.55 128.45 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.484 -0.76 . . . . 0.0 110.2 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.52 -178.68 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.668 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.52 -175.42 36.41 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.255 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.1 m-20 60.76 40.82 15.66 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.764 0.792 . . . . 0.0 109.889 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.45 -35.73 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.38 42.14 30.4 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.67 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.33 136.94 19.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 108.942 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.42 25.35 19.68 Favored 'Cis proline' 0 C--N 1.316 -1.141 0 C-N-CA 123.735 -1.36 . . . . 0.0 110.242 -1.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.95 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.238 -0.914 . . . . 0.0 112.011 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.45 -21.81 4.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.991 -1.068 . . . . 0.0 111.021 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.68 158.31 43.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.098 -1.001 . . . . 0.0 110.179 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.86 -18.72 15.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.288 -0.883 . . . . 0.0 111.07 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -173.96 179.08 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.967 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.58 162.67 67.59 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.21 143.32 89.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.29 1.153 . . . . 0.0 110.315 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.93 -55.56 9.65 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.09 -36.86 73.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.849 -1.157 . . . . 0.0 111.706 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.4 m-30 -64.28 -39.85 94.76 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.033 -1.042 . . . . 0.0 111.038 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.54 -38.12 71.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 108.672 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.96 -36.15 77.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.669 -0.644 . . . . 0.0 109.602 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.7 OUTLIER -65.12 -37.95 89.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.357 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.696 HD23 HD13 ' B' ' 714' ' ' LEU . 97.9 mt -87.43 133.75 33.69 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.03 -1.043 . . . . 0.0 111.773 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.8 m -148.47 146.27 22.26 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.597 -0.689 . . . . 0.0 109.963 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.54 149.89 56.49 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.595 1.313 . . . . 0.0 110.957 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.86 -6.91 79.54 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.024 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -108.15 -26.29 10.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.25 -1.147 . . . . 0.0 110.985 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.422 HD11 HD11 ' B' ' 714' ' ' LEU . 70.7 mt -111.93 132.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.57 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -100.94 -22.32 14.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.74 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.3 m-70 -136.3 138.63 41.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.127 -0.983 . . . . 0.0 110.972 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 66.9 mt -129.67 123.39 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 110.662 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 57' ' ' HIS . 79.1 mt -110.37 129.27 55.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 108.997 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.0 t -118.56 131.26 56.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.378 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.842 HG22 HD21 ' A' ' 84' ' ' LEU . 69.0 p -103.84 -59.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.936 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.803 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.38 162.88 32.28 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.231 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -71.55 147.56 47.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.886 -0.773 . . . . 0.0 110.151 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.2 mt -54.51 -62.12 1.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 0.0 111.512 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.66 -21.78 16.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 119.893 -1.754 . . . . 0.0 110.045 -1.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 t -67.72 142.45 56.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.466 -0.771 . . . . 0.0 110.847 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -59.47 -27.76 66.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.091 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -51.74 -41.12 61.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.336 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 62.4 m -66.83 -34.52 77.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.408 -0.807 . . . . 0.0 109.961 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.4 t80 -59.3 -42.93 92.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.313 -0.867 . . . . 0.0 110.02 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.21 -40.11 88.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.813 . . . . 0.0 109.569 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.46 -44.37 96.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 110.065 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 49' ' ' LEU . 80.0 mt -63.15 -38.6 91.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -62.18 -32.87 73.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.456 -0.777 . . . . 0.0 109.743 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -63.26 -43.58 97.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.365 -0.834 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.51 -36.9 84.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 110.592 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.29 154.48 35.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.147 -0.971 . . . . 0.0 110.554 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.45 -43.48 12.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.2 110.25 19.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.181 -1.188 . . . . 0.0 110.36 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.43 133.72 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.365 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.516 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.68 127.28 54.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.305 -0.872 . . . . 0.0 109.538 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -131.22 151.27 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.943 . . . . 0.0 111.53 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -121.1 157.78 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -76.83 130.65 37.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.721 -1.237 . . . . 0.0 112.0 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.42 38.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.35 0.48 37.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.086 -1.243 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.87 25.81 3.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 111.184 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.36 133.03 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.083 -1.011 . . . . 0.0 110.37 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.62 -46.04 70.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.31 119.63 19.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.466 0.65 . . . . 0.0 110.179 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.43 -1.15 57.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.5 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -75.51 -3.93 36.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 111.237 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.1 147.81 80.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.948 -1.095 . . . . 0.0 109.45 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.2 Cg_endo -76.7 140.47 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.832 1.438 . . . . 0.0 110.918 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.41 81.06 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -0.917 . . . . 0.0 109.136 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.62 150.29 29.34 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.55 147.65 34.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.949 -1.095 . . . . 0.0 111.567 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.74 113.25 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.33 131.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.79 130.48 37.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -121.53 86.95 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.507 -0.746 . . . . 0.0 109.174 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.91 -119.28 5.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.29 50.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.852 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.72 137.28 36.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.047 -1.033 . . . . 0.0 113.257 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.49 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.9 140.56 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 112.184 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.43 159.33 16.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.842 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.78 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.368 . . . . 0.0 111.864 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.62 149.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.554 -0.716 . . . . 0.0 109.508 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.803 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -61.03 -60.37 3.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.885 -1.134 . . . . 0.0 110.469 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.54 3.41 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.313 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.431 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.76 -17.3 55.41 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.969 -1.312 . . . . 0.0 110.065 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.72 -5.98 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.4 113.09 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.16 129.63 24.38 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 110.149 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 154.95 97.18 Favored 'Cis proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.797 -2.168 . . . . 0.0 111.648 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -39.01 -57.58 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.34 34.19 5.66 Favored Glycine 0 N--CA 1.5 2.951 0 C-N-CA 118.973 -1.584 . . . . 0.0 112.495 -177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.34 135.05 36.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.726 -1.455 . . . . 0.0 110.402 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.9 -40.43 63.17 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.509 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.94 -38.71 86.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.3 m -67.0 -42.12 85.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 109.201 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.74 -42.04 97.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.461 -0.775 . . . . 0.0 109.463 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.772 . . . . 0.0 109.452 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.15 -35.55 67.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.151 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.0 tp -72.01 -35.39 69.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 0.0 109.643 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.75 -45.49 85.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.421 -0.799 . . . . 0.0 109.837 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.01 -57.03 12.53 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.115 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.8 -45.55 70.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.747 -0.596 . . . . 0.0 110.651 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.9 m-30 -72.13 -29.04 63.67 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.356 -0.84 . . . . 0.0 111.398 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.44 47.98 10.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.178 -0.951 . . . . 0.0 109.852 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.01 156.05 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.412 -0.805 . . . . 0.0 110.268 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.13 -32.03 33.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -0.798 . . . . 0.0 109.027 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.6 mt -129.21 140.52 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.533 -0.729 . . . . 0.0 110.041 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.64 123.36 42.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -0.886 . . . . 0.0 109.845 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.537 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -105.97 131.67 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.252 -0.905 . . . . 0.0 109.958 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.0 p -157.57 160.78 38.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.05 -120.73 1.97 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.67 -34.3 0.24 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.974 -0.721 . . . . 0.0 111.575 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.8 p -87.93 -9.58 53.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.803 -1.186 . . . . 0.0 111.429 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.56 24.96 7.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.039 -1.038 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.64 114.3 19.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.317 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.2 t80 -54.52 137.91 41.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.029 -1.045 . . . . 0.0 110.284 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.94 122.37 7.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.514 -0.741 . . . . 0.0 110.308 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.56 97.73 3.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.44 -0.787 . . . . 0.0 109.84 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.62 21.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.19 145.46 37.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.425 -0.797 . . . . 0.0 110.287 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -146.63 117.63 7.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.128 -0.982 . . . . 0.0 110.858 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.86 58.17 5.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.565 -0.709 . . . . 0.0 111.398 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.14 15.3 6.18 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.804 -0.56 . . . . 0.0 112.375 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.69 154.87 38.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.827 -1.171 . . . . 0.0 109.848 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 179' ' ' TYR . 5.6 t80 -113.23 140.97 47.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 0.0 111.244 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.14 134.27 53.38 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 121' ' ' ALA . 13.6 mm -134.06 136.03 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.17 -0.957 . . . . 0.0 111.913 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.43 109.0 14.77 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.05 -29.97 47.94 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.467 1.246 . . . . 0.0 111.502 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.86 -139.4 14.82 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.6 t -117.8 111.72 19.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -1.133 . . . . 0.0 110.458 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.51 -20.62 47.48 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -0.884 . . . . 0.0 110.468 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.8 p -113.53 13.2 18.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.298 -0.876 . . . . 0.0 110.54 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.4 36.55 63.57 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -49.99 146.84 4.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.94 . . . . 0.0 110.808 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.14 46.19 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.738 0.78 . . . . 0.0 111.426 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.9 115.92 5.66 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.07 10.87 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.29 -28.73 47.59 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.641 -1.287 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.26 116.23 22.34 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.775 -1.203 . . . . 0.0 109.886 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.94 -15.89 60.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.724 . . . . 0.0 111.291 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.5 94.17 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.135 -0.978 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.78 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.508 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.8 mt -112.98 120.98 39.41 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.54 134.79 39.67 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.504 1.265 . . . . 0.0 109.881 -178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.7 p -167.96 153.93 7.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.078 . . . . 0.0 112.023 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.579 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.1 p90 -136.97 160.8 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.78 136.09 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 113.613 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.805 HD11 HD12 ' B' ' 714' ' ' LEU . 13.7 mt -108.16 134.49 50.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 56.0 mtp -114.25 123.78 50.41 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.946 -1.096 . . . . 0.0 110.436 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -100.27 117.75 35.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.771 . . . . 0.0 109.621 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.551 HG12 HG23 ' A' ' 160' ' ' VAL . 96.5 mt -115.13 123.91 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.898 . . . . 0.0 111.093 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.74 -54.77 2.74 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.621 0.724 . . . . 0.0 109.396 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.48 106.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 m 60.28 10.11 2.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.1 m -139.32 132.77 30.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 108.842 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 HG12 ' A' ' 155' ' ' ILE . 9.4 p -132.27 138.66 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.879 -1.138 . . . . 0.0 111.599 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.07 124.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.425 HG21 ' HE1' ' A' ' 128' ' ' PHE . 61.2 p -105.7 134.83 48.18 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.612 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.835 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.31 127.97 56.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.09 132.31 59.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.719 ' CE2' HD12 ' A' ' 152' ' ' LEU . 66.0 m-85 -111.01 113.56 26.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.23 -0.919 . . . . 0.0 109.803 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -107.76 137.23 46.14 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.642 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 172' ' ' VAL . 41.1 tp -93.94 82.2 4.22 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.673 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.5 mt -99.49 118.71 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.37 -161.11 54.17 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -71.73 -44.01 64.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -1.23 . . . . 0.0 110.591 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -76.29 155.87 33.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 0.0 110.798 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.758 HG12 HD12 ' A' ' 167' ' ' LEU . 24.6 m -104.23 128.56 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.596 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.89 149.54 21.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.825 . . . . 0.0 110.047 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.494 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.2 p -132.38 141.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 111.042 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.4 tt0 -121.36 150.92 40.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 109.439 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -115.98 127.11 54.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.113 -0.992 . . . . 0.0 111.69 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.3 mm -126.36 132.8 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -115.3 140.9 48.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.015 -1.053 . . . . 0.0 111.502 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.22 141.74 37.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.679 -0.638 . . . . 0.0 109.966 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.26 147.69 42.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 50.3 mttm -50.51 147.62 4.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.384 -0.822 . . . . 0.0 110.632 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.232 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.08 -17.65 40.58 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.875 1.461 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . 0.555 HD22 ' N ' ' B' ' 689' ' ' LEU . 4.4 mm? -87.67 144.94 26.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.194 -0.941 . . . . 0.0 110.083 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 106.96 -103.57 2.02 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 51.7 m -115.7 145.91 42.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 110.022 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . 0.448 HG22 ' H ' ' B' ' 694' ' ' GLU . 41.3 m -92.15 135.01 34.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.57 -28.75 68.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.401 -0.812 . . . . 0.0 110.73 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.448 ' H ' HG22 ' B' ' 692' ' ' THR . 96.6 mt-10 -57.07 136.0 56.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -65.77 -41.52 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.439 -0.788 . . . . 0.0 110.747 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 84.3 mt -113.17 134.25 54.66 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.78 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -107.07 -71.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.972 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -128.6 -173.01 2.85 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -69.62 119.5 13.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.865 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.49 -35.53 81.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.44 -0.787 . . . . 0.0 110.586 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -91.47 173.94 7.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.409 -0.807 . . . . 0.0 110.67 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 15.0 t -127.28 154.29 45.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 59.9 t -128.15 -63.79 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.34 -0.85 . . . . 0.0 110.305 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 86.7 p -61.58 -29.19 69.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.434 -0.791 . . . . 0.0 110.325 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -121.92 151.57 40.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 110.265 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -133.07 -162.15 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -122.67 73.19 42.83 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.0 110.331 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.69 -21.22 34.11 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.763 1.401 . . . . 0.0 110.446 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -113.18 163.62 14.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 110.605 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -55.52 149.1 14.23 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.531 0.681 . . . . 0.0 111.633 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 58.4 m -63.73 -40.15 96.02 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.351 1.072 . . . . 0.0 108.155 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.857 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.16 -179.14 0.53 Allowed Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.857 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.0 Cg_endo -59.72 138.05 80.71 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 122.898 0.946 . . . . 0.0 110.397 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.024 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.6 mt 68.56 52.02 0.61 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -139.24 78.11 1.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.239 -1.538 . . . . 0.0 108.867 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -82.09 18.5 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.075 0.94 . . . . 0.0 109.677 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.627 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 24.8 p -45.17 171.99 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.397 179.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.6 Cg_endo -71.09 -55.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 124.282 1.675 . . . . 0.0 108.879 176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 97.9 mttt -160.49 -15.11 0.05 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.883 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.05 27.22 7.26 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.292 -1.374 . . . . 0.0 107.292 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -128.73 159.25 69.15 Favored Pre-proline 0 N--CA 1.484 1.254 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.42 104.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.798 1.42 . . . . 0.0 110.058 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -64.85 -34.07 77.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.34 -0.85 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -126.07 163.65 22.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.391 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -68.19 156.48 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.948 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -59.61 133.51 56.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.813 . . . . 0.0 110.486 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.576 HD12 ' N ' ' B' ' 727' ' ' LEU . 6.6 mp -73.3 -34.08 65.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 109.926 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 729' ' ' LYS . . . -109.13 155.87 20.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 0.0 110.427 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 728' ' ' ALA . 17.1 mttp 58.75 44.51 16.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.537 -0.727 . . . . 0.0 110.558 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 730' ' ' VAL . 12.8 p -110.39 116.35 53.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.143 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 126.67 13.58 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.32 1.168 . . . . 0.0 110.317 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.56 74.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.182 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 16.7 m -79.62 84.45 5.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -87.31 178.87 47.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.53 -35.01 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -1.14 . . . . 0.0 110.098 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 162.2 -114.33 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.57 128.67 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.093 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -153.08 171.66 18.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.3 119.71 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -0.945 . . . . 0.0 110.096 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 60.0 m -79.22 -36.68 39.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 110.382 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.4 m -65.81 159.71 24.73 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.469 -0.769 . . . . 0.0 110.775 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -93.82 126.33 38.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.54 -0.725 . . . . 0.0 109.91 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -84.83 119.43 25.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.367 -0.833 . . . . 0.0 110.464 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -89.44 109.87 3.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 33.8 t -145.49 157.01 44.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -1.061 . . . . 0.0 110.232 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 49.3 m -115.88 148.02 40.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.442 -0.786 . . . . 0.0 110.08 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.288 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.05 150.58 95.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 110.167 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.86 150.51 73.6 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.75 1.395 . . . . 0.0 110.262 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.9 137.23 33.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.868 . . . . 0.0 110.363 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -141.97 161.42 38.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.433 -0.792 . . . . 0.0 110.063 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 89.57 -52.24 3.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 63.6 p -70.58 -19.87 62.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.432 -1.04 . . . . 0.0 110.119 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -117.14 144.22 44.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.348 -0.845 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -82.76 150.42 26.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 111.019 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.479 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 36.0 ptt-85 -111.0 150.75 28.83 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.98 140.72 52.11 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.439 -1.304 . . . . 0.0 110.391 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.3 tp -95.09 133.42 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.482 -0.762 . . . . 0.0 110.871 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.704 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.0 t -120.86 137.49 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 0.0 110.043 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 31' ' ' ILE . 53.4 tp -99.94 131.12 46.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.538 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -122.64 128.56 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.267 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? -164.34 -178.39 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.693 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.15 -175.64 36.07 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.335 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.711 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.4 m-20 61.01 40.81 14.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.746 0.784 . . . . 0.0 109.822 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.58 -35.68 65.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.3 m80 55.31 42.09 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.719 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.5 mt -100.21 136.85 19.97 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 109.049 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.4 Cg_endo -98.36 25.23 19.9 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 123.862 -1.308 . . . . 0.0 110.23 -1.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -60.9 -48.05 83.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.21 -0.931 . . . . 0.0 111.963 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.3 mtt180 -124.54 -21.75 4.79 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.988 -1.07 . . . . 0.0 111.061 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 98.2 m -133.79 158.4 43.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.123 -0.986 . . . . 0.0 110.129 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.95 -18.65 15.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 111.105 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -173.93 179.05 2.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.097 -1.002 . . . . 0.0 110.638 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.56 162.73 67.41 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -63.14 141.91 84.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.338 1.178 . . . . 0.0 110.169 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.44 -54.88 8.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -58.6 -36.87 74.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.929 -1.107 . . . . 0.0 111.838 -178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -64.0 -39.77 94.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.982 -1.074 . . . . 0.0 111.115 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -56.49 -36.55 69.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.98 -1.075 . . . . 0.0 108.744 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -69.12 -37.06 78.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.597 -0.689 . . . . 0.0 109.789 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.824 ' O ' ' HB3' ' B' ' 714' ' ' LEU . 0.3 OUTLIER -65.71 -38.23 88.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.203 -0.936 . . . . 0.0 110.314 179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.803 HD23 ' CD1' ' B' ' 714' ' ' LEU . 94.6 mt -85.75 130.93 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.876 -1.14 . . . . 0.0 111.54 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.1 m -148.22 146.7 23.89 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.745 -0.597 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.15 148.59 56.44 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.542 1.285 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.06 -5.25 78.61 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.954 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.6 mmmt -109.06 -25.74 10.53 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.217 -1.166 . . . . 0.0 111.11 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 4' ' ' LEU . 73.0 mt -113.25 132.5 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 110.653 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -99.98 -23.41 14.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.507 -0.746 . . . . 0.0 110.756 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.704 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.2 m-70 -135.61 139.97 44.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.159 -0.963 . . . . 0.0 111.047 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.4 mt -130.49 123.0 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.377 -0.827 . . . . 0.0 110.739 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.1 mt -109.87 129.14 55.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.4 t -118.76 129.98 55.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.45 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HD21 ' A' ' 84' ' ' LEU . 71.0 p -103.38 -59.48 1.71 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.925 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -62.24 160.92 30.72 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.19 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -70.87 148.07 48.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.76 -0.847 . . . . 0.0 110.088 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.4 mt -55.04 -62.62 1.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -0.817 . . . . 0.0 111.634 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.593 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.0 p -98.88 -20.68 16.7 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.801 -1.812 . . . . 0.0 110.248 -1.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.5 t -68.79 142.67 54.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.82 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 67.9 tttt -59.39 -28.19 66.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -51.5 -41.15 60.76 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HD22 ' A' ' 40' ' ' LEU . 62.1 m -66.44 -34.6 78.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.47 -0.768 . . . . 0.0 109.824 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.0 t80 -59.59 -43.15 93.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.059 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -60.08 -40.33 89.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 0.0 109.61 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.2 -44.51 96.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 110.079 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.3 mt -62.91 -38.45 91.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 110.168 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.36 -32.57 73.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.491 -0.756 . . . . 0.0 109.787 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.7 m -63.41 -43.36 97.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.405 -0.809 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.13 -36.31 83.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.207 -0.933 . . . . 0.0 110.617 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.69 154.52 35.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.72 -43.77 11.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -85.51 110.21 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.23 -1.159 . . . . 0.0 110.391 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.37 134.08 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.92 127.26 54.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 75.5 mt -131.61 151.36 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 111.632 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.4 m -120.93 156.53 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -75.92 130.93 39.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.801 -1.187 . . . . 0.0 111.817 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.6 -175.51 38.55 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.55 36.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.068 -1.254 . . . . 0.0 110.757 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.93 25.81 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 111.104 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.27 132.99 35.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.64 -46.0 70.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -75.3 119.75 19.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.633 -0.667 . . . . 0.0 110.092 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 tt -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.68 . . . . 0.0 110.516 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.6 -3.82 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 111.262 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.02 147.7 80.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.831 -1.168 . . . . 0.0 109.545 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.58 140.39 21.22 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.936 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.69 -39.44 80.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.912 . . . . 0.0 109.152 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.67 150.35 29.37 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.6 147.69 34.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.528 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.74 113.3 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.39 131.73 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.364 -0.835 . . . . 0.0 110.257 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 m -91.65 130.49 37.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.394 -0.816 . . . . 0.0 109.979 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -121.58 86.9 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.522 -0.736 . . . . 0.0 109.209 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.88 -119.22 5.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.23 50.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.284 -1.127 . . . . 0.0 110.859 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.78 137.38 36.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.095 -1.003 . . . . 0.0 113.213 -177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -105.33 107.54 18.58 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.98 140.44 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 112.226 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.29 159.22 16.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.879 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.09 131.64 27.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.992 -1.299 . . . . 0.0 111.952 -179.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.51 149.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.526 -0.734 . . . . 0.0 109.556 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.93 -60.27 4.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.947 -1.095 . . . . 0.0 110.564 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.95 -26.72 3.4 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.23 54.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.98 -1.306 . . . . 0.0 110.092 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.78 -5.98 59.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 109.955 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.38 113.13 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.21 129.48 24.52 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.34 154.99 97.35 Favored 'Cis proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.778 -2.176 . . . . 0.0 111.701 -0.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.07 -57.53 1.27 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.33 33.92 5.82 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.096 -1.526 . . . . 0.0 112.559 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.27 135.11 36.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.678 -1.484 . . . . 0.0 110.352 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -74.0 -40.38 62.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.92 -38.67 86.6 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.538 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.4 m -67.11 -42.15 85.03 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.272 -0.892 . . . . 0.0 109.071 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.68 -42.08 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.497 -0.752 . . . . 0.0 109.426 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.1 94.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.507 -0.746 . . . . 0.0 109.463 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.28 -35.47 67.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.499 -0.751 . . . . 0.0 109.169 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.97 -35.4 69.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.591 -0.693 . . . . 0.0 109.71 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.8 -45.45 86.03 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.44 -0.788 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -57.03 12.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 0.0 110.181 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.78 -45.44 70.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.641 . . . . 0.0 110.731 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.94 63.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 111.439 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.29 48.04 10.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.0 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.467 -0.77 . . . . 0.0 110.254 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.2 -31.92 33.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.369 -0.832 . . . . 0.0 109.055 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.26 140.44 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.648 -0.657 . . . . 0.0 110.045 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.56 123.41 42.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.577 HG22 HG21 ' A' ' 37' ' ' THR . 36.4 mm -105.96 131.63 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.934 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.3 p -157.55 160.75 38.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.06 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.3 t60 75.67 -34.25 0.24 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.906 -0.761 . . . . 0.0 111.587 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.4 p -87.96 -9.58 53.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.8 -1.187 . . . . 0.0 111.474 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 24.84 7.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.995 -1.066 . . . . 0.0 110.813 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.59 114.28 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.23 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.54 137.89 42.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 110.291 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.44 7.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.57 -0.706 . . . . 0.0 110.257 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.62 97.76 3.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.502 -0.749 . . . . 0.0 109.828 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.98 167.56 21.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.248 -0.907 . . . . 0.0 111.05 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -110.16 145.46 37.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.448 -0.782 . . . . 0.0 110.248 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.56 117.52 7.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.154 -0.966 . . . . 0.0 110.956 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.3 mt-10 52.98 58.03 5.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.525 -0.734 . . . . 0.0 111.426 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.23 15.33 6.31 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.793 -0.567 . . . . 0.0 112.415 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.72 154.9 38.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 109.812 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.32 140.91 47.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 111.243 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.98 134.21 53.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.06 136.05 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.091 -1.006 . . . . 0.0 111.965 -178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.41 109.01 14.79 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.04 -30.03 47.96 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.485 1.255 . . . . 0.0 111.436 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.91 -139.46 14.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.2 t -117.78 111.75 19.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.354 -1.086 . . . . 0.0 110.499 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.55 -20.66 48.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.868 . . . . 0.0 110.454 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.44 13.05 18.85 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.2 -0.937 . . . . 0.0 110.544 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.59 36.54 64.84 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.12 146.98 4.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.969 . . . . 0.0 110.763 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.96 151.15 46.57 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.7 0.762 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.89 116.0 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.94 -29.1 11.24 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.65 47.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.587 -1.321 . . . . 0.0 112.36 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.836 -1.165 . . . . 0.0 109.865 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.01 -15.8 60.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.577 -0.702 . . . . 0.0 111.248 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.17 4.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.008 . . . . 0.0 110.096 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.56 139.77 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.92 120.97 39.51 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.804 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.5 Cg_endo -65.52 134.72 39.49 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.482 1.254 . . . . 0.0 110.0 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.2 p -167.45 155.35 9.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.87 -1.144 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.609 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 23.0 p90 -137.98 160.64 38.81 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.53 135.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.938 -1.101 . . . . 0.0 113.463 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 165' ' ' TYR . 12.8 mt -107.91 136.24 47.95 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.4 mtp -114.72 124.21 51.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.911 -1.118 . . . . 0.0 110.445 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -100.67 117.14 34.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.562 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.0 mt -115.4 123.69 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 111.242 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.479 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.17 -55.09 2.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.581 0.705 . . . . 0.0 109.39 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.25 107.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.3 m 59.61 10.76 2.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.324 -0.86 . . . . 0.0 110.448 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 67.1 m -139.9 132.68 29.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 108.808 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.562 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.8 p -132.31 139.25 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.89 -1.131 . . . . 0.0 111.481 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.3 t -115.88 124.55 72.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.48 HG21 ' HE1' ' A' ' 128' ' ' PHE . 62.9 p -105.11 135.16 46.97 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.51 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.859 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.81 128.76 56.54 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.6 p -110.43 130.47 63.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.242 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.701 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.3 m-85 -109.62 109.54 20.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -105.23 139.19 40.26 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.457 -0.777 . . . . 0.0 109.767 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.804 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.1 tp -97.42 94.71 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.191 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.79 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.2 mt -108.56 124.63 65.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.41 -133.09 32.95 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -95.53 -53.13 3.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.139 -1.212 . . . . 0.0 110.217 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.47 155.71 40.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.496 -0.753 . . . . 0.0 110.325 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 167' ' ' LEU . 58.4 t -102.79 128.96 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.795 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.79 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -95.23 146.87 24.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.406 -0.809 . . . . 0.0 109.808 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.515 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 8.2 p -131.1 140.27 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 36.0 tt0 -120.19 151.97 38.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.763 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -116.33 127.2 54.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.16 -0.963 . . . . 0.0 111.703 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.53 132.43 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -115.19 141.42 48.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.026 -1.046 . . . . 0.0 111.402 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -139.74 141.79 36.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -139.02 147.09 41.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.183 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.4 mttm -50.23 144.39 7.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.307 -0.871 . . . . 0.0 110.685 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.36 -18.64 44.17 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.727 1.383 . . . . 0.0 110.8 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.1 mt -87.3 142.69 27.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.155 -0.966 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 86.64 -171.09 42.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 14.9 p -147.07 68.2 1.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.361 -1.082 . . . . 0.0 110.335 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 11.3 t -136.01 160.73 37.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 110.387 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -94.8 150.09 20.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 110.048 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.6 138.51 57.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.332 -0.855 . . . . 0.0 110.365 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.7 118.88 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.412 -0.805 . . . . 0.0 110.04 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 23.7 tp -98.86 122.01 41.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -137.08 148.03 46.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 110.056 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -158.08 162.77 38.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . 0.842 ' HB3' ' CG2' ' B' ' 702' ' ' THR . . . -151.07 150.94 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 110.131 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.66 -33.82 73.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 31.6 p-10 -141.1 111.95 7.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.835 . . . . 0.0 110.468 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . 0.842 ' CG2' ' HB3' ' B' ' 699' ' ' ALA . 54.4 p -122.63 156.59 33.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.72 136.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.251 -0.905 . . . . 0.0 110.596 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 49.1 m -119.23 147.23 44.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -145.26 154.67 42.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.584 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -143.17 93.27 2.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.471 -0.768 . . . . 0.0 109.879 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -125.43 87.86 55.05 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.408 -0.808 . . . . 0.0 110.291 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 137.16 40.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.736 1.388 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -72.26 147.12 46.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -99.57 142.52 30.95 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.838 0.828 . . . . 0.0 111.791 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 55.9 m -65.25 -39.09 92.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.859 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 p80 -174.66 177.28 0.63 Allowed Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.9 Cg_endo -60.6 139.83 87.97 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.204 1.107 . . . . 0.0 110.338 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.954 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.1 mt 74.65 41.36 0.34 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.492 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.5 t -133.0 85.34 2.21 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.476 -1.39 . . . . 0.0 107.588 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -78.99 15.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.79 0.805 . . . . 0.0 110.299 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.587 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 28.1 p -48.78 170.26 0.13 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.905 -0.497 . . . . 0.0 111.294 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 35.8 Cg_endo -68.05 -53.21 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.054 1.555 . . . . 0.0 108.134 176.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 26.2 mtmt -164.7 -15.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.412 ' H ' ' H ' ' B' ' 719' ' ' LYS . 20.8 m 53.82 26.48 6.13 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -132.73 168.22 18.93 Favored Pre-proline 0 N--CA 1.486 1.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.544 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' B' ' 723' ' ' ALA . 44.3 Cg_endo -75.86 -59.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.825 1.434 . . . . 0.0 110.27 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 722' ' ' PRO . . . 177.88 44.16 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.191 -0.943 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -104.8 133.06 50.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.219 -0.926 . . . . 0.0 110.589 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -112.95 154.1 26.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.478 -0.764 . . . . 0.0 110.051 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -86.42 152.35 22.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.994 . . . . 0.0 110.537 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' B' ' 729' ' ' LYS . 21.3 tp -100.11 125.94 46.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.384 -0.822 . . . . 0.0 109.771 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -105.54 29.72 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.263 -0.898 . . . . 0.0 110.499 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' B' ' 727' ' ' LEU . 25.0 mttt -93.11 145.05 24.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.852 . . . . 0.0 110.153 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.431 HG22 ' H ' ' B' ' 730' ' ' VAL . 35.3 m -100.18 160.33 27.38 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.842 . . . . 0.0 110.489 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.32 159.54 53.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -55.62 147.97 17.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.365 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 32.8 t -74.41 146.72 42.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.371 -0.831 . . . . 0.0 110.434 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -177.98 69.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.32 136.42 34.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.329 -1.1 . . . . 0.0 110.299 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -60.23 -32.44 76.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -129.84 144.8 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -1.102 . . . . 0.0 110.287 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -99.99 131.32 46.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.357 -0.839 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.15 138.24 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 31.7 m -77.26 131.59 38.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 49.8 m -128.91 149.56 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.422 -0.799 . . . . 0.0 110.316 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 51.12 73.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.321 -0.862 . . . . 0.0 110.654 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -57.45 -38.2 74.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.209 -0.932 . . . . 0.0 110.269 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.99 47.98 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 13.7 t -170.01 -58.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.38 -1.071 . . . . 0.0 110.261 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.7 t -122.01 144.24 49.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 0.0 110.168 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.179 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.91 85.64 60.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.076 . . . . 0.0 110.57 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.97 -23.16 47.22 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.586 1.308 . . . . 0.0 110.138 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.68 -20.62 65.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.46 -0.775 . . . . 0.0 110.055 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -50.65 -41.67 55.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 111.064 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 177.81 -82.84 0.07 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.407 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 57.9 m -69.33 137.71 53.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.354 -1.086 . . . . 0.0 110.897 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -89.67 146.34 24.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -67.8 133.55 49.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.322 -0.861 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 59.6 ttp180 52.24 108.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.624 -0.672 . . . . 0.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.61 135.57 49.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.935 -1.103 . . . . 0.0 110.464 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' B' ' 713' ' ' PRO . 47.9 tp -91.37 130.46 37.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 110.56 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.746 HG22 ' HB2' ' A' ' 33' ' ' HIS . 41.6 t -118.0 138.17 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.273 -0.892 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.563 ' HA ' HD23 ' A' ' 152' ' ' LEU . 51.8 tp -98.14 131.26 44.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 110.526 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.0 129.3 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 110.08 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.02 -176.02 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 157.17 -175.42 34.62 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.699 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.5 m-20 61.21 40.73 14.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.865 -0.785 . . . . 0.0 109.849 -179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.8 mt -73.59 -35.67 65.44 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.38 42.03 30.5 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.686 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.94 19.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.878 . . . . 0.0 109.0 178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.3 Cg_endo -98.42 25.28 19.77 Favored 'Cis proline' 0 C--N 1.317 -1.119 0 C-N-CA 123.773 -1.345 . . . . 0.0 110.181 -1.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -60.85 -48.08 83.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 111.958 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.6 mtt180 -124.48 -21.89 4.78 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.011 -1.055 . . . . 0.0 111.005 -178.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.66 158.4 43.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.142 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -101.85 -18.78 15.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.206 -0.934 . . . . 0.0 111.053 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -173.92 179.12 2.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.047 -1.033 . . . . 0.0 110.6 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.69 162.62 67.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.4 Cg_endo -63.3 144.02 90.47 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.36 1.189 . . . . 0.0 110.425 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -56.17 8.46 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -58.05 -36.74 73.21 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.8 -1.188 . . . . 0.0 111.739 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.575 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.86 -39.97 95.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.964 -1.085 . . . . 0.0 110.916 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.26 -38.35 71.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 108.778 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.89 -34.84 76.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.634 -0.666 . . . . 0.0 109.433 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.786 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -65.23 -40.2 93.75 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.403 -0.811 . . . . 0.0 110.387 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.918 HD23 HD13 ' B' ' 714' ' ' LEU . 87.6 mt -85.33 135.14 34.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.165 -0.959 . . . . 0.0 111.674 -178.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.17 145.15 18.88 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.65 -0.656 . . . . 0.0 110.103 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.8 158.41 53.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.564 1.297 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.42 8.34 87.66 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.7 ' HG2' ' CD2' ' B' ' 714' ' ' LEU . 18.5 tptt -119.08 -47.95 2.46 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -1.039 . . . . 0.0 111.41 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 4' ' ' LEU . 21.7 mt -96.12 126.68 48.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.706 -177.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -89.75 -27.88 19.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.687 -0.633 . . . . 0.0 111.037 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.746 ' HB2' HG22 ' A' ' 3' ' ' VAL . 70.3 m-70 -131.47 140.63 49.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.159 -0.963 . . . . 0.0 111.46 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.8 mt -130.31 123.31 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.527 -0.733 . . . . 0.0 110.676 178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 57' ' ' HIS . 77.9 mt -109.91 129.35 55.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 0.0 109.046 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.403 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.4 t -119.55 130.02 54.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.405 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.84 HG22 HD21 ' A' ' 84' ' ' LEU . 73.2 p -103.21 -61.84 1.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.476 -0.765 . . . . 0.0 110.785 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -59.2 162.9 12.15 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -178.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -72.84 148.34 44.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.645 -0.915 . . . . 0.0 110.245 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.7 mt -54.9 -62.56 1.58 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.356 -0.84 . . . . 0.0 111.577 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.2 p -98.69 -21.14 16.57 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 119.785 -1.822 . . . . 0.0 110.122 -1.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -68.58 142.95 55.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.86 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.86 -27.74 66.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 110.209 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -51.95 -40.76 61.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.212 -0.93 . . . . 0.0 110.138 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB2' HD22 ' A' ' 40' ' ' LEU . 67.2 m -66.62 -34.46 77.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.947 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' N ' HD22 ' A' ' 40' ' ' LEU . 77.8 t80 -59.66 -43.0 94.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.337 -0.852 . . . . 0.0 110.026 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.15 -39.92 88.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 0.0 109.648 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -62.68 -44.62 95.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.43 -0.794 . . . . 0.0 110.035 179.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.8 mt -62.82 -38.28 90.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.347 -0.845 . . . . 0.0 110.091 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -62.38 -32.8 73.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.502 -0.749 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.35 -43.44 97.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.454 -0.778 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.83 -36.66 83.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 0.0 110.549 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.36 154.63 36.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.459 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.44 -43.42 12.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -86.19 110.16 19.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -1.13 . . . . 0.0 110.404 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.2 133.95 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.493 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.83 126.68 53.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 0.0 109.518 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 36' ' ' CYS . 73.4 mt -131.28 150.87 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 111.383 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -119.8 155.75 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -74.63 130.7 40.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.797 -1.19 . . . . 0.0 111.627 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.5 -175.56 38.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.34 0.54 36.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.137 -1.214 . . . . 0.0 110.836 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.77 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 111.177 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.33 133.0 35.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.58 -46.11 70.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.088 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.23 119.62 19.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.685 -0.634 . . . . 0.0 110.221 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.46 -1.07 57.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.677 . . . . 0.0 110.589 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.5 -3.95 36.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.12 -0.988 . . . . 0.0 111.216 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -75.98 147.73 80.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.069 . . . . 0.0 109.451 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.498 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.68 140.42 20.99 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.922 1.485 . . . . 0.0 110.93 -178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.71 -39.36 80.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.272 -0.892 . . . . 0.0 109.204 179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.7 150.33 29.33 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.67 147.7 34.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.863 -1.148 . . . . 0.0 111.592 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.77 113.28 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.78 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.31 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.0 m -91.74 130.46 37.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.816 . . . . 0.0 109.945 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.55 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.482 -0.762 . . . . 0.0 109.173 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.03 -119.27 5.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.419 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.34 -6.14 50.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.279 -1.13 . . . . 0.0 110.864 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.4 m-85 -97.77 137.34 36.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.023 -1.048 . . . . 0.0 113.275 -177.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.53 18.57 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.95 140.54 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 112.2 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.28 16.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.74 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.39 . . . . 0.0 111.888 -179.245 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.61 149.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.38 3.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.856 -1.152 . . . . 0.0 110.489 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.73 3.39 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.398 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.433 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.7 p-80 -61.75 -17.27 55.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.913 -1.345 . . . . 0.0 110.033 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.433 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -5.94 59.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.359 -0.838 . . . . 0.0 109.977 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.46 113.16 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.219 -0.926 . . . . 0.0 109.635 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.15 129.54 24.45 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.31 -0.869 . . . . 0.0 110.181 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.889 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.5 Cg_endo -71.23 154.98 97.19 Favored 'Cis proline' 0 C--N 1.319 -0.988 0 C-N-CA 121.799 -2.167 . . . . 0.0 111.692 -0.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -39.0 -57.59 1.24 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.32 34.04 5.75 Favored Glycine 0 N--CA 1.5 2.936 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.537 -177.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.889 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.31 135.12 36.65 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.66 -1.494 . . . . 0.0 110.307 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.97 -40.45 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.437 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.88 -38.81 86.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.485 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.01 -42.09 85.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.164 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.68 -42.14 98.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.447 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.15 94.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.446 -0.784 . . . . 0.0 109.441 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.19 -35.62 67.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.721 . . . . 0.0 109.088 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.9 -35.39 69.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -57.89 -45.39 86.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.484 -0.76 . . . . 0.0 109.804 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -54.05 -57.02 12.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.365 -0.834 . . . . 0.0 110.154 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.84 -45.54 70.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.618 . . . . 0.0 110.635 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.11 -29.02 63.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 0.0 111.422 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.12 10.41 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 0.0 109.841 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.06 155.93 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 0.0 110.288 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -81.13 -31.98 33.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.117 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.22 140.59 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.693 -0.63 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.71 123.42 42.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.898 . . . . 0.0 109.858 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.611 HG22 HG21 ' A' ' 37' ' ' THR . 36.6 mm -106.06 131.71 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.4 p -157.5 160.77 38.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.13 -120.72 1.96 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.1 t60 75.64 -34.21 0.24 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.875 -0.78 . . . . 0.0 111.585 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 p -88.0 -9.52 53.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.838 -1.164 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 24.97 7.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.086 -1.009 . . . . 0.0 110.739 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.7 114.25 19.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 137.84 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.302 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.38 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.336 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.53 97.69 3.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.451 -0.781 . . . . 0.0 109.875 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.92 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -0.928 . . . . 0.0 111.003 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -110.19 145.47 37.21 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.513 -0.742 . . . . 0.0 110.239 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.55 117.46 7.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.147 -0.97 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.89 58.09 5.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.503 -0.748 . . . . 0.0 111.436 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.29 15.26 6.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.754 -0.591 . . . . 0.0 112.399 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.74 154.94 38.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.916 -1.115 . . . . 0.0 109.772 178.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.35 140.95 47.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.877 . . . . 0.0 111.205 -179.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.07 134.24 53.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.4 mm -134.12 136.11 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.092 -1.005 . . . . 0.0 111.878 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.42 109.0 14.79 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.01 -30.08 48.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.622 1.327 . . . . 0.0 111.424 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.87 -139.4 14.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.82 111.71 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 0.0 110.473 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.52 47.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.342 -0.849 . . . . 0.0 110.499 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.51 13.06 18.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.163 -0.96 . . . . 0.0 110.537 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.46 36.55 64.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.97 4.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.993 . . . . 0.0 110.74 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.1 46.52 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.696 0.76 . . . . 0.0 111.488 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.81 115.97 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.87 -29.23 11.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.11 -28.76 48.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.628 -1.295 . . . . 0.0 112.402 -178.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.23 116.29 22.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.836 -1.165 . . . . 0.0 109.884 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.97 -15.91 60.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.493 -0.754 . . . . 0.0 111.228 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.48 94.21 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 110.089 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.62 139.72 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 110.496 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.95 121.04 39.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.7 Cg_endo -65.93 133.8 34.94 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.38 1.2 . . . . 0.0 109.678 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 84.1 p -166.96 154.81 9.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.79 -1.194 . . . . 0.0 111.905 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.786 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 19.1 p90 -137.21 159.6 41.45 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.1 t -127.14 139.52 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.679 -176.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.882 HD11 ' CD1' ' B' ' 714' ' ' LEU . 37.5 mt -109.26 144.61 37.16 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.9 mtp -122.34 114.4 20.72 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.888 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -91.91 117.23 29.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.641 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.774 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.2 mt -114.81 122.53 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 111.133 -179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -53.96 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.675 0.75 . . . . 0.0 109.241 178.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.04 106.85 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.0 m 60.38 8.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.333 -0.854 . . . . 0.0 110.549 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.2 m -138.07 133.14 33.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 108.876 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' CG1' ' A' ' 155' ' ' ILE . 9.5 p -131.61 138.82 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.461 -179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.23 125.22 73.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.8 p -106.19 136.7 45.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.064 -1.055 . . . . 0.0 110.757 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.27 129.26 56.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 6.0 p -113.26 132.78 61.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.369 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.696 ' CE2' HD12 ' A' ' 152' ' ' LEU . 60.5 m-85 -111.79 111.44 22.41 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.271 -0.893 . . . . 0.0 109.907 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -105.49 135.21 47.3 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.465 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.8 tp -92.74 94.09 8.8 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.269 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.765 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.5 mt -108.41 124.91 65.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.03 -133.73 34.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.19 -55.84 2.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.122 -1.222 . . . . 0.0 110.059 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -65.99 160.41 23.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 172' ' ' VAL . 12.4 p -108.04 131.16 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 109.81 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.765 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.9 mttt -96.77 148.45 22.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.47 -0.768 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.495 HG21 ' CD2' ' B' ' 712' ' ' HIS . 11.7 p -132.13 141.01 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 111.041 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 81.0 tt0 -120.26 149.74 41.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.619 -0.675 . . . . 0.0 109.37 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -114.93 126.67 55.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.561 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.11 132.32 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.91 140.96 48.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.017 -1.052 . . . . 0.0 111.437 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 160' ' ' VAL . 72.2 t80 -139.05 141.77 38.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.651 -0.656 . . . . 0.0 109.934 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.17 146.92 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.22 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 49.0 mttm -50.11 -34.38 21.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.395 -0.816 . . . . 0.0 110.612 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.617 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.78 -17.94 42.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.808 1.425 . . . . 0.0 110.532 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.83 145.64 26.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.326 -0.859 . . . . 0.0 110.104 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 138.82 -24.56 2.86 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 47.3 m -118.27 146.85 43.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -1.114 . . . . 0.0 110.024 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 73.3 p -83.69 127.29 33.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.398 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -69.58 -35.12 75.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.072 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -123.82 -178.47 4.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.475 -0.765 . . . . 0.0 110.259 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.34 143.81 48.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 110.293 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.72 -174.86 4.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 110.445 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 56.66 47.7 17.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.48 -0.763 . . . . 0.0 110.129 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.07 -38.44 76.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 0.0 110.416 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -171.09 67.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.22 -0.925 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.8 -29.22 68.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -58.93 -32.93 70.02 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.407 -0.808 . . . . 0.0 110.879 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 13.8 t -129.64 157.03 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.37 -179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.59 133.14 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 50.7 m -123.56 145.84 48.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.747 . . . . 0.0 109.874 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.75 38.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.94 . . . . 0.0 110.427 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 719' ' ' LYS . . . -73.42 142.85 46.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.828 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.53 156.27 91.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 0.0 110.255 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.7 -20.97 45.89 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.73 1.384 . . . . 0.0 110.486 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.1 150.64 20.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.358 -0.839 . . . . 0.0 110.055 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -55.87 139.91 44.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.288 -0.883 . . . . 0.0 111.427 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 45.3 m -74.05 -39.78 63.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.122 0.963 . . . . 0.0 108.849 179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.85 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.5 OUTLIER -171.21 -178.74 0.5 Allowed Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.4 Cg_endo -59.05 135.76 68.6 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 122.9 0.947 . . . . 0.0 110.489 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.918 HD13 HD23 ' A' ' 26' ' ' LEU . 9.4 mt 74.18 44.04 0.26 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.585 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -138.99 80.86 1.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.288 -1.507 . . . . 0.0 109.261 178.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -83.94 17.76 2.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.093 0.949 . . . . 0.0 109.353 178.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.62 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 27.8 p -45.59 170.69 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.821 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -73.79 -55.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.518 1.799 . . . . 0.0 108.817 175.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' B' ' 706' ' ' ALA . 51.0 mtmt -159.43 -13.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.598 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 18.9 m 59.47 27.36 16.49 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -175.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -75.66 171.11 12.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.852 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 41.7 Cg_endo -67.87 121.77 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.593 1.312 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -75.86 -19.94 58.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 110.661 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -70.53 142.48 51.81 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.867 . . . . 0.0 110.734 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -103.31 159.85 15.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.902 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -114.87 144.17 43.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.16 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 72.4 mt -99.17 138.3 36.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 110.067 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -90.67 109.49 20.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.095 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -131.79 147.16 52.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.45 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' B' ' 731' ' ' PRO . 35.1 m -97.0 164.08 18.65 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.429 -0.794 . . . . 0.0 109.64 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' B' ' 730' ' ' VAL . 43.9 Cg_endo -71.25 57.03 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.523 1.275 . . . . 0.0 110.651 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.48 64.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.1 t -55.3 -35.82 65.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -58.7 -34.1 75.5 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.0 tp -103.94 130.25 51.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.438 -1.036 . . . . 0.0 110.2 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -126.97 42.71 1.43 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.8 145.22 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.313 -1.11 . . . . 0.0 110.323 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.36 135.13 57.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.376 -0.828 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 137.92 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.376 -0.827 . . . . 0.0 110.179 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 55.7 p -118.45 164.28 15.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.463 -0.773 . . . . 0.0 110.352 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 32.8 t -110.66 151.32 27.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.469 -0.77 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -127.96 159.38 35.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 0.0 110.285 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.97 116.65 22.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.455 -0.778 . . . . 0.0 110.44 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -129.71 -64.57 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 32.9 t -124.69 143.58 50.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -1.08 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 53.5 p -70.17 161.53 30.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.121 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.138 -179.987 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' -7' ' ' PRO . 0.4 OUTLIER -103.25 -64.41 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.829 -179.83 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' -8' ' ' SER . 43.6 Cg_endo -70.64 133.76 24.65 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 O-C-N 123.225 1.118 . . . . 0.0 110.711 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -68.53 -31.49 70.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.18 157.74 25.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.533 -0.73 . . . . 0.0 110.495 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 175.95 -127.0 1.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 48.3 m -58.24 -36.04 72.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.047 . . . . 0.0 110.966 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -135.07 146.22 48.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.1 -1.0 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 156' ' ' GLN . 27.3 t70 -97.29 113.67 25.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.447 ' HG3' ' C ' ' A' ' 155' ' ' ILE . 59.4 ttp180 -132.59 134.77 45.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.446 -0.783 . . . . 0.0 109.521 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.85 138.63 54.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.399 -1.32 . . . . 0.0 110.401 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' B' ' 713' ' ' PRO . 37.1 tp -95.01 132.81 39.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 110.64 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.735 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.6 t -119.87 139.7 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.285 -0.884 . . . . 0.0 110.681 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 34' ' ' ILE . 62.5 tp -99.66 132.45 45.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.405 -0.809 . . . . 0.0 110.565 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.0 129.67 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.368 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -166.8 -178.7 4.41 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.432 -0.792 . . . . 0.0 109.783 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 159.91 -176.23 36.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.276 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.683 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.2 m-20 61.26 40.64 14.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.85 -0.794 . . . . 0.0 109.844 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.43 -35.72 65.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.35 42.07 30.52 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.636 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.4 mt -100.16 136.86 19.99 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.865 . . . . 0.0 109.05 178.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.2 Cg_endo -98.42 25.23 19.83 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 123.805 -1.331 . . . . 0.0 110.208 -1.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.93 -47.98 83.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.204 -0.935 . . . . 0.0 112.008 -178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.43 -21.83 4.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 111.086 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.1 m -133.72 158.3 43.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.125 -0.984 . . . . 0.0 110.153 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.81 -18.76 15.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 111.092 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.3 p -173.91 179.07 2.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.53 162.66 67.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.2 Cg_endo -62.58 140.52 81.82 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.318 1.168 . . . . 0.0 110.358 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.97 -59.64 2.2 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -55.97 -35.53 66.84 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.961 -1.087 . . . . 0.0 111.661 -178.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -64.14 -39.82 94.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.981 -1.074 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -56.96 -41.01 77.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.949 -1.095 . . . . 0.0 108.952 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.55 -37.25 82.41 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.738 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.8 tp -64.28 -34.62 78.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.686 -0.634 . . . . 0.0 110.748 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.566 HD23 ' CD1' ' B' ' 714' ' ' LEU . 96.4 mt -92.65 134.4 35.05 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.786 -1.196 . . . . 0.0 111.258 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.2 m -147.85 147.59 27.52 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.529 -0.732 . . . . 0.0 110.319 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.46 152.8 49.47 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.7 1.368 . . . . 0.0 111.051 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.1 -4.77 84.69 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.013 ' HE2' HD23 ' B' ' 714' ' ' LEU . 2.3 mmmt -110.77 -25.98 9.61 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.192 -1.181 . . . . 0.0 111.013 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.496 HD11 HD11 ' B' ' 714' ' ' LEU . 67.7 mt -111.66 132.62 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.518 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -100.68 -21.59 15.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.931 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.735 ' HB2' HG22 ' A' ' 3' ' ' VAL . 60.0 m-70 -136.75 138.89 41.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.196 -0.94 . . . . 0.0 111.108 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 60.5 mt -129.75 122.92 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 0.0 110.791 178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -109.98 128.91 55.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -0.843 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.1 t -119.06 130.22 55.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.119 -0.988 . . . . 0.0 110.506 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.817 HG22 HD21 ' A' ' 84' ' ' LEU . 68.3 p -103.4 -63.48 1.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.778 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -58.12 163.64 8.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -72.96 149.03 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.666 -0.902 . . . . 0.0 110.385 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 2.3 mt -55.58 -62.46 1.67 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.837 . . . . 0.0 111.514 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.91 -21.6 16.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.841 -1.787 . . . . 0.0 110.155 -0.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -68.46 143.08 55.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.426 -0.796 . . . . 0.0 110.837 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 68.2 tttt -59.69 -28.3 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.506 -0.747 . . . . 0.0 110.135 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -51.39 -40.96 60.33 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.234 -0.917 . . . . 0.0 110.208 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.39 -34.4 77.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.45 -0.781 . . . . 0.0 109.859 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 77.8 t80 -59.9 -43.2 94.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.449 -0.782 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -0.823 . . . . 0.0 109.692 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -62.52 -44.81 95.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 0.0 110.013 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.1 mt -62.65 -38.4 90.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -62.44 -32.56 73.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.468 -0.77 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -63.43 -43.56 97.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.43 -0.794 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.56 -37.06 84.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.1 -1.0 . . . . 0.0 110.565 -179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.588 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.73 154.42 36.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.463 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.47 -43.75 12.04 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.33 110.22 19.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.306 -1.114 . . . . 0.0 110.41 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.11 134.14 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.413 -0.804 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.513 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.5 m-70 -116.53 126.64 53.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.392 -0.818 . . . . 0.0 109.613 179.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.4 mt -131.47 151.22 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.905 . . . . 0.0 111.447 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.531 HG13 HD13 ' A' ' 84' ' ' LEU . 27.4 m -119.25 154.33 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -73.73 130.59 40.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.687 -1.258 . . . . 0.0 111.451 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.54 -175.53 38.65 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 178.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.31 0.53 36.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.816 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.86 25.75 3.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 111.216 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 110.379 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -68.75 -46.04 69.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.302 -0.874 . . . . 0.0 109.981 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.18 119.66 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.446 0.641 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.57 -1.0 57.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.687 . . . . 0.0 110.494 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -75.64 -3.79 36.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 111.248 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.427 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.21 147.75 80.1 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.873 -1.142 . . . . 0.0 109.429 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.3 Cg_endo -76.66 140.46 21.09 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.846 1.445 . . . . 0.0 110.885 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.8 -39.28 80.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.218 -0.926 . . . . 0.0 109.187 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.73 150.31 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.708 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.502 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.67 34.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.842 -1.161 . . . . 0.0 111.561 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.74 113.25 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.624 -0.673 . . . . 0.0 109.192 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.35 131.77 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.41 37.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.986 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.45 86.82 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.215 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.98 -119.2 4.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB3' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.23 -6.37 50.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.229 -1.159 . . . . 0.0 110.864 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.66 137.38 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 113.294 -177.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.34 107.54 18.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.6 mt -107.98 140.51 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 112.203 -176.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.39 159.3 16.24 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.817 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.2 131.72 27.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.944 -1.327 . . . . 0.0 111.893 -179.232 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.59 149.1 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 178.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.806 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.86 -60.46 3.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.988 -1.07 . . . . 0.0 110.547 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.07 -26.68 3.38 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.298 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.72 -17.26 55.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.886 -1.361 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.76 -6.01 59.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.228 -0.92 . . . . 0.0 109.889 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.37 113.18 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.17 -0.956 . . . . 0.0 109.711 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 ' C ' ' A' ' 90' ' ' VAL . 2.5 mp -113.19 129.5 24.51 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.813 . . . . 0.0 110.122 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.886 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.7 Cg_endo -71.3 155.05 97.27 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.766 -2.181 . . . . 0.0 111.655 -0.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.7 m0 -39.13 -57.47 1.3 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 34.13 5.68 Favored Glycine 0 N--CA 1.501 2.973 0 C-N-CA 119.007 -1.568 . . . . 0.0 112.507 -177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.886 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.36 135.12 36.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.724 -1.456 . . . . 0.0 110.296 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.93 -40.48 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.83 -38.78 86.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.788 . . . . 0.0 109.541 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.09 85.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 109.166 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.71 -42.06 98.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.419 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.24 94.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.495 -0.753 . . . . 0.0 109.411 179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.13 -35.59 67.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.486 -0.759 . . . . 0.0 109.16 178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.7 tp -71.9 -35.36 69.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.736 . . . . 0.0 109.778 178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.86 -45.41 86.35 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.532 -0.73 . . . . 0.0 109.835 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.8 mtt180 -53.99 -57.01 12.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.505 -0.747 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -53.76 -45.54 70.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.703 -0.623 . . . . 0.0 110.655 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.22 -28.97 63.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.481 -0.762 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 59.34 48.02 10.61 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.071 -1.018 . . . . 0.0 109.935 -178.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.3 m -113.95 155.92 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.503 -0.748 . . . . 0.0 110.368 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.12 -31.94 34.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 109.139 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.17 140.53 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 110.094 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -106.02 131.65 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.2 p -157.53 160.75 38.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.343 -0.848 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.75 1.97 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.8 t60 75.55 -34.21 0.24 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.896 -0.767 . . . . 0.0 111.671 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.9 p -87.89 -9.68 52.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.79 -1.194 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.4 m170 55.72 24.87 7.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.07 -1.019 . . . . 0.0 110.755 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.6 114.23 19.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.378 -0.826 . . . . 0.0 109.274 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.1 t80 -54.51 138.0 41.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 110.29 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.97 122.45 7.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.767 . . . . 0.0 110.315 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.59 97.67 3.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.94 167.54 21.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.058 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -110.09 145.5 37.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.554 -0.717 . . . . 0.0 110.313 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.57 117.53 7.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.276 -0.89 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.91 58.13 5.65 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 0.0 111.378 179.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.27 6.29 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.823 -0.548 . . . . 0.0 112.396 178.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.73 154.83 38.92 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.856 -1.152 . . . . 0.0 109.848 178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 111.212 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -124.06 134.26 53.44 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.09 136.04 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.049 -1.032 . . . . 0.0 111.915 -178.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.46 109.08 14.75 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.08 -30.01 47.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.522 1.275 . . . . 0.0 111.45 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.84 -139.37 14.81 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.3 t -117.86 111.78 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -1.068 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.59 -20.62 48.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.294 -0.879 . . . . 0.0 110.463 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.5 13.13 18.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.522 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.39 36.71 63.87 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.11 146.93 4.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.535 -0.979 . . . . 0.0 110.723 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.89 151.11 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.722 0.772 . . . . 0.0 111.407 -179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.85 115.98 5.7 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.13 11.04 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.23 -28.76 47.98 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.566 -1.333 . . . . 0.0 112.314 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.25 116.22 22.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 109.923 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 -15.93 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 111.27 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.21 4.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.04 -1.038 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.55 139.79 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.93 . . . . 0.0 110.563 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.2 mt -113.03 121.05 39.18 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 43.7 Cg_endo -66.43 136.48 43.36 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.503 1.265 . . . . 0.0 109.854 -178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 85.1 p -169.08 154.43 6.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.738 -1.226 . . . . 0.0 111.892 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 165' ' ' TYR . 14.9 p90 -137.89 158.87 43.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 85.7 t -122.2 138.73 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.915 -1.116 . . . . 0.0 113.719 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.605 HD23 ' HE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -107.75 131.94 53.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.017 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.4 125.13 52.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.543 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -103.58 118.08 35.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.505 -0.747 . . . . 0.0 109.751 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 160' ' ' VAL . 96.2 mt -115.77 109.8 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 111.246 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' -1' ' ' ASP . 0.1 OUTLIER -80.42 -40.85 25.6 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.837 0.827 . . . . 0.0 108.871 178.396 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.23 -105.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.3 m -85.37 8.69 17.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.685 -1.26 . . . . 0.0 110.116 178.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.8 m -124.55 139.39 53.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 155' ' ' ILE . 11.7 p -130.39 139.85 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.049 -1.032 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.05 126.18 73.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.9 p -107.43 134.98 49.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.605 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.785 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.086 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.5 p -111.73 132.68 59.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 59.3 m-85 -110.77 114.21 27.4 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -108.16 136.41 47.89 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.456 178.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.652 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 43.0 tp -93.55 83.6 4.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.65 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.66 HD12 ' HD2' ' A' ' 173' ' ' LYS . 71.7 mt -101.08 119.16 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.67 -161.3 53.79 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.74 -44.43 64.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.119 -1.224 . . . . 0.0 110.711 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -75.49 156.99 34.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 110.961 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.626 HG22 ' CD1' ' A' ' 167' ' ' LEU . 51.7 t -104.87 129.12 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 109.594 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.7 mttt -97.55 148.06 23.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.85 . . . . 0.0 110.01 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.2 p -131.59 140.88 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 110.908 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 35.2 tt0 -120.73 150.33 41.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.397 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.31 127.11 55.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.061 -1.024 . . . . 0.0 111.644 -178.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -126.56 132.09 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -114.84 141.0 48.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.015 -1.053 . . . . 0.0 111.55 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.0 t80 -139.07 142.04 38.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.704 -0.622 . . . . 0.0 109.981 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.75 146.84 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 79' ' ' GLN . 49.7 mttm -50.55 -34.37 25.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.236 -0.915 . . . . 0.0 110.694 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.185 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.83 161.63 45.21 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.794 1.418 . . . . 0.0 110.395 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 75.5 mt -74.04 144.25 45.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -71.27 136.25 24.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 30.0 t -126.57 142.52 51.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.474 -1.015 . . . . 0.0 109.648 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 45.2 m -122.98 137.18 55.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 110.752 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.92 169.64 10.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 109.561 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.11 137.06 56.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.183 -0.948 . . . . 0.0 109.961 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.64 119.76 29.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 110.653 -179.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.4 mt -93.79 142.28 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.463 -0.773 . . . . 0.0 109.702 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.02 141.68 33.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.304 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 55.2 t0 49.5 37.81 13.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 110.721 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -124.4 -85.46 0.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.414 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -123.79 144.88 49.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 110.435 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -125.12 173.63 8.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.802 . . . . 0.0 110.205 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.0 m -76.06 134.4 40.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 110.202 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . 0.43 HG12 ' O ' ' B' ' 705' ' ' ALA . 47.2 t -122.62 131.32 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.406 -0.809 . . . . 0.0 110.141 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 23.2 t -61.17 -38.61 87.11 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.17 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . 0.43 ' O ' HG12 ' B' ' 703' ' ' VAL . . . -149.58 154.69 39.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.459 -0.775 . . . . 0.0 109.975 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.04 94.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.242 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.59 80.82 18.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 110.504 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.44 -171.09 0.57 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.714 1.376 . . . . 0.0 110.251 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -55.01 147.73 15.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.23 -0.919 . . . . 0.0 110.152 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -100.99 131.12 47.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 111.595 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.61 -41.11 76.13 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.26 1.029 . . . . 0.0 108.703 178.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.909 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -167.17 -176.63 0.49 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.909 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.4 Cg_endo -59.62 137.97 80.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 122.762 0.875 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.013 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.6 mt 69.48 45.48 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.526 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -136.21 80.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.189 -1.57 . . . . 0.0 108.888 178.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -82.92 17.16 2.0 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.034 0.921 . . . . 0.0 109.673 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.624 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.253 26.5 p -45.64 172.18 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.6 179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.1 Cg_endo -72.49 -55.47 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.398 1.736 . . . . 0.0 108.842 175.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.411 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 97.6 mttt -160.5 -14.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.779 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 19.9 m 55.49 27.28 10.02 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -107.1 164.85 13.93 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.208 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 41.7 Cg_endo -68.59 143.69 57.79 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.705 1.371 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -90.95 145.44 24.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.263 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . 0.429 HE21 HD23 ' B' ' 727' ' ' LEU . 63.4 tt0 -94.12 128.17 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.927 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -79.92 132.99 36.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.851 . . . . 0.0 110.628 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 46.89 -168.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.557 -0.714 . . . . 0.0 111.184 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.429 HD23 HE21 ' B' ' 724' ' ' GLN . 28.5 tp 50.43 64.01 1.98 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.467 -0.771 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -102.82 143.86 31.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -82.23 132.7 35.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.5 t -70.47 139.7 86.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.07 104.17 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.654 1.344 . . . . 0.0 110.287 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -175.8 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.392 -0.817 . . . . 0.0 110.154 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 23.5 m -58.48 -36.31 73.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.299 -0.875 . . . . 0.0 110.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.2 36.22 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.35 142.0 30.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -1.055 . . . . 0.0 109.989 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -156.99 -178.14 30.77 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 49.0 t -120.41 137.88 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.394 -1.062 . . . . 0.0 110.04 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -101.41 136.03 41.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.67 137.92 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.389 -0.819 . . . . 0.0 109.97 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 69.2 p -101.67 149.23 24.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.204 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 52.6 p -93.47 -3.57 52.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -115.24 146.53 41.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.059 -1.026 . . . . 0.0 110.653 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -172.39 32.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.454 -0.779 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -120.74 89.68 0.45 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 46.6 t -82.93 -0.45 48.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -1.046 . . . . 0.0 110.666 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 22.2 t -57.24 -34.78 68.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.0 110.542 -179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 92.7 m95 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 179.97 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.87 64.17 6.91 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.251 -1.147 . . . . 0.0 110.485 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.25 159.75 52.55 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.813 1.428 . . . . 0.0 110.575 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.29 148.12 15.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.399 -0.813 . . . . 0.0 110.52 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -63.55 155.64 28.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -0.817 . . . . 0.0 110.147 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.69 22.63 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' -1' ' ' ASP . 38.3 m -89.49 147.04 24.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.429 -1.042 . . . . 0.0 110.688 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -56.65 -27.91 59.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.521 -0.737 . . . . 0.0 110.514 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' -3' ' ' THR . 93.1 m-20 -52.8 -35.72 57.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.694 ' HG2' ' HG2' ' A' ' 156' ' ' GLN . 26.2 mtp180 -81.79 128.79 34.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.448 -0.782 . . . . 0.0 109.182 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.91 138.54 48.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 115.9 -2.32 . . . . 0.0 110.442 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 713' ' ' PRO . 40.2 tp -95.22 132.73 39.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.53 -0.731 . . . . 0.0 110.501 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.8 t -119.8 140.35 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD22 HD13 ' A' ' 31' ' ' ILE . 63.9 tp -100.04 132.59 45.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 110.59 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.71 129.23 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -164.98 -177.86 4.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 158.79 -175.43 35.8 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.722 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.82 40.8 15.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.827 . . . . 0.0 109.876 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.55 -35.69 65.54 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.11 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.641 179.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -100.25 136.87 19.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.295 -0.878 . . . . 0.0 108.975 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 53.1 Cg_endo -98.48 25.26 19.72 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 123.808 -1.33 . . . . 0.0 110.153 -1.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.89 -48.11 83.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.899 . . . . 0.0 111.943 -178.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.5 mtt180 -124.4 -21.84 4.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.081 -1.012 . . . . 0.0 111.072 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.2 m -133.66 158.35 43.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -101.89 -18.63 15.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.285 -0.884 . . . . 0.0 111.179 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.01 179.05 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.12 -0.987 . . . . 0.0 110.639 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.57 162.69 67.55 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.39 144.52 91.14 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.314 1.165 . . . . 0.0 110.471 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.78 -55.42 11.57 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -58.19 -37.2 74.3 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.776 -1.202 . . . . 0.0 111.9 -178.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.6 m-30 -63.89 -39.46 94.24 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.873 -1.142 . . . . 0.0 111.131 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -56.65 -37.63 71.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.019 . . . . 0.0 108.834 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.58 -36.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.603 -0.685 . . . . 0.0 109.727 178.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' HZ ' ' A' ' 150' ' ' PHE . 0.5 OUTLIER -64.87 -39.09 92.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.326 -0.859 . . . . 0.0 110.373 -179.796 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.824 HD23 HD13 ' B' ' 714' ' ' LEU . 92.2 mt -86.13 134.2 33.82 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.194 -0.942 . . . . 0.0 111.667 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -149.79 146.55 20.75 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.673 -0.642 . . . . 0.0 109.914 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.55 149.66 62.19 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.592 1.311 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.15 -6.37 81.37 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.923 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.3 mmmt -107.37 -26.21 11.09 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.19 -1.183 . . . . 0.0 110.945 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 HD11 HD11 ' B' ' 714' ' ' LEU . 71.1 mt -113.46 133.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.763 -179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -101.08 -21.99 14.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.518 -0.739 . . . . 0.0 110.724 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 3' ' ' VAL . 61.0 m-70 -136.67 138.74 41.4 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.123 -0.986 . . . . 0.0 111.057 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 63.5 mt -129.28 123.67 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.351 -0.843 . . . . 0.0 110.837 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.2 mt -110.74 129.18 55.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.053 178.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.417 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.3 t -118.54 130.54 55.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.391 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 HD21 ' A' ' 84' ' ' LEU . 70.5 p -103.32 -56.79 2.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 111.094 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.805 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -66.13 164.7 39.92 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.268 -178.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.16 147.37 44.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.826 -0.808 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -54.47 -61.93 1.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.499 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.6 p -98.59 -20.43 17.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.907 -1.746 . . . . 0.0 110.045 -1.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.7 t -69.01 143.27 54.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.402 -0.812 . . . . 0.0 110.81 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -59.93 -28.12 67.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.223 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -51.58 -41.01 60.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 40' ' ' LEU . 68.5 m -66.33 -34.61 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.807 . . . . 0.0 109.922 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.424 ' N ' HD22 ' A' ' 40' ' ' LEU . 78.1 t80 -59.7 -43.05 94.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.399 -0.813 . . . . 0.0 110.049 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.05 -40.27 88.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 0.0 109.61 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -62.63 -44.59 95.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.483 -0.761 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 78.5 mt -62.73 -38.71 91.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.372 -0.83 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -62.33 -31.91 72.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -63.09 -43.95 97.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.582 -0.699 . . . . 0.0 110.975 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.22 -36.74 84.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.24 -0.913 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.58 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -151.96 155.18 37.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.204 -0.935 . . . . 0.0 110.536 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.97 -42.84 11.69 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -86.56 110.14 19.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.108 . . . . 0.0 110.415 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.3 133.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.509 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.8 m-70 -117.01 127.57 54.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.8 mt -131.55 151.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.262 -0.899 . . . . 0.0 111.433 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.5 m -121.15 158.41 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -77.28 130.66 37.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.815 -1.178 . . . . 0.0 112.012 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.63 -175.41 38.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.43 0.5 37.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.256 . . . . 0.0 110.749 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.85 25.83 3.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.102 -0.998 . . . . 0.0 111.093 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.39 132.99 35.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.121 -0.987 . . . . 0.0 110.377 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.54 -46.07 70.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.232 -0.918 . . . . 0.0 110.083 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.33 119.67 19.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.625 -0.672 . . . . 0.0 110.136 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.4 -1.27 57.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.709 . . . . 0.0 110.621 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.47 -3.88 36.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.077 -1.015 . . . . 0.0 111.251 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -76.12 147.73 80.35 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.919 -1.113 . . . . 0.0 109.424 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.1 Cg_endo -76.63 140.46 21.16 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.902 1.475 . . . . 0.0 110.855 -178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.74 -39.4 80.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.205 -0.934 . . . . 0.0 109.139 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.71 150.32 29.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.63 147.7 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.0 111.609 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.77 113.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.703 . . . . 0.0 109.163 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.37 131.8 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.249 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -91.8 130.49 37.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.955 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.49 86.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.441 -0.787 . . . . 0.0 109.169 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.96 -119.28 5.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 27.0 mm100 -92.19 -6.37 50.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -1.156 . . . . 0.0 110.902 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.5 m-85 -97.61 137.29 36.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.038 -1.039 . . . . 0.0 113.258 -177.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.29 107.59 18.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.8 mt -108.01 140.52 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.226 -0.921 . . . . 0.0 112.204 -176.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.4 159.28 16.25 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.862 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.19 131.81 27.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.885 -1.362 . . . . 0.0 111.917 -179.313 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.64 149.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.805 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.92 -60.42 3.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.96 -1.088 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.05 -26.61 3.39 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.362 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.82 -17.25 55.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.948 -1.325 . . . . 0.0 110.06 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.7 -5.99 59.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.993 178.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.3 t -98.42 113.1 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 109.745 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.47 24.5 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.204 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.2 154.95 97.12 Favored 'Cis proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.789 -2.171 . . . . 0.0 111.663 -0.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 26.8 m0 -39.02 -57.57 1.25 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.39 34.11 5.7 Favored Glycine 0 N--CA 1.501 2.972 0 C-N-CA 119.01 -1.567 . . . . 0.0 112.515 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.892 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.37 135.17 36.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.791 -1.417 . . . . 0.0 110.325 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.99 -40.42 62.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.9 -38.72 86.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.2 m -67.09 -42.1 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.149 178.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.63 -42.09 98.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.462 -0.774 . . . . 0.0 109.501 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.07 94.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.524 -0.735 . . . . 0.0 109.452 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.32 -35.48 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.105 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.99 -35.37 69.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.83 -45.43 86.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 109.844 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -54.01 -57.05 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.422 -0.799 . . . . 0.0 110.185 179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.73 -45.5 70.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.662 -0.649 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.94 63.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.418 -0.801 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 59.37 48.0 10.56 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.083 -1.011 . . . . 0.0 109.878 -178.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -113.95 155.94 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.15 -32.0 33.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.044 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.2 140.5 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.72 . . . . 0.0 110.019 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.67 123.34 42.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 109.847 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.92 131.62 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.5 p -157.53 160.71 38.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.37 -0.831 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -136.99 -120.76 1.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 39.0 t60 75.53 -34.06 0.24 Allowed 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.886 -0.773 . . . . 0.0 111.625 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.3 p -88.05 -9.6 52.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.794 -1.191 . . . . 0.0 111.401 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.59 24.94 7.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.014 . . . . 0.0 110.797 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -123.63 114.26 19.77 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.355 -0.841 . . . . 0.0 109.248 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.5 137.91 41.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.287 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.88 122.39 7.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.341 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.57 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.833 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.93 167.63 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.254 -0.904 . . . . 0.0 110.986 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -110.19 145.5 37.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.461 -0.775 . . . . 0.0 110.244 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.64 117.62 7.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.906 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.2 mt-10 52.84 58.13 5.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.584 -0.697 . . . . 0.0 111.444 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.2 15.32 6.26 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.788 -0.57 . . . . 0.0 112.352 178.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.77 154.89 38.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.839 -1.163 . . . . 0.0 109.863 178.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.3 140.92 47.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 111.221 -179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -124.05 134.29 53.44 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.6 mm -134.07 136.01 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.12 -0.988 . . . . 0.0 111.955 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.1 t-20 -131.34 108.95 14.88 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.03 -30.04 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.456 1.24 . . . . 0.0 111.425 -178.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.81 -139.44 14.85 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.78 111.67 19.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.344 -1.092 . . . . 0.0 110.575 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.53 -20.53 46.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 18' ' ' LEU . 34.9 p -113.54 13.13 18.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.27 -0.894 . . . . 0.0 110.521 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.29 36.77 63.31 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.16 146.87 4.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.54 -0.976 . . . . 0.0 110.809 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.82 151.13 46.19 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.799 0.809 . . . . 0.0 111.448 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.83 115.93 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.12 11.11 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.2 -28.79 48.15 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.625 -1.297 . . . . 0.0 112.342 -178.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.7 tp10 -124.23 116.32 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.765 -1.21 . . . . 0.0 109.894 179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.96 -15.9 60.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.474 -0.766 . . . . 0.0 111.295 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.55 94.33 4.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.049 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.6 mm -101.59 139.73 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -0.871 . . . . 0.0 110.541 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.6 mt -112.92 120.96 39.52 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.3 Cg_endo -65.65 133.86 35.85 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.529 1.278 . . . . 0.0 109.679 -178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 90.0 p -167.03 154.59 9.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.883 -1.136 . . . . 0.0 111.917 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.808 ' HZ ' HD22 ' A' ' 25' ' ' LEU . 22.1 p90 -137.81 161.08 37.52 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.91 139.38 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.936 -1.103 . . . . 0.0 113.775 -176.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.723 HD21 HD11 ' B' ' 714' ' ' LEU . 0.1 OUTLIER -108.33 132.21 53.95 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 61.0 mtp -114.57 125.3 53.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.702 -1.249 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.57 118.32 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.451 -0.78 . . . . 0.0 109.761 179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.517 HG12 HG23 ' A' ' 160' ' ' VAL . 97.2 mt -116.53 121.7 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 0.0 110.976 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.694 ' HG2' ' HG2' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -100.49 -54.91 2.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.585 0.707 . . . . 0.0 109.296 178.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.33 106.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.1 m 60.19 10.06 2.15 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.311 -0.868 . . . . 0.0 110.441 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.4 m -139.37 132.71 30.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 108.826 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.517 HG23 HG12 ' A' ' 155' ' ' ILE . 10.1 p -131.56 139.22 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.481 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -116.17 124.94 72.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.49 HG21 ' HE1' ' A' ' 128' ' ' PHE . 72.4 p -105.64 134.9 48.0 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.714 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.774 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.58 128.21 56.35 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.4 p -111.72 132.6 59.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.512 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.648 ' CD2' ' CZ ' ' A' ' 150' ' ' PHE . 51.2 m-85 -110.34 111.95 23.58 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.699 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.86 136.39 46.79 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.406 179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 38.9 tp -94.48 94.34 8.16 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.234 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.777 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.6 mt -108.99 124.61 65.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.89 -131.8 31.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -98.26 -51.31 4.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -1.196 . . . . 0.0 110.278 179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -69.61 156.07 39.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 167' ' ' LEU . 52.4 t -101.6 128.38 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.735 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.777 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.3 mttt -95.93 148.22 22.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 12.4 p -132.64 141.53 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 111.193 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.463 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.9 tt0 -121.15 150.05 41.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.363 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -115.42 126.97 55.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.03 -1.044 . . . . 0.0 111.7 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.8 mm -126.38 132.74 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.646 -0.659 . . . . 0.0 109.246 178.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -115.61 140.86 48.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.988 -1.07 . . . . 0.0 111.408 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 72.9 t80 -138.83 142.17 38.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.655 -0.653 . . . . 0.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -139.55 147.4 41.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 47.8 mttm -50.17 -34.32 22.13 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.342 -0.849 . . . . 0.0 110.668 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.248 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.35 -26.45 35.18 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.769 1.405 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.42 -36.33 75.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 0.0 110.364 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 142.58 58.62 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 29.3 t -110.42 146.22 36.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.459 -1.024 . . . . 0.0 110.058 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 52.9 m -107.85 136.03 48.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.0 150.04 39.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.122 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' B' ' 728' ' ' ALA . 96.9 mt-10 -62.28 139.43 58.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.026 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -142.69 141.37 31.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.384 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 21.2 tp -105.73 126.72 52.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.307 -0.871 . . . . 0.0 110.192 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -127.11 123.87 37.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.394 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.19 -29.52 67.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.208 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.14 68.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.519 -0.738 . . . . 0.0 110.969 -179.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -104.6 149.83 25.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.127 -0.983 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -138.25 171.84 13.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.649 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 14.9 t -133.8 141.67 47.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.09 -1.006 . . . . 0.0 111.355 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.88 140.69 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.579 -0.7 . . . . 0.0 109.352 179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 82.5 p -147.72 162.46 39.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.081 -1.012 . . . . 0.0 111.063 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -144.14 156.01 44.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.679 . . . . 0.0 109.715 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -97.04 136.07 38.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.172 -0.955 . . . . 0.0 110.47 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -162.7 129.38 2.45 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.69 -18.58 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.612 1.322 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -96.44 168.22 10.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.129 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 7.6 m-30 -46.89 156.78 0.18 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.049 0.928 . . . . 0.0 112.007 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 57.0 m -56.69 -36.14 69.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.826 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.9 p80 -171.13 -179.03 0.53 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.826 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 36.6 Cg_endo -60.6 139.17 84.51 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 122.852 0.922 . . . . 0.0 110.33 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.923 HD23 ' HE2' ' A' ' 30' ' ' LYS . 7.0 mt 71.39 44.71 0.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.5 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.4 t -135.57 81.22 1.88 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.241 -1.537 . . . . 0.0 108.733 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.466 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 11.9 mp0 -82.49 18.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.088 0.947 . . . . 0.0 109.757 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.583 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 26.2 p -46.25 169.62 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.254 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 36.5 Cg_endo -70.3 -55.04 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.313 1.691 . . . . 0.0 108.672 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.433 ' CG ' ' O ' ' B' ' 718' ' ' PRO . 73.8 mttt -160.89 -15.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.569 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . . . . . . . . . 20.1 m 54.54 26.81 7.65 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -175.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -85.57 143.99 39.41 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.812 -178.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.77 153.97 59.0 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.791 1.416 . . . . 0.0 110.592 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' B' ' 724' ' ' GLN . . . -152.19 -147.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.84 . . . . 0.0 110.078 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' B' ' 723' ' ' ALA . 92.3 mt-30 58.58 48.59 11.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.311 -0.868 . . . . 0.0 110.543 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -73.26 125.03 26.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.259 -0.901 . . . . 0.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -137.74 141.75 40.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.349 -0.844 . . . . 0.0 110.038 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 77.8 mt -88.07 8.33 27.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.283 -0.886 . . . . 0.0 110.794 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . 0.419 ' HB3' ' OE2' ' B' ' 694' ' ' GLU . . . -63.23 -21.82 66.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.657 -179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -66.53 142.63 57.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.289 -0.882 . . . . 0.0 110.173 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 65.0 t -123.44 77.22 54.25 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.422 -0.799 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.81 156.48 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.781 1.411 . . . . 0.0 110.299 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -56.55 148.73 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 87.3 p -103.48 154.14 19.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -149.9 -138.31 2.89 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.4 tp -99.14 134.56 41.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -1.049 . . . . 0.0 110.34 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -81.84 -174.16 49.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.16 130.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.291 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -168.39 132.89 1.64 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.474 -0.766 . . . . 0.0 110.086 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.18 153.42 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.308 -0.87 . . . . 0.0 110.329 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 49.2 m -124.82 137.53 54.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.196 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 27.2 t -132.38 148.08 52.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 125.3 34.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.949 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -165.66 174.45 9.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.082 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.52 9.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 29.2 t -108.75 87.38 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -1.202 . . . . 0.0 109.993 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 74.1 m -86.55 5.52 35.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.348 -0.845 . . . . 0.0 110.689 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.247 -179.835 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.36 142.8 31.92 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.204 -1.174 . . . . 0.0 110.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.53 168.02 25.82 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.708 1.373 . . . . 0.0 110.462 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.15 146.63 18.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -90.14 135.5 33.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.563 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 86.63 178.49 49.33 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . . . . . . . . . 64.1 p -99.99 -0.38 39.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.444 -1.033 . . . . 0.0 110.6 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -127.02 152.65 46.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.84 172.03 15.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.37 -0.831 . . . . 0.0 110.144 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -110.34 150.69 28.41 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.48 136.67 37.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 110.498 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' B' ' 713' ' ' PRO . 41.3 tp -93.75 132.6 37.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.519 -0.738 . . . . 0.0 110.606 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 33' ' ' HIS . 43.2 t -118.25 138.73 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.283 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 31' ' ' ILE . 55.6 tp -98.76 131.16 45.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.395 -0.815 . . . . 0.0 110.519 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.61 128.86 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.259 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.4 pt? -165.44 -175.77 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.484 -0.76 . . . . 0.0 109.682 179.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.41 -175.32 34.1 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.6 m-20 61.27 40.72 14.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.837 -0.802 . . . . 0.0 109.834 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.7 mt -73.54 -35.65 65.56 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.2 m80 55.26 42.08 30.73 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.672 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.6 mt -100.24 136.89 19.95 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.883 . . . . 0.0 108.983 178.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.6 Cg_endo -98.48 25.31 19.66 Favored 'Cis proline' 0 C--N 1.317 -1.096 0 C-N-CA 123.77 -1.346 . . . . 0.0 110.128 -1.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -60.99 -47.95 84.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 0.0 111.968 -178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.51 -21.83 4.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.019 -178.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m -133.65 158.43 43.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.09 -1.006 . . . . 0.0 110.214 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.92 -18.74 15.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.2 p -173.9 179.12 2.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.118 -0.989 . . . . 0.0 110.579 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.4 mp -77.67 162.74 67.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.6 Cg_endo -63.43 144.66 91.22 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.29 1.153 . . . . 0.0 110.446 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.95 -55.86 10.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -58.0 -37.13 73.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.698 -1.251 . . . . 0.0 111.769 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.1 m-30 -64.1 -39.51 94.2 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.994 -1.066 . . . . 0.0 110.979 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -56.66 -38.84 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.996 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -69.43 -39.2 77.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.538 178.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' B' ' 714' ' ' LEU . 40.5 tp -64.42 -35.54 81.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.445 -0.784 . . . . 0.0 110.958 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.779 HD23 HD21 ' B' ' 714' ' ' LEU . 78.5 mt -89.54 133.87 34.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.895 -1.128 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' C ' ' A' ' 26' ' ' LEU . 34.8 m -149.79 149.23 27.54 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.755 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.08 151.57 55.76 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.561 1.295 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.31 -4.72 84.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.635 ' HE2' HD12 ' B' ' 714' ' ' LEU . 1.5 mmmt -109.07 -27.36 9.67 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.325 -1.103 . . . . 0.0 110.887 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 4' ' ' LEU . 74.0 mt -112.09 130.85 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.738 -179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.64 -23.77 15.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.546 -0.721 . . . . 0.0 110.438 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.738 ' HB2' HG22 ' A' ' 3' ' ' VAL . 65.4 m-70 -135.62 139.21 43.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -0.899 . . . . 0.0 110.917 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 62.2 mt -129.27 123.13 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.711 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.0 mt -109.79 128.25 55.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.798 . . . . 0.0 108.992 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HB3' HG12 ' A' ' 58' ' ' ILE . 3.3 t -118.53 129.38 55.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.534 -179.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.806 HG22 HD21 ' A' ' 84' ' ' LEU . 72.6 p -102.88 -63.06 1.2 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.485 -0.759 . . . . 0.0 110.701 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.81 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -57.58 161.61 9.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -71.93 149.1 45.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.63 -0.923 . . . . 0.0 110.348 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.0 mt -55.56 -62.83 1.42 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.329 -0.857 . . . . 0.0 111.533 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.3 p -98.95 -21.02 16.47 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.832 -1.793 . . . . 0.0 110.246 -0.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -69.06 143.52 54.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.9 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -59.89 -28.14 67.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.46 -40.83 60.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD22 ' A' ' 40' ' ' LEU . 63.4 m -66.5 -34.32 77.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 109.931 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -59.88 -43.51 94.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.084 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.79 -40.08 87.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 109.711 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -62.4 -44.74 95.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 49' ' ' LEU . 80.7 mt -62.79 -38.52 90.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.306 -0.871 . . . . 0.0 110.084 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.14 -32.83 73.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.426 -0.796 . . . . 0.0 109.837 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -63.32 -43.24 98.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.388 -0.82 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.89 -36.22 82.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.204 -0.935 . . . . 0.0 110.62 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.89 153.65 33.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 -43.56 14.14 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.79 110.05 19.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -1.138 . . . . 0.0 110.379 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.98 134.26 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 110.353 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.504 ' HB2' HD23 ' A' ' 35' ' ' LEU . 97.0 m-70 -116.59 126.31 53.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 36' ' ' CYS . 74.6 mt -130.89 150.3 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 0.0 111.385 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 84' ' ' LEU . 27.6 m -118.74 153.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -72.88 130.78 41.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 -178.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.45 -175.42 38.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.42 0.56 37.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.032 -1.275 . . . . 0.0 110.785 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.88 25.76 3.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.115 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.12 35.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.912 . . . . 0.0 110.376 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.74 -46.07 69.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.373 -0.83 . . . . 0.0 110.002 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -75.29 119.7 19.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.653 -0.654 . . . . 0.0 110.125 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.54 -1.03 57.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.64 -3.82 36.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 111.283 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.43 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.3 m-30 -76.06 147.71 80.53 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 120.828 -1.17 . . . . 0.0 109.539 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 54.9 Cg_endo -76.7 140.49 21.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.917 1.483 . . . . 0.0 110.956 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.72 -39.39 80.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.245 -0.909 . . . . 0.0 109.213 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.3 29.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.684 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.58 147.7 34.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.809 -1.182 . . . . 0.0 111.566 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.76 113.33 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.45 131.83 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.73 130.5 37.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.51 86.85 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.457 -0.777 . . . . 0.0 109.209 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.93 -119.21 5.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' O ' ' HE3' ' A' ' 181' ' ' LYS . 26.9 mm100 -92.28 -6.23 50.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.315 -1.109 . . . . 0.0 110.871 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -97.76 137.31 36.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.133 -0.979 . . . . 0.0 113.292 -177.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.25 107.52 18.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.92 140.52 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 112.265 -176.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.36 159.33 16.26 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.806 HD21 HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.18 131.76 27.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.941 -1.329 . . . . 0.0 111.87 -179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.4 tt -156.66 149.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.769 . . . . 0.0 109.483 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.81 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.89 -60.37 3.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.879 -1.138 . . . . 0.0 110.524 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.98 -26.68 3.4 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.325 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.432 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.5 p-80 -61.71 -17.25 54.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.916 -1.344 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.5 mp0 -85.82 -5.92 59.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -0.878 . . . . 0.0 109.934 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.5 t -98.45 113.1 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.12 129.49 24.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 0.0 110.178 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.891 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 32.8 Cg_endo -71.24 155.0 97.2 Favored 'Cis proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.74 -2.192 . . . . 0.0 111.64 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.9 m0 -39.09 -57.42 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.41 33.98 5.77 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.013 -1.565 . . . . 0.0 112.542 -177.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.891 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.28 135.15 36.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.736 -1.449 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.94 -40.55 63.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.279 -0.888 . . . . 0.0 109.438 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.82 -38.85 86.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.481 -0.762 . . . . 0.0 109.487 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -67.0 -42.09 85.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.171 178.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.69 -42.04 98.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.455 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.2 94.3 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.451 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.59 67.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.547 -0.721 . . . . 0.0 109.121 178.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.9 tp -71.92 -35.44 69.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.81 -45.43 86.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.412 -0.805 . . . . 0.0 109.822 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.04 -56.97 13.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.81 -45.56 70.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.716 -0.615 . . . . 0.0 110.679 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.15 -28.95 63.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.46 -0.775 . . . . 0.0 111.478 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.29 48.05 10.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.134 -0.979 . . . . 0.0 109.953 -178.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.0 156.01 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -81.19 -31.94 33.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 0.0 109.105 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.21 140.56 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.682 -0.636 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.68 123.39 42.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.957 . . . . 0.0 109.84 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.631 HG22 HG21 ' A' ' 37' ' ' THR . 36.2 mm -105.99 131.63 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.179 -0.951 . . . . 0.0 110.011 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 94.1 p -157.56 160.7 38.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.396 -0.815 . . . . 0.0 110.201 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.04 -120.72 1.97 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.9 t60 75.57 -34.14 0.24 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.888 -0.772 . . . . 0.0 111.627 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -87.97 -9.65 52.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.816 -1.178 . . . . 0.0 111.427 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.63 25.0 7.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.14 -0.975 . . . . 0.0 110.782 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.66 114.32 19.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.473 -0.767 . . . . 0.0 109.234 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 40.0 t80 -54.56 137.9 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.028 -1.045 . . . . 0.0 110.302 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.86 122.32 7.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.496 -0.753 . . . . 0.0 110.405 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.47 97.64 3.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.523 -0.735 . . . . 0.0 109.913 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.89 167.61 21.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.0 110.986 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -110.21 145.49 37.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.493 -0.755 . . . . 0.0 110.272 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -146.61 117.54 7.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.1 mt-10 52.92 58.04 5.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.743 . . . . 0.0 111.41 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.27 15.34 6.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.809 -0.557 . . . . 0.0 112.398 178.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.78 154.89 38.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.916 -1.115 . . . . 0.0 109.827 178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CE1' HD11 ' A' ' 130' ' ' ILE . 5.7 t80 -113.3 140.98 47.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 111.227 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.12 134.31 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.7 mm -134.09 135.97 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 111.992 -178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.0 t-20 -131.32 108.96 14.91 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.06 -29.96 47.9 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.54 1.284 . . . . 0.0 111.451 -178.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.79 -139.4 14.83 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.4 t -117.86 111.77 19.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.58 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 0.0 110.471 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.1 p -113.5 13.1 18.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.208 -0.932 . . . . 0.0 110.501 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.41 36.51 63.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.964 -1.655 . . . . 0.0 108.964 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.08 146.95 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.524 -0.986 . . . . 0.0 110.769 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.82 151.16 46.11 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.673 0.749 . . . . 0.0 111.457 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.94 115.99 5.67 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.93 -29.17 11.39 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.2 mt -78.2 -28.68 48.11 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.551 -1.343 . . . . 0.0 112.313 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.31 116.3 22.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.831 -1.168 . . . . 0.0 109.872 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -76.03 -15.78 60.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.611 -0.681 . . . . 0.0 111.274 -179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.54 94.2 4.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.986 . . . . 0.0 110.082 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.5 mm -101.49 139.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.875 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.92 121.08 39.24 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.67 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 42.6 Cg_endo -65.94 133.41 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.496 1.261 . . . . 0.0 109.581 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' TYR . 83.9 p -167.25 154.61 8.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.776 -1.203 . . . . 0.0 111.969 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 25' ' ' LEU . 20.7 p90 -137.9 160.15 40.08 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.02 136.53 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.02 -1.05 . . . . 0.0 113.481 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.079 HD11 HD22 ' B' ' 714' ' ' LEU . 14.9 mt -107.07 136.54 46.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 60.7 mtp -115.4 121.52 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.081 . . . . 0.0 110.317 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -98.31 117.56 32.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 109.701 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 160' ' ' VAL . 96.4 mt -114.87 122.97 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 111.033 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -55.25 2.7 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.599 0.714 . . . . 0.0 109.301 178.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -176.19 106.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m 61.05 8.87 2.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.829 . . . . 0.0 110.457 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.1 m -138.17 133.73 33.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 108.761 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.0 p -132.6 139.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.933 -1.104 . . . . 0.0 111.704 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.05 124.85 72.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.411 HG21 ' HE1' ' A' ' 128' ' ' PHE . 68.0 p -105.88 134.29 49.25 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.05 -1.031 . . . . 0.0 110.636 -178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.705 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -112.63 126.91 55.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 4.9 p -110.92 130.74 63.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.727 ' CE2' HD12 ' A' ' 152' ' ' LEU . 65.9 m-85 -109.15 112.55 24.78 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -106.04 136.2 46.14 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.514 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.67 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.3 tp -93.51 94.33 8.6 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.336 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.803 HD12 ' HD2' ' A' ' 173' ' ' LYS . 69.7 mt -109.42 125.32 66.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.28 -131.2 32.69 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -99.51 -49.34 4.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -1.132 . . . . 0.0 110.335 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.98 156.58 39.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.448 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.513 HG22 HD12 ' A' ' 167' ' ' LEU . 58.8 t -102.54 127.98 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.368 -0.832 . . . . 0.0 109.785 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.5 mttt -95.58 147.43 23.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.462 -0.774 . . . . 0.0 109.781 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 7.7 p -130.95 139.82 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.95 . . . . 0.0 110.929 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 40.4 tt0 -120.62 151.07 39.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.456 -0.777 . . . . 0.0 109.484 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -116.92 126.99 53.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.005 -1.06 . . . . 0.0 111.797 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.3 131.74 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.29 141.11 48.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.993 -1.067 . . . . 0.0 111.54 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.421 ' O ' HG12 ' A' ' 160' ' ' VAL . 71.9 t80 -139.11 141.78 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.674 -0.642 . . . . 0.0 109.986 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -139.29 146.45 40.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 79' ' ' GLN . 46.9 mttm -50.04 144.38 6.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.392 -0.817 . . . . 0.0 110.681 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.216 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.63 149.64 73.94 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.751 1.395 . . . . 0.0 110.402 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.52 138.59 32.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -0.81 . . . . 0.0 110.289 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 94.68 -167.89 27.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 56.3 p -70.29 161.61 30.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -1.078 . . . . 0.0 110.55 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 55.6 m -119.16 141.04 49.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.456 -0.778 . . . . 0.0 109.894 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.04 141.75 55.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.293 -0.879 . . . . 0.0 110.569 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.31 149.5 27.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.772 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -60.25 136.6 58.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 79.3 mt -92.49 3.96 54.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.811 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.99 141.99 54.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.02 -1.05 . . . . 0.0 110.207 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -133.49 164.53 26.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 110.202 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -112.28 148.16 34.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.638 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . 0.806 ' HG3' HG23 ' B' ' 702' ' ' THR . 22.7 pt-20 -108.57 164.6 12.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.475 -0.766 . . . . 0.0 109.828 179.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' B' ' 701' ' ' ASP . 23.8 p-10 -81.72 100.38 9.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.21 -0.931 . . . . 0.0 111.451 -179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . 0.806 HG23 ' HG3' ' B' ' 700' ' ' GLU . 34.0 p -126.87 142.39 51.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.07 -1.019 . . . . 0.0 109.645 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.88 123.64 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.625 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 53.0 p -97.45 -3.09 40.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.861 . . . . 0.0 110.409 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.04 72.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 0.0 110.903 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -61.82 136.02 57.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.246 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -157.16 72.69 4.54 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 110.39 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.2 154.18 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.632 1.333 . . . . 0.0 110.329 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -55.96 146.46 22.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 716' ' ' GLN . 8.6 m-30 -110.44 149.53 30.16 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 122.226 1.012 . . . . 0.0 112.478 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 83.6 m -60.34 -34.14 73.4 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.818 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 0.3 OUTLIER -175.63 179.87 0.41 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.193 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 33.6 Cg_endo -60.25 143.51 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 152' ' ' LEU . 5.5 mp 74.46 36.09 0.66 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.535 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.2 t -137.3 77.4 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.418 -1.426 . . . . 0.0 107.411 177.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 710' ' ' PHE . 27.8 mp0 -76.67 18.39 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.879 0.847 . . . . 0.0 110.091 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.515 ' HB2' ' HD2' ' B' ' 718' ' ' PRO . 29.7 p -52.62 167.4 0.38 Allowed Pre-proline 0 C--N 1.297 -1.707 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.572 179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.552 ' O ' ' HG3' ' B' ' 719' ' ' LYS . 36.7 Cg_endo -70.22 -51.47 0.34 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.143 1.601 . . . . 0.0 108.641 176.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' B' ' 718' ' ' PRO . 10.3 mtmt -164.38 -14.53 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 20.2 m 56.89 26.52 11.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -175.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . . . . . . . . . . . -138.57 161.84 56.46 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.742 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.7 126.09 11.73 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.545 1.287 . . . . 0.0 109.896 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -113.7 143.56 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.55 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -120.49 139.31 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.81 . . . . 0.0 110.01 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -130.63 148.76 52.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.95 126.86 51.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 109.857 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . 0.413 ' O ' ' HB3' ' B' ' 728' ' ' ALA . 27.4 tp -60.46 -38.8 85.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.514 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' B' ' 727' ' ' LEU . . . 57.56 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.362 -0.836 . . . . 0.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' B' ' 727' ' ' LEU . 60.1 tttp -130.24 139.91 50.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.222 -0.924 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.98 140.19 86.98 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.376 -0.828 . . . . 0.0 109.926 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.91 -36.66 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.992 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -68.01 140.14 56.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 95.8 p -122.14 151.35 41.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.076 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.35 96.98 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . . . . . . . . . 26.6 tp -111.51 128.39 56.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.232 -1.158 . . . . 0.0 110.403 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . -90.34 178.91 43.34 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.26 153.34 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -1.143 . . . . 0.0 110.234 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -115.89 147.83 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.171 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.29 153.89 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.337 -0.852 . . . . 0.0 110.254 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 35.6 m -125.24 138.69 54.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 93.8 p -126.26 153.71 44.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.08 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -58.67 -37.44 76.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.362 -0.837 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.84 -36.4 74.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . -64.48 145.63 49.69 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . . . . . . . . . 50.4 m -121.32 150.45 41.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.51 -0.994 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 25.9 t -111.95 142.76 43.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.822 . . . . 0.0 110.035 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.17 -179.833 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -8' ' ' SER . . . . . . . . . . . . . 3.6 m -65.01 141.7 98.46 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.094 . . . . 0.0 110.223 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -7' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.65 137.43 35.74 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.686 1.361 . . . . 0.0 110.227 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -6' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -113.41 131.52 55.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 110.208 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -115.0 137.83 51.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . 171.05 37.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.319 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -3' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 78' ' ' GLY . 30.5 m -58.4 -40.79 83.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.996 -1.296 . . . . 0.0 109.54 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -58.11 -35.58 71.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.589 -0.694 . . . . 0.0 109.661 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -75.67 134.05 40.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.664 -0.648 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 155' ' ' ILE . 16.9 ptt85 -53.39 145.98 13.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.29 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.64 138.55 53.92 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' B' ' 713' ' ' PRO . 48.1 tp -94.46 127.07 40.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.347 -0.846 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 33' ' ' HIS . 40.4 t -117.38 138.34 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.293 -0.879 . . . . 0.0 110.206 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HB3' HG12 ' A' ' 34' ' ' ILE . 54.8 tp -98.32 130.54 45.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.41 -0.806 . . . . 0.0 110.397 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' PRO . 89.6 t -122.36 128.18 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.5 pt? -164.11 -176.48 4.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 109.646 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASP . . . 156.84 -175.06 34.48 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.204 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' H ' ' HA3' ' A' ' 38' ' ' GLY . 50.3 m-20 60.97 40.77 14.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.888 -0.772 . . . . 0.0 109.832 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' CD2' ' HB3' ' A' ' 135' ' ' ALA . 10.6 mt -73.56 -35.66 65.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 14' ' ' ARG . 14.1 m80 55.36 42.06 30.53 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.615 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -100.23 136.85 19.96 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 52.5 Cg_endo -98.42 25.21 19.85 Favored 'Cis proline' 0 C--N 1.316 -1.158 0 C-N-CA 123.823 -1.324 . . . . 0.0 110.222 -1.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -60.87 -48.01 83.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 112.047 -178.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 51.7 mtt180 -124.5 -21.78 4.8 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.091 -1.006 . . . . 0.0 111.05 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' PRO . 96.7 m -133.73 158.4 43.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.069 -1.019 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -101.9 -18.63 15.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.853 . . . . 0.0 111.091 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.0 p -174.05 179.02 2.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 ' H ' ' A' ' 18' ' ' LEU . 5.3 mp -77.56 162.67 67.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 22' ' ' PHE . 37.7 Cg_endo -63.57 144.89 91.05 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.333 1.175 . . . . 0.0 110.385 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.17 -55.36 12.68 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.26 -36.62 73.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.766 -1.209 . . . . 0.0 111.802 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 3.2 m-30 -63.54 -39.78 95.31 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.915 -1.116 . . . . 0.0 111.083 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -56.69 -40.7 76.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.026 -1.046 . . . . 0.0 108.957 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -68.3 -36.69 79.72 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.764 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.5 tp -64.77 -33.9 77.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.713 -0.617 . . . . 0.0 110.867 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.591 HD23 HD13 ' B' ' 714' ' ' LEU . 95.9 mt -94.01 134.01 36.86 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.9 -1.125 . . . . 0.0 111.2 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 26' ' ' LEU . 35.9 m -147.01 147.41 29.17 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.433 -0.792 . . . . 0.0 110.435 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.71 152.84 48.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.631 1.332 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.88 -5.93 83.1 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.995 ' HE2' HD23 ' B' ' 714' ' ' LEU . 1.2 mmmt -110.48 -25.46 10.02 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.283 -1.128 . . . . 0.0 110.982 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.412 HD11 HD11 ' B' ' 714' ' ' LEU . 69.3 mt -111.07 131.41 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -99.97 -22.41 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.557 -0.714 . . . . 0.0 110.818 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.744 ' HB2' HG22 ' A' ' 3' ' ' VAL . 63.1 m-70 -136.12 138.73 42.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.135 -0.978 . . . . 0.0 111.089 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 61.9 mt -129.59 123.59 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.783 . . . . 0.0 110.671 178.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 57' ' ' HIS . 78.3 mt -110.61 128.98 55.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 108.967 178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 59' ' ' VAL . 3.2 t -118.64 129.54 55.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.823 HG22 ' CD2' ' A' ' 84' ' ' LEU . 71.3 p -102.65 -58.6 1.85 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.76 . . . . 0.0 110.82 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.811 ' HA2' ' CD2' ' A' ' 86' ' ' HIS . . . -63.08 163.16 30.62 Favored Glycine 0 N--CA 1.489 2.199 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.247 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -72.42 148.14 45.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.851 -0.794 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 3.3 mt -55.05 -62.25 1.78 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.366 -0.834 . . . . 0.0 111.479 -179.241 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 28.5 p -98.86 -20.52 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 119.863 -1.773 . . . . 0.0 110.112 -1.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 t -69.09 143.11 54.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.748 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -59.89 -28.36 67.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.53 -0.731 . . . . 0.0 110.172 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -51.66 -40.82 60.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.202 -0.936 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB2' HD22 ' A' ' 40' ' ' LEU . 61.3 m -66.43 -34.81 78.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 76.2 t80 -59.78 -42.87 94.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.407 -0.808 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.04 -40.23 88.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -62.26 -44.43 96.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 49' ' ' LEU . 79.5 mt -62.89 -38.61 91.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.132 179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -62.21 -32.48 73.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.774 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.9 m -63.72 -43.31 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.435 -0.791 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.8 -36.4 83.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.265 -0.897 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . . . -152.51 154.37 35.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.42 -43.57 12.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.66 110.3 19.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t -126.14 134.36 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HB2' HD23 ' A' ' 35' ' ' LEU . 96.9 m-70 -116.87 126.78 53.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.595 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.8 150.74 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.259 -0.9 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 84' ' ' LEU . 27.3 m -120.63 156.47 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -75.26 130.83 39.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.861 -1.149 . . . . 0.0 111.78 -178.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.56 -175.5 38.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -81.4 0.47 37.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.04 -1.271 . . . . 0.0 110.817 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -136.8 25.7 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 111.197 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 1.4 m-20 -82.3 133.07 35.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.073 -1.017 . . . . 0.0 110.372 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -68.68 -46.08 70.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.246 -0.908 . . . . 0.0 110.02 179.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -75.15 119.6 19.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.581 -0.699 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.1 tt -86.51 -1.15 57.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.711 . . . . 0.0 110.541 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.6 -3.71 35.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.126 -0.984 . . . . 0.0 111.267 -179.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 40' ' ' LEU . 8.2 m-30 -76.13 147.7 80.28 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.0 109.437 178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HG3' ' HE3' ' A' ' 73' ' ' LYS . 55.4 Cg_endo -76.6 140.28 21.08 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.829 1.436 . . . . 0.0 111.005 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.57 -39.44 80.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.253 -0.905 . . . . 0.0 109.194 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.68 150.33 29.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HE3' ' HG3' ' A' ' 70' ' ' PRO . 38.9 ttmt -143.62 147.7 34.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.865 -1.147 . . . . 0.0 111.583 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.4 t -113.77 113.28 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 75' ' ' VAL . 14.6 p -115.3 131.87 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.1 m -91.88 130.52 37.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.96 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.4 t -121.5 86.88 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.495 -0.753 . . . . 0.0 109.199 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' -3' ' ' THR . . . 78.89 -119.23 5.01 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -92.36 -5.96 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.259 -1.142 . . . . 0.0 110.84 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 160' ' ' VAL . 8.3 m-85 -97.98 137.32 36.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 113.272 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.31 107.55 18.59 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.5 mt -107.85 140.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 112.185 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -104.41 159.3 16.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 178.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.823 ' CD2' HG22 ' A' ' 37' ' ' THR . 0.3 OUTLIER -140.23 131.77 27.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.35 . . . . 0.0 111.858 -179.248 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.3 tt -156.58 149.06 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.427 -0.796 . . . . 0.0 109.579 178.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.811 ' CD2' ' HA2' ' A' ' 38' ' ' GLY . 8.3 t-80 -60.88 -60.45 3.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.896 -1.127 . . . . 0.0 110.484 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.04 -26.53 3.4 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.306 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.435 ' CE1' ' CD ' ' A' ' 89' ' ' GLN . 47.6 p-80 -61.81 -17.33 55.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.972 -1.311 . . . . 0.0 110.079 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CD ' ' CE1' ' A' ' 88' ' ' HIS . 8.4 mp0 -85.68 -5.99 59.19 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.285 -0.885 . . . . 0.0 109.942 178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 ' C ' HD12 ' A' ' 91' ' ' ILE . 46.2 t -98.36 113.03 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.717 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 91' ' ' ILE . 2.5 mp -113.1 129.45 24.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.214 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.893 ' HG2' ' HB2' ' A' ' 95' ' ' ASP . 33.0 Cg_endo -71.27 155.01 97.24 Favored 'Cis proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.714 -2.202 . . . . 0.0 111.734 -0.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 26.8 m0 -39.17 -57.46 1.32 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.29 34.07 5.74 Favored Glycine 0 N--CA 1.499 2.865 0 C-N-CA 119.008 -1.567 . . . . 0.0 112.573 -177.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.893 ' HB2' ' HG2' ' A' ' 92' ' ' PRO . 10.8 t70 -79.4 135.16 36.61 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.77 -1.429 . . . . 0.0 110.263 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.4 ttp -73.92 -40.57 63.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . . . -60.72 -38.9 86.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.505 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 73.1 m -66.95 -42.11 85.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.0 109.209 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.72 -42.03 97.97 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.429 179.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.34 -45.19 94.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 0.0 109.413 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.3 tp -56.17 -35.64 67.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -0.75 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -71.89 -35.41 69.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.515 -0.741 . . . . 0.0 109.726 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -57.73 -45.5 85.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.51 -0.744 . . . . 0.0 109.868 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -54.02 -57.07 12.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.404 -0.81 . . . . 0.0 110.168 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -53.71 -45.5 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.713 -0.617 . . . . 0.0 110.73 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' HB3' HG13 ' A' ' 108' ' ' VAL . 5.8 m-30 -72.24 -28.92 63.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.403 -0.811 . . . . 0.0 111.399 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 59.33 48.0 10.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.102 -0.999 . . . . 0.0 109.97 -178.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 106' ' ' PHE . 35.4 m -114.04 155.94 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -81.13 -32.02 33.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.028 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.8 mt -129.15 140.57 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.682 -0.636 . . . . 0.0 110.07 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 tt -120.7 123.38 42.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.225 -0.922 . . . . 0.0 109.801 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 37' ' ' THR . 36.5 mm -105.95 131.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.969 . . . . 0.0 109.974 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -157.56 160.75 38.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 110.185 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 115' ' ' HIS . . . -137.08 -120.71 1.96 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 38.4 t60 75.6 -34.2 0.24 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.96 -0.729 . . . . 0.0 111.654 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 p -87.89 -9.65 53.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.9 -1.125 . . . . 0.0 111.441 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 117' ' ' HIS . 22.4 m170 55.67 25.01 7.68 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.025 -1.047 . . . . 0.0 110.768 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -123.76 114.18 19.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.344 -0.848 . . . . 0.0 109.252 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CE2' ' HB ' ' A' ' 164' ' ' VAL . 39.9 t80 -54.52 137.97 41.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 110.303 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -151.92 122.35 7.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.479 -0.763 . . . . 0.0 110.341 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HA ' HD13 ' A' ' 130' ' ' ILE . . . -137.58 97.72 3.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.47 -0.769 . . . . 0.0 109.874 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -140.94 167.61 21.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.324 -0.86 . . . . 0.0 110.993 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -110.17 145.51 37.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.484 -0.76 . . . . 0.0 110.287 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -146.62 117.52 7.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.182 -0.949 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 28.0 mt-10 52.94 58.06 5.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 1.9 m-20 61.36 15.15 6.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.837 -0.539 . . . . 0.0 112.393 178.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -123.66 154.93 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.846 -1.159 . . . . 0.0 109.851 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.573 ' HE1' HG21 ' A' ' 162' ' ' THR . 5.6 t80 -113.35 141.03 47.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 111.171 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -124.17 134.31 53.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 112' ' ' ILE . 13.5 mm -134.13 135.99 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.099 -1.0 . . . . 0.0 111.912 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 39.2 t-20 -131.4 109.01 14.82 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HG3' HG12 ' A' ' 5' ' ' VAL . 40.9 Cg_endo -65.98 -30.13 48.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.586 1.308 . . . . 0.0 111.452 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.92 -139.38 14.79 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 46.0 t -117.91 111.81 19.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.292 -1.123 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -58.57 -20.68 48.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.363 -0.835 . . . . 0.0 110.458 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 18' ' ' LEU . 35.0 p -113.43 13.14 18.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.574 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.43 36.59 63.86 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -50.14 146.87 4.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.478 -1.013 . . . . 0.0 110.734 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.75 151.15 45.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.715 0.769 . . . . 0.0 111.478 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 -149.9 115.94 5.67 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -50.77 -29.27 11.09 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.3 mt -78.11 -28.82 48.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.649 -1.282 . . . . 0.0 112.359 -178.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.606 ' HB3' HD11 ' A' ' 146' ' ' ILE . 7.6 tp10 -124.21 116.23 22.36 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.816 -1.178 . . . . 0.0 109.947 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.3 p -75.92 -15.92 60.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.467 -0.771 . . . . 0.0 111.272 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -119.51 94.24 4.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 143' ' ' GLU . 42.8 mm -101.57 139.69 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 78.5 mt -112.84 121.02 39.51 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.734 ' HG2' ' HB3' ' A' ' 167' ' ' LEU . 41.8 Cg_endo -65.53 133.57 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.419 1.221 . . . . 0.0 109.663 -178.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 89.6 p -167.24 155.05 9.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 112.115 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.593 ' CE1' ' CD2' ' A' ' 165' ' ' TYR . 20.3 p90 -137.21 160.08 40.05 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.2 t -124.87 135.52 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.018 -1.051 . . . . 0.0 113.539 -177.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.756 HD11 HD12 ' B' ' 714' ' ' LEU . 12.6 mt -107.07 134.76 49.71 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 58.8 mtp -113.61 123.58 50.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.932 -1.105 . . . . 0.0 110.455 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -99.16 117.59 33.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.399 -0.813 . . . . 0.0 109.677 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 0' ' ' ARG . 96.8 mt -115.51 123.21 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 0' ' ' ARG . 0.0 OUTLIER -101.39 -54.51 2.75 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.612 0.72 . . . . 0.0 109.33 178.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -177.05 106.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.69 -0.631 . . . . 0.0 109.309 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.8 m 60.46 9.48 2.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.339 -0.851 . . . . 0.0 110.482 -178.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 79.1 m -138.97 133.12 31.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 108.923 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CG1' ' A' ' 155' ' ' ILE . 10.2 p -132.81 138.47 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.893 -1.129 . . . . 0.0 111.611 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.9 t -115.78 124.42 72.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.573 HG21 ' HE1' ' A' ' 128' ' ' PHE . 69.5 p -104.2 136.61 43.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 110.723 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.799 ' CE1' ' HB3' ' B' ' 712' ' ' HIS . 0.2 OUTLIER -113.49 128.47 56.46 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 175' ' ' GLU . 5.7 p -111.13 132.34 59.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.36 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.715 ' CE2' HD12 ' A' ' 152' ' ' LEU . 68.7 m-85 -111.61 110.53 20.98 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.717 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -106.8 137.55 44.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.46 -0.775 . . . . 0.0 109.646 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.734 ' HB3' ' HG2' ' A' ' 148' ' ' PRO . 37.4 tp -95.8 95.47 8.31 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.187 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.801 HD12 ' HD2' ' A' ' 173' ' ' LYS . 70.4 mt -109.09 124.58 65.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.38 -132.15 32.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -178.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.98 -55.46 2.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.231 -1.158 . . . . 0.0 110.076 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.92 157.84 32.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.364 -0.835 . . . . 0.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 172' ' ' VAL . 13.3 p -105.76 130.08 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.717 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.801 ' HD2' HD12 ' A' ' 168' ' ' ILE . 99.8 mttt -95.74 148.28 22.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.424 -0.797 . . . . 0.0 110.015 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 163' ' ' TYR . 9.3 p -132.26 140.05 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.78 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 164' ' ' VAL . 80.4 tt0 -119.77 151.02 39.45 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -115.45 127.23 55.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.111 -0.993 . . . . 0.0 111.713 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.7 mm -126.37 133.22 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.91 140.87 48.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.014 -1.054 . . . . 0.0 111.526 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 128' ' ' PHE . 68.3 t80 -138.86 142.12 38.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.672 -0.643 . . . . 0.0 109.914 179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -139.22 146.22 40.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.235 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -49.81 -34.67 20.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.318 -0.864 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.19 -179.987 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 149.65 68.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.791 1.417 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 689' ' ' LEU . . . . . . . . . . . . . 22.7 tp -94.7 127.71 40.87 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.075 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.35 -122.61 29.84 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 60.6 p -68.54 166.58 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -1.099 . . . . 0.0 109.545 179.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 692' ' ' THR . . . . . . . . . . . . . 65.1 p -63.64 146.91 52.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.832 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 693' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.18 -56.49 2.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 694' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -113.26 128.24 56.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 695' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' B' ' 695' ' ' ASP . 26.8 p-10 -67.42 -33.22 74.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.429 -0.794 . . . . 0.0 110.545 179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 696' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.81 147.02 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.46 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 697' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.85 140.61 45.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.362 -0.836 . . . . 0.0 110.167 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 698' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -110.01 149.07 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.289 -0.882 . . . . 0.0 110.475 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 699' ' ' ALA . . . . . . . . . . . . . . . -71.22 158.32 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 109.928 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 700' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -55.64 142.68 32.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.3 -0.875 . . . . 0.0 110.185 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 701' ' ' ASP . . . . . . . . . . . . . 50.5 p30 -143.42 170.06 16.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.856 . . . . 0.0 110.433 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 702' ' ' THR . . . . . . . . . . . . . 44.9 p -123.29 161.38 24.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 703' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.83 141.71 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.025 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 704' ' ' SER . . . . . . . . . . . . . 54.7 p -78.62 155.15 29.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 110.351 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 705' ' ' ALA . . . . . . . . . . . . . . . -111.78 143.29 42.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.092 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 706' ' ' ALA . . . . . . . . . . . . . . . -167.82 30.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.338 -0.851 . . . . 0.0 110.168 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 707' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 75.87 78.33 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.47 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 708' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.48 -21.29 46.76 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.756 1.398 . . . . 0.0 110.004 179.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 709' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.35 168.68 11.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.988 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 710' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -49.59 139.2 12.82 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.69 0.757 . . . . 0.0 111.587 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 711' ' ' CYS . . . . . . . . . . . . . 47.5 m -71.46 -38.29 71.29 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.037 0.922 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 712' ' ' HIS . . . . . 0.897 ' HB2' ' HD2' ' B' ' 713' ' ' PRO . 1.6 p80 -174.0 -176.26 0.29 Allowed Pre-proline 0 C--N 1.301 -1.528 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 713' ' ' PRO . . . . . 0.897 ' HD2' ' HB2' ' B' ' 712' ' ' HIS . 35.6 Cg_endo -59.31 139.27 89.16 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.807 0.898 . . . . 0.0 110.609 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 714' ' ' LEU . . . . . 0.995 HD23 ' HE2' ' A' ' 30' ' ' LYS . 8.5 mt 68.02 46.22 1.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 715' ' ' CYS . . . . . 0.53 ' HB2' ' CE1' ' B' ' 712' ' ' HIS . 5.3 t -137.84 77.02 1.61 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.186 -1.571 . . . . 0.0 108.964 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 716' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -82.86 18.63 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.217 1.008 . . . . 0.0 109.238 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 717' ' ' CYS . . . . . 0.593 ' HB2' ' HD2' ' B' ' 718' ' ' PRO 0.251 27.0 p -46.14 170.12 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.692 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 718' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' B' ' 717' ' ' CYS . 37.2 Cg_endo -72.83 -54.31 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.529 1.805 . . . . 0.0 108.972 176.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 719' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' B' ' 720' ' ' CYS . 52.0 mtpt -160.75 -14.01 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 720' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' B' ' 719' ' ' LYS . 19.6 m 58.22 27.47 15.19 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 721' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' B' ' 722' ' ' PRO . . . -95.38 168.47 10.91 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.006 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 722' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' B' ' 721' ' ' ALA . 42.3 Cg_endo -68.8 145.4 62.67 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.645 1.34 . . . . 0.0 110.549 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 723' ' ' ALA . . . . . . . . . . . . . . . -141.95 151.67 42.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.138 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 724' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -85.25 -1.84 57.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.358 -0.839 . . . . 0.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -79.39 141.86 36.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.115 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 726' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -138.73 161.05 38.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.896 . . . . 0.0 110.442 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 727' ' ' LEU . . . . . . . . . . . . . 75.8 mt -84.13 150.57 25.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.448 -0.783 . . . . 0.0 109.927 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 728' ' ' ALA . . . . . . . . . . . . . . . -58.17 140.68 52.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 110.339 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 729' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -96.48 147.05 24.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.409 -0.807 . . . . 0.0 110.104 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 730' ' ' VAL . . . . . . . . . . . . . 34.2 m -54.84 149.9 21.08 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.271 -0.893 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 731' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.99 -21.14 43.79 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.739 1.389 . . . . 0.0 110.859 -179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 732' ' ' ALA . . . . . . . . . . . . . . . -86.51 127.22 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 733' ' ' SER . . . . . . . . . . . . . 83.9 p -142.88 158.6 43.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 734' ' ' GLY . . . . . . . . . . . . . . . 173.25 -169.9 43.04 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 735' ' ' LEU . . . . . 0.577 ' O ' HG21 ' B' ' 739' ' ' VAL . 9.1 tt -93.1 125.41 37.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -1.009 . . . . 0.0 110.041 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 736' ' ' GLY . . . . . . . . . . . . . . . 80.29 -169.16 52.48 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 737' ' ' VAL . . . . . 0.805 ' O ' HG13 ' B' ' 739' ' ' VAL . 32.7 m -129.88 149.08 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 110.013 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 738' ' ' ASN . . . . . . . . . . . . . 21.3 m120 53.26 38.56 27.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.369 -0.832 . . . . 0.0 109.98 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 739' ' ' VAL . . . . . 0.805 HG13 ' O ' ' B' ' 737' ' ' VAL . 33.0 m -132.28 172.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 740' ' ' THR . . . . . . . . . . . . . 59.8 p -62.48 148.61 45.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 741' ' ' SER . . . . . . . . . . . . . 43.5 t -142.51 125.45 16.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.85 . . . . 0.0 110.623 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 742' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -140.91 154.03 45.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.406 -0.809 . . . . 0.0 110.051 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 743' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -84.91 138.89 32.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 744' ' ' GLY . . . . . . . . . . . . . . . 85.14 -173.39 48.45 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 745' ' ' SER . . . . . 0.465 ' HG ' ' HD1' ' B' ' 747' ' ' TRP . 1.8 t -128.12 141.24 51.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 110.005 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 746' ' ' SER . . . . . . . . . . . . . 31.0 t -75.59 -84.19 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.068 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 747' ' ' TRP . . . . . 0.465 ' HD1' ' HG ' ' B' ' 745' ' ' SER . 98.0 m95 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.562 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B 1000 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_